Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3005013	p-psa-v	ug/l (ug/l)	39152	109594	0.01%
3005013	p-psa-v	— (—)	25209	60514	100.00%	Distribution not available
3005013	s-psa-v	— (—)	21399	37001	100.00%	Distribution not available
3005013	s-psa-v	ug/l (ug/l)	7745	15925	0.00%
3005013	s-psa-v	µg/l (ug/l)	3337	5833	0.00%
3005013	p-psa-v	ug/l______ (ug/l)	1294	1966	0.00%
3005013	p-prostataspesifinenantigeeni,vapaa	— (—)	1063	1223	100.00%	Distribution not available
3005013	s-prostataspesifinenantigeeni,vapaa	ug/l (ug/l)	727	1158	0.00%
3005013	p-psa-v	µg/l (ug/l)	709	1096	0.00%
3005013	p-prostataspesifinenantigeeni,vapaa	ug/l______ (ug/l)	613	705	0.00%
3005013	s-psa-v	ug/l______ (ug/l)	399	479	0.00%
3005013	prostataspesifinenantigeeni,vapaa	ug/l (ug/l)	185	217	0.00%
3005013	p-prostataspesifinenantigeeni,vapaa	ug/l (ug/l)	108	138	0.00%
3005013	p-psa-v	µg/L (ug/l)	83	107	0.00%
3005013	s-prostataspesifinenantigeeni,vapaa	— (—)	72	81	100.00%	Distribution not available
3005013	prostataspesifinenantigeeni,vapaa(p-psa-v)	ug/l (ug/l)	65	113	0.00%
3005013	prostataspesifinenantigeeni,vapaa	— (—)	59	83	100.00%	Distribution not available
3005013	prostataspesifinenantigeeni,vapaa(4900p-psa-v)	ug/l (ug/l)	55	95	0.00%
3005013	prostataspesifinenantigeeni,vapaa(psa-v)	ug/l (ug/l)	54	83	0.00%
3005013	prostataspesifinenantigeeni,vapaa	µg/l (ug/l)	48	72	0.00%
3005013	s-fpsa	ug/l (ug/l)	28	29	0.00%
3005013	s-psa-v	UG/L (ug/l)	17	23	0.00%
3005013	s-psa-v(pi)	ug/l (ug/l)	16	21	0.00%
3005013	s-prostataspesifinenantigeeni,vapaa	µg/l (ug/l)	10	12	0.00%
3005013	p-psa-v	UG/L (ug/l)	7	7	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal spermatozoa

3590

21656

3.19

317.38

6.0

3.3

0.95

0.78

ug/l

21.99

3253

15074

Any death

4445

54935

0.50

307.65

2.8

3.4

0.95

0.74

ug/l

8.45

3198

37053

malignant neoplasm of male genital organs

8476

33795

2.17

307.65

5.1

2.9

1.06

0.70

ug/l

50.99

6801

22143

Malignant neoplasm of prostate, including Hilmo

8557

33489

2.20

307.65

5.1

2.9

1.06

0.70

ug/l

51.87

6933

22095

Hernia

11891

53788

1.59

307.65

3.1

3.0

0.73

0.77

ug/l

3.77

7569

32896

Abnormal findings on examination of blood, without diagnosis

8990

54437

1.77

307.65

4.4

3.1

1.06

0.73

ug/l

57.94

7129

36249

malignant neoplasm of male genital organs, including Hilmo

8687

34431

2.18

307.65

5.1

2.9

1.05

0.70

ug/l

51.36

6996

22421

Malignant neoplasm of prostate

8345

32831

2.19

307.65

5.2

2.9

1.07

0.70

ug/l

51.50

6732

21806

Symptoms and signs involving the urinary system

12008

54798

1.88

307.65

3.7

3.0

0.82

0.75

ug/l

5.83

8965

34265

Hyperplasia of prostate

11118

37225

2.58

307.65

4.2

2.7

0.81

0.76

ug/l

5.18

8800

22232

Unspecified haematuria

7943

43026

1.77

307.65

3.9

3.2

0.89

0.78

ug/l

9.98

6040

28820

Abnormal serum enzyme levels

7359

46942

2.03

307.65

4.7

3.2

1.13

0.74

ug/l

62.70

6048

32183

Diseases of male genital organs

12734

42812

1.85

307.65

3.6

2.5

0.77

0.74

ug/l

1.81

8609

23694

Inguinal hernia

11210

53485

1.57

293.52

3.3

3.0

0.75

0.78

ug/l

1.04

7293

32840

Sleep apnoea

12299

56738

1.46

258.43

3.3

3.1

0.70

0.79

ug/l

20.53

7750

35931

Genitourinary diseases

9457

33135

1.57

254.86

3.3

2.5

0.74

0.71

ug/l

2.32

6170

17340

Coxibs

3873

11808

1.92

223.07

3.5

3.0

0.75

0.90

ug/l

9.29

2468

8029

Sleep apnoea, including avohilmo

12306

55654

1.42

220.79

3.3

3.1

0.69

0.79

ug/l

22.42

7731

35358

Retention of urine

6504

37392

1.62

192.08

3.7

3.3

0.95

0.79

ug/l

13.34

5134

25802

376

12421

0.23

183.39

2.2

3.3

0.67

0.79

ug/l

1.91

264

8338

Inflammatory diseases of prostate (prostatitis)

3048

19630

2.14

174.72

3.9

2.7

0.74

0.75

ug/l

0.22

2091

11878

Other diseases of hard tissues of teeth

7943

29800

1.49

173.35

3.5

3.1

0.78

0.82

ug/l

2.12

5457

18626

Artrosis, including avohilmo

10953

45970

1.38

164.37

3.2

3.0

0.72

0.80

ug/l

9.18

6915

28347

Pain in throat and chest

10109

45287

1.39

164.16

3.2

3.0

0.70

0.79

ug/l

17.53

6549

27666

Hypothyreosis and Thyroxine purchase for inclusion criteria

5633

52304

0.67

159.16

3.3

0.72

0.79

ug/l

6.89

3816

34811

Acetic acid derivatives and related substances

3632

11784

1.74

155.60

3.4

3.0

0.78

0.90

ug/l

5.37

2343

8026

All kidney diseases

11222

58322

1.35

155.25

3.2

3.1

0.84

0.74

ug/l

10.38

7995

35820

Hypothyroidism, other/unspecified

5611

51802

0.68

150.51

3.3

0.72

0.79

ug/l

6.78

3803

34416

Hypothyroidism, strict autoimmune

4608

43356

0.66

139.20

3.3

0.72

0.80

ug/l

5.91

3106

28940

Exposure to unspecified factor

11779

63665

1.31

134.87

3.2

3.1

0.71

0.78

ug/l

6.59

7541

40102

Diseases of oral cavity, salivary glands and jaws

7805

30181

1.42

134.48

3.4

3.1

0.80

0.83

ug/l

0.62

5307

18868

Oter anti-inflammatory and antirheumatic agents, non-steroids

3208

11298

1.74

132.82

3.6

3.1

0.72

0.91

ug/l

18.50

2176

7889

Injuries to the shoulder and upper arm

10621

64724

1.33

132.75

3.2

3.1

0.72

0.78

ug/l

4.70

6804

40764

Oxicams

3159

11564

1.71

126.14

3.4

3.1

0.73

0.90

ug/l

10.30

2070

7968

Mood [affective] disorders

7377

61893

0.73

124.52

2.9

3.1

0.65

0.77

ug/l

14.82

4872

38058

Persons encountering health services for other counselling and medical advice, not elsewhere classified

13442

57915

1.29

124.35

3.4

3.0

0.75

0.78

ug/l

1.83

8829

35905

Mood disorders

7412

61949

0.73

123.14

2.9

3.1

0.65

0.77

ug/l

14.86

4901

38091

Chronic periodontitis, including avohilmo

11913

61179

1.30

122.83

3.3

3.1

0.73

0.77

ug/l

2.57

8070

38062

Depression

6580

58394

0.72

122.51

2.9

3.0

0.65

0.76

ug/l

11.35

4337

35447

Hypothyroidism, strict autoimmune, 3 medication purchases required

4547

43030

0.68

122.02

3.3

0.72

0.79

ug/l

5.24

3061

28875

Periodontitis

11904

61186

1.30

120.48

3.3

3.1

0.73

0.77

ug/l

2.50

8077

38047

Polyuria

3554

24648

1.65

120.46

4.0

3.3

0.64

0.79

ug/l

15.61

2646

16865

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4557

61477

0.67

118.97

2.8

3.1

0.66

0.77

ug/l

10.01

3130

38470

Artificial joint operation, meniscal resection

11877

61516

1.30

118.83

3.3

3.1

0.70

0.78

ug/l

17.23

7723

39393

Disease of hard tissues of teeth, NOS

7259

28832

1.41

118.02

3.6

3.1

0.71

0.81

ug/l

13.09

4961

17939

Basal cell carcinoma, including Hilmo

5869

29464

1.45

117.57

3.7

3.0

0.82

0.71

ug/l

9.65

4302

19783

Mood disorders, excluding more controls

7287

55716

0.74

116.86

2.9

3.2

0.65

0.79

ug/l

18.86

4856

34422

Basal cell carcinoma

5638

28391

1.46

115.91

3.8

3.0

0.81

0.71

ug/l

8.68

4160

19203

Other disorders of ear

11034

57423

1.30

113.22

3.4

3.1

0.76

0.78

ug/l

1.07

7442

36506

Alcohol use disorder, ICD-based

4160

56935

0.67

112.46

2.8

3.1

0.66

0.77

ug/l

8.66

2846

35594

Pure hypercholesterolaemia

10235

52218

1.31

110.58

3.3

3.1

0.78

0.77

ug/l

0.29

7078

32636

Disorders of the thyroid gland

7120

59739

0.74

110.30

3.3

3.2

0.74

0.79

ug/l

3.64

4871

39330

Disorders of lipoprotein metabolism and other lipidaemias

10874

53399

1.30

110.06

3.2

3.1

0.77

ug/l

0.03

7390

32932

Benign neoplasms

12359

54862

1.28

109.04

3.2

3.0

0.75

0.77

ug/l

0.84

8074

33515

Dental operations

8332

33481

1.35

108.20

3.4

3.1

0.79

0.82

ug/l

0.84

5635

20872

Codeine or tramadol medication

12974

57755

1.27

108.13

3.2

3.1

0.71

0.79

ug/l

12.37

8231

36378

Other diseases of intestines

11949

54217

1.27

105.46

3.2

3.0

0.72

0.78

ug/l

6.65

7744

33050

Statin medication

6399

27101

1.39

104.72

2.9

2.8

0.72

0.78

ug/l

3.86

3756

15253

Persons encountering health services in other circumstances, wide

13708

58218

1.26

104.69

3.3

3.0

0.74

0.78

ug/l

2.76

9053

36102

Sleep disorders (combined)

12324

52598

1.27

104.54

3.4

3.1

0.70

0.80

ug/l

19.32

7865

33484

Dental caries, including avohilmo

9184

37340

1.32

102.80

3.4

3.1

0.80

0.81

ug/l

0.54

6277

23327

Mental and behavioural disorders due to alcohol

5276

65811

0.71

102.67

2.8

3.1

0.67

0.77

ug/l

7.60

3609

41087

Malignant neoplasm of skin, including Hilmo

6564

33783

1.39

101.99

3.7

2.9

0.80

0.70

ug/l

9.79

4753

21936

Diseases of pulp and periapical tissues and dental caries

8283

33352

1.34

101.64

3.4

3.1

0.82

0.81

ug/l

0.04

5674

20766

Other malignant neoplasms of skin (=non-melanoma skin cancer)

5723

29322

1.42

101.64

3.7

3.0

0.81

0.71

ug/l

8.06

4167

19709

Codeine

10520

45846

1.29

101.57

3.2

3.1

0.71

0.78

ug/l

7.97

6622

28409

Malignant neoplasm of skin

6255

32361

1.40

101.34

3.7

2.9

0.81

0.70

ug/l

9.02

4566

21271

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

5965

30578

1.41

101.21

3.7

2.9

0.81

0.71

ug/l

8.64

4313

20376

Dermatophytosis, including avohilmo

8036

62497

1.33

100.47

3.2

3.1

0.70

0.77

ug/l

5.78

5030

39245

Metabolic disorders

11111

54320

1.28

100.36

3.1

0.77

ug/l

0.09

7422

33140

Injuries to the head

12624

61745

1.26

100.22

3.1

0.74

0.78

ug/l

2.74

8147

38783

COPD, hospital admissions 1, only main diagnosis

3047

37057

0.64

99.60

3.1

3.5

0.77

0.83

ug/l

2.15

2129

26536

Alcohol dependence

2602

37494

0.62

98.93

2.8

3.1

0.63

0.76

ug/l

6.74

1793

23536

Diverticular disease of intestine

9634

48456

1.31

98.76

3.5

3.2

0.75

0.80

ug/l

3.27

6887

31420

Paracetamol or NSAID medication

1982

5979

1.80

98.73

3.1

2.9

0.77

0.90

ug/l

4.27

1227

3864

Testicular dysfunction

1005

5713

2.86

96.13

3.4

2.7

0.63

0.68

ug/l

1.23

549

3048

Injuries to the wrist and hand

11412

62176

1.26

95.76

3.1

0.72

0.77

ug/l

4.17

7143

39476

Renal tubulo-interstitial diseases

9647

57307

1.28

93.84

3.3

3.2

0.88

0.75

ug/l

13.71

7198

37006

Anxiety disorders, excluding more controls

5827

48446

0.74

93.53

2.9

3.0

0.63

0.77

ug/l

27.72

3658

28880

Chronic apical periodontitis

12468

57941

1.25

93.25

3.3

3.1

0.77

ug/l

0.29

8427

35904

Propionic acid derivatives

3408

11826

1.54

93.22

3.2

3.0

0.75

0.90

ug/l

10.47

2171

8034

COPD, hospital admission 2, with asthma infections

2951

35563

0.65

91.04

3.0

3.5

0.75

0.83

ug/l

2.96

2077

25240

Mycoses, including avohilmo

10261

64031

1.27

90.18

3.2

3.1

0.70

0.77

ug/l

8.35

6531

40282

Substance abuse

5696

67613

0.74

88.89

2.8

3.1

0.66

0.78

ug/l

13.41

3886

42185

COPD, hospital admissions 3, with asthma pneumonia sepsis

2444

30125

0.63

88.70

3.0

3.6

0.76

0.84

ug/l

2.48

1722

21711

Tramadol

9320

45443

1.28

88.26

3.1

0.71

0.78

ug/l

6.61

6123

28376

Testicular hypofunction

892

5035

2.91

87.64

3.4

2.7

0.63

0.68

ug/l

1.02

482

2689

Dislocation, sprain and strain of joints and ligaments of knee

6647

47248

1.33

87.01

3.0

0.67

0.74

ug/l

9.03

3824

28434

L02BX Other hormone antagonists and related agents

1409

9265

2.49

86.94

5.4

3.6

1.93

0.77

ug/l

24.50

1170

6752

Caries of dentine, including avohilmo

9462

39288

1.28

86.15

3.4

3.1

0.79

0.81

ug/l

0.46

6456

24490

Acute alcohol intoxication

2314

33399

0.63

85.85

2.9

3.2

0.68

0.77

ug/l

2.75

1595

21243

L02BB Anti-androgens

2102

14706

1.91

84.63

5.8

3.5

1.62

0.81

ug/l

22.16

1666

10788

Myocardial infarction, unclassifiable

1714

23468

0.59

84.00

3.1

3.5

0.90

0.85

ug/l

0.81

1233

16870

Arthrosis

9143

40801

1.28

83.53

3.3

3.0

0.71

0.80

ug/l

11.97

5919

25374

Meniscus derangement

7399

39319

1.32

83.36

3.3

3.1

0.71

0.80

ug/l

11.19

4762

24726

Other soft tissue disorders, not elsewhere classified

10389

48687

1.26

82.54

3.3

3.0

0.72

0.80

ug/l

8.97

6888

30220

Solid cancers, including Hilmo

9442

44957

1.27

82.47

3.7

2.7

0.83

0.68

ug/l

19.58

6748

26116

Gingivitis and periodontal diseases

11734

50511

1.24

82.41

3.3

3.1

0.74

0.79

ug/l

4.35

7819

31511

Sub-endpoint used in defining T1D endpoints

1688

25816

0.60

82.24

2.5

3.1

0.76

0.78

ug/l

0.15

1082

15923

COPD related to multimorbidity

3887

43378

0.70

81.91

3.1

3.5

0.75

0.82

ug/l

3.40

2755

31090

Intracranial trauma

6240

32896

1.33

81.90

3.0

0.71

0.80

ug/l

7.38

3986

19866

Neoplasms

8388

35417

1.29

81.44

3.2

2.5

0.75

0.68

ug/l

6.88

5252

19154

Anti-inflammatory and antirheumatic products, non-steroids

3336

11826

1.50

81.40

3.3

3.0

0.76

0.90

ug/l

8.65

2132

8034

Malignant neoplasm, wide definition

9474

45312

1.26

78.21

3.6

2.7

0.82

0.68

ug/l

17.93

6740

26192

Malignant neoplasm, including Hilmo

9454

45257

1.26

77.79

3.6

2.7

0.82

0.68

ug/l

17.89

6723

26156

Mental and behavioural disorders due to psychoactive substance use

5930

67900

0.76

76.43

2.8

3.1

0.67

0.78

ug/l

11.30

4042

42423

Shoulder lesions

9489

46988

1.26

76.42

3.2

3.1

0.70

0.80

ug/l

13.55

6214

29678

Abnormalities of breathing

9602

45295

1.25

75.09

3.1

3.0

0.71

0.79

ug/l

9.91

6004

27672

Schizophrenia or delusion, excluding more controls

1597

24357

0.61

74.20

2.4

2.8

0.56

0.74

ug/l

23.70

1084

13260

Lung cancer and mesothelioma

1607

20569

0.60

74.06

3.1

3.6

0.81

0.83

ug/l

0.22

1152

14909

Finngen Rheumatological endpoints

10762

51048

1.24

73.79

3.2

3.0

0.72

0.79

ug/l

7.37

6913

31087

Alcohol use disorder, Swedish definition

6010

67659

0.76

73.60

2.8

3.1

0.67

0.78

ug/l

14.23

4105

42547

6215

68578

0.77

73.40

2.8

3.1

0.68

0.78

ug/l

9.82

4249

43151

Benign neoplasm of colon, rectum, anus and anal canal

8152

56783

1.28

73.22

3.5

3.3

0.77

0.79

ug/l

0.96

5944

38224

Bacterial pneumonia (organism specified)

3612

43368

0.71

72.74

2.9

3.3

0.78

0.80

ug/l

0.36

2461

29202

In situ neoplasms

3624

26914

1.42

72.46

3.8

3.6

0.77

0.83

ug/l

2.89

2694

19423

Rotator cuff syndrome

8046

45455

1.28

72.43

3.2

3.1

0.69

0.80

ug/l

15.28

5362

29095

Any event in cancer register

9585

46370

1.25

72.29

3.7

2.7

0.83

0.68

ug/l

18.27

6853

27113

Kela-code for severe mental illness

1962

28899

0.64

72.00

2.6

2.9

0.60

0.73

ug/l

12.84

1337

16588

COPD, early/later onset

4534

48471

0.73

71.45

3.1

3.5

0.75

0.81

ug/l

3.86

3207

34298

Anxiety disorders

5948

51247

0.77

71.05

2.9

3.0

0.63

0.74

ug/l

20.45

3706

30207

Solid cancers

9147

44374

1.25

70.70

3.8

2.7

0.84

0.68

ug/l

20.35

6593

25966

COPD, hospital admissions

4498

48178

0.73

69.86

3.1

3.5

0.75

0.81

ug/l

3.85

3188

34093

Neurotic, stress-related and somatoform disorders

5853

50571

0.77

69.11

2.9

0.62

0.74

ug/l

20.50

3635

29722

Other joint disorders

9688

41989

1.24

69.03

3.2

3.0

0.71

0.80

ug/l

10.70

6029

25630

Bacterial pneumonia, not elsewhere classified

3125

36841

0.70

68.74

2.9

3.4

0.78

0.79

ug/l

0.09

2138

24746

Gonarthrosis

8418

39261

1.27

68.69

3.3

3.1

0.72

0.81

ug/l

10.74

5583

25005

Early onset COPD

1816

26232

0.63

68.24

2.9

3.3

0.68

0.77

ug/l

2.95

1220

17541

Malignant neoplasm of bronchus and lung

1312

17089

0.58

68.05

3.0

3.1

0.82

0.74

ug/l

1.26

934

12158

Excessive earwax

7802

58400

1.27

67.90

3.5

3.2

0.75

0.78

ug/l

1.49

5286

38535

Bacterial pneumoniae

3355

39034

0.71

67.38

2.9

3.4

0.78

0.79

ug/l

0.02

2287

26028

Schizophrenia

747

13404

0.51

66.17

2.1

2.8

0.53

0.70

ug/l

11.67

512

7374

Unspecified mental disorder

2187

31095

0.67

65.71

2.7

2.9

0.60

0.73

ug/l

13.23

1488

17844

Malignant neoplasm

9191

44873

1.24

65.61

3.7

2.7

0.83

0.68

ug/l

18.32

6585

26092

Malignant neoplasm

9199

44924

1.24

65.53

3.7

2.7

0.83

0.68

ug/l

18.35

6592

26108

Schizophrenia, schizotypal and delusional disorders

1608

24179

0.63

65.41

2.4

2.8

0.57

0.72

ug/l

16.70

1095

13516

Schizophrenia or delusion

1597

24036

0.63

65.26

2.4

2.8

0.56

0.72

ug/l

17.81

1084

13407

Early onset COPD, excluding more controls

1816

25987

0.63

65.01

2.9

3.3

0.68

0.79

ug/l

3.91

1220

17291

Spondylopathies

9694

48176

1.24

64.80

3.3

3.1

0.70

0.80

ug/l

13.30

6544

30468

Alcoholic liver disease

792

13307

0.51

64.50

2.7

3.2

0.70

0.76

ug/l

0.89

530

8704

Varicose veins

4015

39253

0.74

63.55

3.4

0.80

0.81

ug/l

0.16

2819

27094

Status post-ami

2849

28587

0.69

63.30

3.2

3.6

0.86

0.82

ug/l

0.71

2090

20440

Actinic keratosis

4632

33239

1.35

63.12

3.9

3.6

0.78

0.84

ug/l

2.23

3448

24388

Conductive and sensorineural hearing loss

9584

53662

1.23

63.07

3.5

3.2

0.78

0.79

ug/l

0.42

6642

35176

Presbycusis

1695

11240

1.64

62.86

3.9

3.6

0.86

0.89

ug/l

0.28

1148

8349

Exposure to other specified factors

8640

62052

1.24

62.48

3.1

0.71

0.76

ug/l

3.69

5254

38835

Skin changes due to chronic exposure to nonionizing radiation

4706

33710

1.35

62.29

3.9

3.6

0.79

0.83

ug/l

1.99

3496

24697

Other symptoms and signs involving the urinary system

1598

10821

1.72

62.26

4.6

3.2

0.80

0.77

ug/l

0.38

1254

7201

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

6261

49275

1.28

61.32

3.2

3.1

0.68

0.77

ug/l

9.09

3842

31183

Disorders of choroid and retina

9945

59139

1.22

60.86

3.4

3.2

0.79

0.78

ug/l

0.65

7027

38358

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1194

18168

0.58

60.62

2.7

3.2

0.74

0.77

ug/l

0.40

797

12077

Malignant neoplasm of bronchus and lung, including Hilmo

1561

19101

0.63

60.26

3.1

0.81

0.74

ug/l

1.29

1111

13519

Chronic rhinitis, nasopharyngitis and pharyngitis

2918

21592

1.42

59.46

3.4

3.0

0.67

0.76

ug/l

3.39

1875

13430

Malignant neoplasm of respiratory system and intrathoracic organs

1637

19616

0.64

58.43

3.1

0.82

0.73

ug/l

1.80

1173

13840

Soft tissue disorders

11199

49003

1.20

58.12

3.2

3.0

0.72

0.80

ug/l

10.65

7095

30358

Other diseases of upper respiratory tract

12421

55794

1.19

58.09

3.3

3.1

0.72

0.80

ug/l

13.01

7946

35847

Erysipelas, including avohilmo

9298

58482

1.22

57.96

3.1

0.74

0.76

ug/l

0.93

6301

36380

Other arrhythmias

6843

42091

1.26

57.43

3.4

3.1

0.73

0.77

ug/l

2.13

4516

26395

Type 1 diabetes

1548

22693

0.64

57.39

2.5

3.0

0.76

0.75

ug/l

0.09

984

13503

Gonarthrosis [arthrosis of knee](FG)

9751

47734

1.22

57.21

3.3

3.1

0.72

0.80

ug/l

9.57

6534

30281

Non-invasive ventilation

1449

18684

0.63

57.14

2.5

3.1

0.79

0.78

ug/l

0.18

764

11111

4890

35311

1.32

56.89

3.9

3.5

0.78

0.83

ug/l

2.44

3612

25694

Sensorineural hearing loss

9230

52234

1.22

56.67

3.6

3.2

0.78

0.79

ug/l

0.41

6466

34614

Parasetamol

8645

36621

1.23

56.62

3.1

3.0

0.75

0.78

ug/l

1.37

5400

21777

Other inflammation of eyelid, including avohilmo

3420

26136

1.35

54.40

3.3

3.0

0.71

0.74

ug/l

1.62

2103

15589

Other heart diseases, wide

9195

47184

1.21

53.55

3.0

0.71

0.76

ug/l

3.49

5648

28044

6615

68553

0.80

53.19

2.8

3.1

0.68

0.78

ug/l

10.62

4503

43100

Sulfonylureas

3165

32335

0.73

52.80

3.2

3.6

0.85

0.82

ug/l

0.55

2247

23417

Later onset COPD

2767

28873

0.71

52.13

3.2

3.7

0.79

0.85

ug/l

2.57

2019

21804

Polyarthropathies

7566

40756

1.23

51.66

3.2

3.0

0.78

0.80

ug/l

1.00

5184

25371

Cardiac arrhythmias

5509

28621

1.27

51.59

2.9

0.69

0.74

ug/l

2.61

3204

16042

Diseases of the eye and adnexa

8700

36830

1.22

51.52

3.0

2.8

0.72

0.76

ug/l

2.83

5343

21280

Insulin, combination of fast acting with intermediate-acting or long-acting

5936

64684

0.80

51.25

2.9

3.2

0.80

0.78

ug/l

0.72

4030

41916

Diseases of pulp and periapical tissues, including avohilmo

11198

50140

1.18

49.22

3.4

3.1

0.79

ug/l

0.01

7570

31163

Any prescribed medicine buy

10.67

49.17

3.1

1.5

0.85

0.54

ug/l

2.41

Diabetic retinopathy, strict definition

907

12663

0.58

49.05

2.7

3.1

0.80

0.76

ug/l

0.53

613

8460

Acute alcohol intoxication, ICD10

1676

23275

0.66

48.95

2.8

3.0

0.67

0.74

ug/l

1.30

1140

14238

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

9909

57674

1.19

48.36

3.1

0.76

ug/l

0.27

6751

35516

Redundant prepuce, phimosis and paraphimosis

3710

29364

1.37

48.35

3.0

2.5

0.71

0.72

ug/l

0.08

2152

15534

Substance abuse, excluding more controls

5696

57076

0.80

47.85

2.8

3.2

0.66

0.79

ug/l

16.35

3886

35459

Insulin, fast-acting or short human

2950

37898

0.74

47.74

2.8

3.2

0.80

0.77

ug/l

0.55

1968

24251

Other disorders of penis

1830

13545

1.59

47.11

3.4

2.7

0.68

0.76

ug/l

3.23

1190

7883

Other hearing loss

3329

25303

1.35

46.97

3.7

3.4

0.84

ug/l

0.08

2338

17873

Other chronic obstructive pulmonary disease

4445

44345

0.78

46.45

3.1

3.5

0.74

0.82

ug/l

5.17

3150

31207

Spirochaetal infections, other/unspecified, including avohilmo

3201

24949

1.35

46.43

3.5

3.2

0.72

0.76

ug/l

1.52

2057

16302

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1910

21305

0.69

46.34

3.1

0.81

0.73

ug/l

1.78

1367

14925

Hypogonadotropic hypogonadism

633

3819

2.32

46.28

3.3

2.6

0.55

0.66

ug/l

4.77

332

1946

Other spirochaetal diseases, including avohilmo

3238

25302

1.34

46.01

3.5

3.2

0.72

0.76

ug/l

1.48

2077

16523

Coxarthrosis

6691

36374

1.24

45.76

3.5

3.2

0.74

0.82

ug/l

9.01

4700

23987

Lyme disease, including avohilmo

3177

24786

1.35

45.75

3.5

3.2

0.72

0.76

ug/l

1.38

2038

16186

Lyme disease

3177

24786

1.35

45.75

3.5

3.2

0.72

0.76

ug/l

1.38

2038

16186

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3886

15334

1.32

45.39

2.9

2.4

0.74

0.69

ug/l

1.76

2260

7703

Acute tubulo-interstitial nephritis

6199

43728

1.23

45.21

3.5

3.4

0.86

0.78

ug/l

4.53

4716

29963

Insulin, fast-acting

2938

37469

0.74

45.03

2.8

3.2

0.80

0.76

ug/l

0.66

1958

23922

Other spirochaetal diseases

3194

24999

1.34

44.83

3.5

3.2

0.72

0.76

ug/l

1.42

2049

16330

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3742

22899

1.30

44.82

5.9

3.3

0.95

0.78

ug/l

21.68

3348

15836

Other bacterial diseases, including avohilmo

10836

58968

1.18

44.72

3.0

3.1

0.78

0.76

ug/l

0.86

7222

36256

Other disorders of prostate

734

4656

2.15

44.56

3.9

2.8

0.91

0.82

ug/l

0.91

549

2964

Type 1 diabetes, wide definition

1260

18336

0.65

44.51

2.4

3.0

0.75

0.74

ug/l

0.09

779

10709

Adjustment and management of implanted device

2522

19398

1.42

44.50

3.5

0.79

0.81

ug/l

0.20

1894

13944

Atherosclerosis, excluding cerebral and coronary sclerosis

4249

40668

0.78

44.31

3.1

3.6

0.80

0.82

ug/l

0.22

3041

29196

Symptoms and signs involving cognition, perception, emotional state and behaviour

10631

61983

1.18

44.05

3.3

3.1

0.74

0.78

ug/l

2.63

7348

38957

GASTRO-related operations

7521

31857

1.21

43.90

3.1

2.8

0.77

0.73

ug/l

1.17

4680

17953

Any gastric operation

7521

31857

1.21

43.90

3.1

2.8

0.77

0.73

ug/l

1.17

4680

17953

Benign neoplasm: Colon

6772

54151

1.23

43.02

3.5

3.3

0.76

0.79

ug/l

1.05

4935

37093

Fitting and adjustment of other devices

4537

32782

1.28

42.94

3.6

3.5

0.82

0.79

ug/l

1.19

3094

23312

Episodal and paroxysmal disorders

11204

49666

1.17

42.66

3.2

3.1

0.72

0.80

ug/l

7.77

7054

31079

Medical observation and evaluation for suspected diseases and conditions

7847

34240

1.21

42.12

3.1

3.0

0.74

0.80

ug/l

2.71

5144

20545

Provisional assignment of new diseases of uncertain etiology

5445

45040

1.24

41.94

3.1

3.3

0.80

0.78

ug/l

0.46

3736

29437

Diseases of oesophagus, stomach and duodenum

11675

60650

1.16

41.86

3.3

3.1

0.73

0.78

ug/l

4.91

7854

37696

Codes for special purposes

5447

45077

1.24

41.70

3.1

3.3

0.80

0.78

ug/l

0.45

3738

29462

Opioids

10225

46015

1.17

40.83

3.1

0.75

0.78

ug/l

0.99

6333

28493

Peripheral artery disease

4548

43133

0.79

40.55

3.1

3.5

0.80

0.81

ug/l

0.27

3244

30637

Insulin, fast-acting (human)

626

10394

0.56

40.42

2.3

2.9

0.73

ug/l

0.04

375

5926

Disorders of other endocrine glands

3454

27056

1.30

40.34

3.4

3.0

0.72

0.76

ug/l

0.97

2195

16707

Diseases of the ear and mastoid process

12178

53859

1.16

40.20

3.2

3.0

0.75

0.77

ug/l

0.72

7673

33073

Other dorsopathies, not elsewhere classified

10881

49546

1.17

40.15

3.2

3.1

0.72

0.80

ug/l

10.40

6949

30758

Concussion

5112

32845

1.24

40.09

3.0

0.70

0.80

ug/l

9.11

3208

19855

Follow-up examination after treatment for conditions other than malignant neoplasms

2950

25010

0.76

39.97

3.1

0.73

0.80

ug/l

1.63

2099

15788

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1200

17203

0.66

39.58

2.7

2.9

0.61

0.75

ug/l

5.36

822

9523

Gonarthrosis,primary

11012

58612

1.17

39.47

3.4

3.2

0.73

0.79

ug/l

6.68

7622

38453

Exclusions for E4_PCOS_CONSORTIUM

1634

14252

0.70

39.19

3.2

2.8

0.65

0.73

ug/l

1.35

1005

8107

Hydrocele

2137

16588

1.46

39.06

3.4

2.8

0.78

0.80

ug/l

0.15

1497

10342

Spermatocele

1492

11112

1.62

38.99

3.5

2.8

0.69

0.79

ug/l

5.17

1003

6953

Ill-defined and unknown causes of mortality

677

10662

0.57

38.91

3.0

3.5

0.89

0.84

ug/l

0.41

462

7524

Gout

4501

32255

1.28

38.82

3.3

0.83

ug/l

0.06

3289

21983

Degeneration of macula and posterior pole

5696

37148

1.23

38.52

3.7

3.5

0.81

0.82

ug/l

0.37

4246

26750

COPD

4696

45444

0.80

38.41

3.1

3.4

0.74

0.82

ug/l

5.59

3327

31844

Persons encountering health services for specific procedures and health care

11147

58039

1.16

37.96

3.2

3.0

0.81

0.74

ug/l

5.36

7467

35532

Fall on same level

12381

58591

1.15

37.73

3.1

0.73

0.78

ug/l

3.43

7929

36510

ILD medications: prednisolone, methylprednisolone, prednisone

11922

58772

1.15

37.30

3.1

0.76

0.77

ug/l

0.11

7719

36646

Dorsalgia

10621

49534

1.16

37.03

3.1

0.70

0.80

ug/l

13.64

6824

30755

Orchitis and epididymitis

1676

12693

1.52

36.96

3.5

2.7

0.80

0.78

ug/l

0.21

1138

7622

Arthropathies

9519

42003

1.17

36.90

3.1

3.0

0.72

0.80

ug/l

7.30

5864

25638

Hypopituitarism

948

6387

1.69

36.80

3.4

2.8

0.58

0.71

ug/l

7.74

553

3513

Covid-19 confirmed case

4198

34713

1.26

36.46

3.2

3.4

0.81

0.80

ug/l

0.12

2984

23579

Non-small cell lung cancer, including Hilmo

1128

14968

0.65

36.07

3.2

3.1

0.82

0.75

ug/l

0.93

807

10597

Disorders of lens

8400

45501

1.18

35.95

3.5

3.1

0.77

ug/l

0.08

6039

29587

Progressive vascular leukoencephalopathy

465

2625

2.08

35.86

3.4

3.7

0.76

0.86

ug/l

1.39

381

1939

Any operation in hilmo

526

1476

1.97

35.70

2.5

1.9

0.78

0.69

ug/l

0.66

262

510

Any mental disorder

10080

57188

0.86

35.70

3.0

3.2

0.70

0.79

ug/l

11.28

6792

35527

Other and unspecified tonsillitis

3580

24162

1.28

35.60

2.6

0.65

0.68

ug/l

1.16

1804

12752

Continuous positive airway pressure

2717

18016

1.35

35.51

3.5

3.1

0.79

0.78

ug/l

0.05

1753

10964

Peripheral artery operations in Hilmo

1059

14965

0.65

35.33

2.8

3.5

0.78

0.84

ug/l

0.70

732

10595

Deviated nasal septum

4909

41613

1.25

35.22

3.2

3.1

0.70

0.77

ug/l

3.68

3017

26263

Benzodiazepine use

8696

66872

0.86

35.08

3.2

3.1

0.71

0.78

ug/l

5.33

5789

42124

Type 1 diabetes, wide definition, subgroup 1

1232

17240

0.68

35.01

2.5

3.0

0.76

0.74

ug/l

0.16

762

9942

Anxiety (asthma-related co-morbidities)

3603

33561

0.80

34.42

2.7

2.8

0.59

0.72

ug/l

19.31

2215

18025

Pain in limb

8622

47929

1.17

34.04

3.3

3.1

0.72

0.80

ug/l

10.47

5847

29969

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1582

11683

1.46

33.77

3.6

3.2

0.84

0.77

ug/l

1.24

1152

8475

COPD-related respiratory insufficiency

948

13519

0.64

33.73

2.9

3.5

0.75

0.83

ug/l

0.91

636

9700

Hypertension, essential

8047

39607

1.18

33.67

3.0

2.9

0.73

0.74

ug/l

0.56

5101

22947

Non-small cell lung cancer, squamous, helper endpoint

301

5612

0.47

33.62

3.1

3.5

0.83

0.86

ug/l

0.15

213

4033

Pain (limb, back, neck, head abdominally)

8895

39108

1.17

33.01

3.1

0.73

0.81

ug/l

7.13

5673

24290

Suicide or other Intentional self-harm

1199

16742

0.69

32.54

2.7

2.9

0.61

0.71

ug/l

3.21

822

9546

Diseases of the musculoskeletal system and connective tissue

5569

23636

1.21

32.24

3.1

2.9

0.73

0.83

ug/l

8.25

3351

14068

Headache

4741

43398

0.82

32.07

3.1

0.67

0.76

ug/l

8.17

2984

26232

Other ill-defined and unspecified causes of mortality

631

9655

0.59

31.87

3.0

3.5

0.90

0.84

ug/l

0.53

431

6822

Other intervertebral disc disorders

9287

48915

1.16

31.83

3.1

0.70

0.80

ug/l

13.55

5950

30569

Conduction disorders

3881

25917

1.26

31.65

3.5

3.4

0.79

0.81

ug/l

0.36

2780

18040

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1200

16743

0.69

31.48

2.7

2.8

0.61

0.71

ug/l

3.21

822

9546

Emergency coronary revascularization (for ACS)

10000

53699

1.15

31.45

3.0

3.1

0.75

0.78

ug/l

1.61

6496

33739

Heart failure and coronary heart disease

4489

36976

0.81

31.38

3.1

3.5

0.78

0.81

ug/l

0.70

3232

25766

ILD medications

12198

58963

1.14

31.30

3.1

0.76

0.77

ug/l

0.45

7820

36675

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

10089

56631

1.15

31.24

3.2

3.1

0.76

0.77

ug/l

0.41

6898

35227

Insulin, intermediate and long-acting

5588

62354

0.83

31.22

2.9

3.2

0.81

0.77

ug/l

0.93

3782

40538

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2830

21614

1.28

31.07

3.2

2.9

0.68

0.73

ug/l

1.30

1604

12322

Melanocytic naevi

2579

20535

1.30

30.87

3.5

3.2

0.73

0.76

ug/l

1.03

1703

13246

Certain infectious and parasitic diseases, including avohilmo

7798

34089

1.17

30.81

3.1

0.75

0.80

ug/l

2.80

5039

21389

Hypertension

8043

39757

1.17

30.51

3.0

2.9

0.72

0.74

ug/l

0.78

5025

22974

Hypertensive diseases

8038

39760

1.17

30.25

3.0

2.9

0.72

0.74

ug/l

0.76

5021

22976

Alcohol abuse, main dg, excluding more controls

1289

17273

0.69

30.12

2.8

3.0

0.65

0.76

ug/l

2.77

881

10219

Diaphragmatic hernia

3365

27757

1.26

29.75

3.4

3.3

0.72

0.80

ug/l

3.60

2402

18730

Squamous cell neoplasms and carcinomas of the skin

1272

9373

1.49

29.66

3.5

3.1

0.87

0.77

ug/l

1.44

926

6833

All chronic kidney diseases

6623

46084

1.18

29.51

3.2

3.3

0.95

0.76

ug/l

18.41

4914

30386

Macular pucker

1899

14870

1.38

29.32

3.7

3.6

0.78

0.81

ug/l

0.44

1425

10974

Malignant melanoma, including Hilmo

2007

15769

1.36

29.20

3.8

3.0

0.79

0.73

ug/l

1.88

1493

10786

Allergic conjunctivitis

2949

22898

1.26

29.16

3.2

2.9

0.68

0.72

ug/l

1.39

1678

13119

Carcinoma in situ of skin of other and unspecified parts of face

953

6699

1.57

29.11

3.9

3.7

0.78

0.85

ug/l

1.31

735

4950

Senile cataract

7813

41918

1.17

28.92

3.5

3.2

0.78

ug/l

0.14

5680

28062

Heart failure,strict

5761

46137

0.84

28.89

3.1

3.4

0.78

0.79

ug/l

0.39

4176

31665

Other disorders of veins

3197

25814

1.26

28.62

3.4

3.3

0.70

0.78

ug/l

5.99

2222

17033

Voice disturbances

2088

16371

1.33

28.49

3.6

3.4

0.70

0.78

ug/l

3.40

1465

11158

Other external causes of accidental injury

8320

36716

1.16

28.44

3.2

3.1

0.77

0.80

ug/l

1.53

5350

23058

Symptoms and signs involving the circulatory and respiratory systems

10153

45363

1.14

28.34

3.1

3.0

0.72

0.79

ug/l

7.48

6308

27678

Malignant melanoma

1805

14084

1.37

27.92

3.8

3.0

0.80

0.73

ug/l

1.77

1348

9632

Other cataract

5243

33588

1.20

27.73

3.6

3.3

0.80

0.79

ug/l

0.32

3865

22706

All-cause Heart Failure

6231

49306

0.85

27.21

3.1

3.4

0.79

0.80

ug/l

0.39

4526

34244

Chronic sinusitis

3785

31732

1.23

27.08

3.3

3.0

0.67

0.77

ug/l

13.02

2334

19860

Other bacterial diseases

10343

61589

1.14

26.65

3.1

0.80

0.76

ug/l

2.03

7090

38134

Inflammatory bowel disease treatment related agents

12193

61209

1.12

26.60

3.1

0.75

0.77

ug/l

1.13

7877

38192

Impotence

1101

8344

1.59

26.58

3.5

2.7

0.73

0.75

ug/l

0.29

744

4962

Heart failure, strict

6347

50035

0.85

26.50

3.1

3.4

0.78

0.80

ug/l

0.41

4601

34672

Accidents

8283

36716

1.15

26.43

3.2

3.1

0.77

0.80

ug/l

1.42

5312

23058

Seborrhoeic keratosis

2502

20313

1.29

26.42

3.6

3.4

0.81

0.80

ug/l

0.09

1739

14177

Other heart diseases

4258

23388

1.21

26.41

2.8

0.67

0.72

ug/l

2.58

2445

12205

Cardiac arrest

603

7556

0.60

26.28

2.8

3.5

0.68

0.80

ug/l

3.52

417

5142

Migraine, single triptan purchase ok & required. ICD-code if available is included

3802

30679

0.82

26.24

2.8

2.7

0.66

0.69

ug/l

2.27

2072

16522

Triptan medication for migraine, single purchase ok

3802

30679

0.82

26.24

2.8

2.7

0.66

0.69

ug/l

2.27

2072

16522

Coxarthrosis [arthrosis of hip](FG)

6977

42357

1.17

26.20

3.5

3.2

0.74

0.81

ug/l

6.95

4931

28073

Other special examinations and investigations of persons without complaint or reported diagnosis

7662

34248

1.16

26.14

3.2

3.0

0.73

0.79

ug/l

4.72

4913

20548

Factors influencing health status and contact with health services

4482

19164

1.22

25.89

3.1

2.9

0.76

0.78

ug/l

0.35

2778

10996

Alcohol withdrawal state with delirium

645

9216

0.61

25.74

2.8

3.1

0.63

0.75

ug/l

2.56

472

5788

Persons encountering health services for examination and investigation

7723

34248

1.16

25.52

3.1

3.0

0.76

0.79

ug/l

1.75

4931

20548

Other chronic obstructive pulmonary disease, including avohilmo

5780

53955

0.85

25.46

3.2

3.4

0.73

0.80

ug/l

5.90

4065

37344

All anxiety disorders

3606

33299

0.82

25.30

2.7

0.59

0.71

ug/l

15.99

2216

17982

Amputation

824

11436

0.66

25.04

2.7

3.5

0.83

ug/l

0.04

582

8069

Abdominal and pelvic pain

11842

53917

1.12

24.99

3.1

0.73

0.78

ug/l

4.45

7555

33466

Biguanides

10261

55850

1.13

24.76

3.1

0.77

ug/l

0.05

6655

35060

Other retinal disorders

7436

50233

1.16

24.56

3.5

3.3

0.79

ug/l

0.00

5378

33683

Inguinal hernia, bilateral

1957

16020

1.38

24.48

3.4

0.76

0.81

ug/l

1.12

1364

10953

Diseases of liver

2900

34726

0.80

24.48

3.0

3.2

0.72

0.76

ug/l

1.29

1922

22496

Alcohol abuse, main dg

1289

16789

0.72

24.46

2.8

3.0

0.65

0.74

ug/l

2.03

881

10136

Other and unspecified nonorganic psychotic disorders

856

12035

0.68

24.11

2.3

2.6

0.53

0.68

ug/l

8.75

572

6043

Inguinal or femoral hernia, bilateral

1966

16116

1.38

24.10

3.4

0.76

0.81

ug/l

1.14

1372

11022

Malaise and fatigue

5719

39377

1.17

24.01

3.2

3.3

0.83

0.79

ug/l

0.85

3952

26018

Diseases of the skin and subcutaneous tissue

10951

49724

1.12

23.76

3.2

3.1

0.73

0.79

ug/l

5.12

6998

30896

Respiratory insufficiency

584

8557

0.62

23.64

2.8

3.6

0.69

0.86

ug/l

6.72

406

6123

Use of hypnotics and sedatives

11927

62075

1.12

23.51

3.3

3.1

0.70

0.78

ug/l

13.60

7848

39052

Diabetic maculopathy, excluding more controls

742

10463

0.66

23.51

2.6

3.2

0.77

ug/l

0.01

489

6641

Memory loss

935

6797

1.50

23.46

3.5

0.81

0.83

ug/l

0.17

662

4784

Carcinoma in situ of skin of scalp and neck

451

2933

1.94

23.46

3.9

3.7

0.82

0.86

ug/l

0.18

327

2163

Dipeptidyl peptidase 4 (DPP-4) inhibitors

6938

48454

1.16

23.29

3.2

3.3

0.84

0.78

ug/l

2.37

4926

32400

Chronic diseases of tonsils and adenoids

5648

40685

0.86

23.16

2.9

0.69

0.75

ug/l

3.48

3162

24502

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2279

18453

1.27

23.13

3.3

3.1

0.73

0.75

ug/l

0.21

1473

11492

Constipation

9554

58427

1.13

23.01

3.5

3.2

0.75

0.79

ug/l

1.44

6686

38314

Haemorrhage from respiratory passages

4399

33687

1.20

22.99

3.4

3.3

0.77

0.83

ug/l

2.38

3061

22792

AV-block

2585

18348

1.28

22.94

3.5

3.6

0.80

0.84

ug/l

0.88

1873

13269

Other specific joint derangements/joint disorders

7303

40418

1.15

22.83

3.1

3.0

0.68

0.79

ug/l

12.29

4513

24608

Contraceptive management

2365

20237

0.80

22.69

2.6

2.5

0.65

0.64

ug/l

0.25

1072

9834

Other and unspecified disorders of vitreous body

3723

31063

1.21

22.45

3.8

3.4

0.75

0.78

ug/l

0.60

2717

21657

Non-small cell lung cancer

802

10912

0.68

22.23

3.2

3.1

0.79

0.76

ug/l

0.44

581

7767

Dorsopathies

10789

49565

1.12

22.16

3.2

3.1

0.71

0.80

ug/l

13.12

6868

30761

Urolithiasis

4621

40496

1.20

22.07

3.4

3.3

0.79

ug/l

0.03

3225

27429

Other disorders of male genital organs

660

4675

1.67

21.94

3.1

2.5

0.67

0.71

ug/l

0.81

388

2482

Substance use, excluding alcohol

1280

16601

0.74

21.94

2.6

2.8

0.54

0.72

ug/l

18.23

857

9203

Small cell lung cancer, helper endpoint

106

2461

0.37

21.83

2.6

3.5

0.79

0.84

ug/l

0.16

1762

Retinal breaks without detachment

1738

13908

1.33

21.77

3.6

3.3

0.75

0.77

ug/l

0.42

1199

9442

Impacted cerumen

1256

9669

1.40

21.58

4.0

3.5

0.81

0.80

ug/l

0.06

835

6768

Retinal detachments and breaks

4213

36601

1.20

21.49

3.5

3.4

0.78

0.79

ug/l

0.20

2941

25108

Acute upper respiratory infections of multiple and unspecified sites

7231

47036

1.14

21.45

3.0

3.1

0.71

0.77

ug/l

6.02

4320

29856

Irritable bowel syndrome

1687

13292

1.30

21.42

3.3

3.1

0.65

0.77

ug/l

8.45

1064

8232

Hyperlipidaemia, other/unspecified

5128

40611

1.18

21.26

3.4

3.3

0.81

0.79

ug/l

0.38

3684

27377

Percutaneous Coronary Intervention

9054

49823

1.13

21.17

3.0

3.1

0.74

0.77

ug/l

1.62

5797

30959

Carcinoma in situ of skin

876

6420

1.48

21.04

3.7

3.5

0.80

0.81

ug/l

0.11

633

4590

Non-small cell lung cancer, squamous

301

4966

0.55

20.96

3.1

3.0

0.83

0.76

ug/l

0.31

213

3516

Need for other prophylactic measures

579

3943

1.62

20.72

3.5

3.1

0.76

0.74

ug/l

0.14

425

2424

Zoster [herpes zoster], including avohilmo

4851

40968

1.17

20.66

3.4

3.3

0.75

0.79

ug/l

2.55

3383

27836

Fentanyl

631

8985

0.66

20.64

3.4

1.25

0.82

ug/l

3.16

457

6267

Tinnitus

2306

19059

1.26

20.58

3.4

3.2

0.67

0.76

ug/l

3.19

1555

12448

Diseases of external ear

3726

32110

1.20

20.47

3.6

3.2

0.76

0.78

ug/l

0.28

2498

21223

Dermatitis and eczema

10098

65560

0.90

20.37

3.1

0.71

0.78

ug/l

6.28

6464

41318

Other respiratory disorders and diseases

1691

20906

0.77

20.35

2.9

3.5

0.74

0.83

ug/l

2.08

1159

14737

Other diseases of the respiratory system

1691

20906

0.77

20.35

2.9

3.5

0.74

0.83

ug/l

2.08

1159

14737

Implicit Sepsis, including avohilmo

9158

59352

1.12

20.34

3.1

3.2

0.76

0.77

ug/l

0.13

6384

37361

Fever of other and unknown origin

6073

46736

1.15

20.20

3.2

0.78

ug/l

0.14

4216

29711

Other disorders of fluid, electrolyte and acid-base balance

2508

28138

0.81

19.72

3.1

3.4

0.81

0.79

ug/l

0.30

1822

19083

Cholelithiasis

6914

52543

0.88

19.28

3.4

3.3

0.79

0.80

ug/l

0.19

4769

35380

Other antidepressants

11872

55653

1.11

19.26

3.2

3.1

0.69

0.80

ug/l

19.33

7787

34950

Acute sinusitis

4359

34522

1.17

19.09

2.8

2.9

0.67

0.74

ug/l

5.28

2455

20669

Diabetic maculopathy

738

9502

0.69

19.03

2.7

3.1

0.77

0.76

ug/l

0.05

488

6304

Degeneration of nervous system due to alcohol

163

2925

0.45

18.64

2.6

3.3

0.67

0.74

ug/l

0.68

128

1954

Malignant neoplasm of bladder, including Hilmo

1810

14758

1.31

18.61

3.4

3.1

0.77

0.75

ug/l

0.58

1344

10558

Wet age-related macular degeneration

1687

13153

1.30

18.55

3.8

3.6

0.85

0.86

ug/l

0.15

1259

9743

Unspecified privation

1043

7973

1.39

18.48

3.1

3.2

0.70

0.77

ug/l

1.24

703

5072

Peripheral arterial reconstruction

1655

20167

0.77

18.47

2.9

3.6

0.81

0.83

ug/l

0.17

1178

14721

Ascites

420

6302

0.62

18.44

2.6

3.4

0.88

0.79

ug/l

0.46

282

4247

Malignant melanoma of skin, including Hilmo

1634

13255

1.31

18.36

3.8

3.0

0.81

0.73

ug/l

2.12

1222

9049

Other nutritional deficiencies

4842

50069

0.87

18.34

3.0

3.1

0.68

0.75

ug/l

4.09

3149

31351

Excessive attrition of teeth

5469

48068

1.15

18.34

3.3

3.0

0.68

0.74

ug/l

5.32

3525

29482

Degeneration of the brain due to alcohol

163

2911

0.45

18.30

2.6

3.3

0.67

0.75

ug/l

0.75

128

1940

Other diseases of urinary system

10913

56213

1.11

18.23

3.6

3.2

0.78

ug/l

0.06

8002

36365

Myalgia

1654

13285

1.28

18.18

3.4

3.1

0.74

0.79

ug/l

0.52

1058

8292

Internal derangement of knee

4127

35761

1.18

18.16

3.2

3.0

0.72

0.79

ug/l

4.76

2594

22376

Oral corticosteroids

11299

60880

1.10

18.15

3.2

3.1

0.77

ug/l

0.04

7444

38131

Other diseases of anus and rectum

3104

26511

1.20

18.07

3.7

3.3

0.78

0.82

ug/l

1.05

2136

17817

Lumbar disc prolapse

7003

46739

1.13

17.98

3.1

0.69

0.79

ug/l

10.69

4415

29172

Dizziness and giddiness

7643

53780

1.13

17.98

3.4

3.2

0.75

0.79

ug/l

2.42

5369

35348

Condition for Implicit Sepsis (Organ dysfunction codes)

9347

59143

1.11

17.92

3.1

0.77

0.76

ug/l

0.10

6493

36886

Acute alcohol intoxication ICD-9

231

3833

0.52

17.90

3.0

3.3

0.58

0.76

ug/l

3.82

155

2497

Recurrent or chronic depression

2702

22158

0.83

17.90

2.7

2.8

0.64

0.74

ug/l

2.82

1664

12120

Melanoma in situ

513

3548

1.63

17.88

3.9

3.5

0.77

0.78

ug/l

0.08

370

2504

First line medication for Crohn's disease

11666

57791

1.10

17.59

3.1

0.78

0.76

ug/l

0.85

7480

35825

Asthma/COPD (KELA code 203)

8412

61690

0.90

17.55

3.1

0.69

0.78

ug/l

15.82

5275

38775

Myocardial infarction, with ST-elevation

1899

22663

0.79

17.35

3.2

3.4

0.84

0.81

ug/l

0.41

1383

15877

Other disorders of bladder

1684

13893

1.31

17.35

3.8

3.4

0.62

0.81

ug/l

22.87

1229

9701

Presence of other functional implants

6840

42263

1.13

17.33

3.7

3.3

0.77

0.80

ug/l

1.61

4983

28990

Symptoms and signs involving speech and voice

2735

23259

1.21

17.22

3.6

3.4

0.72

0.80

ug/l

3.62

1942

15968

Ptosis of eyelid

1072

8322

1.37

17.05

3.7

3.4

0.74

0.80

ug/l

1.23

795

5808

Calculus of kidney and ureter

4138

36627

1.18

17.02

3.4

3.3

0.76

0.79

ug/l

0.75

2866

24679

Small cell lung cancer

106

2250

0.42

16.98

2.6

3.0

0.79

0.77

ug/l

0.09

1584

Small cell lung cancer, including Hilmo

106

2250

0.42

16.98

2.6

3.0

0.79

0.77

ug/l

0.09

1584

Type 1 diabetes, wide definition, subgroup 2

967

0.15

16.96

1.8

3.5

0.77

0.86

ug/l

0.31

661

Abnormalities of heart beat

3188

26614

1.19

16.94

3.4

3.2

0.77

0.82

ug/l

1.09

2099

17700

Personality disorders, excluding more controls

1356

16965

0.78

16.90

2.6

2.8

0.56

0.72

ug/l

12.33

909

8960

Gastroduodenal ulcer

2462

28785

0.82

16.89

3.3

3.4

0.79

0.83

ug/l

1.01

1813

20045

Disturbances of skin sensation

2028

16796

1.24

16.85

3.2

3.0

0.63

0.74

ug/l

6.18

1328

10252

Cardiovascular diseases (excluding rheumatic etc)

4771

23999

1.15

16.84

2.7

0.68

0.71

ug/l

1.29

2678

12327

Cholelithiasis, broad definition with cholecystitis

7407

54295

0.89

16.80

3.4

3.3

0.79

ug/l

0.20

5112

36408

Carcinoma in situ of prostate

131

733

4.91

16.79

6.2

3.4

1.02

0.78

ug/l

3.32

118

491

Type 2 diabetes, definitions combined, including avohilmo

9778

51818

1.11

16.73

3.1

0.76

0.77

ug/l

0.37

6300

32060

Migraine with aura

958

7209

1.35

16.68

3.1

2.8

0.65

0.74

ug/l

2.59

606

4131

Sequelae of cerebrovascular disease

3656

35569

0.85

16.65

3.2

3.5

0.83

0.81

ug/l

0.43

2612

24959

Enthesopathies of lower limb, excluding foot

1988

16492

1.25

16.63

3.3

3.0

0.69

0.76

ug/l

3.61

1231

10136

Nontraumatic intracranial haemmorrhage

1591

19396

0.79

16.59

3.2

3.5

0.88

0.81

ug/l

1.05

1132

13533

Hallux valgus (acquired)

1297

11731

0.77

16.45

3.3

0.71

0.83

ug/l

2.54

902

8003

Presence of other devices

2713

22865

1.21

16.44

3.9

3.5

0.80

0.84

ug/l

1.22

1995

16487

Malignant melanoma of skin

1363

10987

1.32

16.41

3.8

3.0

0.82

0.73

ug/l

2.14

1031

7508

Coronary revascularization (ANGIO or CABG)

8958

49832

1.11

16.38

3.0

3.1

0.73

0.77

ug/l

1.87

5727

30961

Hypertensive diseases (excluding secondary)

4567

23389

1.16

16.38

2.8

0.68

0.72

ug/l

1.25

2647

12204

Tonsillectomy and adenotomy

2830

23068

0.84

16.29

2.6

0.64

0.68

ug/l

1.92

1389

11814

Injury of muscle and tendon at lower leg level

2048

17275

1.26

16.27

3.2

3.1

0.72

0.75

ug/l

0.32

1265

10677

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1398

17234

0.78

16.26

3.3

3.0

1.00

0.72

ug/l

5.71

993

11742

Antihypertensive medication - note that there are other indications

4270

19493

1.16

16.21

2.8

2.7

0.68

0.72

ug/l

1.57

2414

10202

Blepharochalasis

2209

18549

1.23

16.11

3.8

3.5

0.79

0.80

ug/l

0.21

1619

13153

Coronary artery bypass grafting

3527

29559

0.84

16.04

3.3

3.6

0.82

ug/l

0.07

2506

21338

Vasomotor and allergic rhinitis

2571

21328

1.20

15.82

3.1

2.8

0.67

0.74

ug/l

2.66

1459

12327

Specific personality disorders

1052

13493

0.76

15.76

2.7

2.8

0.55

0.70

ug/l

10.18

702

7422

Cardiodefibrillation

5022

45112

1.16

15.64

3.5

3.4

0.78

0.79

ug/l

0.57

3535

31503

Abrasion of teeth

2634

22489

1.20

15.57

3.3

3.1

0.67

0.74

ug/l

5.56

1765

14305

Nasal polyp

2500

21487

1.22

15.56

3.3

3.2

0.70

0.79

ug/l

5.36

1618

14070

Melanocytic naevi of trunk

1117

8810

1.33

15.44

3.6

3.2

0.77

0.76

ug/l

0.07

775

5721

Oesophageal varices

280

4312

0.58

15.39

2.4

3.2

0.74

0.76

ug/l

0.06

190

2831

Pneumonia, organism unspecified

9392

59220

1.10

15.32

3.0

3.1

0.77

0.76

ug/l

0.40

6250

36769

Diseases of middle ear and mastoid

3808

35380

0.86

15.30

3.0

0.79

0.75

ug/l

0.87

2243

20844

Persons encountering health services in circumstances related to reproduction

4141

31416

0.87

15.26

2.6

0.64

0.67

ug/l

1.29

1991

16153

Injury of muscle and tendon at shoulder and upper arm level

5142

46427

1.15

15.19

3.3

3.2

0.71

0.77

ug/l

3.37

3385

30363

Carcinoma in situ of skin of ear and external auricular canal

282

1849

1.99

15.06

3.8

3.7

0.87

0.86

ug/l

0.02

216

1342

Syncope and collapse

5268

39490

1.14

15.04

3.4

3.3

0.78

0.79

ug/l

0.40

3671

26205

Use of biperiden

253

4042

0.58

15.03

2.4

3.0

0.54

0.71

ug/l

4.85

178

2473

Heart failure, not strict

7520

55173

0.90

14.93

3.1

3.3

0.78

0.77

ug/l

0.10

5426

35980

Other diseases of lip and oral mucosa

3366

29388

1.17

14.91

3.3

3.2

0.70

0.75

ug/l

1.14

2261

18816

Focal epilepsy

1477

17977

0.79

14.86

3.0

3.2

0.75

0.78

ug/l

0.29

1027

11723

Acute and transient psychotic disorders

544

7554

0.69

14.82

2.5

2.7

0.53

0.70

ug/l

9.73

385

4050

Other disorders of eyelid

4157

34769

1.15

14.77

3.6

3.4

0.79

0.81

ug/l

0.72

3031

24553

Viral warts, including avohilmo

1737

14385

1.24

14.73

3.0

2.9

0.65

0.73

ug/l

5.42

1027

8531

Other superficial mycoses, including avohilmo

854

6520

1.37

14.70

3.1

2.9

0.60

0.72

ug/l

4.05

510

3736

Pneumonias (Asthma/COPD co-morbidities)

10070

60722

1.10

14.67

2.9

3.1

0.76

ug/l

0.01

6623

37569

Unknown and unspecified causes of morbidity

319

4870

0.62

14.67

3.5

3.3

0.77

0.80

ug/l

0.32

231

3098

Myocardial infarction, strict

5451

42571

0.88

14.63

3.2

3.3

0.80

0.79

ug/l

0.23

3852

28365

Symptoms and signs involving the digestive system and abdomen

11594

53917

1.09

14.61

3.1

0.73

0.78

ug/l

3.46

7458

33466

Exclusions for E4_PCOS_BROAD

1421

11558

1.28

14.52

3.4

3.0

0.73

ug/l

0.05

890

6927

Injuries to the elbow and forearm

4853

46452

0.88

14.41

3.2

3.1

0.74

0.76

ug/l

0.33

3109

28630

Diseases of appendix

7597

62168

1.11

14.41

3.0

3.1

0.76

ug/l

0.15

4626

38804

Pneumonitis due to solids and liquids

655

8673

0.70

14.41

2.8

3.4

0.87

0.84

ug/l

0.18

458

5984

Urethral stricture

999

8058

1.40

14.37

3.8

3.4

0.65

0.81

ug/l

7.07

685

5547

All pneumoniae

10103

60659

1.10

14.37

2.9

3.1

0.76

ug/l

0.00

6638

37532

Poisoning by drugs, medicaments and biological substances

1179

14731

0.78

14.33

2.6

2.8

0.58

0.70

ug/l

5.33

785

8111

Carcinoma in situ of skin of trunk

424

2977

1.63

14.31

4.0

3.6

0.83

ug/l

0.01

333

2178

Injuries to the knee and lower leg

12114

60900

1.09

14.28

3.2

3.1

0.73

0.78

ug/l

4.49

7709

38714

Appendicitis, broad definition

7550

62023

1.11

14.25

3.0

3.1

0.76

ug/l

0.14

4593

38700

Pain associated with micturition

882

6790

1.35

14.23

3.6

3.2

0.67

0.78

ug/l

4.22

606

4462

Type 2 diabetes, strict (exclude DM1)

9803

52675

1.10

14.18

3.1

0.76

0.77

ug/l

0.55

6339

32653

Type 2 diabetes, definitions combined

9773

52509

1.10

14.15

3.1

0.76

0.77

ug/l

0.62

6320

32531

Epilepsy

2405

27879

0.84

14.04

2.9

3.1

0.73

0.80

ug/l

1.80

1625

17936

Examination and observation for other reasons

6603

33841

1.12

14.00

3.0

0.67

0.79

ug/l

15.58

4613

20308

Neurological diseases

8278

38079

1.11

13.92

3.1

3.0

0.71

0.81

ug/l

9.10

5150

23301

Neurological diseases, wide definition

2373

10083

1.20

13.88

2.9

2.8

0.72

0.83

ug/l

4.22

1342

5503

Disorders of adult personality and behaviour

1425

17402

0.80

13.86

2.6

2.7

0.55

0.69

ug/l

9.95

949

9446

Any dementia, excluding more controls

3445

26763

0.86

13.78

3.2

3.7

0.83

0.85

ug/l

0.54

2515

19807

Smoking dependency

544

7387

0.69

13.71

2.8

3.1

0.62

0.75

ug/l

4.68

387

4678

Asthma (diagnoses ohter than nonallergic)

7267

64026

0.90

13.68

3.2

0.69

0.79

ug/l

12.60

4729

41121

Mental and behavioural disorders due to tobacco

544

7382

0.69

13.65

2.8

3.1

0.62

0.75

ug/l

4.75

387

4669

Bleeding

9429

61197

1.10

13.62

3.3

3.1

0.77

ug/l

0.08

6533

39060

Mouth breathing

4920

44402

1.14

13.60

3.2

3.1

0.67

0.75

ug/l

4.99

3038

28032

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

869

6666

1.33

13.52

2.6

2.5

0.62

0.65

ug/l

0.31

451

3211

Testicular dysfunction, other/unspecified

118

636

3.00

13.50

3.1

2.7

0.64

0.72

ug/l

0.54

338

Restless leg syndrome

1037

8209

1.31

13.49

3.7

3.2

0.67

0.78

ug/l

1.56

698

5375

Diabetic nephropathy

1298

15531

0.78

13.48

2.8

3.3

0.93

0.78

ug/l

2.44

966

10709

Anoxic brain damage

1424

0.36

13.45

3.0

3.3

0.65

0.81

ug/l

1.12

940

Erosion of teeth , including avohilmo

2015

17049

1.21

13.41

3.2

2.9

0.70

0.72

ug/l

0.46

1268

10048

Gastric ulcer

1463

17589

0.80

13.38

3.2

3.4

0.77

0.83

ug/l

1.16

1067

12317

Acute appendicitis

7097

60332

1.11

13.37

3.0

3.1

0.76

0.75

ug/l

0.08

4295

37446

Personality disorders

1356

16570

0.80

13.33

2.6

2.7

0.56

0.70

ug/l

8.74

909

9079

Malignant neoplasm of pancreas

443

6179

0.67

13.32

3.0

0.75

0.74

ug/l

0.10

300

4246

Disorders of lacrimal system

2910

24886

1.17

13.31

3.5

3.3

0.72

0.78

ug/l

2.78

2039

16441

Influenza and pneumonia

10386

59453

1.09

13.29

2.9

3.1

0.75

0.76

ug/l

0.35

6710

36806

Other disorders of lacrimal gland

2343

20059

1.19

13.24

3.5

3.2

0.71

0.78

ug/l

3.73

1653

13197

Thoracic aortic aneurysm

2419

21220

1.23

13.17

3.6

3.5

0.77

0.79

ug/l

0.29

1707

14718

Amputation of toe

606

7947

0.70

13.11

2.8

3.5

0.78

0.81

ug/l

0.26

431

5580

Type 1 diabetes, strict (exclude DM2)

347

5104

0.65

13.00

2.2

2.4

0.62

0.66

ug/l

0.40

186

2395

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

849

10825

0.76

12.97

2.7

3.0

0.74

0.76

ug/l

0.11

520

6573

Heart failure and bmi 25plus

3598

26917

0.86

12.91

3.1

3.4

0.76

0.79

ug/l

1.26

2581

18100

Insulin medication

5936

53945

0.89

12.89

2.9

3.2

0.80

0.77

ug/l

0.77

4030

34062

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

9891

61107

1.09

12.86

2.9

3.1

0.77

0.76

ug/l

0.26

6532

37862

Umbilical hernia

3717

33255

1.16

12.85

3.2

3.1

0.69

0.76

ug/l

4.57

2449

21061

Rheumatoid arthritis

1974

20552

0.83

12.82

3.3

0.75

0.83

ug/l

1.77

1375

13855

Type 1 diabetes, definitions combined

355

5181

0.66

12.79

2.2

2.4

0.62

0.66

ug/l

0.47

191

2427

Gastrointestinal diseases

5232

23576

1.13

12.79

3.0

2.9

0.72

0.79

ug/l

3.35

3144

13565

Degenerative diseases of the nervous system

3343

27132

0.86

12.73

3.2

3.7

0.86

0.85

ug/l

0.21

2443

19991

Hallux rigidus

1123

9053

1.29

12.72

3.3

0.65

0.81

ug/l

11.48

805

6172

Focal epilepsy, strict definition

1403

16884

0.80

12.68

2.9

3.2

0.76

0.78

ug/l

0.19

974

11065

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

355

5062

0.64

12.65

2.7

3.0

0.74

0.75

ug/l

0.08

247

3485

Special screening examination for neoplasms

910

7267

1.35

12.58

3.8

3.1

0.94

0.79

ug/l

3.82

653

4673

Symptoms and signs involving the skin and subcutaneous tissue

6805

58926

1.11

12.42

3.3

3.2

0.72

0.78

ug/l

5.35

4635

38212

Other inflammation of eyelid

1099

8853

1.29

12.40

3.7

3.3

0.72

0.78

ug/l

1.30

795

5831

Poisoning by medicine

1050

13065

0.78

12.37

2.6

2.8

0.59

0.70

ug/l

4.16

702

7205

Non-ischemic cardiomyopathy

3014

27027

0.86

12.30

3.3

3.5

0.85

0.81

ug/l

0.77

2208

18794

Hernia of abdominal wall, postoperative

2199

18862

1.20

12.25

3.3

3.0

0.72

0.75

ug/l

0.70

1509

11830

Other medical care

5263

40100

1.12

12.24

3.6

3.4

1.07

0.78

ug/l

17.92

3795

27606

Carcinoma in situ, bladder

600

4655

1.50

12.21

3.5

3.6

0.76

0.81

ug/l

0.77

455

3357

Herpesviral [herpes simplex] infections, including avohilmo

1412

11639

1.24

12.13

3.2

3.0

0.70

0.76

ug/l

1.17

879

7071

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

693

9036

0.75

12.02

2.5

2.7

0.55

0.69

ug/l

4.54

463

4792

Persons with potential health hazards related to communicable diseases

2345

20049

1.18

11.91

3.2

2.8

0.73

0.70

ug/l

0.57

1426

11024

Acute peritonitis

402

5576

0.67

11.90

2.7

3.3

0.74

0.79

ug/l

0.72

289

3690

Other diseases of intestine

1801

15386

1.22

11.86

3.4

3.3

0.78

0.79

ug/l

0.17

1288

10318

Other (not insulin) diabetes medications

10113

55273

1.09

11.86

3.0

3.1

0.76

0.77

ug/l

0.22

6519

34568

Mental retardation, excluding more controls

107

1979

0.49

11.84

2.2

2.9

0.71

0.74

ug/l

0.19

1063

Myocardial infarction

5714

43528

0.89

11.82

3.2

3.3

0.79

ug/l

0.11

4045

28769

Atrial fibrillation and flutter

3679

21177

1.15

11.81

2.9

0.69

0.73

ug/l

1.12

2240

11730

Spinal stenosis

6133

41426

1.12

11.80

3.4

3.3

0.71

0.82

ug/l

8.94

4351

28014

Cardiomyopathy (excluding other)

1394

16481

0.80

11.77

2.9

3.4

0.78

0.79

ug/l

0.17

988

11177

Focal epilepsy, mode (most common among epilepsy diagnosis)

1304

15689

0.80

11.77

3.0

3.2

0.77

0.78

ug/l

0.11

909

10246

Subjective visual disturbances

1915

16331

1.20

11.76

3.4

3.2

0.70

0.77

ug/l

2.46

1338

10641

Dilated cardiomyopathy

1259

14980

0.79

11.75

2.9

3.3

0.79

ug/l

0.05

896

10153

Osteopathies and chondropathies

4019

40907

0.88

11.74

3.2

0.75

0.77

ug/l

0.27

2622

26233

Dementia in Alzheimer disease

1348

13544

0.80

11.72

3.0

3.7

0.90

0.91

ug/l

0.06

925

10112

Asthma (only as main-diagnosis)

6322

38582

0.90

11.67

3.1

0.68

0.78

ug/l

9.74

3947

23943

Benign paroxysmal vertigo

2116

18198

1.19

11.65

3.5

3.3

0.77

0.79

ug/l

0.34

1450

12448

Other septicaemia

3730

39162

0.88

11.65

3.2

3.4

0.86

0.79

ug/l

1.48

2702

26946

Abdominal aortic aneurysm (AAA)

1157

13766

0.78

11.63

3.2

3.6

0.83

0.88

ug/l

0.70

845

10142

Hepatic failure, not elsewhere classified

205

3203

0.58

11.52

2.8

3.3

0.71

0.76

ug/l

0.30

140

2091

Lung diseases due to external agents

1224

14706

0.79

11.52

3.0

3.4

0.84

0.83

ug/l

0.06

869

10224

Liquid cancers, including Hilmo

3770

29799

1.14

11.41

3.3

2.9

0.89

0.71

ug/l

9.95

2684

19584

Infections with a predominantly sexual mode of transmission

1463

12132

1.22

11.40

2.7

2.6

0.63

0.68

ug/l

1.32

823

6307

Other headache syndromes

2651

23071

1.16

11.40

3.1

3.0

0.63

0.77

ug/l

16.36

1666

14325

Other extrapyramidal and movement disorders in other diseases

2150

18593

1.19

11.39

3.5

3.4

0.71

0.79

ug/l

2.34

1488

12659

Type 1 diabetes, strict definition

223

3501

0.61

11.34

1.8

2.1

0.59

0.60

ug/l

0.07

106

1360

Dissocial personality disorder

1603

0.44

11.25

2.2

2.5

0.56

0.68

ug/l

0.47

784

Spirochaetal infections, other/unspecified

771

6067

1.34

11.13

3.6

3.3

0.72

0.77

ug/l

1.22

527

4059

Status epilepticus

177

2855

0.57

11.08

3.0

3.2

0.68

0.78

ug/l

1.14

126

1873

Carcinoma in situ of other and unspecified sites

628

4955

1.45

11.05

3.5

3.6

0.75

0.82

ug/l

1.00

475

3567

Schizoaffective disorder

301

4395

0.65

11.03

2.4

2.8

0.52

0.68

ug/l

7.11

216

2434

Cough

3673

30676

1.14

11.02

3.4

3.2

0.71

0.81

ug/l

8.42

2454

20383

Carcinoma in situ of skin of lower limb, including hip

204

1278

1.79

10.98

4.0

3.5

0.81

0.82

ug/l

0.07

157

908

COPD (mode)

3402

29553

0.87

10.97

3.0

3.4

0.73

0.80

ug/l

3.96

2410

20352

Persistent delusional disorders

349

4939

0.67

10.96

2.5

3.0

0.59

0.74

ug/l

4.38

237

2921

Persons encountering health services for specific procedures, not carried out

799

6326

1.33

10.88

2.9

3.0

0.56

0.72

ug/l

9.69

562

3757

L01XE Protein kinase inhibitors

280

4066

0.64

10.83

2.7

3.5

0.89

0.77

ug/l

0.94

203

2835

Other septicaemia, including avohilmo

3841

39914

0.88

10.81

3.2

3.4

0.85

0.79

ug/l

1.35

2783

27418

Convulsions, not elsewhere classified

1983

22613

0.84

10.80

3.0

3.1

0.71

0.77

ug/l

1.37

1335

13970

Haemorrhoids and perianal venous thrombosis

3451

30668

1.14

10.77

3.5

3.3

0.78

0.81

ug/l

0.55

2374

20445

Intracerebral haemorrhage

1027

12474

0.79

10.70

3.2

3.5

0.90

0.83

ug/l

0.74

746

8826

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

2501

21927

1.17

10.69

2.9

0.70

0.72

ug/l

0.34

1474

12705

Ectropion of eyelid

485

3640

1.46

10.64

3.4

3.6

0.82

0.87

ug/l

0.47

365

2627

Obesity and other hyperalimentation

4625

47823

0.90

10.64

3.0

3.1

0.68

0.75

ug/l

3.97

2996

29901

Amputation of ankle bones

134

2235

0.53

10.56

2.5

3.4

0.72

0.78

ug/l

0.37

1495

3102

23744

1.15

10.55

3.8

3.7

0.84

0.85

ug/l

0.42

2319

17560

Osteomyelitis

513

6693

0.71

10.53

3.0

3.3

0.76

0.78

ug/l

0.27

345

4483

Other and unspecified glaucoma

619

4775

1.37

10.48

3.6

3.5

0.82

0.84

ug/l

0.10

461

3343

Gout, idiopatic and unspecified

3914

35655

1.15

10.45

3.3

3.4

0.83

0.79

ug/l

0.78

2873

24846

Asthma, hospital admissions , main diagnosis only

6505

61265

0.91

10.45

3.1

0.68

0.78

ug/l

11.70

4062

38759

Diabetic neuropathy

902

10957

0.77

10.39

2.9

3.2

0.77

0.79

ug/l

0.15

649

7528

Diseases of peritoneum

575

7465

0.74

10.37

2.9

3.3

0.73

0.79

ug/l

1.23

410

4990

Obesity

4604

47619

0.90

10.35

3.0

3.1

0.68

0.75

ug/l

3.96

2982

29771

Overexertion and strenuous or repetitive movements

953

7771

1.29

10.25

3.0

2.9

0.64

0.73

ug/l

2.18

595

4564

ILD medications: immunosuppressive drugs

5386

53150

0.90

10.24

2.9

3.1

0.71

0.75

ug/l

1.38

3585

32829

Abnormalities of gait and mobility

1339

11319

1.24

10.23

3.3

3.5

0.74

0.82

ug/l

1.33

989

8067

Benign neoplasm: Rectum, anus and anal canal

2223

19527

1.18

10.15

3.7

3.4

0.78

0.79

ug/l

0.16

1654

13630

Mental retardation, wide definition

117

2067

0.53

10.14

2.2

2.8

0.71

0.72

ug/l

0.05

1146

Type 1 diabetes, strict definition, subgroup 1

204

3185

0.62

10.13

1.8

2.1

0.59

0.60

ug/l

0.07

1209

Amputation of thigh

162

2592

0.57

10.13

2.5

3.6

0.96

0.84

ug/l

0.18

122

1842

Special screening examination for infectious and parasitic diseases

2347

14956

1.17

10.08

2.8

2.6

0.61

0.72

ug/l

3.84

1330

7210

Carpal tunnel syndrome

4739

44975

0.90

10.06

3.2

0.70

0.76

ug/l

4.70

3057

28885

Suppurative and necrotic conditions of lower respiratory tract

470

6139

0.71

10.03

3.0

3.3

0.73

0.78

ug/l

0.60

343

4102

Accidental poisoning by and exposure to alcohol

1231

0.40

10.02

2.5

3.0

0.62

0.74

ug/l

1.27

712

Other benign neoplasms of skin

3231

28922

1.14

10.01

3.5

3.3

0.76

0.80

ug/l

1.12

2215

19637

Primary open-angle glaucoma, strict

2453

21582

1.17

9.97

3.6

0.81

0.83

ug/l

0.29

1775

15569

Falls/tendency to fall

10895

51219

1.08

9.94

3.1

0.73

0.78

ug/l

4.36

6915

31833

Malignant neoplasm of liver and intrahepatic bile ducts

229

3352

0.62

9.94

2.7

3.0

0.78

0.75

ug/l

0.21

151

2338

Malignant neoplasm of pancreas, including Hilmo

600

7669

0.74

9.93

3.1

3.0

0.84

0.74

ug/l

0.66

425

5292

Adenocarcinoma and ductal carcinoma of pancreas

191

2940

0.60

9.92

2.8

3.0

0.65

0.75

ug/l

1.22

130

2013

Any event in hilmo or specialist outpatient

135

2.85

9.89

2.6

1.8

0.84

0.71

ug/l

0.41

Autoimmune diseases related-to ILD

7395

66362

0.92

9.88

3.0

3.1

0.70

0.78

ug/l

9.15

4777

41659

Nonorganic sleeping disorders

1474

12478

1.21

9.85

3.0

2.9

0.63

0.75

ug/l

4.23

914

7330

Visual disturbances and blindness

4577

41677

1.11

9.84

3.3

0.74

0.78

ug/l

1.33

3122

27527

Other specified/unspecified hearing loss

853

6904

1.30

9.81

3.5

3.3

0.82

ug/l

0.01

678

4786

847

6785

1.28

9.80

3.0

2.9

0.66

0.74

ug/l

1.58

604

3960

Obesity related asthma

3244

29102

1.14

9.80

3.2

0.62

0.76

ug/l

24.07

2102

18599

Cyst of kidney

831

6765

1.32

9.76

3.8

3.4

0.80

0.78

ug/l

0.09

579

4705

Bacterial infection, other or unspecified, including avohilmo

6683

50768

1.10

9.74

3.2

3.3

0.86

0.78

ug/l

4.38

4854

33620

Acute appendicitis, no complications

5321

48575

1.11

9.72

3.0

0.75

0.73

ug/l

0.34

3136

29048

Stroke, including SAH

6648

51342

0.91

9.71

3.3

0.84

0.78

ug/l

2.51

4741

34680

Fracture of femur

2072

21353

0.85

9.70

3.2

3.4

0.84

ug/l

0.01

1445

14931

Subarachnoid haemorrhage

650

8224

0.76

9.66

3.2

3.3

0.85

0.80

ug/l

0.32

451

5592

Disorders of vitreous body

4646

40383

1.11

9.59

3.7

3.4

0.76

0.78

ug/l

0.64

3364

27901

Aneurysms, operations, SAH

1061

12763

0.80

9.57

3.2

3.3

0.80

0.78

ug/l

0.13

719

8571

Major coronary heart disease event excluding revascularizations

6760

47934

0.91

9.56

3.1

3.3

0.76

0.78

ug/l

0.79

4693

31250

Gastro-oesophageal reflux disease

7191

56391

1.09

9.55

3.5

3.1

0.71

0.78

ug/l

7.85

4778

36037

Disorders of vestibular function (Vertigo)

3847

33933

1.12

9.40

3.5

3.3

0.78

0.79

ug/l

0.04

2626

23037

Soft tissue disorders related to use, overuse and pressure

2551

22622

1.15

9.39

3.3

3.1

0.66

0.79

ug/l

16.32

1679

14452

Stroke, excluding SAH

6382

49566

0.91

9.38

3.3

3.4

0.84

0.79

ug/l

2.16

4575

33801

Benign neoplasm: Rectum

2012

17672

1.18

9.35

3.7

3.4

0.78

0.79

ug/l

0.13

1509

12313

Mental retardation

107

1890

0.53

9.30

2.2

2.8

0.71

0.72

ug/l

0.05

1035

Schizotypal disorder

1379

0.45

9.29

2.4

2.5

0.39

0.67

ug/l

7.25

664

Cardiomyopathies, Primary/intrinsic

1362

15813

0.82

9.28

2.9

3.4

0.78

0.80

ug/l

0.15

968

10751

Polypectomy (DHB20)

886

7336

1.31

9.27

3.2

0.72

0.75

ug/l

0.54

584

4705

Gout, strict definition

2875

25995

1.16

9.21

3.3

3.5

0.84

0.80

ug/l

0.89

2134

18241

Anogenital herpesviral [herpes simplex] infection, including avohilmo

461

3426

1.38

9.19

3.2

2.7

0.65

0.68

ug/l

0.20

282

1830

2011

16415

1.18

9.19

3.8

3.6

0.85

0.86

ug/l

0.10

1514

12124

Fibroblastic disorders

2779

24894

1.15

9.17

3.5

3.3

0.77

0.83

ug/l

2.16

1936

17027

Occupational exposure to risk-factors

260

3645

0.64

9.16

2.8

3.4

0.74

0.76

ug/l

0.17

156

2422

Nonischemic cardiomyopathy

951

11378

0.79

9.14

3.1

3.4

0.84

0.79

ug/l

0.36

692

7622

Other predominantly sexually transmitted diseases, not elsewhere classified

706

5566

1.29

9.12

2.7

2.5

0.61

0.66

ug/l

0.60

377

2746

Benign neoplasm: Colon, unspecified

2946

26521

1.15

9.07

3.5

3.4

0.78

0.80

ug/l

0.19

2105

18538

Other anxiety disorders

2448

23561

0.87

9.04

2.7

0.58

0.71

ug/l

11.50

1544

12423

Temporomandibular joint disorders, including avohilmo

1924

16158

1.17

8.95

3.3

2.9

0.65

0.72

ug/l

2.97

1144

9548

Arterial embolism and thrombosis

407

5376

0.71

8.93

3.0

3.5

0.75

0.85

ug/l

1.36

293

3767

Any dementia

3717

28257

0.89

8.92

3.2

3.7

0.83

0.85

ug/l

0.37

2712

21029

Degenerative macular diseases

1062

8870

1.25

8.90

3.6

3.5

0.80

0.82

ug/l

0.43

785

6269

Disorders of conjunctiva

5954

49835

0.92

8.89

3.2

3.0

0.72

0.75

ug/l

1.33

3682

30529

Gout, unspecified

3174

28876

1.15

8.86

3.4

3.5

0.83

0.80

ug/l

0.54

2339

20133

Non-selective monoamine reuptake inhibitors

2431

26275

0.87

8.82

3.1

3.2

0.64

0.79

ug/l

16.93

1614

17154

Undefined dementia

748

8533

0.78

8.74

2.9

3.6

0.90

0.91

ug/l

0.05

513

6233

Other disorders of patella

1258

10634

1.21

8.73

3.1

2.8

0.67

0.74

ug/l

2.98

708

6118

Amputation of foot

210

3014

0.62

8.73

2.4

3.5

0.71

0.78

ug/l

0.62

142

2085

Cardiovascular diseases

4293

20692

1.11

8.72

2.7

0.67

0.71

ug/l

1.00

2318

10466

Oxycodone

3997

37362

0.90

8.68

3.4

3.3

1.06

0.80

ug/l

9.19

2804

25324

Cerebral cysts

267

3787

0.67

8.63

2.9

3.2

0.64

0.76

ug/l

2.29

174

2406

Polymyalgia rheumatica

1164

9829

1.23

8.61

3.6

0.74

0.82

ug/l

2.25

849

7089

Coxarthrosis, primary, with hip surgery

4986

42655

1.11

8.60

3.6

3.4

0.74

0.81

ug/l

6.79

3531

29932

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

155

2439

0.60

8.58

2.0

2.4

0.61

0.62

ug/l

0.07

1147

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

512

6516

0.74

8.57

2.9

3.0

0.73

ug/l

0.07

356

4452

Visual disturbances

4188

38285

1.11

8.57

3.2

3.3

0.74

0.78

ug/l

1.11

2854

25204

Valvular heart disease excluding rheumatic fever

5540

36622

1.10

8.52

3.3

3.2

0.78

ug/l

0.04

3904

24201

Melanoma in situ of trunk

218

1509

1.71

8.51

3.9

3.4

0.75

0.79

ug/l

0.28

154

1040

Unspecified dementia

749

8279

0.79

8.50

2.9

3.6

0.90

0.92

ug/l

0.15

514

6081

Cirrhosis of liver, NAS

432

5584

0.72

8.50

2.6

3.4

0.73

0.77

ug/l

0.55

291

3788

Dental pulpitis, including avohilmo

7949

54330

0.93

8.49

2.9

3.0

0.67

0.74

ug/l

7.27

4848

32996

Calculus of lower urinary tract

805

6703

1.32

8.48

3.7

3.5

0.91

0.81

ug/l

1.37

597

4724

Pyothorax

369

4849

0.70

8.46

2.9

3.3

0.75

0.77

ug/l

0.20

268

3245

Alcohol-induced chronic pancreatitis

683

8300

0.76

8.46

2.9

3.1

0.62

0.74

ug/l

4.84

478

5117

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

321

4408

0.70

8.41

2.3

2.4

0.43

0.66

ug/l

10.37

190

1969

Non-rheumatic valve diseases

5523

36504

1.10

8.38

3.3

3.2

0.79

0.78

ug/l

0.06

3891

24152

Glomerular disorders in diseases classified elsewhere

1021

12073

0.81

8.34

2.7

3.3

0.97

0.77

ug/l

2.81

743

7993

Benign neoplasm: Sigmoid colon

2087

18511

1.17

8.33

3.6

3.4

0.75

0.79

ug/l

0.60

1558

12803

Organic, including symptomatic, mental disorders

5258

39914

0.91

8.33

3.3

3.6

0.79

0.82

ug/l

1.42

3846

28506

General examination and investigation of persons without complaint and reported diagnosis

7064

34172

1.09

8.32

3.1

3.0

0.72

0.79

ug/l

8.76

4318

20500

Systemic atrophies primarily affecting the central nervous system

255

3575

0.66

8.29

2.8

3.4

0.79

0.78

ug/l

0.08

182

2418

Non-small cell lung cancer, adenocarcinoma, helper endpoint

475

6073

0.74

8.26

3.4

3.6

0.79

0.82

ug/l

0.37

344

4375

Enterocolitis due to Clostridium difficile

645

8029

0.77

8.24

3.1

3.4

0.92

0.82

ug/l

0.63

458

5553

Glomerular diseases

1607

18378

0.84

8.24

2.8

3.3

0.97

0.77

ug/l

3.57

1161

12121

Psychiatric diseases

9807

52072

0.93

8.20

3.1

3.2

0.71

0.80

ug/l

10.90

6468

32437

Retinal detachment with retinal break

1550

13524

1.20

8.20

3.4

3.3

0.80

0.78

ug/l

0.19

1058

9185

Other arthrosis

6115

38094

1.09

8.19

3.3

3.1

0.70

0.80

ug/l

10.65

4049

24251

Macular hole

492

3818

1.37

8.17

3.6

3.5

0.78

0.80

ug/l

0.17

374

2759

Adenocarcinoma of pancreas

146

2281

0.59

8.17

2.9

3.0

0.61

0.75

ug/l

2.08

100

1565

Male infertility

567

4516

1.35

8.11

2.4

2.0

0.57

0.59

ug/l

0.26

238

1758

Malignant neoplasm of oesophagus, including Hilmo

318

4226

0.68

8.08

2.9

3.0

0.70

0.73

ug/l

0.36

231

2822

Fibrosis and cirrhosis of liver

535

6742

0.75

8.07

2.7

3.3

0.73

0.78

ug/l

0.64

355

4563

246

3502

0.67

8.02

2.6

3.3

0.84

0.89

ug/l

0.22

154

2370

Diabetic nephropathy, excluding more controls

1287

12147

0.83

7.93

2.8

3.3

0.93

0.76

ug/l

3.06

960

8146

Asthma (only as main-diagnosis), excluding more controls

6119

36360

0.92

7.85

3.1

0.68

0.77

ug/l

8.99

3800

22378

Disorders of vitreous body and globe

4770

41649

1.10

7.82

3.7

3.4

0.76

0.78

ug/l

0.67

3458

28758

Malignant neoplasm of oesophagus

223

3109

0.64

7.79

2.8

2.9

0.66

0.74

ug/l

1.22

159

2067

Hepatocellular carcinoma

176

2562

0.61

7.77

2.6

3.0

0.86

0.75

ug/l

0.72

115

1770

Glaucoma-related operations

470

3650

1.36

7.74

3.9

3.5

0.79

0.80

ug/l

0.08

351

2573

Infections, IBD-co-morbidities

1451

8791

1.19

7.71

3.1

3.0

0.81

0.85

ug/l

0.34

971

5242

Chronic periodontitis, complicated

6439

58717

1.09

7.70

3.3

3.2

0.74

0.77

ug/l

1.06

4583

37980

Intentional self-harm by hanging, strangulation and suffocation

703

0.33

7.67

1.9

2.8

0.55

0.79

ug/l

2.33

392

Conjunctivitis (acute, non atopic), including avohilmo

9489

60600

0.94

7.65

3.2

3.1

0.71

0.77

ug/l

5.87

5965

38184

Achilles tendinitis

1058

8978

1.23

7.63

3.5

3.1

0.69

0.77

ug/l

2.45

691

5651

Benign neoplasm: Skin of eyelid, including canthus

1172

9991

1.21

7.62

3.6

3.4

0.77

0.79

ug/l

0.23

821

6874

Chronic ulcer of skin, not elsewhere classified

472

5993

0.75

7.59

2.8

3.4

0.70

0.81

ug/l

2.47

333

4075

Type1 diabetes, definitions combined, early onset

122

2003

0.59

7.58

1.8

1.9

0.52

0.53

ug/l

0.05

700

Unstable angina pectoris

4272

36281

0.90

7.58

3.2

3.5

0.78

0.81

ug/l

0.56

2980

25354

Mild mental retardation

1294

0.49

7.57

2.1

2.9

0.66

0.71

ug/l

0.22

726

GI-bleeding

3325

36353

0.89

7.57

3.2

3.4

0.82

0.81

ug/l

0.21

2317

25098

Chronic pancreatitis

1280

14715

0.83

7.57

3.0

3.2

0.66

0.76

ug/l

5.21

917

9502

Fissure and fistula of anal and rectal regions

2404

21560

1.14

7.55

3.4

3.1

0.70

0.78

ug/l

5.96

1530

13678

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1179

7046

1.22

7.53

3.2

0.70

0.88

ug/l

7.96

830

4587

Primary open-angle glaucoma

2997

26159

1.13

7.47

3.7

3.6

0.81

0.83

ug/l

0.47

2181

18854

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

402

5159

0.73

7.45

2.8

3.0

0.74

ug/l

0.01

269

3525

Benign neoplasm of other and unspecified endocrine glands

1131

9655

1.21

7.42

3.6

3.3

0.79

0.76

ug/l

0.31

811

6375

Adult respiratory distress syndrome

1149

0.47

7.42

3.0

3.4

0.61

0.81

ug/l

1.43

769

Unspecified jaundice

348

4573

0.72

7.39

2.9

3.4

0.83

0.80

ug/l

0.11

233

3092

Benign neoplasm: Ascending colon

1507

13207

1.19

7.36

3.7

3.4

0.78

0.79

ug/l

0.02

1140

9270

Type 2 diabetes

9695

53047

1.07

7.31

3.0

3.1

0.76

0.77

ug/l

0.59

6255

32672

Duodenal ulcer

1062

12370

0.82

7.31

3.3

3.4

0.83

0.84

ug/l

0.08

796

8596

Ischaemic Stroke, excluding all haemorrhages

6039

47465

0.92

7.31

3.3

3.4

0.85

0.79

ug/l

1.88

4319

32700

Disorders of refraction and accommodation

1904

16746

1.15

7.28

3.1

3.0

0.71

0.73

ug/l

0.17

1126

9963

Primary coxarthrosis, bilateral

2830

25674

1.13

7.28

3.7

3.5

0.74

0.81

ug/l

3.44

2034

18006

Benign lipomatous neoplasm

2661

24040

1.13

7.27

3.4

3.2

0.76

0.77

ug/l

0.08

1795

15632

Trigger finger

1115

9497

1.21

7.26

3.5

3.1

0.67

0.78

ug/l

5.08

741

6048

Colorectal cancer, including Hilmo

2888

24447

1.13

7.24

3.3

3.0

0.83

0.72

ug/l

4.65

2044

16566

Allergic rhinitis

1644

14174

1.16

7.23

2.9

2.7

0.62

0.70

ug/l

3.80

882

7727

Unattended death

919

0.42

7.23

2.6

3.3

0.85

0.81

ug/l

0.09

610

Other sexually transmitted chlamydial diseases, including avohilmo

380

2849

1.36

7.21

2.4

2.1

0.60

ug/l

0.02

181

1093

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

8840

64995

1.07

7.13

3.2

3.1

0.71

0.77

ug/l

6.56

5649

41004

Hypotension

1946

17350

1.16

7.10

3.5

0.82

0.84

ug/l

0.16

1431

12461

Emphysema

722

8637

0.79

7.09

2.9

3.5

0.70

0.84

ug/l

3.34

509

6110

Implicit bacterial Sepsis

4621

42623

0.91

7.06

3.1

3.4

0.83

0.80

ug/l

0.85

3379

29243

Gonarthrosis, primary, with knee surgery

5626

46820

0.92

6.97

3.5

3.4

0.71

0.80

ug/l

11.39

4005

32704

Dysphagia

2541

22980

1.13

6.89

3.4

0.71

0.82

ug/l

6.39

1800

15765

Tuberculosis

396

5083

0.74

6.88

3.1

3.4

0.84

0.86

ug/l

0.05

274

3555

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9882

63140

1.06

6.88

3.2

3.1

0.82

0.76

ug/l

3.68

6803

39854

Hypo-osmolality and hyponatraemia

1213

13904

0.84

6.83

3.1

3.4

0.79

ug/l

0.01

867

9432

Varicose veins of other sites

747

6244

1.27

6.81

3.1

3.0

0.80

0.73

ug/l

0.33

454

3662

Paroxysmal tachycardia

2078

15409

1.14

6.80

3.2

3.1

0.74

0.76

ug/l

0.23

1406

9408

Complications of surgical and medical care, not elsewhere classified

10105

63974

1.06

6.79

3.3

3.1

0.76

0.78

ug/l

1.13

6926

40491

Adenocarcinoma and papillary adenocarcinoma of stomach

182

2605

0.65

6.79

2.7

2.9

0.73

0.76

ug/l

0.32

131

1758

Dyspnoea

9219

63040

1.07

6.69

3.3

3.2

0.72

0.79

ug/l

6.47

6293

40623

Benign neoplasm: Caecum

1080

9306

1.21

6.68

3.5

0.80

ug/l

0.03

829

6558

Toxic effect of ethanol

213

2978

0.67

6.66

2.4

2.9

0.60

0.73

ug/l

2.19

142

1709

Transport accidents

4457

34342

1.09

6.66

3.0

3.1

0.69

0.79

ug/l

12.45

2672

21287

Dentofacial anomalies [including malocclusion]

4070

34514

0.91

6.62

3.1

2.8

0.65

0.71

ug/l

4.66

2364

19723

Endovascular or surgical operations to intracerebral aneurysms

314

4142

0.72

6.59

2.6

3.3

0.83

0.74

ug/l

0.31

206

2696

Migraine with aura and triptan purchases

363

2734

1.34

6.58

2.9

2.7

0.59

0.67

ug/l

1.71

218

1444

Extreme obesity with alveolar hypoventilation

217

3013

0.68

6.57

2.8

3.2

0.59

0.75

ug/l

2.82

142

1912

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

500

4022

1.33

6.57

3.4

3.0

0.84

0.75

ug/l

0.98

373

2776

Palmar fascial fibromatosis [Dupuytren]

2218

20109

1.15

6.56

3.6

3.4

0.79

0.84

ug/l

1.14

1561

14075

Coxarthrosis, primary

6606

51600

1.08

6.56

3.6

3.4

0.73

0.81

ug/l

9.66

4688

35631

Diabetes, varying definitions

9725

53462

1.06

6.56

3.0

3.1

0.75

0.77

ug/l

0.88

6250

32760

Entropion and trichiasis of eyelid

879

7459

1.23

6.54

3.5

3.6

0.85

0.84

ug/l

0.05

659

5438

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1116

9618

1.20

6.52

3.5

3.1

0.79

0.75

ug/l

0.37

733

6044

Charcot foot

127

1900

0.60

6.49

2.7

3.4

0.71

0.72

ug/l

0.04

1248

Striking against or struck by other objects

3557

32719

1.11

6.48

3.1

2.9

0.71

0.73

ug/l

0.25

2105

19231

Dialysis, with operation codes

1224

13967

0.84

6.46

2.5

3.3

0.90

0.75

ug/l

4.60

957

9125

Left bundle-branch block

774

6503

1.25

6.45

3.6

3.4

0.82

ug/l

0.04

556

4500

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

3196

29335

1.11

6.44

3.1

3.0

0.68

0.74

ug/l

3.65

1946

17672

Personality and behavioural disorders due to brain disease, damage and dysfunction

1279

0.52

6.43

2.4

3.1

0.63

0.80

ug/l

1.62

805

Carcinoma in situ of skin of upper limb, including shoulder

278

2086

1.47

6.42

3.7

3.6

0.80

0.81

ug/l

0.07

206

1500

Nonorganic sleeping disorders, excluding more controls

1474

12924

1.16

6.41

3.0

0.63

0.76

ug/l

5.22

914

7409

Persons encountering health services in other circumstances

3460

31445

1.10

6.40

3.5

3.1

0.75

0.77

ug/l

0.54

2518

19762

Other/unspecified seropositive rheumatoid arthritis

1304

14964

0.86

6.38

3.2

3.3

0.71

0.79

ug/l

1.41

894

10223

Emotionally unstable personality disorder

328

4340

0.74

6.38

2.6

0.45

0.66

ug/l

12.91

218

2171

Schizoid personality disorder

1490

0.56

6.37

2.6

2.8

0.54

0.71

ug/l

2.03

840

Infections with a predominantly sexual mode of transmission, including avohilmo

1888

15330

1.14

6.36

2.7

2.6

0.62

0.68

ug/l

1.51

1044

7820

Other diseases of the digestive system

3312

35930

0.90

6.35

3.3

3.4

0.82

0.81

ug/l

0.24

2320

24829

Covid-19 suspected case

1391

12152

1.17

6.35

2.7

3.0

0.77

0.74

ug/l

0.38

860

7226

Ulcer of oesophagus

610

7331

0.79

6.28

3.3

3.4

0.84

0.81

ug/l

0.23

431

5023

Anogenital herpesviral [herpes simplex] infection

296

2194

1.39

6.28

3.2

2.7

0.72

0.69

ug/l

0.13

179

1174

Contact with and exposure to communicable diseases

1519

13269

1.15

6.26

3.1

2.6

0.70

0.68

ug/l

0.42

828

6898

Seropositive rheumatoid arthritis, wide

1327

15186

0.86

6.25

3.2

3.3

0.71

0.79

ug/l

1.43

911

10377

Chronic gastritis

2439

22117

1.12

6.24

3.6

3.4

0.77

0.83

ug/l

1.10

1789

15530

ILD-related respiratory insufficiency

246

3277

0.69

6.21

2.5

3.6

0.69

0.79

ug/l

0.75

160

2334

Atrial fibrillation and flutter with reimbursement

3193

18478

1.12

6.20

3.1

3.0

0.69

0.74

ug/l

1.89

2105

10922

Decubitus ulcer and pressure area

460

5709

0.77

6.19

2.9

3.4

0.83

ug/l

0.03

326

3980

Other viral diseases, not elsewhere classified, including avohilmo

1855

16429

1.14

6.19

2.8

2.9

0.71

0.73

ug/l

0.46

1050

9424

Nephropathy related operations

1149

13127

0.84

6.19

2.5

3.2

0.87

0.77

ug/l

3.00

892

8554

Disorders of sclera, cornea, iris and ciliary body

5079

47465

1.08

6.18

3.1

0.71

0.76

ug/l

3.81

3239

29463

Septicaemia

4346

42518

0.92

6.16

3.2

3.4

0.85

0.79

ug/l

1.51

3131

28993

Respiratory tuberculosis, confirmed and not-confirmed

346

4446

0.74

6.16

3.1

3.5

0.87

0.84

ug/l

0.11

237

3104

Respiratory tuberculosis

346

4446

0.74

6.16

3.1

3.5

0.87

0.84

ug/l

0.11

237

3104

Acquired absence of limb

974

0.47

6.16

3.4

3.1

0.78

0.75

ug/l

0.15

657

Other specified and unspecified disorders of eye and adnexa

264

1947

1.43

6.15

3.4

3.2

0.64

0.75

ug/l

1.68

182

1224

Transient global amnesia

708

5908

1.24

6.13

3.7

3.5

0.72

0.80

ug/l

1.10

512

4142

Nontoxic goitre/thyroid nodule

1091

9360

1.18

6.12

3.7

3.4

0.83

0.80

ug/l

0.37

801

6480

Other blood glucose lowering drugs, excl. Insulins

1312

14903

0.85

6.12

3.2

3.5

0.74

0.78

ug/l

0.65

901

10363

Drug-induced neutropenia

332

4310

0.74

6.12

2.7

3.3

0.89

0.74

ug/l

1.16

228

2883

Alzheimer’s disease (Early onset), excluding more controls

216

2817

0.69

6.11

2.8

3.3

0.99

0.90

ug/l

0.23

146

1963

Exposure to excessive natural cold

1027

0.49

6.09

2.4

3.1

0.85

0.80

ug/l

0.16

651

Diseases of salivary glands

2362

21372

1.12

6.08

3.3

3.1

0.70

0.76

ug/l

1.87

1527

13629

Diabetes medication

10098

56105

1.06

6.07

3.0

3.1

0.76

0.77

ug/l

0.22

6470

34736

Other systemic involvement of connective tissue (FG)

1545

13378

1.15

6.03

3.5

3.4

0.74

0.82

ug/l

3.17

1097

9277

Complications following myocardial infarction

814

0.44

6.00

3.0

3.6

1.03

0.77

ug/l

0.43

573

Crushed, pushed or stepped on by crowd or human stampede

537

4358

1.27

5.94

2.6

0.62

0.68

ug/l

0.86

292

2273

Vocal cord dysfunction

1182

9041

1.18

5.91

3.3

3.1

0.70

0.77

ug/l

2.60

756

5484

Hepatocellular carcinoma, including Hilmo

257

3359

0.70

5.89

2.7

3.0

0.80

0.74

ug/l

0.50

169

2347

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1285

14671

0.86

5.88

3.2

3.3

0.71

0.79

ug/l

1.38

882

10022

Other and unspecified nerve root and plexus disorders, also in other diseases

1594

17889

0.87

5.87

3.1

0.69

0.74

ug/l

1.60

972

11023

Brain glioblastoma, helper endpoint

1316

0.55

5.86

2.5

3.1

0.56

0.73

ug/l

2.97

836

Cystitis

6759

42610

0.93

5.84

3.7

3.3

0.80

ug/l

0.08

5033

29141

Alzheimer’s disease (Early onset)

216

2963

0.70

5.82

2.8

3.5

0.99

0.85

ug/l

0.41

146

2033

Agranulocytosis

573

6953

0.80

5.78

2.9

3.3

0.82

0.77

ug/l

0.50

396

4656

Unspecified chronic bronchitis

207

2834

0.69

5.78

3.5

3.4

0.76

0.86

ug/l

0.98

143

1911

Diseases of the digestive system

4392

46660

0.92

5.78

3.2

3.3

0.80

ug/l

0.10

3032

31750

Somnolence, stupor and coma

243

3251

0.71

5.76

3.0

3.2

0.89

0.78

ug/l

0.31

169

2089

Epileptic seizures related to alcohol

732

0.42

5.75

2.6

3.1

0.59

0.73

ug/l

1.14

453

Presbyopia

637

5296

1.25

5.75

3.0

0.67

0.71

ug/l

0.68

344

3109

Tobacco use

347

4413

0.75

5.74

2.5

3.1

0.61

0.72

ug/l

2.95

224

2744

Liquid cancers

2983

25959

1.11

5.73

3.1

3.0

0.79

0.72

ug/l

3.47

2074

17287

Diabetes mellitus

9728

53471

1.06

5.72

3.0

3.1

0.75

0.77

ug/l

0.85

6252

32764

Suppurative and unspecified otitis media

1948

19202

0.89

5.72

2.7

0.76

0.71

ug/l

0.55

1085

10418

Focal brain injury

611

7288

0.80

5.72

3.3

3.2

0.70

0.82

ug/l

3.48

426

4630

Endocrine, nutritional and metabolic diseases

7697

36742

1.07

5.70

3.0

0.72

0.77

ug/l

2.42

4726

21391

Macular cyst

295

2262

1.40

5.70

3.5

0.75

0.80

ug/l

0.46

230

1586

Other disorders of glucose regulation and pancreatic internal secretion

511

6244

0.79

5.68

2.7

3.2

0.65

0.76

ug/l

2.41

348

3967

Use of antiglaucoma preparations and miotics

622

5165

1.25

5.66

3.8

3.5

0.80

0.85

ug/l

0.53

462

3654

Chronic viral hepatitis

281

3679

0.73

5.66

2.3

2.5

0.49

0.66

ug/l

5.80

184

1769

Heartburn

916

7856

1.20

5.66

3.4

3.2

0.68

0.76

ug/l

2.01

612

4985

Diagnoses used for exclusion with ILD

2303

25256

0.89

5.63

3.0

3.3

0.81

0.80

ug/l

0.10

1545

16925

Tuberculosis, IBD comorbidity

459

5651

0.78

5.60

3.1

3.4

0.80

0.85

ug/l

0.37

315

3921

Problems related to lifestyle

759

8930

0.82

5.59

2.7

2.9

0.62

0.73

ug/l

3.15

513

5187

Explicit Sepsis

4391

42753

0.92

5.58

3.2

3.4

0.84

0.80

ug/l

1.27

3178

29200

Ethmoidectomy

1161

10168

1.18

5.58

3.5

3.0

0.72

0.74

ug/l

0.43

699

6218

Extracorporeal dialysis

515

6208

0.78

5.57

2.5

3.3

0.98

0.77

ug/l

4.82

414

4072

Other disorders of conjunctiva

1295

11432

1.17

5.54

3.6

3.4

0.75

0.80

ug/l

1.18

902

7881

Candidiasis, including avohilmo

1725

15406

1.13

5.53

3.3

3.2

0.71

0.77

ug/l

1.15

1209

10046

Other viral diseases, including avohilmo

2694

24396

1.11

5.49

2.8

0.71

0.72

ug/l

0.17

1525

13669

Primary gonarthrosis, bilateral

4839

43159

0.93

5.48

3.6

3.4

0.74

0.81

ug/l

2.83

3400

30028

Benign neoplasm of eye and adnexa

833

7121

1.21

5.48

3.6

3.4

0.76

0.79

ug/l

0.24

571

4843

Arterial embolism and thrombosis of lower extremity artery

238

3143

0.71

5.46

2.9

3.5

0.82

0.83

ug/l

0.05

174

2204

Tuberculosis, wide

468

5734

0.79

5.44

3.1

3.4

0.79

0.85

ug/l

0.40

321

3978

Localized swelling, mass and lump of skin and subcutaneous tissue

2824

25951

1.11

5.44

3.3

3.2

0.75

0.78

ug/l

0.78

1934

17041

Infective dermatitis

824

9597

0.83

5.43

3.0

3.3

0.75

0.77

ug/l

0.16

546

6330

Injury, poisoning and certain other consequences of external causes

4880

22840

1.08

5.42

3.2

3.1

0.75

0.82

ug/l

2.99

3089

14360

Chronic kidney disease

4018

36117

1.09

5.41

3.2

3.5

0.96

0.80

ug/l

10.51

3057

25250

Other specified and unspecified personality disorders

426

5295

0.78

5.39

2.7

2.9

0.55

0.71

ug/l

5.96

304

2960

Other specified disorders of external ear

522

4367

1.30

5.36

3.8

3.4

0.80

0.77

ug/l

0.18

351

2952

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

7096

58585

1.07

5.25

3.3

0.77

0.79

ug/l

0.54

4920

39176

Motor neuron disease ALS

127

1837

0.63

5.23

2.6

3.4

0.81

0.87

ug/l

0.29

1257

Secondary malignant neoplasm of respiratory and digestive organs

1390

0.59

5.23

2.6

3.0

0.82

0.75

ug/l

0.35

960

Azathioprine

879

10193

0.84

5.22

2.8

3.0

0.73

ug/l

0.03

574

6033

External causes of morbidity and mortality

6115

28870

1.07

5.20

3.1

0.77

0.80

ug/l

1.32

3887

18082

Cardiomyopathy

1973

21613

0.89

5.19

2.9

3.4

0.79

0.80

ug/l

0.15

1390

14615

Disorders of ocular muscles, binocular movement, accommodation and refraction

3566

32806

1.09

5.13

3.1

0.75

ug/l

0.03

2213

20107

ILD medications: azathioprine

879

10179

0.84

5.13

2.8

3.0

0.73

ug/l

0.01

574

6027

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1462

0.61

5.12

2.5

2.8

0.66

0.76

ug/l

0.57

822

Fracture of forearm

2993

29157

0.91

5.11

3.2

3.1

0.74

0.76

ug/l

0.24

1928

18217

Motor neuron disease (with DMD)

128

1843

0.64

5.11

2.6

3.4

0.81

0.87

ug/l

0.32

1261

Chalazion

907

7846

1.19

5.10

3.3

3.1

0.71

0.75

ug/l

1.00

596

4878

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2526

22810

1.10

5.09

2.8

0.64

0.70

ug/l

3.62

1371

12468

Toxic effect of alcohol

139

1963

0.65

5.09

2.6

2.9

0.64

0.73

ug/l

1.02

1147

Melanocytic naevi of other and unspecified parts of face

342

2683

1.32

5.07

3.3

3.1

0.73

0.75

ug/l

0.10

216

1685

Injury of muscle and tendon at hip and thigh level

1033

9058

1.18

5.06

3.3

3.1

0.74

ug/l

0.03

630

5678

Faecal incontinence

318

2457

1.32

5.05

3.9

3.4

0.85

0.80

ug/l

0.16

231

1669

933

0.51

5.05

2.3

3.0

0.59

0.76

ug/l

1.14

560

Other and unspecified visual disturbances

762

6508

1.20

5.00

3.1

3.2

0.78

0.76

ug/l

0.16

500

4209

Nontoxic single thyroid nodule

312

2415

1.32

5.00

3.8

3.4

0.87

0.77

ug/l

0.51

223

1628

Pollen allergy

751

6274

1.19

5.00

2.9

2.5

0.61

0.66

ug/l

0.65

374

3118

Gout, FINNGEN

4501

42167

1.09

4.99

3.3

3.4

0.83

0.80

ug/l

0.60

3289

29427

Trochanteric bursitis

566

4678

1.23

4.99

3.3

3.2

0.62

0.82

ug/l

8.16

398

3102

Pain, not elsewhere classified

2303

21042

1.11

4.97

3.2

0.71

0.77

ug/l

1.25

1516

13330

Laparoscopic right hemicolectomy

544

4551

1.26

4.96

3.6

3.5

0.78

ug/l

0.01

408

3203

Hypoglycaemia, other or unspecified

393

4858

0.78

4.95

2.6

3.2

0.65

0.76

ug/l

1.68

259

3075

Conjunctivitis (acute, non atopic)

2034

18390

1.12

4.94

3.1

3.0

0.74

ug/l

0.07

1310

11266

Sexual dysfunction

246

1900

1.43

4.93

3.1

2.9

0.67

0.73

ug/l

0.54

151

1079

Nutritional anaemias

3973

40487

0.92

4.92

3.3

3.4

0.88

0.81

ug/l

2.13

2864

28205

Alcoholic cardiomyopathy

728

0.46

4.90

2.3

3.3

0.61

0.79

ug/l

0.92

474

Brain glioblastoma and astrocytoma

1452

0.61

4.89

2.4

2.8

0.56

0.71

ug/l

2.33

863

Alcoholic gastritis

125

1753

0.63

4.86

3.4

3.1

0.74

ug/l

0.00

1111

Explicit Sepsis, including avohilmo

4504

43397

0.93

4.86

3.2

3.4

0.84

0.79

ug/l

1.12

3260

29591

Extrapyramidal and movement disorders

3696

34509

1.09

4.86

3.4

0.73

0.80

ug/l

3.45

2602

23875

Sciatica+with lumbago

4480

42214

0.93

4.84

3.0

3.1

0.66

0.78

ug/l

12.30

2928

26530

Tuberculosis, wide, including avohilmo

481

5802

0.80

4.83

3.1

3.4

0.79

0.85

ug/l

0.43

329

4024

Bronchitis

10668

61306

1.05

4.82

3.0

3.2

0.73

0.79

ug/l

4.99

6676

39487

Other systemic involvement of connective tissue

1582

14190

1.13

4.81

3.5

3.4

0.73

0.80

ug/l

2.18

1120

9856

Encephalopathy

859

0.51

4.79

2.5

3.2

0.53

0.76

ug/l

3.75

579

Carcinoma in situ of rectum

173

1282

1.55

4.78

3.9

3.3

0.72

0.78

ug/l

0.47

128

857

Pulmonary oedema

1412

0.61

4.78

2.3

3.5

1.02

0.84

ug/l

0.52

983

Dementia in other diseases classified elsewhere

307

3864

0.76

4.77

2.8

3.6

0.76

0.82

ug/l

0.39

217

2779

Malignant neoplasm of stomach, including Hilmo

464

5586

0.79

4.76

3.1

3.0

0.75

0.74

ug/l

0.04

327

3800

Respiratory tuberculosis, not confirmed

248

3206

0.73

4.75

2.9

3.5

0.93

0.85

ug/l

0.34

171

2252

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

1407

12606

1.14

4.71

2.9

3.2

0.79

0.76

ug/l

0.31

961

8094

Other specified/unspecified arthritis

2291

21006

1.11

4.68

3.3

3.1

0.75

0.80

ug/l

1.31

1553

13591

Morphin

146

2024

0.67

4.67

3.2

3.5

0.73

0.86

ug/l

1.34

1454

FESS (DNB20)

1097

9698

1.16

4.65

3.5

3.0

0.71

0.73

ug/l

0.44

666

5901

conjunctival haemorrhage

674

5763

1.21

4.63

3.7

3.4

0.71

0.80

ug/l

1.93

458

3950

Other disorders of eye and adnexa

838

7239

1.18

4.63

3.3

3.1

0.65

0.74

ug/l

3.19

554

4511

Use of disulfiram, acamprosate or naltrexone

846

9650

0.84

4.62

2.8

0.60

0.70

ug/l

3.05

579

5300

Dialysis

297

3717

0.75

4.61

2.7

3.2

0.94

0.73

ug/l

4.05

243

2321

Benign neoplasm of other and ill-defined parts of digestive system

1421

12752

1.14

4.59

3.5

3.4

0.76

0.79

ug/l

0.40

1040

8799

Hypothyroidism (congenital or acquired)

1884

9538

1.12

4.55

2.8

2.3

0.62

0.69

ug/l

3.04

1061

4080

Other acute lower respiratory infections

4776

48197

0.93

4.54

3.0

3.1

0.72

0.78

ug/l

3.76

3023

30353

Disorders of thyroid, IBD co-morbidities

1320

8031

1.14

4.52

3.3

3.1

0.74

0.86

ug/l

3.71

895

4936

Normotensive glaucoma

622

5280

1.22

4.52

3.8

3.5

0.79

0.82

ug/l

0.42

450

3803

Malignant neoplasm of stomach

405

4910

0.79

4.52

3.0

0.77

0.75

ug/l

0.24

285

3360

Use of pramipexole

1719

15589

1.12

4.51

3.4

0.69

0.79

ug/l

5.28

1169

10625

Implicit Sepsis

8333

58681

1.06

4.51

3.1

3.2

0.79

0.77

ug/l

0.54

5907

37554

Brain glioblastoma

1238

0.59

4.50

2.5

2.8

0.56

0.71

ug/l

2.48

770

Undetermined asthma

1053

9274

1.16

4.49

3.6

3.3

0.68

0.79

ug/l

4.45

695

6147

Ganglion

1313

11706

1.14

4.49

3.0

0.68

0.77

ug/l

3.66

795

7179

Non-small cell lung cancer, adenocarcinoma

475

5673

0.80

4.49

3.4

3.0

0.79

0.74

ug/l

0.54

344

4011

Malignant neoplasm of brain

203

2674

0.72

4.48

2.6

2.7

0.68

0.71

ug/l

0.24

127

1602

Thyrotoxicosis

1128

9950

1.15

4.48

3.2

0.76

0.77

ug/l

0.10

761

6536

Respiratory tuberculosis, not confirmed, including avohilmo

252

3223

0.74

4.46

2.9

3.5

0.93

0.85

ug/l

0.34

173

2263

Cervicalgia

1584

14298

1.13

4.46

3.3

3.1

0.72

0.79

ug/l

1.18

1049

9143

Zoster [herpes zoster]

1500

13520

1.13

4.44

3.3

3.4

0.77

0.81

ug/l

0.50

1063

9361

Senility

456

1.74

4.43

3.3

3.7

0.72

0.91

ug/l

1.39

320

Melanoma in situ of other and unspecified parts of face

124

868

1.59

4.41

4.0

3.5

0.84

0.81

ug/l

0.09

626

Other pleural conditions

959

10832

0.86

4.40

3.3

3.5

0.81

0.83

ug/l

0.22

703

7723

Hypothyroidism and >3 levothyroxin purchases

1875

9518

1.12

4.40

2.9

2.3

0.63

0.69

ug/l

2.11

1062

4078

Hypothyroidism, levothyroxine purchases

1875

9518

1.12

4.40

2.9

2.3

0.63

0.69

ug/l

2.11

1062

4078

Other disorders of kidney and ureter

1357

12224

1.14

4.39

3.4

3.3

0.81

0.78

ug/l

0.46

979

8300

156

2110

0.69

4.39

3.2

3.6

0.61

0.82

ug/l

3.74

111

1507

Abnormal findings on diagnostic imaging of other body structures

1060

9372

1.16

4.36

3.5

3.3

0.83

0.77

ug/l

0.80

785

6288

Caries of enamel

8513

58141

0.95

4.35

3.1

3.0

0.68

0.75

ug/l

10.55

5384

35754

Major coronary heart disease event

9111

52228

1.05

4.34

3.0

3.1

0.74

0.77

ug/l

1.85

5844

32633

Renal failure

5972

48391

1.07

4.33

3.1

3.4

0.95

0.79

ug/l

12.53

4494

33312

Other congenital malformations of skin, including avohilmo

452

3727

1.24

4.33

3.1

0.75

0.73

ug/l

0.24

283

2263

Pneumonia due to Streptococcus pneumoniae

303

3768

0.77

4.32

2.8

3.2

0.76

ug/l

0.01

201

2389

Other neurological diseases

7649

56672

1.06

4.30

3.3

0.78

0.79

ug/l

0.25

5341

37872

Kela-code for behavioural disturbances in mental retardation

582

0.45

4.29

2.2

3.1

0.60

0.74

ug/l

0.36

371

Malignant neoplasm of brain, including Hilmo

292

3659

0.77

4.28

2.7

2.8

0.74

0.71

ug/l

0.26

199

2231

Problems related to social environment

1426

0.64

4.28

3.2

3.1

0.76

0.83

ug/l

0.27

915

Hyperaldosteronism

266

2098

1.35

4.27

3.6

3.2

0.76

0.74

ug/l

0.18

183

1343

Other diseases of pleura

5174

47338

0.94

4.26

3.3

3.4

0.77

0.81

ug/l

2.09

3694

33186

Benign neoplasm: Adrenal gland

675

5819

1.20

4.24

3.5

3.3

0.78

0.77

ug/l

0.15

494

3922

Collagenous colitis

581

4923

1.21

4.22

3.2

3.3

0.73

0.75

ug/l

0.21

399

3197

Cardiomyopathies, Secondary/extrinsic

763

0.51

4.21

2.2

3.1

0.56

0.75

ug/l

1.17

485

Diseases of inner ear

4832

43697

1.07

4.19

3.4

3.3

0.78

ug/l

0.10

3231

29417

Thiamine deficiency

585

0.45

4.18

3.6

3.0

0.67

0.74

ug/l

0.24

376

Undetermined asthma, excluding more controls

1053

9322

1.15

4.18

3.6

3.4

0.68

0.80

ug/l

4.81

695

6213

Other pulmonary heart/vessel disease

274

3441

0.76

4.17

3.0

3.5

0.92

0.82

ug/l

0.39

177

2409

Complications peculiar to reattachment and amputation

594

0.46

4.16

2.3

3.2

0.57

0.81

ug/l

0.91

385

Iron deficiency anaemia secondary to blood loss (chronic)

1059

11916

0.87

4.16

3.1

3.4

0.89

0.81

ug/l

0.72

725

8221

Viral infections characterized by skin and mucous membrane lesions

3910

36734

1.08

4.15

3.0

3.1

0.72

0.75

ug/l

1.41

2459

22655

Glaucoma, exfoliation

811

7074

1.18

4.14

3.8

3.6

0.79

0.87

ug/l

1.62

609

5171

General symptoms and signs

10809

52065

1.05

4.13

3.0

3.1

0.74

0.77

ug/l

1.18

6957

31828

Bacterial Sepsis

5291

46014

0.94

4.11

3.1

3.4

0.82

0.79

ug/l

0.78

3850

31200

Bicipital tendinitis

514

4362

1.24

4.11

3.0

0.65

0.75

ug/l

2.00

341

2700

Melanocytic naevi of lower limb, including hip

272

2139

1.32

4.10

3.4

3.2

0.68

0.75

ug/l

0.90

180

1348

Thyrotoxicosis, other and/or unspecified

950

8344

1.15

4.09

3.1

3.2

0.77

0.78

ug/l

0.10

630

5440

Plantar fascial fibromatosis

577

4893

1.20

4.09

3.3

3.1

0.68

0.79

ug/l

2.22

386

3091

Diarrhoea and gastroenteritis of presumed infectious origin

6726

57256

1.06

4.08

2.9

3.1

0.73

0.77

ug/l

1.58

4003

35283

Seropositive rheumatoid arthritis

1328

14688

0.89

4.08

3.2

3.3

0.71

0.81

ug/l

2.05

911

9941

Oral lichen planus, including avohilmo , including avohilmo

338

2722

1.27

4.05

3.6

3.1

0.62

0.71

ug/l

2.29

213

1683

Malignant neoplasm of eye, brain and central nervous system

272

3407

0.76

4.05

2.7

2.8

0.72

0.71

ug/l

0.09

178

2061

Sequelae of other accidents

1241

0.62

4.04

2.5

3.2

0.65

0.80

ug/l

1.50

787

Other specified/unspecified diseases of inner ear

286

2.00

4.03

4.4

3.0

0.91

0.72

ug/l

0.75

186

Open wound of lower leg

1273

11442

1.14

4.03

3.0

3.1

0.72

0.76

ug/l

0.70

811

7143

Melanoma in situ of upper limb, including shoulder

472

1.76

4.02

3.9

3.4

0.77

0.79

ug/l

0.07

306

Superficial injury of wrist and hand

1454

13137

1.12

4.01

2.9

0.67

0.73

ug/l

2.28

879

7679

Hydrocephalus

482

5705

0.82

4.00

2.9

3.5

0.69

0.82

ug/l

3.42

344

4024

Other CVD

2117

19540

1.11

4.00

3.5

0.82

0.83

ug/l

0.25

1550

13986

Generalized epilepsy

147

2015

0.71

4.00

2.8

2.9

0.70

0.76

ug/l

0.36

1129

Laparoscopic left hemicolectomy

192

1476

1.43

3.99

3.1

3.3

0.84

0.76

ug/l

0.54

137

979

Functional dyspepsia

1808

16514

1.11

3.98

3.5

3.2

0.67

0.78

ug/l

6.29

1153

10639

Secondary parkinsonism+Parkinsonism in other disease

171

2256

0.71

3.97

3.2

3.4

0.76

0.78

ug/l

0.13

124

1532

Recurrent dislocation and subluxation of joint

459

3834

1.23

3.94

2.6

2.5

0.62

0.70

ug/l

1.44

249

1909

Assault

926

10461

0.87

3.94

2.5

2.6

0.58

0.67

ug/l

1.99

552

5188

Carcinoma in situ of other and unspecified digestive organs

497

4238

1.24

3.94

3.6

3.4

0.75

ug/l

0.02

361

2902

Necrosis of pulp, including avohilmo

5435

51027

1.06

3.93

3.1

3.0

0.72

0.73

ug/l

0.43

3411

30459

Abscess of lung

108

1513

0.65

3.93

3.1

3.2

0.66

0.78

ug/l

0.99

954

Injuries to the ankle and foot

5763

51695

0.94

3.93

2.8

3.0

0.67

0.74

ug/l

8.31

3343

30912

Other congenital malformations, including avohilmo

649

5567

1.18

3.93

3.0

0.76

0.72

ug/l

0.31

409

3358

Examination and encounter for administrative purposes

1059

9503

1.16

3.92

3.3

0.77

0.82

ug/l

0.87

677

6336

Later onset COPD, excluding more controls

2323

19057

0.91

3.90

3.3

3.7

0.75

0.84

ug/l

5.85

1716

14401

Other disorders of the genitourinary system

419

3455

1.23

3.90

3.7

3.6

0.87

0.82

ug/l

0.17

282

2457

Systemic connective tissue disorders

2170

19995

1.10

3.89

3.4

0.73

0.80

ug/l

2.95

1539

13809

Colorectal cancer

2572

22967

1.09

3.88

3.2

3.0

0.83

0.72

ug/l

3.58

1808

15665

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

537

4558

1.21

3.86

2.6

0.63

0.71

ug/l

1.80

295

2361

Dementia

4416

31880

0.93

3.86

3.3

3.7

0.81

0.84

ug/l

1.24

3230

23651

Intestinal stricture

2763

29585

0.92

3.85

3.1

3.4

0.77

0.80

ug/l

0.74

1930

20284

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1636

14944

1.12

3.85

3.0

3.2

0.77

0.76

ug/l

0.16

1104

9592

Other enthesopathies

2309

21355

1.09

3.84

3.1

3.0

0.67

0.77

ug/l

6.98

1442

13232

Secondary parkinsonism

168

2209

0.72

3.83

3.2

3.4

0.74

0.76

ug/l

0.18

121

1494

Other disorders of skin and subcutaneous tissue

6469

57113

0.95

3.81

3.3

0.76

0.79

ug/l

0.93

4446

38071

Other viral hepatitis

359

4349

0.80

3.81

2.4

2.6

0.54

0.65

ug/l

3.35

236

2194

Keratitis

3123

29243

1.08

3.81

3.1

0.73

0.76

ug/l

1.13

1956

18071

Embedded and impacted teeth

923

8499

0.87

3.78

2.4

2.5

0.64

0.66

ug/l

0.24

460

4095

Secondary right heart disease

241

3034

0.76

3.78

3.0

3.5

0.90

0.81

ug/l

0.27

155

2123

Other infectious diseases, including avohilmo

636

7324

0.84

3.75

2.9

3.3

0.79

0.81

ug/l

0.24

462

4923

COPD/asthma related infections

8821

45988

0.95

3.73

3.1

3.2

0.75

0.78

ug/l

1.16

5645

29654

COPD/asthma/ILD related infections

8821

45988

0.95

3.73

3.1

3.2

0.75

0.78

ug/l

1.16

5645

29654

Other postsurgical states

386

4630

0.81

3.73

2.9

3.2

0.64

0.75

ug/l

1.37

271

3052

Disorders of synovium and tendon

4473

40044

0.94

3.72

3.1

0.69

0.79

ug/l

11.91

2760

25107

Bacterial infection, other or unspecified

6059

48803

1.06

3.71

3.2

3.3

0.87

0.78

ug/l

4.05

4419

32709

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

163

2149

0.72

3.70

3.0

3.5

0.94

0.84

ug/l

0.34

121

1516

Other infectious diseases

525

6122

0.83

3.69

3.0

3.3

0.80

0.82

ug/l

0.12

380

4114

Otitis externa

1908

17567

1.10

3.69

3.5

3.1

0.75

0.76

ug/l

0.20

1281

11251

Myocardial infarction, without ST-elevation

4939

46742

0.94

3.67

3.2

3.5

0.80

0.81

ug/l

0.07

3558

32809

Alzheimer disease

2977

22711

0.92

3.66

3.2

3.7

0.87

ug/l

0.12

2163

16990

Other or ill-defined heart diseases

414

4911

0.81

3.66

2.9

3.1

0.77

0.80

ug/l

0.21

257

3055

Blood alcohol or alcohol intoxication level

136

1833

0.70

3.64

2.6

2.8

0.77

0.70

ug/l

0.18

1021

Primary hyperparathyroidism

492

4158

1.20

3.63

3.8

3.4

0.78

0.77

ug/l

0.12

357

2802

Glucosamine medication

3347

28413

0.93

3.63

3.9

3.5

0.75

0.82

ug/l

3.26

2410

20451

Migraine without aura and triptan purchases

332

2686

1.25

3.63

2.7

2.6

0.62

0.67

ug/l

0.69

193

1344

Open wound of head

6636

59690

1.05

3.62

3.2

3.1

0.75

0.78

ug/l

1.04

4376

37587

Malignant neoplasm, without specification of site, including Hilmo

286

3519

0.78

3.62

3.0

2.9

0.74

0.76

ug/l

0.13

209

2420

Cervicocranial syndrome

654

5664

1.18

3.62

3.4

3.1

0.66

0.80

ug/l

3.97

441

3620

Metatarsalgia

492

4160

1.20

3.62

3.3

3.1

0.66

0.78

ug/l

3.73

329

2620

Rash and other nonspecific skin eruption

599

5160

1.19

3.61

3.2

3.3

0.72

0.78

ug/l

0.66

413

3374

Phlebitis and thrombophlebitis (not including DVT)

1937

17873

1.10

3.60

3.3

3.2

0.81

0.78

ug/l

0.69

1327

11711

Other other unspecified disorders of the circulatory system

184

2381

0.74

3.58

3.3

3.4

0.71

0.78

ug/l

0.67

127

1615

Other sexually transmitted chlamydial diseases

263

2086

1.29

3.57

2.4

2.1

0.63

0.60

ug/l

0.08

127

807

Other viral hepatitis, including avohilmo

381

4560

0.81

3.57

2.4

2.6

0.55

0.65

ug/l

2.36

249

2299

Open wound of wrist and hand

5467

50410

1.06

3.55

3.1

3.0

0.73

0.75

ug/l

0.70

3343

30819

Vascular dementia (multiple infarctions)

967

0.60

3.55

2.9

3.5

0.83

0.92

ug/l

0.42

709

Other/unspecified enthesopathies of lower limb, excluding foot

449

3781

1.22

3.55

3.0

2.9

0.68

0.74

ug/l

0.72

260

2240

Migraine without aura

515

4360

1.19

3.53

2.7

2.6

0.61

0.68

ug/l

1.75

298

2280

Alcohol induced polyneuropathy

1251

0.63

3.53

2.7

3.3

0.61

0.77

ug/l

1.42

822

Benign neoplasm: Pituitary gland, craniopharyngeal duct

409

3435

1.24

3.53

3.6

3.2

0.78

0.74

ug/l

0.17

288

2154

Spondylosis

5999

44795

1.06

3.51

3.3

3.2

0.69

0.80

ug/l

12.57

4124

29066

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3663

21725

1.07

3.51

2.9

0.73

0.72

ug/l

0.04

2258

11852

Adverse effects, not elsewhere classified

1059

9473

1.13

3.50

3.2

3.1

0.69

0.75

ug/l

1.48

695

5861

Malignant neoplasm of urinary organs, including Hilmo

1330

12139

1.13

3.50

3.4

3.0

0.87

0.73

ug/l

3.92

987

8294

Exposure to other and unspecified inanimate mechanical forces

687

6018

1.18

3.50

2.9

0.71

ug/l

0.03

427

3533

Care involving dialysis

761

8568

0.86

3.49

2.6

3.2

1.04

0.76

ug/l

8.50

615

5603

Acute pharyngitis

1246

11158

1.12

3.49

2.7

0.64

0.67

ug/l

0.93

665

5855

Depression medications

2127

9850

1.10

3.49

2.5

2.3

0.60

0.68

ug/l

2.00

1108

4128

Other/unspecified soft tissue disorders related to use, overuse and pressure

197

1525

1.35

3.46

3.3

2.9

0.66

0.76

ug/l

1.32

118

888

Reimbursement for rheumatic diseases

3824

40206

0.94

3.46

3.1

3.2

0.71

0.77

ug/l

2.87

2550

25836

Other and unspecified dermatitis

4417

41898

1.06

3.45

3.2

0.71

0.78

ug/l

4.10

2984

27263

Assault by bodily force

462

5427

0.83

3.45

2.5

0.63

0.67

ug/l

0.23

265

2656

Injuries to unspecified part of trunk, limb or body region

850

7547

1.15

3.45

3.0

3.2

0.71

0.78

ug/l

1.20

563

4858

Sudden idiopathic hearing loss

927

8289

1.15

3.45

3.5

3.3

0.83

0.78

ug/l

0.38

629

5586

Disorders of gallbladder, biliary tract and pancreas

9638

62120

0.96

3.44

3.3

3.2

0.76

0.78

ug/l

0.86

6640

40073

Dependence on enabling machines and devices, not elsewhere classified

790

0.57

3.44

1.9

3.2

0.70

0.74

ug/l

0.13

513

Suggestive for eosinophilic asthma

898

8023

1.15

3.44

3.4

3.2

0.65

0.78

ug/l

5.55

591

5247

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

456

5345

0.83

3.43

3.0

2.8

0.74

0.71

ug/l

0.33

316

3348

Total colectomy operation

247

3061

0.77

3.41

2.9

3.1

0.85

0.73

ug/l

0.98

160

1852

Total colectomy

247

3061

0.77

3.41

2.9

3.1

0.85

0.73

ug/l

0.98

160

1852

Rheumatoid arthritis, including avohilmo

2210

23801

0.92

3.41

3.3

0.74

0.79

ug/l

0.94

1525

16035

Other respiratory diseases principally affecting the interstitium

1735

18767

0.90

3.39

3.2

3.5

0.74

0.82

ug/l

2.89

1252

13390

Benign thyroid growths and nodules

1388

11706

1.11

3.38

3.7

3.4

0.80

ug/l

0.03

1009

8146

Nontoxic multinodular goitre

650

5639

1.16

3.37

3.7

3.4

0.81

0.80

ug/l

0.08

485

3962

Other arterial embolism and thrombosis

188

2391

0.75

3.37

3.1

3.5

0.65

0.81

ug/l

2.39

134

1648

Lichen ruber planus, wide definition including periferal and oral lichen planus

1475

13476

1.11

3.35

3.3

3.2

0.75

ug/l

0.05

925

8777

Other symptoms and signs involving the digestive system and abdomen

734

6431

1.15

3.35

3.7

3.3

0.73

0.79

ug/l

0.91

512

4304

Methotrexate

656

7511

0.86

3.35

3.0

3.2

0.66

0.78

ug/l

3.09

454

4906

Asthma and allergy

543

4590

1.18

3.34

2.7

2.6

0.54

0.70

ug/l

7.10

278

2372

Cholecystectomy

5548

49304

0.95

3.33

3.3

0.78

0.80

ug/l

0.83

3787

33532

Oedema, not elsewhere classified

3122

28692

1.08

3.33

3.4

0.76

0.80

ug/l

1.30

2209

19303

Malignant neoplasm of other and unspecified parts of biliary tract

1213

0.65

3.32

2.8

3.0

0.64

0.78

ug/l

1.35

833

Erectile dysfunction

1373

12714

1.14

3.32

4.1

3.5

0.75

0.80

ug/l

1.01

865

9076

Diffuse brain injury

276

3360

0.79

3.30

2.9

3.1

0.68

0.78

ug/l

1.67

198

2053

105

1459

0.69

3.29

2.5

2.7

0.70

ug/l

0.00

799

Other protozoal intestinal diseases, including avohilmo

146

1093

1.40

3.27

3.2

3.0

0.53

0.71

ug/l

4.17

101

665

Other diseases of biliary tract

563

6471

0.85

3.25

3.1

3.4

0.74

0.81

ug/l

0.92

396

4401

Vascular diseases of the intestine

247

3039

0.78

3.24

3.2

3.6

0.86

0.82

ug/l

0.15

168

2136

Other shoulder lesions

701

6166

1.16

3.24

3.1

3.0

0.68

0.77

ug/l

0.58

447

3695

Colonic or urogenital fistula

2493

23338

1.08

3.23

3.4

3.2

0.70

0.76

ug/l

3.90

1598

15064

Triptan medication for migraine, min. 3 purchases

1788

14523

0.91

3.23

2.8

2.6

0.65

0.68

ug/l

1.00

948

7654

Manic episode

144

1900

0.73

3.23

2.3

2.9

0.68

0.74

ug/l

0.22

1061

Other mental disorders due to brain damage and dysfunction and to physical disease

929

10332

0.88

3.22

3.3

3.5

0.70

0.83

ug/l

5.61

683

7235

Benign neoplasm: Kidney

274

2237

1.28

3.22

3.4

3.5

0.95

0.80

ug/l

0.60

192

1527

Toxic effects of substances chiefly nonmedicinal as to source

761

8576

0.87

3.22

2.8

3.0

0.69

0.73

ug/l

0.79

498

5071

Use of riluzole

348

0.40

3.21

2.3

3.3

0.95

0.84

ug/l

0.13

235

Pain in thoracic spine

1009

9068

1.13

3.18

3.0

0.68

0.76

ug/l

1.11

666

5458

Urethritis and urethral syndrome

145

1090

1.39

3.18

3.3

2.9

0.66

0.72

ug/l

0.44

639

Other noninfective gastroenteritis and colitis

1776

16386

1.10

3.18

3.2

0.73

0.78

ug/l

1.43

1177

10586

Implicit bacterial Sepsis, including avohilmo

5184

45048

0.95

3.15

3.1

3.4

0.82

0.79

ug/l

0.55

3787

30646

Other disorders affecting eyelid function

710

0.57

3.15

2.0

3.1

0.78

ug/l

0.00

464

Bipolar affective disorders

1038

11513

0.89

3.15

2.8

0.59

0.72

ug/l

5.97

699

6424

Diabetic retinopathy, excluding more controls

2146

12889

0.92

3.15

3.1

3.2

0.80

0.75

ug/l

0.82

1491

8531

Other enthesopathy of foot (+metatarsalgia)

530

4566

1.18

3.15

3.3

3.0

0.66

0.78

ug/l

4.31

351

2859

Paranoid personality disorder

1174

0.66

3.15

2.9

3.0

0.67

0.73

ug/l

0.25

696

Lung transplant status

642

1.59

3.14

1.7

3.0

0.51

0.74

ug/l

3.64

402

Lung transplantation

642

1.59

3.13

1.7

3.0

0.51

0.74

ug/l

3.64

402

Benign neoplasm: Appendix

103

745

1.51

3.12

3.5

3.2

0.74

0.81

ug/l

0.26

483

Other abnormal findings of blood chemistry

398

3379

1.22

3.12

3.5

3.1

0.72

0.70

ug/l

0.13

236

2156

Infectious mononucleosis

395

3323

1.21

3.12

2.4

2.5

0.68

0.64

ug/l

0.44

183

1559

Infectious mononucleosis, including avohilmo

395

3323

1.21

3.12

2.4

2.5

0.68

0.64

ug/l

0.44

183

1559

Urticaria

1583

14534

1.10

3.12

3.1

3.0

0.73

0.74

ug/l

0.17

990

8883

Thyrotoxicosis with toxic multinodular goitre

227

1804

1.28

3.11

4.0

3.4

0.67

0.79

ug/l

2.08

172

1221

Disorders of oesophagus in diseases classified elsewhere

128

1691

0.71

3.10

3.1

3.3

0.86

0.76

ug/l

0.24

101

1138

Personal history of malignant neoplasm

153

1148

1.35

3.10

3.1

0.85

0.73

ug/l

0.45

108

733

Desensitization to allergens

196

1529

1.31

3.09

2.6

2.4

0.61

0.65

ug/l

0.31

690

Secondary parkinsonism, excluding more controls

168

2142

0.74

3.08

3.2

3.4

0.74

0.88

ug/l

1.35

121

1448

Other/unspecified rheumatoid arthritis

541

6234

0.85

3.08

3.3

3.4

0.69

0.80

ug/l

3.02

379

4295

Malignant neoplasm of bladder

890

8026

1.15

3.07

3.1

0.77

ug/l

0.07

639

5720

Occlusion and stenosis of arteries, not leading to stroke

1069

0.65

3.07

2.5

3.6

0.89

0.85

ug/l

0.12

755

Seropositive rheumatoid arthritis, strict definition

729

8232

0.87

3.07

3.1

3.3

0.74

0.79

ug/l

0.38

494

5525

Other sleep disorders

1073

9731

1.13

3.07

3.2

0.75

0.79

ug/l

0.54

676

6275

Reactive arthropathies

715

6333

1.16

3.07

3.1

3.0

0.73

0.79

ug/l

0.51

447

3922

Asthma and allergy, excluding more controls

543

4627

1.17

3.06

2.7

2.6

0.54

0.70

ug/l

7.14

278

2387

Other congenital malformations of urinary system

255

1.87

3.06

3.2

2.8

0.85

0.78

ug/l

0.07

146

Disorders of acoustic nerve

223

1795

1.31

3.05

3.8

3.2

0.69

0.76

ug/l

0.62

151

1175

Hernia of abdominal wall

5422

51982

1.06

3.05

3.3

3.2

0.71

0.77

ug/l

4.82

3627

33955

Acute upper respiratory infections

9358

58004

0.96

3.05

3.1

3.2

0.72

0.79

ug/l

8.38

5859

38169

Idiopathic pulmonary fibrosis

711

7967

0.86

3.05

3.2

3.6

0.70

0.84

ug/l

3.07

521

5823

Fibromyalgia

155

1168

1.34

3.04

2.6

2.7

0.74

0.73

ug/l

0.03

609

Inhalation and ingestion of food causing obstruction of respiratory tract

718

0.58

3.04

2.9

3.3

0.68

0.80

ug/l

0.54

468

Dementia due to Parkinson's disease

187

2337

0.75

3.04

2.8

3.7

0.76

0.81

ug/l

0.32

129

1712

Viral hepatitis

447

5196

0.84

3.03

2.6

2.7

0.56

0.68

ug/l

4.09

295

2762

Benign neoplasm: Transverse colon

1174

10736

1.13

3.03

3.5

3.4

0.72

0.79

ug/l

1.00

887

7479

Other diseases of blood and blood-forming organs

630

5557

1.17

3.02

3.4

3.2

0.67

0.76

ug/l

2.78

414

3625

Use of anticholinesterases

3253

26505

0.93

3.01

3.3

3.7

0.82

0.86

ug/l

1.13

2383

19775

N06DA Anticholinesterases

3253

26505

0.93

3.01

3.3

3.7

0.82

0.86

ug/l

1.13

2383

19775

Left ventricular outflow tract obstruction (LVOTO), broad definition

936

10330

0.88

3.00

2.7

2.9

0.70

0.71

ug/l

0.06

587

6080

Generalized anxiety disorder

700

6154

1.15

3.00

2.8

2.7

0.52

0.69

ug/l

10.32

419

3174

Fall on same level involving ice and snow

4945

47208

1.05

2.99

3.1

0.73

0.76

ug/l

1.32

3182

29968

Dissociative [conversion] disorders

970

0.65

2.99

2.7

2.8

0.60

0.73

ug/l

0.88

550

Acute laryngitis and tracheitis

600

5154

1.16

2.97

2.4

0.73

0.66

ug/l

0.32

259

2444

Peroneal tendinitis

100

715

1.46

2.96

3.3

2.8

0.66

0.71

ug/l

0.36

437

Other infestations, including avohilmo

149

1147

1.38

2.95

3.1

3.2

0.75

0.74

ug/l

0.04

100

729

Autoimmune diseases

11445

59857

0.96

2.93

3.0

3.1

0.73

0.78

ug/l

4.13

7366

37368

Benign neoplasm: Pancreas

239

1954

1.29

2.91

3.6

0.76

0.75

ug/l

0.02

168

1359

Chronic laryngitis and laryngotracheitis

1112

10119

1.12

2.91

3.9

3.2

0.69

0.79

ug/l

4.77

761

6817

Melanocytic naevi of upper limb, including shoulder

155

1195

1.35

2.89

3.6

3.2

0.67

0.76

ug/l

1.01

112

772

Other and unspecified coagulation defects

296

2453

1.24

2.89

3.1

3.0

0.74

0.72

ug/l

0.13

191

1493

Carbimazole or st.post thyroidectomy, condition for graves disease

883

7910

1.13

2.88

3.1

3.2

0.75

ug/l

0.05

589

5059

Adenocarcinoma and Papillary adenocarcinoma of kidney

166

1330

1.41

2.88

3.7

2.9

0.82

0.72

ug/l

1.03

130

885

Sequelae of injuries of head

422

4881

0.83

2.87

3.0

0.63

0.73

ug/l

2.27

286

2962

Alzheimer’s disease (Atypical or mixed), excluding more controls

788

6565

0.88

2.86

2.9

3.9

0.91

0.92

ug/l

0.05

561

4995

Peritonsillar abscess

1744

16185

1.09

2.85

2.9

2.8

0.73

ug/l

0.00

1020

9406

Biomechanical lesions, not elsewhere classified

396

3387

1.21

2.85

3.4

3.3

0.75

0.77

ug/l

0.08

295

2220

Ischemic heart diseases

8716

50137

1.04

2.85

2.9

3.1

0.72

0.77

ug/l

2.85

5546

31033

Vitamin deficiency

241

2944

0.80

2.85

3.2

0.82

0.77

ug/l

0.31

172

1892

Vitamin deficiency, wide

241

2944

0.80

2.85

3.2

0.82

0.77

ug/l

0.31

172

1892

Benign neoplasm: Choroid

493

4287

1.18

2.84

3.8

3.4

0.74

0.76

ug/l

0.30

335

2924

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1007

11086

0.89

2.83

3.3

0.70

0.79

ug/l

4.20

700

7479

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

295

3541

0.82

2.83

2.8

2.9

0.69

0.72

ug/l

0.25

193

2043

Assault by sharp object

114

1505

0.71

2.83

2.2

2.5

0.46

0.67

ug/l

5.92

734

ILD, hospital admissions 3, with pneumonia sepsis

800

8871

0.88

2.82

3.0

3.6

0.74

0.82

ug/l

1.41

578

6361

Open wound of forearm

907

8199

1.13

2.82

3.1

0.75

ug/l

0.00

587

5035

Aortic valve malfunction, age under 60 years

900

9909

0.88

2.81

2.7

2.9

0.68

0.71

ug/l

0.60

567

5830

Fall on and from ladder

1059

9723

1.13

2.81

3.4

3.3

0.77

ug/l

0.00

689

6465

Transient ischemic attack

5754

44018

1.05

2.81

3.4

0.80

ug/l

0.01

4070

30528

Sleep disorders, other/unspecified

176

1378

1.31

2.80

2.6

2.7

0.49

0.71

ug/l

8.13

110

748

Other infective otitis externa

489

4256

1.18

2.80

3.6

3.2

0.76

0.75

ug/l

0.03

350

2768

Other arthritis (FG)

2644

24911

1.07

2.78

3.3

3.2

0.74

0.79

ug/l

1.28

1792

16073

Alzheimer’s disease (Atypical or mixed)

788

8658

0.88

2.78

2.9

3.7

0.91

0.90

ug/l

0.09

561

6491

Evidence of alcohol involvement determined by blood alcohol level

1205

0.68

2.77

2.7

2.9

0.77

0.72

ug/l

0.08

685

Helminthiases, including avohilmo

189

1495

1.30

2.77

2.9

0.67

0.76

ug/l

0.87

107

861

Alcohol-induced acute pancreatitis

397

4553

0.82

2.77

3.0

3.1

0.64

0.73

ug/l

1.66

267

2784

Other disorders of cornea

714

6364

1.15

2.77

3.2

3.1

0.72

0.76

ug/l

0.51

471

3957

Behavioural syndromes associated with physiological disturbances and physical factors

7927

55501

0.96

2.76

3.1

3.0

0.66

0.76

ug/l

9.12

4664

33987

Viral hepatitis, including avohilmo

470

5401

0.85

2.75

2.6

2.7

0.56

0.68

ug/l

3.26

310

2866

Loose body in joint

263

2195

1.27

2.74

3.1

3.0

0.86

0.77

ug/l

0.26

176

1402

Accidental poisoning by and exposure to other gases and vapours

372

0.46

2.74

2.1

3.0

0.86

0.79

ug/l

0.17

224

Reactive arthropathies, FINNGEN

557

4896

1.17

2.74

3.0

0.73

0.77

ug/l

0.25

349

2967

Acidosis

184

2263

0.76

2.73

2.8

3.3

0.78

0.75

ug/l

0.24

133

1512

Assault by unspecified means

103

1384

0.71

2.73

2.9

2.5

0.57

0.66

ug/l

0.86

652

Complications of internal orthopaedic prosthetic devices, implants and grafts

1955

18269

1.09

2.73

3.5

0.70

0.81

ug/l

6.84

1380

12846

Benign neoplasm of male genital organs

336

2912

1.27

2.72

3.9

3.3

0.69

0.78

ug/l

1.59

231

1926

Superficial injury of shoulder and upper arm

991

9003

1.12

2.72

3.4

3.1

0.70

0.77

ug/l

1.16

621

5601

Acute pancreatitis (for exclusion)

2012

21449

0.92

2.71

3.0

3.2

0.71

0.78

ug/l

2.09

1362

14054

Hereditary ataxia

1004

0.66

2.71

3.0

3.3

0.68

0.79

ug/l

0.55

654

Gastrojejunal ulcer

1071

0.67

2.71

2.3

3.2

0.70

0.79

ug/l

0.60

711

Benign neoplasm: Stomach

673

5988

1.15

2.70

3.6

3.4

0.81

0.80

ug/l

0.06

495

4129

Acute gastritis

499

5697

0.85

2.70

3.2

0.85

0.78

ug/l

0.29

351

3717

Injury of unspecified body region

594

5249

1.16

2.69

3.1

3.3

0.70

0.77

ug/l

0.86

391

3384

Colitis due to radiation

133

1040

1.42

2.69

4.7

3.5

0.83

0.82

ug/l

0.00

724

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

552

4853

1.16

2.69

3.5

3.2

0.73

ug/l

0.01

368

3084

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

9281

53292

1.04

2.68

3.0

3.1

0.76

0.77

ug/l

0.38

6012

32725

Diabetes, insulin treatment (Kela reimbursement)

10170

58672

1.04

2.66

3.0

3.1

0.76

0.77

ug/l

0.24

6642

36430

Transient acantholytic dermatosis [Grover]

217

2.18

2.66

3.3

0.67

0.80

ug/l

0.69

149

Mental and behavioural disorders due to opioids

169

2130

0.77

2.66

2.2

2.3

0.46

0.65

ug/l

4.49

103

927

Vascular syndromes of brain in cerebrovascular disorders

320

3757

0.82

2.66

3.0

3.6

0.85

ug/l

0.02

226

2642

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

492

0.53

2.66

3.1

3.2

1.73

0.75

ug/l

0.41

315

Separation of retinal layers (serosa)

487

4285

1.19

2.66

3.1

3.0

0.72

ug/l

0.04

322

2578

Corns and callosities

419

4835

0.84

2.65

3.0

3.2

0.65

0.76

ug/l

3.17

289

3126

Injuries to the hip and thigh

4632

43338

0.95

2.65

3.2

3.3

0.79

0.80

ug/l

0.03

3085

28960

Cerebral aneurysm, nonruptured

482

5516

0.86

2.64

3.1

3.3

0.80

0.76

ug/l

0.18

320

3618

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

8146

45988

1.04

2.64

3.0

3.2

0.76

0.78

ug/l

0.65

5432

29654

8146

45988

1.04

2.64

3.0

3.2

0.76

0.78

ug/l

0.65

5432

29654

Benign neoplasm: Cranial nerves

232

1910

1.27

2.63

3.7

3.3

0.72

0.76

ug/l

0.32

157

1241

Invasive ventilation

584

6569

0.86

2.63

2.8

3.3

0.75

0.77

ug/l

0.13

397

4336

Type 2 diabetes, wide definition

8370

51050

1.04

2.62

3.1

0.78

ug/l

0.00

5703

31940

Malignant neoplasm of testis

199

1630

1.32

2.62

2.8

2.5

0.69

ug/l

0.02

124

853

427

1.53

2.61

2.5

2.9

0.79

0.71

ug/l

0.20

252

Benign neoplasm: Conjunctiva

245

2026

1.26

2.61

3.4

3.2

0.84

0.78

ug/l

0.18

173

1324

Certain infectious and parasitic diseases

9417

45671

1.04

2.61

3.1

0.75

0.78

ug/l

1.12

6032

28479

Vasomotor rhinitis (mode)

482

4206

1.17

2.61

3.8

3.2

0.76

ug/l

0.05

317

2716

Mental and behavioural disorders due to use of other stimulants, including caffeine

118

1552

0.74

2.61

1.9

2.0

0.32

0.60

ug/l

13.23

575

Other and unspecified intracranial injuries

206

2513

0.79

2.60

2.9

3.2

0.71

0.77

ug/l

0.33

135

1595

Psychotic depression

304

3604

0.82

2.60

3.2

3.1

0.74

0.79

ug/l

0.32

196

2197

Benign neoplasm: Anus and anal canal

231

1904

1.27

2.59

3.9

3.4

0.77

0.80

ug/l

0.16

162

1285

Toxic effect of carbon monoxide

102

1353

0.71

2.59

3.0

0.60

0.75

ug/l

1.94

818

Pleural effusion

1616

17310

0.91

2.59

3.3

3.5

0.75

0.83

ug/l

2.61

1210

12357

ILD, hospital admission 2, with pulmonary infections

956

10458

0.89

2.58

3.0

3.5

0.72

0.83

ug/l

2.87

694

7414

Intentional self-harm by sharp object

1084

0.69

2.58

2.2

2.6

0.46

0.71

ug/l

4.83

534

Hereditary corneal dystrophies

216

1761

1.27

2.58

3.4

0.77

0.78

ug/l

0.03

161

1183

Unspecified kidney failure

1159

10673

1.11

2.57

3.1

3.5

0.91

0.82

ug/l

1.24

875

7507

Panic disorder

681

6057

1.14

2.57

2.6

2.7

0.58

0.70

ug/l

3.39

406

3114

Dementia due to Parkinsons disease, excluding more controls

187

2290

0.77

2.56

2.8

3.7

0.76

0.90

ug/l

0.99

129

1694

Shock, not elsewhere classified

837

0.64

2.56

2.6

3.4

0.59

0.77

ug/l

1.83

557

Alzheimer’s disease, strict definition

2187

18762

0.93

2.54

3.3

3.7

0.87

0.88

ug/l

0.06

1622

13977

Frostbite

940

0.66

2.53

2.5

3.0

0.62

0.78

ug/l

1.14

559

Other crystal arthropathies

183

1481

1.31

2.53

3.5

3.3

0.72

0.86

ug/l

1.16

133

1025

Hypothermia

143

1794

0.75

2.51

2.7

3.3

0.77

0.78

ug/l

0.04

1161

UC patients in KELA-register (code 208), prior to 1994

300

3519

0.82

2.50

3.2

0.73

ug/l

0.00

191

2275

Simple and mucopurulent chronic bronchitis

274

3247

0.82

2.50

3.5

0.78

0.86

ug/l

0.64

197

2235

Iron deficiency anaemia

3272

33724

0.94

2.48

3.3

3.4

0.89

0.81

ug/l

2.10

2369

23377

Other and unspecified acquired haemolytic anaemias

693

0.61

2.47

2.9

3.1

0.61

0.83

ug/l

1.51

446

Benign neoplasm of brain and other parts of central nervous system

490

4309

1.17

2.46

3.5

3.2

0.78

0.76

ug/l

0.11

336

2806

Vestibular neuronitis

731

6590

1.14

2.44

3.3

0.77

0.76

ug/l

0.13

490

4333

Rosacea

692

6192

1.13

2.44

3.5

3.3

0.73

0.77

ug/l

0.42

448

4066

Multiple myeloma and malignant plasma cell neoplasms

362

4172

0.84

2.43

3.0

3.5

0.95

0.79

ug/l

1.30

266

2940

Rheumatic fever incl heart disease

168

2081

0.78

2.39

3.2

3.4

0.78

0.82

ug/l

0.24

117

1415

Myeloid leukaemia

167

2061

0.77

2.39

3.0

3.3

0.69

0.79

ug/l

1.11

107

1379

Complications of procedures, not elsewhere classified

7921

61778

1.04

2.39

3.3

3.2

0.76

0.78

ug/l

0.63

5391

39636

Arthropathies in other diseases classified elsewhere

217

2615

0.80

2.39

2.9

3.1

0.65

0.80

ug/l

2.12

147

1656

Complications of cardiac and vascular prosthetic devices, implants and grafts

165

2025

0.77

2.39

2.7

3.4

0.78

0.81

ug/l

0.17

116

1411

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

222

1831

1.25

2.37

2.8

2.9

0.63

0.72

ug/l

0.80

126

1010

Pediculosis, acariasis and other infestations, including avohilmo

1188

10941

1.10

2.37

2.9

0.68

0.71

ug/l

0.68

698

6258

Pneumonia due to other infectious organisms, not elsewhere classified

241

2864

0.81

2.37

2.7

3.3

0.69

0.77

ug/l

0.78

156

1856

Malignant neoplasm, without specification of site

201

2439

0.80

2.37

2.9

0.69

0.77

ug/l

0.98

144

1674

Chromophobe cell carcinoma of kidney

482

1.59

2.36

3.2

2.9

0.73

0.77

ug/l

0.20

320

Other and unspecified mental retardation

573

0.60

2.36

2.6

0.68

0.70

ug/l

0.06

289

Idiopathic gout

1358

12694

1.11

2.35

3.3

3.4

0.82

0.79

ug/l

0.41

992

8803

Otalgia

391

3377

1.18

2.35

3.6

3.2

0.62

0.76

ug/l

5.27

263

2144

Injuries to the abdomen, lower back, lumbar spine and pelvis

3653

34386

1.06

2.35

3.1

3.2

0.72

0.78

ug/l

2.64

2429

22311

Malignant neoplasm of testis, including Hilmo

228

1917

1.27

2.35

2.9

2.5

0.69

0.71

ug/l

0.11

139

1039

Other dialysis

245

2892

0.81

2.34

2.7

3.2

0.97

0.74

ug/l

4.43

201

1819

Exposure to other specified electric current

102

1342

0.73

2.33

2.9

2.6

0.67

0.68

ug/l

0.04

699

Mental and behavioural disorders due to cannabinoids

118

1527

0.75

2.33

1.8

2.0

0.43

0.60

ug/l

3.40

565

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

716

6465

1.13

2.33

3.3

3.2

0.63

0.75

ug/l

4.06

473

4168

Disturbances of smell and taste

261

2192

1.22

2.32

3.3

3.2

0.73

0.75

ug/l

0.09

166

1418

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1114

10300

1.11

2.32

3.5

3.0

0.87

0.73

ug/l

5.84

839

6995

Exposure to smoke, fire and flames

185

2243

0.79

2.31

3.0

0.65

0.73

ug/l

1.13

110

1314

Implicit viral Sepsis, including avohilmo

3001

28501

1.06

2.31

3.3

3.4

0.77

0.80

ug/l

0.54

2169

19304

Malignant neoplasm of urinary organs

1102

10187

1.11

2.31

3.4

3.0

0.85

0.73

ug/l

4.58

825

6938

Portal vein thrombosis

112

1434

0.73

2.31

2.9

3.2

0.59

0.73

ug/l

2.21

900

Late syphilis, including avohilmo

110

1412

0.73

2.30

2.7

3.1

0.75

0.73

ug/l

0.06

872

Pleural plaque without asbestos

433

3831

1.19

2.30

3.8

3.7

0.88

0.82

ug/l

0.40

308

2809

Brain meningioma

221

1822

1.24

2.30

3.4

2.9

0.81

0.74

ug/l

0.64

156

1215

Fungal Sepsis

302

3517

0.83

2.30

3.1

3.5

0.79

0.78

ug/l

0.03

239

2367

Olecranon bursitis

908

8368

1.13

2.29

3.3

3.1

0.67

0.79

ug/l

5.14

598

5350

Other viral diseases

2117

19866

1.07

2.28

2.8

0.71

0.72

ug/l

0.22

1229

11260

Other skin changes

1758

16490

1.08

2.28

3.5

3.4

0.78

0.82

ug/l

0.68

1237

11456

Universal erythroderma, KELA reimbursement

1228

0.72

2.28

2.8

3.1

0.57

0.76

ug/l

3.03

768

Acute myeloid leukaemia and myelodysplastic syndromes

146

1818

0.77

2.27

3.2

3.0

0.82

0.77

ug/l

0.28

1256

Fracture of lower leg, including ankle

4424

45213

0.95

2.27

3.0

0.74

0.76

ug/l

0.56

2831

27820

Scleritis and episcleritis

347

2987

1.19

2.26

2.9

3.0

0.66

0.71

ug/l

0.93

231

1760

Biological medication for rheuma

951

10393

0.90

2.26

2.5

2.7

0.66

0.68

ug/l

0.41

537

5609

Other and unspecified urticaria

1004

9193

1.10

2.25

3.0

3.1

0.75

ug/l

0.04

639

5603

Chondrocostal junction syndrome [Tietze]

167

1340

1.28

2.25

3.4

3.0

0.61

0.75

ug/l

1.99

118

816

Malignant neoplasm of colon, including Hilmo

1823

17064

1.08

2.25

3.3

3.0

0.87

0.73

ug/l

3.94

1311

11761

Disorders of skin appendages

3654

34731

1.05

2.25

3.1

3.0

0.72

0.75

ug/l

0.70

2295

21331

Other diseases of pericardium

379

4324

0.85

2.24

3.2

3.4

0.76

0.81

ug/l

0.43

274

2917

Gluteal tendinitis

185

1501

1.26

2.24

4.0

3.2

0.71

0.80

ug/l

0.85

121

989

Depression or dysthymia

7148

40300

0.96

2.23

3.1

3.2

0.68

0.81

ug/l

14.12

4683

25493

Abnormal involuntary movements

1111

10255

1.10

2.23

3.3

0.72

0.78

ug/l

1.15

793

6802

Superficial injury of lower leg

1709

15994

1.08

2.23

3.1

3.0

0.70

0.75

ug/l

0.94

1097

9844

Right bundle-branch block

432

3819

1.18

2.23

3.5

3.4

0.77

0.83

ug/l

0.84

308

2637

Panhypopituitarism

181

1491

1.29

2.23

4.1

3.1

0.60

0.75

ug/l

3.71

143

930

Other and unspecified vascular occlusions

856

7827

1.12

2.22

3.5

0.84

0.83

ug/l

0.10

634

5587

Other and unspecified hydrocephalus

1067

0.71

2.22

2.5

3.1

0.78

0.80

ug/l

0.05

698

Late syphilis

1221

0.72

2.21

2.8

3.1

0.71

0.74

ug/l

0.16

753

Fracture of lumbar spine and pelvis

1849

17333

1.08

2.21

3.2

3.3

0.76

0.81

ug/l

1.08

1297

11809

Postprocedural disorders of ear and mastoid process, not elsewhere classified

568

0.60

2.21

3.1

3.2

0.65

0.78

ug/l

1.11

383

Complications of medical and surgical care

6834

59418

1.04

2.21

3.3

3.2

0.76

0.78

ug/l

1.13

4685

39295

Care involving use of rehabilitation procedures

5786

53847

0.96

2.21

3.1

0.71

0.75

ug/l

1.50

3858

33948

Periapical abscess

4386

45619

0.95

2.21

3.1

3.0

0.73

0.74

ug/l

0.30

2855

27897

Recurrent aphthous stomatitis , including avohilmo

863

7865

1.11

2.20

3.2

0.66

0.78

ug/l

2.68

552

5100

Crystal arthropathies, rheuma endpoint

183

1507

1.28

2.20

3.5

3.3

0.72

0.83

ug/l

0.81

133

1019

Patellar tendinitis

147

1177

1.31

2.20

2.4

2.5

0.60

0.70

ug/l

0.87

595

Communicating hydrocephalus

104

1346

0.74

2.19

2.8

3.3

0.64

0.78

ug/l

1.27

888

Other ulcerative colitis

347

3996

0.85

2.19

3.0

0.68

0.72

ug/l

0.50

235

2366

Exposure to uncontrolled fire in building or structure

702

0.64

2.18

2.3

2.9

0.62

0.71

ug/l

0.50

405

Pathological resorption of teeth

296

2538

1.21

2.18

3.2

3.1

0.67

0.74

ug/l

0.70

197

1554

Collapsed vertebra, not elsewhere classified

378

1.55

2.17

3.3

3.1

0.86

0.84

ug/l

0.06

264

Crohn's disease NAS

349

4020

0.85

2.17

2.8

3.0

0.65

0.72

ug/l

1.67

211

2368

Sulfasalazine

2054

21769

0.93

2.17

3.0

3.1

0.72

0.76

ug/l

0.75

1327

13755

Diseases of tongue

373

3240

1.17

2.17

3.6

3.1

0.76

0.80

ug/l

0.27

259

2005

Adrenocortical insufficiency

147

1832

0.78

2.16

3.5

3.2

0.92

0.77

ug/l

0.31

111

1163

Primary Sclerosing Cholangitis, IBD and UDCA required

100

1301

0.74

2.16

2.7

2.8

0.73

0.71

ug/l

0.05

707

Other symptoms and signs involving cognitive functions and awareness

4989

42619

1.05

2.14

3.3

0.74

0.81

ug/l

4.68

3573

28995

Brain meningioma, including Hilmo

233

1948

1.22

2.13

3.5

2.9

0.81

0.74

ug/l

0.61

165

1284

Osteoporosis

1069

10662

0.91

2.13

3.3

3.4

0.71

0.82

ug/l

2.90

764

7345

Urticaria and erythema

2060

19413

1.07

2.12

3.1

0.74

0.75

ug/l

0.11

1293

12064

Medicines for HER+ breast cancer

127

915

1.29

2.12

3.5

2.7

1.06

0.75

ug/l

0.40

477

Hypokalaemia

761

8362

0.90

2.12

3.2

3.3

0.81

0.79

ug/l

0.14

547

5594

Impingement syndrome of shoulder

2415

22940

1.07

2.12

3.4

3.2

0.70

0.78

ug/l

2.48

1634

15073

Benign neoplasm: Skin of ear and external auricular canal

338

2939

1.19

2.12

3.9

3.5

0.72

0.81

ug/l

1.19

238

2022

Other neurotic disorders

303

3508

0.84

2.11

3.0

3.2

0.72

0.75

ug/l

0.30

205

2225

Carcinoma in situ of skin, other sites/unspecified

146

1182

1.31

2.10

3.9

3.5

0.76

0.83

ug/l

0.59

830

Aphakia

142

1140

1.31

2.10

3.4

3.3

0.80

ug/l

0.02

107

762

Malignant neoplasm of other and ill-defined sites, including Hilmo

965

0.70

2.10

3.1

2.9

0.65

0.82

ug/l

1.43

650

Exposure to excessive heat of man-made origin

711

0.65

2.09

3.0

3.1

0.71

0.79

ug/l

0.38

450

Abnormal findings in nipple discharge synovial fluid wound secretions

695

1.39

2.09

3.4

2.9

0.79

0.73

ug/l

0.27

421

Pacemaker

4348

38916

1.05

2.08

3.4

3.5

0.81

0.82

ug/l

0.18

3165

27719

Anaemia in chronic diseases classified elsewhere

187

2235

0.80

2.07

2.8

3.4

1.13

0.79

ug/l

2.21

155

1503

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

644

5842

1.13

2.07

3.3

3.2

0.75

ug/l

0.02

439

3777

Tumor necrosis factor alpha inhibitors

812

8898

0.90

2.07

2.5

2.7

0.65

0.68

ug/l

0.79

452

4750

Vascular disorders of the intestines

539

5998

0.88

2.07

3.3

3.5

0.87

0.84

ug/l

0.14

394

4241

Synovial cyst of popliteal space [Baker]

504

4489

1.14

2.07

3.3

3.2

0.69

0.81

ug/l

3.59

356

2977

Bacterial intestinal infections, IBD co-morbidities

1378

14750

0.92

2.06

3.2

3.3

0.86

0.80

ug/l

0.56

943

9905

Episcleritis

285

2436

1.19

2.06

3.0

0.63

0.71

ug/l

1.68

190

1411

Procedures for purposes other than remedying health state

510

1.42

2.06

3.2

3.0

0.67

0.75

ug/l

0.55

313

Visual impairment including blindness (binocular or monocular)

485

4312

1.15

2.06

3.4

0.77

0.80

ug/l

0.23

340

2931

Cardiomyopathy in other diseases

547

1.50

2.05

3.0

3.5

0.71

0.77

ug/l

0.26

404

Moderate mental retardation

305

0.49

2.05

1.8

2.7

0.92

0.67

ug/l

—

166

Hyperkinetic disorders

373

3156

1.16

2.05

2.0

1.9

0.44

0.55

ug/l

4.70

177

1091

Acute posthaemorrhagic anaemia

213

2529

0.82

2.04

3.0

3.5

0.86

0.81

ug/l

0.21

165

1760

Melanoma in situ of lower limb, including hip

276

1.62

2.04

4.0

3.0

0.72

0.77

ug/l

0.27

191

Family history of malignant neoplasm

365

3170

1.16

2.03

3.3

3.0

0.77

0.71

ug/l

0.50

217

1915

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

136

1680

0.77

2.03

2.9

3.0

0.66

0.76

ug/l

1.25

100

1141

Follow-up examination after treatment for malignant neoplasms

822

7524

1.11

2.03

3.5

0.85

0.84

ug/l

0.05

588

5365

Congenital malformations of trachea and bronchus

418

0.57

2.02

3.2

0.68

0.74

ug/l

0.11

266

Behavioural disorders, excluding more controls

849

0.70

2.02

1.9

2.2

0.53

0.68

ug/l

1.39

340

Disorders of eyelid, lacrimal system and orbit

8334

59341

1.03

2.01

3.5

3.2

0.75

0.79

ug/l

2.41

5854

38935

Disturbance of activity and attention

343

2893

1.16

2.00

2.0

1.9

0.44

0.56

ug/l

4.54

155

993

Acute pancreatitis

2012

21221

0.93

2.00

3.0

3.2

0.71

0.78

ug/l

2.18

1362

13846

Infliximab

997

0.72

2.00

2.5

2.3

0.56

0.65

ug/l

0.89

428

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2554

23597

1.06

1.98

4.2

3.0

1.45

0.72

ug/l

25.54

2005

16137

Benign neoplasm: Prostate

118

968

1.42

1.98

4.9

3.5

0.74

0.83

ug/l

0.77

694

Other and unspecified myopathies

743

8112

0.90

1.98

3.0

3.3

0.73

0.80

ug/l

1.12

520

5471

Poisoning by medicine, drug-induced

746

0.68

1.96

2.7

0.38

0.69

ug/l

6.47

386

Benign neoplasm: Rectosigmoid junction

376

3321

1.17

1.96

3.9

3.4

0.92

0.78

ug/l

0.58

282

2286

Malignant neoplasm of head and neck, including Hilmo

960

10350

0.91

1.95

3.0

0.72

ug/l

0.12

673

6876

Other and unspecified medical devices associated with adverse incidents

385

1.56

1.95

3.3

0.59

0.81

ug/l

1.88

263

Rare circulating lymphoid malignancy

441

0.58

1.95

3.5

2.9

0.68

0.85

ug/l

0.99

307

Other and/or unspecified nontoxic goitre

268

2284

1.19

1.94

3.5

3.4

0.90

0.78

ug/l

0.44

195

1559

Unspecified contracted kidney

394

0.56

1.94

2.3

3.1

0.80

0.77

ug/l

0.13

243

Symptoms and signs involving the nervous and musculoskeletal systems

5250

50728

1.04

1.94

3.2

3.3

0.72

0.79

ug/l

5.94

3455

33820

Other mycoses, not elsewhere classified/unspecified, including avohilmo

144

1170

1.29

1.94

3.5

3.2

0.74

ug/l

0.01

719

Nausea and vomiting

1639

16997

0.93

1.93

3.2

3.3

0.82

0.81

ug/l

0.11

1143

11254

Hydrocephalus in other diseases

297

0.50

1.93

3.1

3.0

0.81

0.76

ug/l

0.09

190

Implicit fungal Sepsis

271

3134

0.84

1.93

3.1

3.4

0.77

0.78

ug/l

0.06

212

2119

Any reimbursement code in KELA

4444

23154

0.96

1.93

2.8

2.7

0.69

0.70

ug/l

0.07

2571

12096

Chronic constrictive pericarditis

305

0.50

1.93

1.9

3.2

0.82

0.79

ug/l

0.07

205

Ductal carcinoma of pancreas

640

0.65

1.93

2.3

3.0

0.79

0.73

ug/l

0.14

428

Hydronephrosis

1112

10350

1.09

1.92

3.7

3.4

1.16

0.78

ug/l

8.68

821

7115

Use of tolcapone

0.00

1.92

0.0

3.5

—

0.75

—

Pseudomembranous colitis

362

0.55

1.92

2.4

3.0

0.81

0.84

ug/l

—

217

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

3044

31768

0.95

1.92

2.9

3.1

0.72

0.73

ug/l

0.05

1926

19738

Glucagon-like peptide-1 (GLP-1) analogues

3044

31768

0.95

1.92

2.9

3.1

0.72

0.73

ug/l

0.05

1926

19738

Hyperkalaemia

511

5668

0.88

1.91

3.1

3.4

0.88

0.83

ug/l

0.41

382

3958

Ulcerative colitis, NAS

935

10123

0.91

1.91

2.9

3.0

0.70

0.74

ug/l

0.87

597

6079

Benign neoplasm: Descending colon

723

6630

1.12

1.91

3.6

3.4

0.80

0.78

ug/l

0.10

543

4558

Noise effects on inner ear

522

5733

0.87

1.91

3.1

3.2

0.71

0.76

ug/l

0.63

309

3635

Malignant neoplasm of colon

1484

13948

1.08

1.91

3.3

3.1

0.88

0.74

ug/l

3.75

1059

9668

Nerve, nerve root and plexus disorders

10955

64208

1.03

1.89

3.1

0.72

0.78

ug/l

6.37

7115

40661

Other viral diseases, not elsewhere classified

1327

12368

1.08

1.88

2.8

2.9

0.70

0.74

ug/l

0.72

792

7288

Lichen planus, including avohilmo

1257

11735

1.08

1.87

3.2

0.77

0.76

ug/l

0.09

772

7691

Benign neoplasm of meninges

487

4349

1.13

1.87

3.8

3.4

0.87

0.77

ug/l

0.68

357

3002

Pneumothorax

691

7529

0.89

1.86

3.2

3.4

0.77

0.81

ug/l

0.53

475

5089

Dronedarone medication

307

2695

1.19

1.86

3.9

3.5

0.71

0.81

ug/l

1.33

226

1893

Melanocytic naevi of scalp and neck

160

1317

1.26

1.85

3.1

0.70

0.75

ug/l

0.49

108

823

Disorder of lipoprotein metabolism, unspecified

1472

13870

1.08

1.85

3.2

3.5

0.74

0.79

ug/l

1.26

1066

9632

Peripheral retinal degeneration

219

1859

1.22

1.85

3.4

3.2

0.75

0.76

ug/l

0.14

149

1185

Other bursitis of elbow

116

941

1.35

1.85

3.8

3.2

0.65

0.80

ug/l

1.55

615

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

435

0.58

1.85

3.3

3.1

0.79

0.72

ug/l

0.17

267

Diffuse large B-cell lymphoma, helper endpoint

462

4148

1.15

1.84

3.0

0.81

0.73

ug/l

0.84

322

2812

Diffuse large B-cell lymphoma, including Hilmo

462

4148

1.15

1.84

3.0

0.81

0.73

ug/l

0.84

322

2812

Diffuse large B-cell lymphoma

462

4148

1.15

1.84

3.0

0.81

0.73

ug/l

0.84

322

2812

Non-Hodgkin lymphoma, all, including Hilmo

1305

12242

1.08

1.84

3.1

3.0

0.77

0.72

ug/l

1.04

903

8301

Hyperosmolality and hypernatraemia

1006

0.73

1.83

2.5

3.3

0.77

0.81

ug/l

0.16

682

Malignant neoplasm of renal pelvis, including Hilmo

133

1090

1.31

1.83

3.3

3.0

0.92

0.79

ug/l

0.46

739

Embolic stroke

399

4467

0.87

1.83

3.2

3.6

0.87

0.84

ug/l

0.15

272

3215

Diphtheria, including avohilmo

122

2.06

1.83

3.6

2.9

0.93

0.84

ug/l

0.11

Other disorders following mastoidectomy

261

0.49

1.82

2.6

3.2

0.59

0.72

ug/l

—

174

Lichen simplex chronicus

205

2413

0.82

1.82

2.8

3.2

0.67

0.76

ug/l

1.02

127

1525

Hard cardiovascular diseases

8448

48598

1.03

1.82

2.9

3.1

0.73

0.76

ug/l

1.00

5344

29757

Organ-limited amyloidosis

391

1.53

1.81

2.6

3.3

0.67

0.88

ug/l

1.27

269

Second line medication for Crohn's disease

4357

45095

0.96

1.81

3.0

3.1

0.70

0.75

ug/l

2.21

2843

28132

Open wound of thorax

109

1355

0.76

1.81

2.7

2.9

0.60

0.74

ug/l

1.74

761

Klinefelter syndrome, karyotype 47 XXY

145

1.94

1.81

2.2

0.41

0.68

ug/l

2.73

Hypothyroidism, drug reimbursement

721

5515

0.90

1.81

3.1

2.6

0.67

0.71

ug/l

1.02

495

2904

Foreign body in genitourinary tract

394

0.58

1.81

3.8

3.2

0.88

0.83

ug/l

0.11

255

Diseases of the myoneural junction and muscle

1008

10831

0.92

1.80

3.0

3.3

0.72

0.79

ug/l

1.52

700

7219

Other injuries of lower limb, level unspecified

638

1.38

1.80

2.5

3.1

0.73

0.77

ug/l

0.14

398

Toxic effect of contact with venomous animals

280

2427

1.18

1.80

3.1

0.81

0.73

ug/l

0.62

181

1505

Other/unspecified dorsalgia

2949

27873

1.05

1.79

3.1

0.72

0.80

ug/l

2.02

1958

17516

Benign neoplasm of urinary organs

371

3286

1.16

1.79

3.6

3.5

0.90

0.78

ug/l

0.63

271

2290

Neuromuscular dysfunction of bladder

852

7878

1.10

1.79

3.3

0.60

0.79

ug/l

9.84

632

5294

Chondropathies

1116

10402

1.09

1.78

3.1

3.0

0.67

0.73

ug/l

2.05

661

6174

Dementia, including avohilmo

4766

33587

0.96

1.78

3.3

3.7

0.80

0.84

ug/l

1.36

3499

24816

Pure hyperglyceridaemia

190

2231

0.81

1.78

3.0

3.2

1.05

0.75

ug/l

0.67

121

1414

Maltreatment syndromes

210

2477

0.83

1.78

2.3

2.5

0.52

0.67

ug/l

3.84

116

1192

Benign neoplasm: salivary glands, exclude unknown (D119)

754

6938

1.11

1.78

3.2

3.3

0.73

0.77

ug/l

0.66

510

4659

3302

31431

1.05

1.77

2.9

3.0

0.64

0.76

ug/l

15.34

2030

18924

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

216

1836

1.21

1.77

3.1

0.65

0.73

ug/l

0.94

142

1114

Acute renal failure

2444

25551

0.94

1.77

2.9

3.4

0.92

0.78

ug/l

3.62

1823

17564

Angina pectoris

6428

43841

0.96

1.77

3.2

3.3

0.74

0.79

ug/l

3.06

4377

28920

Atopic dermatitis

3684

30500

0.96

1.77

3.0

2.9

0.68

0.73

ug/l

2.66

2136

17247

Anorexia (incl.atypical)

143

1752

0.81

1.77

2.5

2.9

0.69

0.78

ug/l

0.66

1016

Autoimmune diseases excluding thyroid diseases

10785

59775

0.97

1.76

3.0

3.1

0.74

0.78

ug/l

2.09

7028

37314

severe traumatic brain injury, does not include concussion

2431

25414

0.94

1.76

3.3

3.4

0.79

0.81

ug/l

0.33

1721

17304

Other congenital malformations of upper alimentary tract

514

0.63

1.76

1.9

3.4

0.69

0.81

ug/l

0.20

349

Cutaneous abscess, furuncle and carbuncle

2256

23667

0.94

1.76

2.9

3.0

0.66

0.75

ug/l

6.25

1471

14528

Colorectal adenocarcinoma

2180

20509

1.06

1.75

3.3

3.0

0.82

0.73

ug/l

2.43

1533

14075

Moderate visual impairment, binocular

186

1561

1.22

1.75

3.4

3.5

0.85

0.84

ug/l

0.05

141

1065

Malignant neoplasm of kidney, except renal pelvis

990

9232

1.10

1.75

3.4

3.0

0.87

0.72

ug/l

4.93

751

6259

Somnolence

696

0.69

1.75

3.2

3.1

0.65

0.80

ug/l

0.63

424

Rheumatic valve diseases

121

1490

0.78

1.73

3.0

3.4

0.80

0.83

ug/l

0.13

1020

L04AX Other immunosuppressants

4222

43699

0.96

1.73

3.0

3.1

0.70

0.75

ug/l

2.28

2772

27369

Disorders of eyelid in diseases classified elsewhere

180

1507

1.22

1.73

3.3

3.0

0.72

0.78

ug/l

0.54

126

946

Colitis, primary sclerosing

853

0.72

1.73

2.4

2.6

0.78

0.68

ug/l

0.24

451

Effects of air pressure and water pressure

394

1.50

1.72

2.9

2.6

0.61

0.74

ug/l

0.58

210

Melanoma in situ of scalp and neck

266

1.72

4.4

3.5

0.71

0.81

ug/l

0.45

188

Glaucoma suspect

2934

28119

1.05

1.71

3.5

3.4

0.76

0.80

ug/l

0.82

2018

19403

Right hemicolectomy

411

4585

0.87

1.71

3.1

3.5

0.76

0.82

ug/l

0.72

285

3161

Eating disorders

202

2388

0.84

1.70

2.5

2.9

0.64

0.74

ug/l

0.98

126

1352

Inflammation of lacrimal passages (acute and unspecified)

645

1.34

1.70

2.9

3.0

0.78

0.77

ug/l

0.02

390

Spasmodic torticollis

139

1134

1.25

1.70

2.9

3.1

0.81

0.74

ug/l

0.16

715

Other abnormalities of plasma proteins

139

1147

1.27

1.70

3.8

3.2

0.80

0.72

ug/l

0.57

755

Presence of cardiac and vascular implants and grafts

5979

42736

1.04

1.70

3.3

0.82

0.80

ug/l

0.38

4247

29263

Other or unspecified ileus, impaction or obstruction

1711

18038

0.94

1.70

3.1

3.3

0.78

0.82

ug/l

0.65

1198

12249

Benign neoplasm: Cerebral meninges

432

3858

1.13

1.69

3.7

3.4

0.85

0.78

ug/l

0.48

319

2652

Unspecified event, undetermined intent

131

1596

0.79

1.69

2.9

0.59

0.72

ug/l

1.08

920

Pain and other conditions associated with female genital organs and menstrual cycle

2.93

1.69

1.1

—

Diseases of arteries, arterioles and capillaries

7907

56530

1.03

1.68

3.2

3.3

0.78

0.79

ug/l

0.06

5549

37987

Anosmia

174

1396

1.23

1.68

3.5

3.0

0.77

0.73

ug/l

0.11

111

865

Ménière disease

601

5477

1.11

1.67

3.3

0.80

0.78

ug/l

0.12

395

3721

Iridocyclitis

1839

17455

1.06

1.67

3.2

3.1

0.70

0.76

ug/l

2.27

1230

11011

Use of entacapone

625

0.67

1.67

3.0

3.4

0.66

0.89

ug/l

2.01

436

Epidural haemorrhage

949

0.73

1.67

2.7

3.0

0.71

0.74

ug/l

0.16

562

Other bacterial intestinal infections

1404

14893

0.93

1.66

3.2

3.3

0.85

0.80

ug/l

0.43

955

9995

Acute bronchitis

3402

34654

0.96

1.66

3.1

3.2

0.73

0.80

ug/l

5.26

2209

22387

Clear cell adenocarcinoma of kidney

519

4731

1.13

1.66

3.4

3.0

0.89

0.71

ug/l

4.15

392

3129

L02BG Aromatase inhibitors

470

1.37

1.66

2.8

2.3

0.60

0.69

ug/l

0.41

192

Other peripheral vascular diseases

428

4773

0.88

1.66

3.1

3.4

0.67

0.79

ug/l

2.95

293

3176

Drug-induced hypoglycaemia without coma

103

1277

0.77

1.66

2.7

3.1

0.64

0.79

ug/l

1.34

794

Diphtheria

103

2.09

1.65

3.6

2.9

0.96

0.73

ug/l

—

Injury of eye and orbit

1465

13841

1.07

1.65

2.9

0.69

0.74

ug/l

0.98

827

7922

Pustular psoriasis

184

2176

0.83

1.65

3.2

3.1

0.60

0.73

ug/l

3.11

121

1364

Colitis, primary sclerosing, strict definition

651

0.69

1.65

2.4

2.6

0.82

0.69

ug/l

0.26

338

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

555

0.66

1.65

3.2

3.1

1.46

0.74

ug/l

0.39

341

Vitamin B12 deficiency anaemia

731

7927

0.91

1.64

3.3

3.5

0.85

0.83

ug/l

0.13

519

5664

Other fall from one level to another

2020

21182

0.94

1.64

3.0

3.1

0.74

0.75

ug/l

0.25

1277

13427

Conduct disorder

842

0.73

1.64

1.9

2.3

0.56

0.63

ug/l

0.41

355

Other surgical follow-up care

237

2046

1.19

1.64

3.3

3.1

0.62

0.73

ug/l

2.26

172

1266

Superficial frostbite

563

0.66

1.63

2.1

2.9

0.64

0.80

ug/l

0.67

318

Noninfectious colitis NAS

904

8390

1.09

1.63

3.0

3.1

0.71

0.78

ug/l

1.11

607

5269

Exfoliative dermatitis

1022

0.74

1.62

3.0

3.3

0.51

0.80

ug/l

8.17

659

Otitis media, unspecified

395

4081

0.88

1.62

3.2

2.9

0.74

0.71

ug/l

0.07

235

2384

Malignant neoplasm of digestive organs

3975

31440

0.96

1.62

3.1

2.9

0.79

0.71

ug/l

4.84

2773

20754

Other and unspecified polyneuropathies, also in other diseases

2252

21559

1.06

1.61

3.5

3.4

0.69

0.80

ug/l

5.48

1668

14841

Disorders of continuity of bone

491

5430

0.89

1.61

3.1

3.0

0.76

0.73

ug/l

0.23

318

3227

484

0.64

1.61

2.4

3.2

1.00

0.83

ug/l

0.38

321

Malignant neoplasm of endocrine gland

356

3157

1.14

1.60

3.3

2.8

0.74

0.71

ug/l

0.35

244

1945

Other and unspecified diseases of blood and blood-forming organs

207

1779

1.20

1.59

3.1

3.2

0.59

0.75

ug/l

3.60

145

1171

Chronic tubulo-interstitial nephritis

121

1484

0.80

1.59

3.0

3.2

0.75

0.77

ug/l

0.12

946

Evidence of alcohol involvement determined by level of intoxication

669

0.70

1.59

2.5

2.8

0.77

0.72

ug/l

0.12

376

Urethral discharge

147

1.98

1.58

2.7

2.8

0.64

0.75

ug/l

0.41

Other functional intestinal disorders

3849

33739

1.04

1.58

3.4

3.3

0.76

0.81

ug/l

1.89

2728

22656

Autoimmune diseases excluding thyroid diseases, strict definition

10614

58956

0.97

1.57

3.0

3.1

0.75

0.78

ug/l

1.98

6909

36730

Somatoform disorder

902

8376

1.09

1.57

3.2

3.0

0.60

0.75

ug/l

9.54

590

5039

Contact with sharp object, undetermined intent

239

2084

1.19

1.57

3.1

2.9

0.63

0.72

ug/l

0.83

145

1162

Muscle strain

237

2054

1.18

1.57

3.2

3.0

0.73

0.74

ug/l

0.12

138

1240

Inflammation of lacrimal passages (chronic)

629

1.33

1.56

3.1

0.80

0.84

ug/l

0.11

409

Other and unspecified degenerative diseases of nervous system

204

2358

0.83

1.56

3.4

3.6

0.82

ug/l

0.00

154

1695

Stomatitis and related lesions

1305

12288

1.07

1.55

3.1

0.67

0.76

ug/l

2.15

823

7715

Other symptoms and signs involving the circulatory and respiratory systems

548

5002

1.12

1.54

3.6

3.2

0.69

0.80

ug/l

2.13

387

3291

Other diseases of gallbladder

287

2524

1.16

1.54

3.4

0.72

0.78

ug/l

0.71

189

1658

Herpesviral [herpes simplex] infections

705

6495

1.10

1.54

3.2

0.72

0.78

ug/l

1.00

477

4132

Budesonide

1004

9380

1.08

1.54

3.2

3.1

0.71

0.76

ug/l

1.03

641

5745

Intermittent heterotropia

242

2091

1.17

1.53

3.4

3.0

1.02

0.72

ug/l

0.80

144

1210

Other disorders of adrenal gland

195

2277

0.84

1.53

3.3

3.2

0.89

0.76

ug/l

0.35

141

1440

Other and unspecified injuries of abdomen, lower back and pelvis

105

847

1.29

1.53

2.8

3.0

0.65

0.77

ug/l

1.02

495

Isolated growth hormone deficiency

101

1.84

1.53

2.7

2.0

0.53

0.69

ug/l

0.87

Vertical strabismus

226

1957

1.18

1.53

3.1

3.2

0.74

0.75

ug/l

0.05

154

1241

Sleep disorders

7507

52970

0.97

1.53

3.1

3.0

0.66

0.75

ug/l

7.87

4393

32171

Campylobacter enteritis

228

1982

1.19

1.53

3.1

3.0

0.74

0.75

ug/l

0.02

145

1230

Other general symptoms and signs

260

2244

1.16

1.52

3.3

3.2

0.70

0.75

ug/l

0.50

157

1378

Asthma, hospital admissions 3, pneumonia

2977

30827

0.96

1.52

3.1

3.3

0.68

0.82

ug/l

13.57

2005

20800

Asthma-related pneumonia or sepsis

2977

30827

0.96

1.52

3.1

3.3

0.68

0.82

ug/l

13.57

2005

20800

Seminoma of testis, including Hilmo

120

999

1.30

1.52

2.8

2.4

0.71

0.67

ug/l

0.24

520

Stenosis and insufficiency of lacrimal passages

466

4210

1.12

1.52

3.4

3.3

0.80

0.78

ug/l

0.16

316

2801

Drug-induced osteoporosis

610

0.69

1.52

3.1

0.49

0.75

ug/l

3.46

380

Injuries to the neck

1863

17741

1.06

1.51

3.1

3.0

0.70

0.74

ug/l

0.80

1165

10863

Pneumocystosis

136

1617

0.80

1.51

2.3

3.4

0.67

0.75

ug/l

0.54

1104

Pneumocystosis, including avohilmo

136

1617

0.80

1.51

2.3

3.4

0.67

0.75

ug/l

0.54

1104

Sequelae of injuries of neck and trunk

210

2419

0.84

1.51

2.8

3.1

0.64

0.71

ug/l

0.99

139

1476

Malignant neoplasm of nasal cavity and sinuses

531

0.67

1.51

2.9

2.7

0.74

0.71

ug/l

0.08

336

Other coagulation defects

453

4095

1.12

1.50

3.2

3.3

0.72

0.78

ug/l

0.63

299

2650

Asthma-related pneumonia

2973

30776

0.96

1.50

3.1

3.3

0.68

0.82

ug/l

13.54

2002

20766

Acquired keratosis [keratoderma] palmaris et plantaris

295

0.56

1.50

2.8

3.1

1.05

0.79

ug/l

0.50

178

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

749

0.72

1.49

3.1

2.8

0.75

0.78

ug/l

0.11

486

Thyrotoxicosis with diffuse goitre

455

4102

1.12

1.49

3.0

3.1

0.73

0.74

ug/l

0.09

290

2575

Malignant neoplasm of head and neck

819

8768

0.91

1.49

3.0

2.9

0.73

0.72

ug/l

0.30

573

5840

Ulcer of lower limb, not elsewhere classified

1440

15171

0.94

1.49

2.9

3.4

0.76

0.80

ug/l

0.57

1003

10523

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

1.49

0.0

2.5

—

0.88

—

Causalgia

768

0.73

1.49

2.4

2.8

0.71

ug/l

0.02

448

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

687

0.71

1.49

3.2

2.8

0.72

0.71

ug/l

0.01

388

Other condition

1041

11097

0.93

1.48

2.9

3.0

0.70

0.75

ug/l

1.35

645

6697

Delayed puberty

1.88

1.48

1.6

1.2

0.30

0.33

ug/l

—

Sacrococcygeal disorders, not elsewhere classified

124

1016

1.24

1.48

3.8

2.9

0.53

0.73

ug/l

3.79

606

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

701

7572

0.91

1.48

3.4

3.3

0.77

0.79

ug/l

0.20

480

5126

Other diseases of spinal cord

194

2246

0.84

1.48

3.3

0.75

0.76

ug/l

0.06

139

1466

Cholangitis (primary sclerosing, PSC)

448

4933

0.89

1.48

3.1

3.3

0.80

0.79

ug/l

0.05

292

3273

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

9646

63156

0.98

1.47

2.9

3.1

0.71

0.78

ug/l

6.47

5715

40391

Otitis externa, unspecified

816

7586

1.09

1.47

3.5

3.1

0.80

0.76

ug/l

0.28

552

4762

Radial styloid tenosynovitis [de Quervain]

203

1740

1.18

1.46

3.1

2.9

0.65

0.74

ug/l

0.56

125

1005

Intestinal infectious diseases

8723

66257

0.97

1.45

2.9

3.1

0.74

0.77

ug/l

1.21

5289

41990

Other and unspecified injuries of head

580

5325

1.11

1.45

2.9

3.2

0.77

0.80

ug/l

0.13

402

3357

Malignant neoplasm of endocrine gland, including Hilmo

409

3682

1.12

1.45

3.3

2.8

0.74

0.71

ug/l

0.34

281

2281

Cerebrovascular diseases

8016

56816

0.97

1.45

3.3

0.81

0.77

ug/l

1.51

5700

37653

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

175

0.47

1.44

5.3

2.8

0.98

0.85

ug/l

—

124

Dislocation, sprain and strain of joints and ligaments at neck level

950

8877

1.08

1.44

3.1

2.9

0.72

ug/l

0.01

555

5130

Cerebral palsy and other paralytic syndromes

728

7850

0.92

1.44

2.9

3.2

0.72

0.79

ug/l

0.66

522

5014

Generalized epilepsy, strict definition

935

0.76

1.44

2.1

2.7

0.79

0.74

ug/l

0.14

500

Assault by blunt object

1188

0.78

1.44

2.6

0.65

0.68

ug/l

0.30

600

Colon adenocarcinoma

1193

11263

1.07

1.44

3.3

3.1

0.87

0.74

ug/l

2.54

852

7838

Other and specified injuries of hip and thigh

180

1544

1.20

1.44

3.5

3.3

0.69

0.80

ug/l

1.13

117

1020

Acute myeloid leukaemia, helper endpoint

892

0.75

1.44

3.1

2.9

0.74

0.78

ug/l

0.19

597

Acute myeloid leukaemia

892

0.75

1.44

3.1

2.9

0.74

0.78

ug/l

0.19

597

Acute myeloid leukaemia, including Hilmo

892

0.75

1.44

3.1

2.9

0.74

0.78

ug/l

0.19

597

Endocarditis

368

4062

0.88

1.43

3.3

3.4

0.86

0.81

ug/l

0.21

259

2733

Respiratory tuberculosis, confirmed

120

1440

0.80

1.43

3.4

3.3

0.73

0.83

ug/l

0.77

982

Childhood allergy (age < 16)

170

1179

1.19

1.43

1.3

0.40

0.41

ug/l

0.11

277

Small fibre neuropathy

301

2690

1.16

1.42

3.4

3.3

0.63

0.76

ug/l

2.78

207

1765

Behavioural disorders

800

0.75

1.42

1.9

2.2

0.53

0.63

ug/l

0.82

335

Respiratory tuberculosis, bacteriologically and histologically confirmed

126

1504

0.81

1.42

3.4

3.3

0.73

0.83

ug/l

0.84

1020

Circumscribed brain atrophy

146

1719

0.82

1.42

2.9

3.5

0.97

0.80

ug/l

0.44

112

1188

Respiratory conditions due to other external agents

1182

0.79

1.42

3.0

3.4

0.85

0.80

ug/l

0.15

806

Other disorders of urethra and urinary system

5439

38898

0.97

1.42

3.6

3.4

0.85

0.81

ug/l

1.29

4139

27013

Other CVD (FINNGEN)

1283

9256

1.07

1.42

3.4

3.5

0.79

0.78

ug/l

0.10

932

6334

Malignant neoplasm of floor of mouth, including Hilmo

748

0.72

1.41

3.7

2.9

0.68

0.76

ug/l

0.36

489

Cholangitis (primary sclerosing, PSC), with reimbursement 202

973

0.77

1.41

3.1

2.9

0.89

0.72

ug/l

0.38

546

Myelodysplastic syndrome, including Hilmo

219

2500

0.85

1.41

3.5

3.0

0.79

0.77

ug/l

0.16

142

1766

Other and unspecified injuries of shoulder and upper arm

255

2246

1.17

1.41

3.0

3.1

0.88

0.73

ug/l

0.37

156

1364

L04AA Selective immunosuppressants

1449

15278

0.94

1.41

2.7

3.0

0.73

ug/l

0.10

1027

9369

Caries of dentine

2185

21962

0.95

1.41

2.8

3.0

0.82

0.79

ug/l

0.24

1531

13090

Lesion of sciatic nerve

272

3069

0.87

1.41

3.1

3.5

0.79

0.84

ug/l

0.32

204

2201

Occupant of special vehicle mainly used on industrial premises injured in transport accident

579

0.68

1.41

3.0

3.1

0.77

0.75

ug/l

0.08

359

Fall on and from stairs and steps

2090

20002

1.05

1.40

3.2

0.69

0.77

ug/l

2.98

1398

12866

Severe visual impairment, monocular

599

1.33

1.40

3.3

3.2

1.06

0.82

ug/l

0.39

400

Dislocation of lens

127

1060

1.25

1.40

3.5

0.63

0.79

ug/l

2.45

741

Cytomegalovirus infection, IBD co-morbidity

142

1675

0.82

1.40

3.0

3.1

0.87

0.72

ug/l

1.13

109

1033

Mixed hyperlipidaemia

383

4216

0.88

1.39

3.4

3.3

1.02

0.78

ug/l

0.89

266

2793

Pulmonary heart disease, diseases of pulmonary circulation

2835

29399

0.96

1.39

3.3

3.4

0.81

0.80

ug/l

0.13

1992

20124

Retinal vascular occlusion

1146

10822

1.07

1.39

3.5

0.82

ug/l

0.06

834

7715

Dislocation, sprain and strain of joints and ligaments of thorax

276

2446

1.16

1.39

3.5

3.1

0.67

0.74

ug/l

1.03

180

1488

Vascular dementia (sudden onset)

243

0.54

1.39

2.9

3.2

0.75

1.05

ug/l

—

167

Cytomegaloviral disease, including avohilmo

148

1739

0.82

1.38

3.0

3.1

0.85

0.71

ug/l

1.05

114

1049

Allergic colitis

247

1.47

1.38

2.6

2.5

0.62

0.69

ug/l

0.30

118

Other inflammatory liver diseases

414

4561

0.89

1.38

3.0

3.2

0.62

0.75

ug/l

4.39

274

2923

Other problems related to primary support group, including family circumstances

276

3045

0.88

1.38

2.7

0.80

0.68

ug/l

0.26

172

1624

Other and unspecified psoriasis

513

5588

0.90

1.38

3.1

3.3

0.65

0.77

ug/l

2.59

349

3650

Primary_lymphoid and hematopoietic malignant neoplasms

2361

24550

0.95

1.38

3.1

3.4

0.78

0.80

ug/l

0.35

1649

17109

Nonalcoholic fatty liver disease

759

7063

1.09

1.37

2.9

0.67

0.71

ug/l

0.24

471

4114

Sequelae of tuberculosis, including avohilmo

1112

0.78

1.37

3.8

3.5

0.75

0.88

ug/l

1.02

795

Other bursopathies

1165

11003

1.07

1.37

3.4

3.2

0.68

0.80

ug/l

6.55

792

7175

Secondary polycythaemia

259

2303

1.17

1.37

3.3

3.0

0.72

0.73

ug/l

0.17

165

1388

Malignant neoplasm of larynx, including Hilmo

196

2234

0.84

1.36

3.2

3.0

0.73

0.75

ug/l

0.23

142

1535

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

464

5084

0.90

1.36

3.5

3.3

0.74

0.75

ug/l

0.19

334

3549

Erectile dysfunction, exclusion

430

0.64

1.36

2.6

3.3

0.66

0.80

ug/l

0.76

280

Other congenital malformations of male genital organs, including avohilmo

337

1.43

1.36

2.7

0.60

0.77

ug/l

0.67

173

Acquired haemolytic anaemia

140

1651

0.82

1.36

3.1

3.3

0.93

0.78

ug/l

0.61

109

1099

Other orthopaedic follow-up care

418

3794

1.12

1.36

2.9

3.2

0.61

0.74

ug/l

2.97

289

2378

Fracture of rib(s), sternum and thoracic spine

3674

35622

1.04

1.36

3.3

3.2

0.73

0.78

ug/l

2.67

2481

23381

Frostbite with tissue necrosis

305

0.59

1.36

3.1

0.63

0.76

ug/l

0.44

192

Impacted maxillary molar

141

1178

1.21

1.35

2.2

2.4

0.59

0.66

ug/l

0.73

539

Ocular pain

412

3726

1.12

1.35

3.1

0.66

0.74

ug/l

1.40

269

2278

Alzheimer’s disease (Late onset)

2029

17430

0.95

1.35

3.3

3.7

0.87

0.89

ug/l

0.18

1514

13084

Acute and subacute iridocyclitis

1527

14528

1.06

1.35

3.2

3.1

0.71

0.75

ug/l

1.27

1019

9081

Sequelae of tuberculosis

1098

0.79

1.35

3.7

3.5

0.76

0.89

ug/l

0.94

785

Viral hepatitis, IBD co-morbidity

372

4117

0.89

1.34

2.4

2.5

0.55

0.81

ug/l

7.90

242

2002

Ankylosing spondylitis, ICD10

761

7099

1.09

1.34

3.0

0.68

0.72

ug/l

0.77

509

4192

Conductive hearing loss, unspecified

579

5335

1.10

1.34

3.2

0.68

0.78

ug/l

2.33

358

3456

Toxic encephalopathy

251

0.54

1.34

2.3

3.2

0.64

0.76

ug/l

0.78

179

All influenza

2536

26322

0.95

1.34

2.9

3.2

0.76

0.77

ug/l

0.23

1648

16875

Obstructive hydrocephalus

907

0.77

1.33

3.1

0.65

0.79

ug/l

1.19

571

Bell's palsy

957

8991

1.08

1.33

3.2

0.82

0.77

ug/l

0.40

624

5778

Other demyelinating diseases of the central nervous system

116

1399

0.82

1.33

3.3

2.8

0.68

0.69

ug/l

0.10

776

Degenerative conditions of globe

380

0.64

1.32

3.3

0.76

0.83

ug/l

0.25

251

Other acantholytic disorders

262

1.58

1.32

3.3

3.2

0.71

0.77

ug/l

0.24

181

Other diseases of arteries and capillaries

667

7179

0.92

1.32

3.2

3.4

0.88

0.83

ug/l

0.26

449

4937

Gilbert syndrome

536

1.35

1.32

2.9

0.77

0.73

ug/l

0.11

334

Diplopia

1099

10376

1.07

1.32

3.2

3.3

0.74

0.78

ug/l

0.67

749

6911

Pneumonia derived septicemia

233

2637

0.86

1.31

2.7

3.3

0.68

0.76

ug/l

1.03

153

1731

Unspecified urinary incontinence

282

2497

1.14

1.31

3.1

3.3

0.79

0.77

ug/l

0.10

197

1689

Benign neoplasm: Liver/bile ducts

139

1172

1.21

1.31

3.5

3.2

0.78

0.72

ug/l

0.36

101

749

Visual field defects

617

6656

0.91

1.31

3.3

3.4

0.76

0.80

ug/l

0.28

438

4546

Tubulo-interstitial nephritis, not specified as acute or chronic

438

3988

1.11

1.31

3.0

3.4

0.86

0.78

ug/l

0.45

305

2705

Other specified and unspecified retinal disorders

278

2478

1.15

1.31

3.0

3.3

0.71

0.76

ug/l

0.57

189

1623

Malignant neoplasm of oral cavity, including Hilmo

360

3965

0.88

1.30

2.9

0.76

0.71

ug/l

0.43

242

2549

Lactose intolerance

148

1254

1.20

1.30

3.5

3.0

0.69

0.73

ug/l

0.21

747

Acquired stenosis of external ear canal

134

1150

1.26

1.30

3.3

3.2

0.72

0.75

ug/l

0.13

738

Cardiomyopathy, Hypertrophic obstructive

141

1646

0.82

1.30

3.3

0.57

0.75

ug/l

3.15

1115

Paget disease

417

1.42

1.30

4.3

3.4

0.74

0.79

ug/l

0.25

293

Other congenital malformations of circulatory system

190

1652

1.18

1.30

3.4

3.2

0.69

0.76

ug/l

0.62

133

1039

Mechanical strabismus

117

1.77

1.30

2.1

3.2

0.84

0.74

ug/l

0.21

Other erythematous conditions

204

1777

1.17

1.30

3.3

0.76

0.77

ug/l

0.06

129

1155

Cytomegaloviral disease

148

1727

0.83

1.29

3.0

3.1

0.85

0.71

ug/l

1.04

114

1045

Obesity due to excess calories

3438

35521

0.96

1.29

3.1

0.68

0.74

ug/l

4.11

2256

22274

Other secondary gout

324

0.61

1.29

2.7

3.5

0.74

0.79

ug/l

0.12

220

Post-traumatic hydrocephalus, unspecified

242

0.55

1.29

2.7

3.3

0.61

0.74

ug/l

—

156

Disorders of muscles

857

8032

1.08

1.29

3.1

3.0

0.69

0.78

ug/l

2.38

541

4984

Adhesive capsulitis of shoulder

1331

12635

1.06

1.29

3.2

0.72

0.79

ug/l

2.02

926

8272

Barrett oesophagus

603

5611

1.11

1.29

3.6

3.3

0.79

ug/l

0.00

411

3687

Autoimmune hepatitis, wide definition

250

2822

0.87

1.29

2.9

3.0

0.56

0.74

ug/l

6.59

156

1720

Volume depletion

801

8553

0.92

1.29

3.1

3.4

0.87

0.83

ug/l

0.31

572

5920

Autism spe, excluding more controls

619

0.73

1.29

1.9

2.0

0.51

0.60

ug/l

0.49

209

Personal history of other diseases and conditions

285

2513

1.14

1.29

3.3

2.9

0.72

ug/l

0.02

199

1491

Merkel cell carcinoma of skin

2.03

1.29

3.1

0.71

0.75

ug/l

—

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

173

1.60

1.28

2.2

3.1

0.52

0.74

ug/l

1.11

118

Other maltreatment syndromes

248

2199

1.16

1.28

2.2

2.5

0.56

0.67

ug/l

0.63

166

1052

therapeutic use

237

2096

1.16

1.28

4.0

3.5

0.73

0.76

ug/l

0.34

182

1473

Benign neoplasm: Parotid gland

675

6287

1.09

1.27

3.3

0.73

0.77

ug/l

0.70

456

4211

Acute suppurative otitis media

1255

12353

0.94

1.27

2.5

0.71

0.66

ug/l

0.53

631

5991

Undescended testis, unilateral

315

1.42

1.27

3.1

2.6

0.49

0.74

ug/l

2.72

159

Drug-induced gout

395

0.65

1.27

3.5

0.91

0.89

ug/l

0.03

271

Chronic lymphocytic leukaemia, helper endpoint

299

2692

1.15

1.27

3.0

0.80

0.74

ug/l

0.35

221

1863

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

299

2692

1.15

1.27

3.0

0.80

0.74

ug/l

0.35

221

1863

Chronic lymphocytic leukaemia

299

2692

1.15

1.27

3.0

0.80

0.74

ug/l

0.35

221

1863

Malignant neoplasm of thyroid gland, including Hilmo

342

3076

1.13

1.27

3.4

2.8

0.72

0.71

ug/l

0.15

239

1891

Personal history of medical treatment

662

1.29

1.27

3.2

0.86

0.75

ug/l

0.49

449

Normal-pressure hydrocephalus

343

3786

0.89

1.27

3.0

3.6

0.72

0.82

ug/l

1.64

250

2763

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

537

0.70

1.26

3.0

2.8

0.73

ug/l

0.01

345

Ectopic testis

124

1.68

1.26

3.3

2.6

0.52

0.60

ug/l

—

Other Crohn's disease

380

4188

0.89

1.26

2.6

2.9

0.65

0.68

ug/l

0.61

238

2366

Short Achilles tendon (acquired)

1029

0.79

1.26

2.4

3.0

0.80

0.75

ug/l

0.51

615

Necrotizing fasciitis

454

0.68

1.26

2.8

3.1

0.67

0.85

ug/l

0.41

280

Unspecified acute lower respiratory infection

1481

15519

0.94

1.25

2.7

3.0

0.69

0.76

ug/l

0.97

897

9371

Giant cell arteritis

289

2588

1.14

1.25

3.7

3.6

0.72

0.79

ug/l

0.49

212

1827

Hyperhidrosis

126

1055

1.21

1.25

3.5

3.0

0.63

0.74

ug/l

1.03

617

Papillary adenocarcinoma of thyroid gland

221

1938

1.16

1.24

3.2

2.8

0.72

0.70

ug/l

0.15

151

1166

Postzoster neuralgia

118

991

1.23

1.24

3.5

3.4

0.81

0.83

ug/l

0.06

685

Pterygium

302

2726

1.15

1.24

4.0

3.5

0.86

0.80

ug/l

0.56

227

1923

Other/unspecified reactive arthropathies

462

4236

1.11

1.24

3.0

3.1

0.75

0.74

ug/l

0.02

295

2609

Leisure time condition

1410

13421

1.06

1.24

3.2

0.76

0.77

ug/l

0.19

899

8517

Pruritus

547

5037

1.10

1.24

3.3

0.73

0.80

ug/l

0.62

379

3357

Retinal vascular disorders

1161

11012

1.07

1.24

3.5

0.82

ug/l

0.06

844

7848

Dental caries

2456

24025

0.96

1.24

2.8

3.0

0.81

0.80

ug/l

0.07

1717

14414

Flatback syndrome

0.00

1.24

0.0

2.7

—

0.68

—

Cramp and spasm

348

3150

1.13

1.24

3.3

3.2

0.61

0.75

ug/l

2.89

242

1955

Malignant neoplasm of thyroid gland

309

2769

1.13

1.23

3.3

2.8

0.71

0.70

ug/l

0.05

215

1707

L02BA Anti-estrogens

529

1.29

1.23

4.0

3.0

1.27

0.77

ug/l

0.46

319

Other lack of coordination

102

1222

0.80

1.23

3.6

3.3

0.82

0.80

ug/l

0.10

800

Myelodysplastic syndrome

991

0.78

1.23

3.2

3.1

0.90

0.80

ug/l

0.50

696

Parkinson's disease

1522

15914

0.94

1.23

3.3

3.6

0.75

0.83

ug/l

2.59

1103

11562

Unspecified misadventure during surgical and medical care

399

4367

0.90

1.22

3.4

0.70

0.77

ug/l

1.42

296

2918

Hyperkinetic disorders, excluding more controls

373

3141

1.11

1.22

2.0

1.9

0.44

0.60

ug/l

8.61

177

1011

Benign neoplasm: Liver

116

969

1.22

3.6

3.1

0.81

0.72

ug/l

0.46

623

Speech disturbances, not elsewhere classified

673

7214

0.92

1.22

3.6

3.4

0.78

0.81

ug/l

0.39

496

4970

Mixed conductive and sensorineural hearing loss

1020

9638

1.07

1.22

3.5

3.4

0.74

0.80

ug/l

1.03

716

6715

Use of levodopa decarbox-comt-inhibitor

278

3083

0.87

1.22

3.1

3.6

0.71

0.79

ug/l

0.68

198

2191

Carcinoma in situ of colon

301

2722

1.15

1.22

3.6

3.4

0.77

0.76

ug/l

0.05

218

1848

Congenital malformations of the urinary system, including avohilmo

401

3654

1.12

1.22

3.4

3.2

0.98

0.74

ug/l

1.92

280

2304

Synovial hypertrophy, not elsewhere classified

538

0.71

1.22

3.0

2.9

0.55

0.71

ug/l

0.83

310

Melanocytic naevi, other sites/unspecified

578

5352

1.09

1.22

3.2

0.72

0.73

ug/l

0.24

376

3413

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1347

14152

0.94

1.22

2.9

0.72

ug/l

0.03

813

8334

Other (seronegative) rheumatoid arthritis, wide

1004

10645

0.94

1.21

3.2

3.4

0.73

0.79

ug/l

0.83

716

7224

Prepatellar bursitis

598

5582

1.10

1.21

3.3

3.0

0.68

0.76

ug/l

2.35

369

3432

Fracture at wrist and hand level

3397

32827

1.04

1.21

2.9

0.70

0.73

ug/l

1.15

2041

19199

Other and unspecified iridocyclitis

318

2866

1.13

1.21

3.3

3.1

0.67

0.74

ug/l

0.78

213

1732

Other and unspecified hereditary haemolytic anaemias

0.00

1.21

0.0

2.7

—

0.71

—

Other vitreous opacities

308

2775

1.13

1.21

3.8

3.4

0.69

0.77

ug/l

1.83

234

1888

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

430

3896

1.11

1.21

3.1

2.8

0.72

0.70

ug/l

0.16

236

2157

Undescended testicle

430

1.34

1.20

3.2

2.8

0.61

0.76

ug/l

0.97

230

Use of amantadine

841

0.77

1.20

3.6

3.2

0.66

0.77

ug/l

0.90

547

Left hemicolectomy

154

1776

0.84

1.20

3.2

3.4

0.83

0.79

ug/l

0.26

115

1207

Superficial injury of head

1906

18257

1.05

1.20

2.9

3.1

0.76

0.78

ug/l

0.31

1241

11424

Monoamine oxidase A inhibitors

883

8307

1.08

1.20

3.3

3.2

0.65

0.77

ug/l

3.93

611

5332

Meningitis, viral

159

1.59

1.20

1.8

2.9

0.81

0.74

ug/l

0.16

Dependent personality disorder

908

0.78

1.19

2.8

2.9

0.55

0.73

ug/l

1.53

534

Parapsoriasis

145

1245

1.20

1.19

3.3

3.1

0.61

0.77

ug/l

2.39

795

Personal history of risk-factors, not elsewhere classified

707

0.75

1.19

2.6

2.7

0.82

0.68

ug/l

0.30

399

Other deformities of toe(s)

159

1367

1.18

1.19

3.5

3.1

0.66

0.80

ug/l

2.13

105

872

Pustulosis palmaris et plantaris

162

1874

0.85

1.19

3.2

0.60

0.74

ug/l

2.88

111

1164

Haemangioma, any site

535

4943

1.10

1.19

3.4

3.2

0.71

0.75

ug/l

0.81

359

3179

Respiratory tuberculosis, clinically confirmed

1008

0.79

1.18

2.8

3.3

0.89

ug/l

0.01

681

Inflammatory bowel disease, strict (require KELA)

1734

18100

0.95

1.18

2.9

0.69

0.73

ug/l

0.93

1037

10593

Foreign body on external eye

1812

18838

0.95

1.18

2.8

2.9

0.72

0.71

ug/l

0.06

1038

10973

Postprocedural endocrine and metabolic disorders, not elsewhere classified

433

3953

1.10

1.18

3.1

0.65

0.75

ug/l

2.48

297

2419

Pneumonia due to Haemophilus influenzae

276

0.61

1.18

3.9

3.2

0.81

0.82

ug/l

0.01

160

Nonsuppurative otitis media

1061

9741

0.94

1.17

3.2

2.9

0.78

0.73

ug/l

0.46

654

5693

DVT of lower extremities

1745

16734

1.05

1.17

3.3

0.84

0.80

ug/l

0.54

1265

11197

Crohn's disease of large intestine

275

3065

0.88

1.17

2.7

2.9

0.66

0.71

ug/l

0.75

171

1746

Kidney transplant status

422

4587

0.90

1.17

2.6

3.1

0.92

0.70

ug/l

4.83

342

2776

Other congenital malformations of integument, including avohilmo

196

1.56

1.16

2.5

3.1

1.51

0.77

ug/l

0.29

130

Burns and corrosions of external body surface, specified by site

860

9126

0.93

1.16

3.0

0.70

0.74

ug/l

0.76

527

5430

Cluster headache, wide,, including avohilmo

338

3063

1.12

1.16

2.8

0.69

0.70

ug/l

0.12

197

1735

Injury of muscle and tendon at ankle and foot level

211

1868

1.16

3.0

3.1

0.85

0.72

ug/l

0.37

135

1114

Other disorders of bone

1495

14280

1.06

1.15

3.1

3.0

0.69

0.73

ug/l

1.24

885

8549

Benign neoplasm of major salivary glands

818

7698

1.08

1.15

3.3

0.74

0.77

ug/l

0.54

556

5201

Fasciculation

762

1.26

1.15

3.2

3.0

0.67

0.74

ug/l

0.26

461

Traumatic amputation of ankle and foot

279

0.60

1.15

1.7

3.0

0.67

0.74

ug/l

—

179

Abnormal reflex

311

0.64

1.15

2.5

3.0

0.64

0.76

ug/l

0.44

196

Corneal ulcer

1492

14258

1.06

1.14

3.0

0.71

0.74

ug/l

0.59

887

8586

Anomalies of pupillary function

793

1.24

1.14

3.6

3.0

0.66

0.80

ug/l

1.04

452

Appendectomy

5113

47446

1.03

1.14

2.9

3.0

0.75

0.74

ug/l

0.25

2989

28249

Other birth injuries to central nervous system

0.00

1.14

0.0

3.5

—

0.85

—

Low back pain

7389

48819

1.02

1.14

3.1

0.68

0.80

ug/l

17.93

4806

30393

Vascular dementia (other)

484

1.33

1.14

3.8

3.4

0.69

0.93

ug/l

1.75

338

Other symptoms and signs involving the nervous and musculoskeletal systems

3092

31903

0.96

1.14

3.2

0.70

0.78

ug/l

6.01

1878

20884

Human immunodeficiency virus [HIV] disease

174

1970

0.85

1.14

2.5

2.6

0.67

ug/l

0.02

122

1009

Ankylosing spondylitis

794

7469

1.08

1.14

3.0

0.69

0.77

ug/l

2.42

535

4487

Explicit fungal Sepsis, including avohilmo

668

0.74

1.14

3.0

3.2

0.93

0.82

ug/l

0.32

422

Abnormal blood-pressure reading, without diagnosis

266

2380

1.13

1.14

3.7

3.0

0.71

0.75

ug/l

0.37

170

1476

Mature T/NK-cell lymphomas, hilmo

106

1247

0.81

1.14

3.0

3.4

0.61

0.79

ug/l

2.59

832

Occupant of pick-up truck or van injured in other and unspecified transport accidents

457

0.69

1.14

2.5

2.8

0.61

0.70

ug/l

0.60

245

Injury of muscle and tendon at forearm level

183

1612

1.18

1.14

2.9

0.71

0.73

ug/l

0.09

124

904

Other benign neoplasms of connective and other soft tissue

672

6278

1.08

1.14

3.4

3.2

0.72

0.76

ug/l

0.45

421

4012

Hidradenitis suppurativa

138

1610

0.84

1.13

2.4

2.7

0.60

0.70

ug/l

0.99

873

Hyperprolactinaemia

109

910

1.21

1.13

3.4

2.8

0.64

0.70

ug/l

0.49

526

Explicit fungal Sepsis

667

0.74

1.13

3.0

3.2

0.93

0.82

ug/l

0.32

422

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

249

2175

1.13

2.8

2.6

0.60

0.70

ug/l

1.46

121

1066

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

210

0.56

1.13

3.2

3.0

0.54

0.83

ug/l

—

120

Polyneuropathies and other disorders of the peripheral nervous system

2524

24428

1.04

1.12

3.4

0.70

0.79

ug/l

4.36

1867

16721

Other disorders of nervous system

543

5836

0.91

1.12

3.2

3.3

0.67

0.76

ug/l

1.90

369

3876

Intentional self-harm by jumping from a high place

276

0.62

1.12

1.7

2.4

0.55

0.67

ug/l

—

121

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

431

1.35

1.12

3.5

3.2

0.61

0.75

ug/l

1.41

285

Acne

350

3153

1.11

1.12

2.6

2.5

0.58

0.65

ug/l

1.37

179

1492

Internuclear ophthalmoplegia

237

0.59

1.12

2.7

3.2

0.76

0.74

ug/l

—

154

Paraplegia, diplegia of upper limbs

144

1660

0.84

1.12

2.9

3.1

0.62

0.77

ug/l

1.61

1062

Acne vulgaris

264

2351

1.13

1.12

2.5

2.3

0.56

0.63

ug/l

1.26

138

1024

Torsion of testis

158

1374

1.18

1.12

2.4

2.1

0.64

ug/l

0.00

544

Other helminthiases, including avohilmo

106

1.73

1.12

3.5

2.8

0.55

0.71

ug/l

—

Rheumatic fever without mention of heart involvement

224

0.58

1.12

3.9

3.1

0.89

0.83

ug/l

—

146

Parkinson's disease, including avohilmo

1596

16627

0.95

1.12

3.4

3.6

0.75

0.83

ug/l

3.14

1159

12076

Dermatographic urticaria

242

2151

1.14

1.11

3.2

3.1

0.81

0.73

ug/l

0.23

153

1303

Osteonecrosis

511

4739

1.10

1.11

3.5

3.3

0.96

0.74

ug/l

1.65

366

3117

Enterobiasis, including avohilmo

381

1.33

1.11

2.7

2.4

0.67

0.66

ug/l

0.02

160

IBD (strict) with PSC

562

0.74

1.10

2.4

2.6

0.83

0.70

ug/l

0.20

280

Abnormal results of function studies

669

6260

1.08

1.10

3.3

3.1

0.73

0.75

ug/l

0.20

447

3930

Myopia

612

5694

1.08

1.10

2.9

2.8

0.66

0.70

ug/l

0.67

360

3158

Other necrotizing vasculopathies (FG)

440

4054

1.10

3.4

0.68

0.83

ug/l

4.29

329

2748

Malignant neoplasm of oral cavity

284

3129

0.88

1.10

2.9

0.82

0.72

ug/l

0.97

193

2011

Autoimmune hyperthyroidism

202

1776

1.15

1.10

3.0

3.1

0.78

0.74

ug/l

0.23

118

1080

Valvular operations

1782

18491

0.95

1.09

3.1

3.4

0.82

0.81

ug/l

0.09

1243

12694

Membranous nephropathy

349

1.41

1.09

2.7

3.2

0.99

0.78

ug/l

0.57

214

Malignant neoplasm of nasal cavity and middle ear

374

0.67

1.09

2.7

0.75

0.69

ug/l

0.16

234

Helminthiases

104

874

1.22

1.09

3.1

0.69

0.78

ug/l

0.65

554

Other articular cartilage disorders

211

1880

1.16

1.08

3.4

3.0

0.68

0.79

ug/l

0.97

129

1178

Ulcerative colitis (strict definition, require KELA)

1241

13015

0.95

1.08

2.9

0.72

ug/l

0.11

759

7655

Herpesviral keratitis and keratoconjunctivitis

319

2901

1.12

1.08

3.2

3.3

0.81

0.77

ug/l

0.35

205

1856

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

523

5611

0.92

1.08

3.0

3.5

0.79

0.83

ug/l

0.32

360

3973

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

702

1.28

1.07

2.9

3.0

0.95

0.81

ug/l

0.17

485

Contact with other hot metals

106

1245

0.82

1.07

2.9

3.0

0.72

0.75

ug/l

0.12

747

Unspecified nephritic syndrome

158

1800

0.85

1.07

3.0

3.2

0.74

ug/l

0.03

124

1130

Other and unspecified acne

537

1.28

1.07

2.9

2.6

0.58

0.72

ug/l

0.89

282

Heterophoria

369

3368

1.11

1.06

3.2

3.1

0.84

0.73

ug/l

0.99

228

2015

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

572

1.26

1.06

3.2

2.8

0.71

0.69

ug/l

0.08

334

Toxic effect of other gases, fumes and vapours

464

0.71

1.06

2.5

2.7

0.55

0.72

ug/l

0.51

255

Use of selegiline

362

3940

0.90

1.06

3.1

3.5

0.66

0.79

ug/l

4.29

258

2755

L01XX Other antineoplastic agents

431

4660

0.91

1.06

3.2

3.5

0.76

0.79

ug/l

0.18

308

3271

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

253

1.47

1.05

2.3

0.49

0.70

ug/l

1.41

111

Disorder of the sleep-wake schedule

110

932

1.21

1.05

2.6

2.8

0.61

0.73

ug/l

1.29

538

Epiphora

111

940

1.21

1.05

3.4

3.3

0.72

0.79

ug/l

0.43

635

Lateral epicondylitis

988

9369

1.06

1.05

3.0

2.9

0.64

0.75

ug/l

4.77

599

5520

Lichen sclerosus et atrophicus

244

2176

1.13

1.05

3.1

3.0

0.67

0.72

ug/l

0.29

166

1273

Wilms' tumor, including Hilmo

396

0.69

1.05

3.0

2.8

0.72

0.76

ug/l

0.15

279

Injury of nerves at shoulder and upper arm level

841

0.79

1.05

2.6

3.0

0.59

0.74

ug/l

1.42

504

Viral agents as the cause of diseases classified to other chapters

147

1278

1.18

1.05

3.0

3.1

0.78

0.77

ug/l

0.05

102

787

Cerebral palsy

617

0.76

1.04

2.0

2.6

0.94

0.76

ug/l

0.18

293

Unspecific neurodegenerative disorder

4250

29821

0.97

1.04

3.4

3.7

0.82

0.85

ug/l

0.93

3094

22285

Myositis ossificans

193

1.53

1.04

3.5

3.2

0.95

0.82

ug/l

0.20

131

Disorders of lacrimal system and orbit in diseases classified elsewhere

655

1.24

1.04

2.9

3.0

0.72

0.76

ug/l

0.26

399

Nontoxic diffuse goitre

773

1.22

1.03

3.6

3.3

1.10

0.79

ug/l

0.52

496

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5566

53370

1.03

3.3

0.76

0.79

ug/l

1.32

3795

35835

Sequelae of transport accidents

337

0.67

1.03

2.8

3.0

0.59

0.74

ug/l

0.78

212

Other and unspecified injuries of ankle and foot

235

2103

1.13

1.03

2.9

3.0

0.70

0.71

ug/l

0.06

142

1203

Chronic conjunctivitis

140

1210

1.18

1.03

3.7

3.0

0.66

0.77

ug/l

0.81

730

Conjunctivitis

4829

39798

0.97

1.03

3.1

2.9

0.71

0.74

ug/l

0.85

2895

23591

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

1113

0.82

1.02

3.3

2.9

0.88

0.79

ug/l

0.23

762

Cluster headache, strict, including avohilmo

315

2867

1.12

1.02

2.8

0.69

ug/l

0.04

183

1605

Postdysenteric arthropathy

618

1.27

1.02

3.2

2.8

0.66

0.74

ug/l

0.52

368

Benign neoplasm: Short bones of lower limb

553

1.28

1.02

3.5

3.1

0.76

0.77

ug/l

0.04

349

Human immunodeficiency virus [HIV] disease, including avohilmo

178

1996

0.86

1.02

2.5

2.7

0.67

ug/l

0.00

126

1023

Tibial collateral bursitis [Pellegrini-Stieda]

479

1.29

1.02

2.7

2.9

0.62

0.73

ug/l

0.64

291

Use of galantamine

615

5760

1.08

1.02

3.4

3.7

0.84

0.89

ug/l

0.47

483

4270

Arthropathy in Crohn disease

500

0.73

1.02

2.5

2.7

0.70

0.73

ug/l

0.09

271

Gastrointestinal stromal tumor and sarcoma

108

924

1.22

1.02

3.8

2.9

0.83

0.77

ug/l

0.38

614

IBD patients in KELA-register

1734

18027

0.96

1.02

2.9

0.69

0.73

ug/l

0.92

1037

10571

Non-allergic asthma (mode), excluding more controls

1383

14314

0.95

1.02

3.0

3.4

0.67

0.81

ug/l

5.68

903

9576

Adalimumab

520

5591

0.92

1.02

2.4

2.7

0.66

0.68

ug/l

0.12

294

3009

Sequelae of injuries of lower limb

724

6817

1.08

1.02

3.1

3.0

0.64

0.72

ug/l

2.72

449

4017

Brain astrocytoma, helper endpoint

232

0.61

1.01

2.2

2.8

0.61

0.77

ug/l

—

126

Other peripheral vertigo

595

5564

1.08

1.01

3.5

3.3

0.75

0.79

ug/l

0.50

424

3790

Temporal arteritis

248

2236

1.13

1.01

3.8

3.5

0.66

0.80

ug/l

3.17

184

1567

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

489

0.74

1.00

2.3

3.0

0.56

0.72

ug/l

0.46

293

Shigellosis, including avohilmo

420

1.32

1.00

2.3

3.0

0.86

0.70

ug/l

0.46

245

Other/unspecified disorders of vestibular function

262

2367

1.13

1.00

3.5

3.3

0.82

0.77

ug/l

0.42

179

1591

Pneumococcal septicemia

227

2522

0.88

1.00

2.7

3.3

0.68

0.77

ug/l

1.05

149

1645

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

587

5489

0.93

1.00

2.1

0.47

0.60

ug/l

6.80

284

2139

Primary biliary cholangitis (PBC)

648

0.77

1.00

2.9

3.2

0.82

0.75

ug/l

0.22

425

Other chondrocalcinosis

122

1057

1.21

1.00

3.2

3.5

0.77

0.82

ug/l

0.21

715

Chronic hepatitis, not elsewhere classified

159

1811

0.86

1.00

2.8

3.1

0.69

0.75

ug/l

0.35

109

1114

Other specified/unspecified nutritional deficiencies

361

0.69

1.00

2.6

3.0

0.56

0.84

ug/l

1.64

227

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

216

1930

1.14

1.00

3.4

3.3

0.69

0.78

ug/l

1.22

151

1247

Anisometropia and aniseikonia

186

1647

1.15

1.00

3.3

3.2

0.75

0.77

ug/l

0.18

125

1056

Chondromalacia

197

1755

1.15

1.00

3.7

3.1

0.67

0.73

ug/l

0.73

121

1066

Respiratory tuberculosis, confirmed, including avohilmo

128

1472

0.84

0.99

3.4

3.3

0.72

0.83

ug/l

1.04

998

Viral and other specified intestinal infections

1104

11319

0.95

0.99

2.5

2.7

0.70

0.74

ug/l

0.22

571

5851

Foreign body in alimentary tract

387

4192

0.91

0.99

3.4

3.3

0.68

0.76

ug/l

1.55

263

2739

Lichen striatus

0.00

0.99

0.0

2.8

—

0.86

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.99

0.0

1.5

—

0.46

—

Other epidermal thickening

290

3183

0.90

0.99

3.4

0.70

0.78

ug/l

1.55

208

2107

Ulcerative enterocolitis

183

2059

0.87

0.99

3.1

3.0

0.74

ug/l

0.01

111

1205

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

216

1932

1.14

0.99

3.2

2.9

0.68

0.72

ug/l

0.46

123

1118

Gonococcal infection, including avohilmo

160

1401

1.16

0.99

2.2

2.4

0.62

0.66

ug/l

0.12

668

Congenital malformations of genital organs

115

970

1.18

0.98

2.9

2.8

0.65

0.77

ug/l

0.93

528

Cachexia

369

0.69

0.98

3.4

3.5

0.89

0.83

ug/l

0.12

250

Other and unspecified erythematous conditions

182

1611

1.15

0.98

3.4

3.3

0.77

ug/l

0.01

115

1037

Pedestrian injured in collision with car, pick-up truck or van

117

1359

0.84

0.98

3.4

3.0

0.78

0.75

ug/l

0.10

824

Haemangioma and lymphangioma, any site

566

5289

1.08

0.98

3.4

3.2

0.71

0.75

ug/l

0.79

375

3379

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1199

12547

0.95

0.98

2.9

0.72

ug/l

0.06

733

7339

Atrophic disorders of skin

427

3935

1.09

0.98

3.2

3.1

0.74

0.72

ug/l

0.06

279

2386

Human immunodeficiency virus [HIV] disease resulting in other conditions

161

1809

0.85

0.97

2.4

2.6

0.67

0.68

ug/l

0.03

111

901

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

161

1809

0.85

0.97

2.4

2.6

0.67

0.68

ug/l

0.03

111

901

Car occupant injured in noncollision transport accident

199

2228

0.88

0.97

2.8

2.9

0.65

0.73

ug/l

0.69

124

1258

Phobic anxiety disorders

541

5790

0.93

0.97

2.7

2.6

0.56

0.68

ug/l

4.08

328

2840

Toxic effect of other and unspecified substances

674

0.78

0.97

2.3

2.6

0.67

0.66

ug/l

0.02

336

Kyphosis

706

0.78

0.96

3.1

0.80

0.81

ug/l

0.01

466

Malignant neoplasm of renal pelvis

517

1.30

0.96

3.6

3.0

0.82

0.79

ug/l

0.12

353

Disorders of speech understanding and production

175

1513

1.15

0.96

2.8

3.1

0.75

0.76

ug/l

0.08

114

919

Viral agents as the cause of diseases classified to other chapters, including avohilmo

163

1437

1.16

0.96

3.0

3.1

0.78

0.76

ug/l

0.13

112

874

Seborrhoeic dermatitis

1012

9651

1.06

0.96

3.2

3.3

0.75

0.78

ug/l

0.20

677

6296

Erythema multiforme

103

1206

0.84

0.96

3.3

3.2

0.84

0.78

ug/l

0.17

767

Familial hypercholesterolemia, with ischemic heart disease

1035

10824

0.94

0.96

3.2

3.6

0.78

0.83

ug/l

0.89

712

7817

Other and unspecified epidermal thickening

149

1695

0.86

0.96

3.4

3.3

0.71

0.77

ug/l

0.62

100

1091

Vitamin D deficiency

861

0.81

0.96

3.1

3.0

0.74

0.73

ug/l

0.04

517

Gonococcal infection

144

1255

1.17

0.96

2.2

2.4

0.64

0.66

ug/l

0.05

607

Giant cell arteritis with polymyalgia rheumatica

248

2244

1.13

0.95

3.8

3.5

0.66

0.80

ug/l

3.26

184

1567

Other/unspecified cytomegaloviral diseases

126

1445

0.85

0.95

3.0

3.1

0.86

0.72

ug/l

0.88

878

Secondary thrombocytopenia

918

0.81

0.95

2.6

3.2

0.77

0.75

ug/l

0.10

581

Graves ophthalmopathy, strict

599

1.24

0.95

2.8

3.1

0.73

0.76

ug/l

0.19

370

Recurrent dislocation of patella

123

1056

1.17

0.95

2.2

2.3

0.79

0.69

ug/l

0.19

484

Mandibular retrognathia

262

2361

1.12

0.95

3.0

2.8

0.65

0.69

ug/l

0.37

130

1296

Postprocedural disorders of digestive system, not elsewhere classified

199

2220

0.88

0.95

3.0

3.4

0.74

0.76

ug/l

0.13

127

1467

Exposure to unspecified smoke, fire and flames

743

0.79

0.95

3.0

2.8

0.69

0.77

ug/l

0.49

425

Deep bite that required surgery

511

1.27

0.95

3.1

2.5

0.60

0.66

ug/l

0.36

248

Effects of foreign body entering through natural orifice

2589

26652

0.96

0.94

3.0

0.73

ug/l

0.00

1558

16056

Other appendicitis

607

5699

1.08

0.94

3.3

3.1

0.80

0.73

ug/l

0.56

392

3504

Other bursitis of knee

151

1336

1.18

0.94

3.1

3.0

0.74

0.76

ug/l

0.11

801

Ulcerative ileocolitis

248

2735

0.89

0.94

3.0

2.9

0.65

0.72

ug/l

0.68

152

1565

Other contact dermatitis

412

4452

0.92

0.94

3.2

3.1

0.69

0.76

ug/l

1.45

254

2741

Mixed and other personality disorders

428

4616

0.92

0.94

2.4

2.7

0.52

0.68

ug/l

3.34

305

2433

Insomnia

7101

50300

0.98

0.94

3.1

3.0

0.65

0.75

ug/l

8.80

4132

30198

Disorders of brain, other and unspecified

667

0.78

0.94

3.0

3.2

0.98

0.79

ug/l

0.20

425

Contusion of toe(s) without damage to nail

135

1174

1.17

0.94

2.9

3.0

0.69

0.72

ug/l

0.16

668

Corneal degeneration

107

917

1.20

0.94

3.4

3.3

0.76

0.79

ug/l

0.14

592

Benign neoplasm: Vertebral column

172

1.53

0.93

5.0

3.0

0.80

0.82

ug/l

0.04

112

Pyoderma

118

1358

0.84

0.93

3.4

3.2

0.62

0.79

ug/l

2.55

870

Secondary hypertension

701

7302

0.93

2.9

3.3

0.91

0.77

ug/l

1.92

514

4575

Other specified transport accidents

366

0.71

0.93

2.7

2.8

0.71

0.75

ug/l

0.08

204

Lactose intolerance, other/unspecified

129

1119

1.17

0.92

3.6

3.0

0.72

0.73

ug/l

0.04

660

Other and unspecified injuries of lower leg

429

3976

1.09

0.92

3.0

0.74

0.71

ug/l

0.18

265

2361

Familial hypercholesterolemia

1651

15931

1.05

0.92

3.3

3.5

0.77

0.80

ug/l

0.55

1159

11209

Drug-induced cataract

128

1465

0.85

0.92

3.1

0.69

0.74

ug/l

0.33

921

Other conjunctival vascular disorders and cysts

144

1264

1.17

0.92

3.5

3.3

0.81

0.79

ug/l

0.06

102

818

Erythema intertrigo

152

1719

0.86

0.92

2.8

3.3

0.61

0.76

ug/l

1.82

1129

Previous suicide attempt

514

0.76

0.92

2.4

2.6

0.85

0.71

ug/l

0.20

271

Unspecified human immunodeficiency virus [HIV] disease

1098

0.82

0.91

2.4

2.6

0.71

0.66

ug/l

0.09

558

Secondary and unspecified malignant neoplasm of lymph nodes

772

7321

1.07

0.91

3.0

2.9

0.80

0.71

ug/l

1.48

516

4823

Spontaneous rupture of synovium and tendon

667

6293

1.07

0.91

3.2

0.71

0.80

ug/l

1.62

419

4153

Hypersomnia

102

875

1.20

0.91

3.0

3.1

0.82

0.74

ug/l

0.21

544

Paralytic ileus

313

3399

0.90

0.91

2.8

3.3

0.69

0.82

ug/l

1.54

215

2269

Haemolytic anaemias

207

2298

0.88

0.91

3.0

3.3

0.84

0.77

ug/l

0.36

150

1490

Combinations of oral blood glucose lowering drugs

3584

36674

0.97

0.91

3.1

3.3

0.76

0.77

ug/l

0.38

2286

24521

Other injuries of upper limb, level unspecified

100

858

1.21

0.90

3.1

3.0

0.60

0.75

ug/l

1.48

511

Other protozoal intestinal diseases

735

1.22

0.90

3.2

3.1

0.52

0.73

ug/l

3.22

462

Biological medicines for asthma

132

1153

1.17

0.90

3.1

2.7

0.55

0.67

ug/l

2.29

628

Disorders of porphyrin and bilirubin metabolism

100

860

1.21

0.90

3.1

0.87

0.73

ug/l

0.58

532

Intestinal adhesions without obstruction

710

6716

1.07

0.90

3.2

3.3

0.81

0.82

ug/l

0.09

491

4564

Disorders of tooth development and eruption

1081

8389

1.05

0.90

3.0

2.8

0.74

0.76

ug/l

0.07

675

4599

Impetigo

216

2396

0.89

3.0

2.9

0.63

0.72

ug/l

1.11

118

1357

Wegener granulomatosis

1042

0.83

0.89

2.7

3.2

0.74

0.77

ug/l

0.15

671

Paralytic ileus and intestinal obstruction

2379

24487

0.96

0.89

3.1

3.3

0.76

0.82

ug/l

1.81

1669

16612

Alcohol abuse counselling and surveillance

173

1551

1.16

0.89

3.0

2.8

0.74

0.69

ug/l

0.27

102

872

Other disorders of the musculoskeletal system and connective tissue

1182

11325

1.05

0.89

3.4

3.2

0.75

0.77

ug/l

0.13

804

7412

Other and unspecified mononeuropathies of upper limb

233

2113

1.13

0.89

2.8

3.0

0.62

0.72

ug/l

1.46

150

1284

Chromomycosis and phaeomycotic abscess, including avohilmo

224

1.42

0.89

4.9

3.0

0.85

0.78

ug/l

0.19

138

Persistent mood disorders

1163

12153

0.95

0.89

2.8

3.1

0.59

0.76

ug/l

12.79

816

7408

Benign neoplasm: Connective and other soft tissue, unspecified

655

1.23

0.88

3.4

3.2

0.79

0.77

ug/l

0.03

418

Anxious personality disorder

745

0.80

0.88

2.4

0.54

0.66

ug/l

0.43

347

Viral meningitis, including avohilmo

185

1651

1.14

0.88

2.5

2.7

0.68

0.71

ug/l

0.20

859

Carrier of infectious disease

109

1261

0.85

0.88

3.0

3.2

0.80

0.74

ug/l

0.38

785

Acute generalized exanthematous pustulosis

243

2203

1.12

0.88

3.5

3.3

0.75

0.78

ug/l

0.11

171

1443

Chronic myeloproliferative disease

1070

0.83

0.88

2.8

3.4

0.78

0.79

ug/l

0.07

749

Eustachian salpingitis and obstruction

455

4237

1.08

0.88

2.6

2.4

0.66

0.63

ug/l

0.25

214

1918

Other and unspecified corneal deformities and disorders

219

1979

1.13

0.88

3.3

3.0

0.73

ug/l

0.02

147

1163

Amyloidosis

206

1862

1.14

0.88

3.2

3.5

0.74

0.84

ug/l

0.76

150

1312

Attention to artificial openings

434

4056

1.09

0.88

3.4

1.01

0.80

ug/l

1.39

331

2789

Malignant neoplasm of accessory sinuses, including Hilmo

337

0.70

0.88

3.4

2.8

0.68

0.80

ug/l

0.42

218

Nail dystrophy

357

1.32

0.87

4.3

3.0

0.61

0.78

ug/l

1.46

218

Other salmonella infections, including avohilmo

301

2763

1.11

0.87

3.4

3.1

0.73

0.75

ug/l

0.10

198

1708

Other congenital malformations of intestine, including avohilmo

564

1.24

0.87

2.8

3.0

0.56

0.82

ug/l

2.70

353

Childhood asthma (age<16), excluding more controls

417

3515

0.92

0.87

1.8

0.49

0.55

ug/l

1.36

133

1161

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

146

1642

0.86

0.87

3.3

3.0

0.86

0.78

ug/l

0.50

102

1150

Ulcer of oesophagus, drug-induced

423

0.73

0.86

3.1

3.3

0.76

0.80

ug/l

0.12

291

Viral meningitis

178

1588

1.14

0.86

2.5

2.7

0.69

0.71

ug/l

0.17

821

Osteonecrosis due to drugs

129

1136

1.18

0.86

4.6

3.4

1.59

0.75

ug/l

2.00

104

771

Rubella [German measles], including avohilmo

594

5656

1.09

0.86

2.6

2.7

0.63

0.67

ug/l

0.74

315

3102

Autism spe

580

0.78

0.86

1.9

2.0

0.51

0.56

ug/l

0.25

206

Rheumatoid lung disease

346

0.70

0.86

3.5

3.6

0.59

0.82

ug/l

1.49

244

Magnesium deficiency

277

0.67

0.86

2.7

3.1

0.39

0.79

ug/l

5.27

175

Pseudopolyposis of colon

220

0.63

0.86

2.9

2.8

0.63

0.72

ug/l

—

118

Juvenile cataract

211

0.63

0.86

3.9

2.5

2.24

0.67

ug/l

—

112

Lagophthalmos

835

1.20

0.86

3.9

3.4

1.06

0.81

ug/l

1.19

565

Selective serotonin reuptake inhibitors

10561

55676

0.98

0.85

3.1

0.67

0.80

ug/l

29.16

6875

34959

Other metabolic disorders

509

4759

1.08

0.85

3.0

3.1

0.64

0.75

ug/l

3.69

342

2923

Traumatic subdural haemorrhage

1659

14998

1.05

0.85

3.4

3.5

0.83

0.85

ug/l

0.21

1189

10513

Disorders of puberty

137

1.47

0.85

1.8

1.5

0.31

0.48

ug/l

—

Anterior Iridocyclitis

1582

15262

1.04

0.85

3.2

3.1

0.71

0.75

ug/l

1.51

1059

9585

Other and unspecified parapsoriasis

418

1.32

0.85

3.7

3.4

0.51

0.79

ug/l

4.63

280

Other mycoses, not elsewhere classified/unspecified

311

0.69

0.85

2.2

3.3

0.74

0.80

ug/l

0.23

210

Hyperparathyroidism

864

8122

1.06

0.85

3.5

3.3

0.82

0.81

ug/l

0.09

633

5520

Spinal enthesopathy

146

1648

0.87

0.85

3.2

3.3

1.02

0.96

ug/l

0.11

1160

Thiazolidinediones

1183

12299

0.95

0.84

3.2

3.5

0.85

0.78

ug/l

1.18

840

8596

Complications of other internal prosthetic devices, implants and grafts

274

2509

1.11

0.84

3.0

3.4

0.65

0.80

ug/l

2.78

194

1731

Routine general health check-up of defined subpopulation

363

1.28

0.84

2.5

2.6

0.74

0.73

ug/l

0.04

174

Astigmatism

383

3549

1.09

0.84

3.0

3.1

0.77

0.75

ug/l

0.06

245

2193

Dislocation, sprain and strain of joint and ligaments of hip

278

2551

1.11

0.84

3.1

3.4

0.66

0.79

ug/l

1.86

178

1674

Rubella [German measles]

593

5653

1.09

0.83

2.6

2.7

0.63

0.67

ug/l

0.73

314

3099

Hypertension, portal

275

0.67

0.83

2.3

3.0

0.46

0.77

ug/l

2.24

162

Reduction defects of unspecified limb, including avohilmo

1.71

0.83

2.6

3.0

0.87

0.59

ug/l

—

Other proliferative retinopathy

345

0.71

0.83

2.9

1.09

0.79

ug/l

0.72

206

Other diseases of peritoneum

176

1965

0.88

0.83

3.4

0.71

0.79

ug/l

0.73

123

1315

Unspecified renal colic

462

1.28

0.83

3.5

3.1

0.61

0.74

ug/l

1.17

299

Fibrosis of liver

609

0.78

0.82

2.5

3.1

0.83

0.74

ug/l

0.30

394

Atypical mycobacterium lung infection

679

0.80

0.82

3.4

0.91

0.84

ug/l

0.09

454

Seminoma of testis

855

1.21

0.82

2.6

2.4

0.74

0.68

ug/l

0.39

436

Other disorders of amino-acid metabolism

311

0.70

0.82

3.9

3.1

0.75

0.76

ug/l

0.02

206

Foreign body entering into or through eye or natural orifice

784

7469

1.06

0.82

3.0

0.67

0.74

ug/l

1.50

487

4448

Iridocyclitis in diseases classified elsewhere

140

1241

1.16

0.82

3.6

3.1

0.71

0.78

ug/l

0.41

104

767

Benign neoplasm: Epididymis

473

1.33

0.81

3.8

3.0

0.74

0.72

ug/l

0.06

301

Obesity, other/unspecified

1965

20290

0.96

0.81

2.8

3.0

0.63

0.74

ug/l

2.94

1252

12466

Demyelinating diseases of the central nervous system

311

3377

0.91

0.81

2.9

0.63

0.71

ug/l

1.39

200

1928

Other nutritional anaemias

644

0.79

0.81

3.3

3.4

0.74

0.80

ug/l

0.23

421

Use of ropinirole

288

3115

0.90

0.81

3.3

3.4

0.66

0.76

ug/l

2.82

198

2142

Viral pneumonia (unknown virus, not influenza)

582

5497

1.07

0.81

2.9

3.1

0.72

0.74

ug/l

0.22

407

3419

Burn and corrosion of shoulder and upper limb, except wrist and hand

144

1616

0.87

0.81

3.1

3.0

0.68

0.73

ug/l

0.40

955

Etanercept

285

3103

0.91

0.81

2.7

2.9

0.58

0.69

ug/l

3.35

163

1767

Blepharospasm

441

1.26

0.81

2.7

3.2

0.78

ug/l

0.00

289

Other diseases of blood and blood-forming organs, wide

1689

17463

0.96

0.81

3.1

3.3

0.75

0.78

ug/l

0.43

1141

11654

Flatulence and related conditions

597

1.23

0.81

3.5

3.3

0.60

0.79

ug/l

2.70

389

Coarctation of the aorta

568

0.78

0.81

2.3

2.7

1.22

0.69

ug/l

0.54

305

Sequelae of injuries of upper limb

724

7618

0.94

0.81

3.0

2.9

0.63

0.72

ug/l

2.97

437

4461

Alopecia areata

740

1.19

0.81

2.7

2.9

0.60

0.74

ug/l

1.63

422

Non-allergic asthma (mode)

1383

14222

0.96

0.80

3.0

3.3

0.67

0.81

ug/l

5.45

903

9495

Other disorders of Eustachian tube

187

1685

1.13

0.80

3.5

3.2

0.67

0.73

ug/l

0.72

137

1064

Iron deficiency

592

1.21

0.80

3.4

2.9

0.76

0.74

ug/l

0.05

357

Polyarthrosis

1110

9571

1.05

0.80

3.6

3.3

0.73

0.83

ug/l

2.29

787

6606

Anankastic personality disorder

150

1687

0.88

0.80

3.1

2.8

0.50

0.70

ug/l

5.37

925

Childhood asthma (age<16)

418

3508

0.93

0.80

1.8

0.49

0.55

ug/l

1.49

134

1165

Other congenital malformations of male genital organs

262

1.34

0.80

2.6

2.7

0.67

0.76

ug/l

0.22

136

Other and unspecified effects of external causes

1714

16567

1.04

0.80

3.0

0.67

0.74

ug/l

2.98

1066

9883

Injury of nerves at forearm level

115

1011

1.18

0.79

2.6

2.9

0.72

0.69

ug/l

0.11

594

Other congenital malformations of peripheral vascular system

541

1.23

0.79

2.3

3.0

0.67

0.74

ug/l

0.41

324

Family history of certain disabilities and chronic diseases leading to disablement

203

1833

1.12

0.79

3.0

2.8

0.67

0.68

ug/l

0.10

116

1000

Graves ophthalmopathy

668

1.20

0.79

2.9

3.1

0.73

0.76

ug/l

0.18

406

Polyarteritis nodosa

400

0.74

0.79

2.5

3.2

0.58

0.77

ug/l

1.34

257

Other renal tubulo-interstitial diseases

845

1.18

0.79

3.4

3.2

1.04

0.78

ug/l

0.32

544

Lichen simplex chronicus and prurigo

409

4375

0.92

0.79

3.0

3.3

0.67

0.76

ug/l

1.27

281

2850

Nystagmus and other irregular eye movements

720

0.81

0.78

3.5

3.0

0.67

0.75

ug/l

0.44

429

Other and unspecified immunodeficiencies with predominantly antibody defects

515

1.24

0.78

2.5

3.0

0.54

0.73

ug/l

2.96

298

Personal history of allergy to analgesic agent

290

1.33

0.78

3.5

2.8

0.49

0.75

ug/l

2.38

160

Inflammatory bowel disease

2515

25836

0.97

0.78

2.9

3.0

0.70

0.74

ug/l

1.58

1554

15693

Benign neoplasm: Penis

246

1.47

0.78

2.6

3.1

0.41

0.75

ug/l

5.68

166

Exposure to high and low air pressure and changes in air pressure

111

1.64

0.78

2.5

2.9

0.49

0.77

ug/l

1.99

Esophageal diverticulum (pouch), including avohilmo

231

1.40

0.78

3.0

3.2

0.89

0.76

ug/l

0.25

169

Lower leg

272

1.33

0.78

3.6

3.1

0.63

0.80

ug/l

0.88

163

Other rupture of muscle

436

1.27

0.78

4.1

3.0

0.66

0.75

ug/l

0.50

267

Disorders of male genital organs in diseases classified elsewhere

758

1.22

0.78

3.3

2.4

0.70

0.73

ug/l

0.15

401

Non-allergic asthma

521

5524

0.93

0.78

3.0

3.2

0.66

0.77

ug/l

3.34

338

3595

Acute drug-induced interstitial lung disorder

519

0.78

3.5

0.90

0.81

ug/l

0.25

363

Osteopathy in diseases classified elsewhere

508

0.77

3.0

3.3

1.13

0.84

ug/l

0.69

332

Congenital malformations of the urinary system

361

3358

1.09

0.77

3.3

3.2

1.00

0.74

ug/l

1.92

255

2115

Labyrinthine fistula

270

0.68

0.77

3.1

3.2

0.70

0.75

ug/l

0.21

181

272

1.33

0.77

3.3

2.7

0.66

0.72

ug/l

0.22

160

Mixed specific developmental disorders

183

0.65

0.77

1.1

1.5

0.33

0.55

ug/l

—

Explicit bacterial Sepsis

1014

10559

0.95

0.77

3.0

3.4

0.75

0.79

ug/l

0.49

706

7131

Deaf mutism, not elsewhere classified

308

0.71

0.77

2.4

3.0

0.85

0.86

ug/l

0.01

191

Congenital obstruction of the pelviureteric junction

308

1.30

0.77

3.4

2.6

0.76

0.68

ug/l

0.27

178

Hordeolum and other deep inflammation of eyelid

373

3474

1.09

0.77

3.1

0.70

0.74

ug/l

0.44

251

2115

Mental disorders, not otherwise specified

334

3604

0.92

0.77

2.7

2.8

0.56

0.69

ug/l

2.92

231

1934

Graves disease, strict definition

283

2599

1.09

0.77

2.9

3.0

0.68

0.72

ug/l

0.56

165

1525

Postprocedural disorders of nervous system

252

2304

1.10

0.77

2.8

0.60

0.71

ug/l

1.85

140

1245

Foreign body in respiratory tract

303

2800

1.10

0.76

3.1

3.3

0.85

0.75

ug/l

0.39

198

1748

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

413

3867

1.08

0.76

2.9

2.8

0.68

0.71

ug/l

0.29

241

2132

Deforming dorsopathies

1834

17758

1.04

0.76

3.2

3.1

0.67

0.77

ug/l

2.83

1188

11177

Other specified/unspecified bacterial intestinal infections

475

4467

1.08

0.76

3.5

3.3

0.87

0.77

ug/l

0.56

319

2947

Acute nephritic syndrome

163

1804

0.88

0.76

2.6

3.2

0.81

0.76

ug/l

0.30

109

1135

Misadventures to patients during surgical and medical care

1027

10703

0.95

0.76

3.3

3.4

0.77

0.79

ug/l

0.28

736

7303

Benign neoplasm: Testis

529

1.28

0.76

3.4

3.2

0.67

0.85

ug/l

0.92

335

Ulcerative colitis

1931

19897

0.97

0.76

2.9

3.0

0.72

0.74

ug/l

0.57

1220

12087

Reiter disease

600

1.24

0.76

2.7

2.9

0.53

0.74

ug/l

3.44

354

Contact with lifting and transmission devices, not elsewhere classified

214

1966

1.13

0.76

3.2

3.0

0.69

0.72

ug/l

0.36

138

1176

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

148

1323

1.14

0.75

3.5

3.2

0.64

0.78

ug/l

2.24

841

Allergic urticaria

354

3288

1.08

0.75

3.2

3.0

0.60

0.73

ug/l

2.82

207

1965

Reduction defects of lower limb, including avohilmo

143

1.47

0.75

2.8

2.5

0.55

0.81

ug/l

0.93

Disorders of parathyroid gland

954

9017

1.05

0.75

3.5

3.3

0.82

0.81

ug/l

0.11

699

6112

Drug-induced tremor

451

0.76

0.75

2.6

3.2

0.74

0.76

ug/l

0.09

296

Hepatomegaly and splenomegaly, not elsewhere classified

755

0.82

0.75

3.5

3.1

0.84

0.76

ug/l

0.29

479

Pleural plaque with presence of asbestos

1036

10733

0.95

0.75

3.8

3.7

0.74

0.84

ug/l

2.82

768

8022

Retinoschisis and retinal cysts

208

1901

1.12

0.75

3.5

0.67

0.78

ug/l

1.44

140

1307

Restrictive cardiomyopathy

270

0.69

0.75

3.3

3.2

1.01

0.75

ug/l

0.52

167

Injuries to the thorax

5376

52789

1.02

0.75

3.2

0.72

0.78

ug/l

3.92

3557

34043

Other degenerative diseases of the basal ganglia

193

1763

1.13

0.75

3.1

3.6

0.61

0.80

ug/l

2.60

149

1260

Bitten or struck by other mammals

578

5461

1.07

0.75

3.1

2.9

0.73

0.72

ug/l

0.05

363

3209

Inhalation and ingestion of other objects causing obstruction of respiratory tract

338

1.30

0.75

4.3

3.1

0.66

0.79

ug/l

0.50

220

Hypotony of eye

1.68

0.75

4.5

3.2

0.77

0.74

ug/l

0.06

Malignant neoplasm of hypopharynx

486

0.76

0.75

2.4

2.8

0.61

0.77

ug/l

1.39

327

Enlarged lymph nodes

1375

13273

1.04

0.75

3.0

3.2

0.70

0.76

ug/l

2.02

893

8510

Toxic effect of organic solvents

304

0.71

0.74

3.1

0.56

0.69

ug/l

0.76

181

Mesial bite

253

0.70

0.74

2.8

2.7

0.63

0.75

ug/l

—

138

Ulcerative colitis (strict) with PSC

463

0.77

0.74

2.3

2.6

0.89

0.73

ug/l

0.23

228

Other superficial mycoses

169

1525

1.13

0.74

3.1

2.9

0.59

0.73

ug/l

2.26

101

883

ILD medications: nintedanib

616

0.79

0.74

2.6

3.6

0.59

0.81

ug/l

2.02

437

Dacryoadenitis

319

1.29

0.74

3.4

3.0

0.62

0.86

ug/l

1.30

211

Other immunodeficiencies

421

0.77

0.74

2.5

2.9

0.58

0.75

ug/l

0.50

259

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

618

0.79

0.74

2.2

2.8

0.56

0.68

ug/l

1.00

340

Other and unspecified types of non-Hodgkin lymphoma, hilmo

316

3394

0.91

0.74

2.9

3.5

0.75

0.78

ug/l

0.33

212

2360

Cholesteatoma of external ear

645

1.22

0.74

3.7

3.3

0.67

0.76

ug/l

0.44

433

Dislocation, sprain and strain of joints and ligaments of elbow

335

3111

1.09

0.74

2.7

2.9

0.71

0.69

ug/l

0.14

180

1718

Molar incisor enamel hypoplasia

396

1.24

0.74

2.9

2.3

0.50

0.65

ug/l

1.37

175

Benign neoplasm: Tongue

201

1832

1.12

0.74

3.0

3.2

0.70

0.74

ug/l

0.31

134

1177

Spondylopathies (FG)

1029

9879

1.05

0.74

3.0

2.9

0.68

0.76

ug/l

2.68

653

5788

Benign neoplasm: Spinal cord

109

960

1.17

0.74

3.6

3.1

0.62

0.74

ug/l

1.39

602

Other/unspecified synovitis and tenosynovitis

772

7362

1.06

0.73

3.1

0.72

0.78

ug/l

0.87

479

4629

Contact with nonpowered hand tool

503

4766

1.08

0.73

3.3

3.1

0.77

0.72

ug/l

0.31

315

2921

Primary adrenocortical insufficiency

464

0.78

0.73

3.3

3.0

0.97

0.78

ug/l

0.44

277

Horner syndrome

801

1.18

0.73

2.8

3.0

0.72

0.77

ug/l

0.27

505

Oral lichen planus and hypothyroidism or thyroxine medication

255

1.31

0.73

4.8

3.2

0.64

0.78

ug/l

0.61

176

Poisoning by narcotics and psychodysleptics [hallucinogens]

801

0.83

0.73

2.2

2.4

0.42

0.70

ug/l

2.54

334

Choroidal haemorrhage and rupture

234

1.37

0.72

3.3

3.2

1.82

0.82

ug/l

0.60

157

Rickettsioses, including avohilmo

173

1.45

0.72

3.4

2.9

0.59

0.73

ug/l

0.73

102

Hypotension due to drugs

138

1239

1.15

0.72

3.1

3.4

0.69

0.83

ug/l

1.44

101

851

Dyshidrosis [pompholyx]

682

0.82

0.72

3.2

3.0

0.79

0.75

ug/l

0.17

403

Exposure to uncontrolled fire, not in building or structure

176

0.63

0.72

1.9

2.6

0.66

0.81

ug/l

—

103

Sequelae of injuries, of poisoning and of other consequences of external causes

2051

21085

0.97

0.72

3.0

0.64

0.73

ug/l

7.45

1278

12666

Congenital malformations of eye, ear, face and neck

296

2738

1.09

0.72

3.1

3.0

0.72

0.73

ug/l

0.03

174

1582

Combined immunodeficiencies

538

0.80

0.71

2.9

3.2

1.23

0.75

ug/l

0.32

338

Thrombotic microangiopathy

360

0.75

0.71

2.4

3.3

0.74

0.75

ug/l

0.03

233

Myeloproliferative diseases

608

6396

0.94

0.71

3.0

3.4

0.75

0.80

ug/l

0.42

412

4378

Other otitis externa (chronic)

470

4430

1.07

0.71

3.5

3.2

0.71

0.75

ug/l

0.69

293

2854

Malignant neoplasm of nasopharynx, including Hilmo

390

0.75

0.71

2.7

0.62

0.75

ug/l

0.82

245

Open wound of neck

685

0.81

0.71

2.8

0.49

0.72

ug/l

4.13

371

Benign neoplasm of mouth and pharynx

849

8131

1.05

0.71

3.2

0.70

0.76

ug/l

1.36

545

5323

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

102

1148

0.85

0.71

2.4

2.7

0.68

0.66

ug/l

0.04

586

Carcinoma in situ of skin of lip

254

1.37

0.71

5.0

3.5

0.66

0.79

ug/l

0.42

179

Glomerulonephritis

818

8539

0.95

0.71

2.9

3.2

0.93

0.76

ug/l

1.86

591

5519

Migraine

2016

16152

0.97

0.71

2.9

2.8

0.68

0.74

ug/l

1.19

1200

9189

Acute otitis externa, noninfective

1021

0.85

0.71

3.1

3.0

0.69

0.76

ug/l

0.38

641

Streptococcal septicaemia, including avohilmo

910

9472

0.95

0.71

3.0

3.4

0.77

0.78

ug/l

0.14

637

6450

Oral lichen planus

114

1005

1.15

0.70

3.3

3.2

0.65

0.74

ug/l

0.71

656

Streptococcal septicaemia

889

9257

0.95

0.70

3.0

3.4

0.78

ug/l

0.06

619

6309

Malignant neoplasm of oropharyng

184

0.63

0.70

1.8

2.9

0.53

0.77

ug/l

—

123

Scissor bite

568

1.20

0.70

2.8

2.6

0.61

0.69

ug/l

0.46

306

Oesophagitis, drug-induced

156

1.47

0.70

3.9

3.3

0.55

0.79

ug/l

1.58

109

Other primary thrombocytopenia

189

1.39

0.70

2.8

3.3

0.73

0.76

ug/l

0.07

129

Atopic dermatitis, strict definition

1277

12032

1.04

0.70

2.7

0.65

0.69

ug/l

0.82

700

6441

Cerebrovascular diseases (FINNGEN)

2970

20328

1.03

0.70

2.8

2.9

0.73

ug/l

0.01

1932

11486

Mandibular hypoplasia

241

1.33

0.70

2.9

2.8

0.55

0.71

ug/l

1.35

131

Hypermobility syndrome

410

0.78

0.70

2.1

2.4

0.90

0.69

ug/l

0.22

193

Malignant neoplasm of larynx

161

1767

0.88

0.70

3.3

3.0

0.72

0.75

ug/l

0.26

117

1225

Crohn disease

842

8794

0.95

0.70

2.8

3.0

0.64

0.73

ug/l

3.64

516

5150

Hypoplasia of dental enamel , including avohilmo

384

1.23

0.70

2.9

2.3

0.49

0.65

ug/l

1.39

168

Oral leukoplakia, including avohilmo

191

2089

0.90

0.70

2.9

3.1

0.61

0.73

ug/l

2.13

117

1280

Injury of cranial nerves

435

0.77

0.70

3.3

3.0

0.63

0.75

ug/l

0.69

260

Explicit bacterial Sepsis, including avohilmo

1038

10774

0.95

0.70

3.0

3.4

0.75

0.79

ug/l

0.64

726

7272

Congenital malformations of the respiratory system

711

0.83

0.69

2.9

3.0

0.64

0.73

ug/l

0.43

434

Secondary uncertain malignant neoplasm

1181

12235

0.96

0.69

3.1

3.0

0.89

0.73

ug/l

4.04

819

8309

Malignant neoplasm of rectum, including Hilmo

1270

12279

1.04

0.69

3.2

3.0

0.80

0.73

ug/l

1.17

885

8404

Acute lymphadenitis

299

3219

0.92

0.69

2.9

0.67

0.73

ug/l

0.39

151

1840

Other injuries of spine and trunk, level unspecified

663

0.82

0.69

2.5

3.0

0.75

0.73

ug/l

0.08

397

Autonomic disorders

170

1542

1.12

0.69

2.9

3.1

0.68

0.75

ug/l

0.59

108

975

Other necrotizing vasculopathies

503

4758

1.07

0.69

3.3

3.4

0.72

0.78

ug/l

0.60

371

3244

Liposarcoma

650

1.21

0.69

3.1

2.8

0.65

0.74

ug/l

0.76

428

Maze procedure for atrial fibrillation

458

1.27

0.69

3.0

3.3

0.72

0.79

ug/l

0.24

297

Mental and behavioural disorders due to hallucinogens

258

0.71

0.69

1.7

2.2

0.41

0.64

ug/l

1.03

103

Other and unspecified abdominal hernia

247

2674

0.91

0.69

3.4

0.64

0.80

ug/l

3.31

173

1820

Neuroendocrine tumor and carcinoma of small intestine

123

1100

1.15

0.69

3.4

3.0

0.79

0.75

ug/l

0.26

737

Sequelae of other and unspecified infectious and parasitic diseases

408

3837

1.08

0.69

2.9

2.8

0.68

0.71

ug/l

0.25

238

2108

Dissection of aorta

317

3385

0.92

0.69

3.2

3.5

0.86

0.80

ug/l

0.16

232

2317

Mental and behavioural disorders due to sedatives or hypnotics

425

4514

0.93

0.68

2.5

2.7

0.50

0.69

ug/l

9.32

294

2432

Malignant neoplasm of oropharynx, including Hilmo

473

0.78

0.68

2.1

2.9

0.82

0.73

ug/l

0.26

307

Other symptoms and signs involving general sensations and perceptions

206

2250

0.90

0.68

3.3

3.2

0.68

0.79

ug/l

1.00

144

1422

Other diseases of pancreas

741

7740

0.95

0.68

3.3

0.72

0.79

ug/l

0.86

544

5166

Mixed connective tissue disease

613

0.82

0.68

2.3

3.2

0.95

0.80

ug/l

0.25

396

Syphilis

225

2434

0.90

0.68

2.8

2.9

0.65

0.72

ug/l

0.64

146

1419

Syphilis, including avohilmo

225

2434

0.90

0.68

2.8

2.9

0.65

0.72

ug/l

0.64

146

1419

Marginal zone B-cell lymphoma

686

1.19

0.68

3.2

2.9

0.83

0.75

ug/l

0.22

457

Drug-induced adrenocortical insufficiency

880

0.85

0.68

3.7

3.2

1.02

0.79

ug/l

0.24

559

Cluster headache, wide

262

2425

1.09

0.67

2.7

2.8

0.67

0.73

ug/l

0.53

154

1408

Brain astrocytoma

211

0.68

0.67

2.2

2.5

0.61

0.77

ug/l

—

108

Brain astrocytoma, including Hilmo

211

0.68

0.67

2.2

2.5

0.61

0.77

ug/l

—

108

Tick-borne viral encephalitis

345

1.28

0.67

3.8

3.2

0.46

0.73

ug/l

3.50

219

Ankylosis of joint

345

0.75

0.67

3.9

3.1

0.96

0.94

ug/l

0.02

221

Superficial injury of hip and thigh

1194

11523

1.04

0.66

3.3

0.75

0.81

ug/l

1.11

812

7815

D07AA Corticosteroids, weak (group I)

807

7709

1.05

0.66

2.9

3.0

0.65

0.75

ug/l

3.01

489

4665

Traumatic ischaemia of muscle

1054

0.86

0.66

2.5

2.9

0.58

0.72

ug/l

1.62

630

Chronic lower respiratory diseases

11597

61745

0.99

0.66

3.0

3.1

0.69

0.78

ug/l

15.83

7263

38791

Congenital malformations of oesophagus, including avohilmo

326

1.28

0.66

2.8

3.1

0.77

0.76

ug/l

0.01

222

Complications following infusion, transfusion and therapeutic injection

887

0.85

0.66

3.5

3.2

0.81

0.79

ug/l

0.09

572

Certain zoonotic bacterial diseases

111

1246

0.87

0.66

2.6

3.1

0.64

0.77

ug/l

1.47

765

Other reaction to severe stress, and adjustment disorders

1876

19286

0.97

0.66

2.8

2.7

0.66

0.71

ug/l

1.41

1143

10127

Disorders of iron metabolism

148

1341

1.13

0.66

3.0

3.1

0.75

0.71

ug/l

0.20

830

Wide developmental disorders, excluding more controls

757

0.84

0.66

1.9

2.1

0.45

0.61

ug/l

1.18

268

Marginal zone B-cell lymphoma, including Hilmo

132

1188

1.14

0.66

3.1

3.0

0.82

0.75

ug/l

0.35

772

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

444

0.79

0.66

2.6

0.50

0.78

ug/l

3.29

270

Scabies, including avohilmo

894

8578

1.05

0.66

2.8

0.67

0.70

ug/l

0.42

500

4764

Thyroiditis

230

2114

1.10

0.65

3.5

3.2

0.67

0.75

ug/l

1.29

159

1320

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

235

0.71

0.65

3.5

2.6

0.67

0.74

ug/l

—

119

Other congenital malformations of skin

181

1648

1.11

0.65

2.7

3.0

0.66

0.73

ug/l

0.53

101

996

Other abnormal auditory perceptions

443

1.22

0.65

3.5

2.9

1.22

0.75

ug/l

0.36

268

Non-seminoma of testis, including Hilmo

466

1.24

0.65

3.1

2.2

0.61

0.64

ug/l

0.13

205

Speech therapy

1963

19110

1.03

0.65

3.1

3.3

0.72

0.79

ug/l

2.24

1511

12792

Benign neoplasm: Skin of trunk

281

2614

1.09

0.65

3.2

0.71

0.75

ug/l

0.52

189

1668

Exposure to ignition of highly flammable material

448

0.78

0.65

4.1

2.9

0.73

0.79

ug/l

0.23

249

Congenital aortic valve stenosis

187

0.67

0.65

2.4

2.5

0.66

0.68

ug/l

—

Other and unspecified spinal muscular atrophies

678

0.82

0.65

3.2

3.4

0.88

0.83

ug/l

0.24

456

Congenital malformations and deformations of the musculoskeletal system

301

2782

1.08

0.65

3.0

2.8

0.71

0.70

ug/l

0.05

171

1494

Dermatitis due to substances taken internally

307

2862

1.08

0.65

3.3

3.2

0.72

0.78

ug/l

0.44

215

1804

Fatigue fracture of vertebra

218

1.33

0.65

2.4

3.0

0.70

0.74

ug/l

0.07

152

Other specified/unspecified soft tissue disorders

237

2186

1.09

0.65

3.3

3.2

0.82

0.81

ug/l

0.04

157

1435

Contact with heat and hot substances

368

3914

0.93

0.64

3.1

3.0

0.75

0.72

ug/l

0.22

213

2379

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1265

11877

1.04

0.64

3.2

3.0

0.80

0.74

ug/l

0.91

810

7173

Exclusion endpoint for supernumerary teeth

379

1.24

0.64

2.4

2.5

0.63

0.75

ug/l

0.47

185

Meralgia paraesthetica

244

2260

1.10

0.64

3.2

3.1

0.63

0.72

ug/l

1.72

158

1405

Orthopaedic devices associated with adverse incidents

130

1170

1.14

0.64

4.5

3.5

0.74

0.79

ug/l

0.44

102

824

Contusion of other and unspecified parts of foot

279

2592

1.09

0.64

2.8

2.9

0.62

0.71

ug/l

1.51

149

1450

Benign neoplasm of bone and articular cartilage

551

5237

1.06

0.64

3.3

3.1

0.73

ug/l

0.01

356

3210

Other mosquito-borne viral fevers

150

1.44

0.64

2.5

2.9

0.72

0.76

ug/l

0.11

Contracture of muscle

183

1.36

0.64

3.6

3.0

0.92

0.76

ug/l

0.34

126

Rheumatism, unspecified

290

2692

1.08

0.64

3.4

3.1

0.80

0.76

ug/l

0.13

190

1723

Melanoma of uvea

784

0.84

0.64

3.8

3.3

0.75

0.82

ug/l

0.36

521

Asymptomatic human immunodeficiency virus [HIV] infection status

629

0.81

0.64

2.7

2.5

0.93

0.64

ug/l

0.42

303

Intermittent hydrarthrosis

132

1.46

0.64

3.6

2.9

0.64

0.76

ug/l

0.66

Intestinal helminthiases, other/unspecified, including avohilmo

167

1.40

0.63

2.5

3.6

0.69

0.78

ug/l

0.26

122

Other and unspecified papulosquamous disorders

355

1.26

0.63

3.0

3.1

0.72

0.77

ug/l

0.13

230

Other endocrine disorders

172

1809

0.90

0.63

3.6

3.1

0.78

0.76

ug/l

0.13

123

1102

Autism

588

0.83

0.63

1.9

2.0

0.48

0.56

ug/l

0.43

207

Venous thromboembolism

5157

50433

0.98

0.63

3.3

0.81

0.79

ug/l

0.43

3619

34035

Hemiplegia

297

3180

0.92

0.63

2.9

3.3

0.72

0.80

ug/l

0.39

219

2105

367

0.77

0.63

2.2

2.7

0.78

0.73

ug/l

0.08

200

Mandibular prognathia AND surgery (LeFortI or BSSO)

186

0.68

0.63

2.7

2.4

0.52

0.68

ug/l

—

Other and unspecified mononeuropathies of lower limb

150

1358

1.12

0.63

3.2

3.1

0.65

0.74

ug/l

0.96

859

Other specified and unspecified disorders of conjunctiva

652

1.19

0.63

2.4

3.0

0.57

0.76

ug/l

2.57

391

Conotruncal defects

356

0.77

0.62

2.2

2.4

0.49

0.71

ug/l

1.86

174

Residual foreign body in soft tissue

474

4499

1.07

0.62

3.2

2.9

0.62

0.74

ug/l

4.59

302

2671

Candidiasis

713

7452

0.95

0.62

3.1

3.2

0.78

0.77

ug/l

0.09

508

4851

Malignant neoplasm of rectosigmoid junction, including Hilmo

224

2415

0.91

0.62

3.3

3.0

0.92

0.76

ug/l

0.64

164

1643

Open bite

127

1136

1.12

0.62

3.4

2.6

0.69

ug/l

0.02

587

Other/unspecified crystal arthropathies

450

1.23

0.62

3.8

3.4

0.60

0.87

ug/l

2.33

309

Amoebiasis, including avohilmo

420

1.23

0.61

3.7

2.9

0.61

0.68

ug/l

0.46

252

Crushing injury of ankle and foot

358

0.76

0.61

2.9

3.1

0.59

0.74

ug/l

0.63

227

Nail disorders

553

5264

1.06

0.61

3.1

3.0

0.66

0.74

ug/l

1.84

352

3088

Pedestrian injured in collision with heavy transport vehicle or bus

217

0.70

0.61

4.1

2.9

0.55

0.87

ug/l

—

141

Primary biliary cholangitis, wide definition

852

0.86

0.61

2.8

3.2

0.83

0.79

ug/l

0.11

534

Benign neoplasm: Bones of skull and face

365

0.78

0.61

2.6

3.0

0.50

0.77

ug/l

2.40

241

Hypertrophic disorders of skin

226

2086

1.09

0.61

3.2

3.0

0.69

0.74

ug/l

0.52

146

1213

Other and unspecified rosacea

495

4697

1.06

0.61

3.5

3.2

0.72

0.76

ug/l

0.34

322

3056

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

493

1.20

0.60

2.6

2.7

0.74

0.69

ug/l

0.15

268

Other and unspecified local infections of skin and subcutaneous tissue

757

7883

0.95

0.60

3.3

3.2

0.73

0.77

ug/l

0.79

518

5098

Other strabismus

1236

11911

1.04

0.60

3.1

3.0

0.81

0.74

ug/l

0.58

762

7082

Oher contracture of tendon (sheath)

250

1.31

0.60

3.4

3.2

0.69

0.94

ug/l

0.93

164

Bruxism

437

1.20

0.60

2.5

2.6

0.73

0.76

ug/l

0.08

242

Open wound of shoulder and upper arm

161

1472

1.12

0.60

2.4

3.0

0.61

0.73

ug/l

1.69

108

852

Hypermetropia

397

3742

1.07

0.60

3.3

3.2

0.72

0.75

ug/l

0.41

251

2352

Overjet

370

1.22

0.60

3.2

2.6

0.63

0.73

ug/l

0.69

192

Disorders of puberty, all

157

1.35

0.59

1.8

1.6

0.31

0.52

ug/l

—

Protozoal diseases

214

2307

0.91

0.59

2.4

3.4

0.64

0.75

ug/l

1.32

143

1519

Malignant neoplasm of eye and adnexa

598

0.82

0.59

3.1

2.9

0.91

0.78

ug/l

0.39

398

Benign neoplasm: Skin of lip

768

1.16

0.59

3.0

3.2

0.77

0.76

ug/l

0.02

514

Syndrome of inappropriate secretion of antidiuretic hormone

349

0.77

0.59

2.4

3.2

0.65

0.76

ug/l

0.66

237

Benign neoplasm: Connective and other soft tissue of head, face and neck

113

1014

1.14

0.59

3.4

3.2

0.82

0.76

ug/l

0.30

630

Benign neoplasm: Brain, infratentorial

294

1.27

0.59

3.1

1.02

0.77

ug/l

0.84

184

Motorcycle rider injured in noncollision transport accidents

274

2564

1.09

0.59

3.0

2.7

0.72

0.68

ug/l

0.25

147

1384

Complications of genitourinary prosthetic devices, implants and grafts

142

1288

1.12

0.59

3.2

3.4

0.94

0.81

ug/l

0.46

102

881

STROKE

5685

37692

1.02

0.58

3.1

3.2

0.75

0.76

ug/l

0.28

3799

23186

Tooth eruption problems

376

3856

0.94

0.58

2.7

2.6

0.65

0.66

ug/l

0.06

199

1916

Burn and corrosion confined to eye and adnexa

194

1793

1.10

0.58

2.8

0.56

0.69

ug/l

3.14

115

960

Other and unspecified disorders of adult personality and behaviour

228

0.72

0.58

3.0

2.4

0.71

0.73

ug/l

—

104

Defect, injury or illness of neck

267

1.27

0.58

3.3

3.0

1.14

0.76

ug/l

0.52

161

Malignant neoplasm of hypopharynx, including Hilmo

740

0.84

0.58

2.3

2.9

0.65

0.76

ug/l

1.09

483

Asthma (mode)

7293

38801

0.98

0.58

3.1

0.68

0.78

ug/l

11.50

4603

24087

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

137

1239

1.12

0.58

2.6

0.62

0.72

ug/l

0.86

606

Tetraplegia

595

0.83

0.58

2.8

3.1

0.69

0.81

ug/l

0.58

381

Chronic suppurative otitis media

403

4256

0.94

0.58

3.1

3.2

0.95

0.77

ug/l

0.95

270

2722

Certain conditions originating in the perinatal period

916

0.88

0.57

2.1

2.2

0.58

0.73

ug/l

0.80

370

Medial epicondylitis

238

2214

1.09

0.57

3.0

2.9

0.73

ug/l

0.04

140

1328

Pilonidal cyst

762

7331

1.05

0.57

2.5

2.6

0.62

0.68

ug/l

1.47

376

3733

Other congenital malformations of intestine

452

1.21

0.57

2.9

3.0

0.58

0.83

ug/l

1.91

280

Idiopathic thrombocytopenic purpura

185

2004

0.91

0.57

2.9

3.3

0.73

0.76

ug/l

0.29

126

1310

Other congenital malformations of the digestive system, including avohilmo

257

2377

1.08

0.56

3.0

3.2

0.69

0.75

ug/l

0.50

177

1484

Other interstitial pulmonary diseases

1550

15908

0.97

0.56

3.2

3.5

0.73

0.82

ug/l

3.48

1122

11346

Other congenital malformations of face and neck

159

1454

1.11

0.56

2.8

2.9

0.67

0.72

ug/l

0.37

829

Benign neoplasm: Skin of other and unspecified parts of face

745

7161

1.05

0.56

3.4

0.80

0.81

ug/l

0.11

516

4890

Senile degeneration of the brain, not elsewhere classified

291

0.76

0.56

2.7

3.6

0.76

0.81

ug/l

0.14

201

Other complications of surgical and medical care, not elsewhere classified

598

5718

1.05

0.56

3.2

0.74

0.78

ug/l

0.33

415

3714

5-aminosalicylic acid

1650

16939

0.97

0.56

2.9

0.70

0.73

ug/l

0.78

994

9985

Livedoid vasculitis

215

1.31

0.56

2.6

2.9

0.53

0.75

ug/l

2.04

128

Other and unspecified injuries of forearm

403

0.80

0.56

3.5

2.7

0.78

0.71

ug/l

0.21

230

Exposure to controlled fire, not in building or structure

245

0.73

0.55

3.5

2.7

0.88

0.77

ug/l

0.37

149

Sicca syndrome [Sjögren]

208

1921

1.09

0.55

3.2

0.69

0.76

ug/l

0.70

140

1250

Panniculitis affecting regions of neck and back

233

2169

1.09

0.55

3.1

0.67

0.75

ug/l

1.04

144

1344

Psoriasis

2477

25293

0.98

0.55

3.0

3.1

0.67

0.75

ug/l

4.11

1618

16066

Drug-induced systemic lupus erythematosus

170

0.69

0.55

1.8

2.7

0.89

0.80

ug/l

—

102

Benign neoplasm: Skin, unspecified

268

2509

1.08

0.55

3.4

3.2

0.81

0.75

ug/l

0.38

179

1610

Impacted teeth

633

5679

0.95

0.55

2.3

2.5

0.62

0.63

ug/l

0.26

306

2659

Other abnormal immunological findings in serum

760

1.15

0.55

3.4

3.0

0.61

0.67

ug/l

0.45

461

Subacute thyroiditis

120

1081

1.12

0.55

3.5

3.2

0.66

0.74

ug/l

0.99

693

Benign lipomatous neoplasm of other sites/unspecified

630

6041

1.05

0.55

3.2

3.3

0.74

0.80

ug/l

0.59

444

4046

Drug-induced myopathy

233

0.73

0.55

2.4

3.2

0.92

ug/l

0.00

153

Oesophageal obstruction

310

3284

0.93

0.55

3.2

3.4

0.81

0.78

ug/l

0.09

224

2240

Pervasive developmental disorders excl. Autism + Asperger

175

1.31

0.55

1.8

0.33

0.61

ug/l

—

Psoriasis (vulgaris), strict definition

285

3028

0.93

0.54

2.3

3.0

0.57

0.71

ug/l

4.70

165

1757

Colorectal neuroendocrine tumor and carcinoma

697

1.16

0.54

2.8

2.7

0.68

0.71

ug/l

0.22

445

Postprocedural musculoskeletal disorders, not elsewhere classified

476

4992

0.94

0.54

3.5

3.3

0.71

0.76

ug/l

0.75

317

3375

Sequelae of other external causes

411

3902

1.06

0.54

3.1

3.2

0.66

0.75

ug/l

1.27

288

2502

Thyroiditis, unspecified

387

1.20

0.54

3.1

3.0

0.67

0.75

ug/l

0.49

244

Use of rivastigmine

1266

12261

1.04

0.54

3.4

3.7

0.74

0.88

ug/l

7.19

928

9125

Dystonia

258

2411

1.08

0.54

3.0

3.1

0.72

0.74

ug/l

0.09

171

1502

Injury of blood vessels at lower leg level

354

0.78

0.54

2.4

3.0

0.73

0.81

ug/l

0.24

211

Chronic myringitis

344

0.78

0.54

3.2

1.13

0.74

ug/l

0.68

216

Leiomyosarcoma, including Hilmo

417

1.20

0.54

3.8

3.0

0.68

0.75

ug/l

0.44

271

L04AC Interleukin inhibitors

390

4112

0.94

0.53

2.6

2.8

0.72

0.68

ug/l

0.37

205

2262

Acquired pure red cell aplasia [erythroblastopenia]

244

1.28

0.53

3.3

3.1

1.17

0.82

ug/l

0.30

165

Psoas tendinitis

252

1.27

0.53

4.3

2.9

0.97

0.77

ug/l

0.32

163

Neovascular glaucoma

303

3213

0.93

0.53

3.3

3.4

0.87

0.80

ug/l

0.43

217

2178

Nonspecific lymphadenitis

341

3220

1.07

0.53

2.6

2.8

0.77

0.70

ug/l

0.24

184

1829

Benign neoplasm of thyroid gland

129

1171

1.11

0.53

3.9

3.3

0.80

0.77

ug/l

0.12

763

Infection due to other mycobacteria

995

0.88

0.53

3.6

3.4

0.80

ug/l

0.00

666

Infections of the skin and subcutaneous tissue

5839

58181

0.98

0.53

3.0

0.68

0.76

ug/l

7.53

3629

35739

Moderate visual impairment, monocular

309

1.25

0.53

3.9

3.1

0.60

0.76

ug/l

1.22

210

Cardiomyopathy, other and unspecified

765

7924

0.96

0.53

2.8

3.3

0.84

0.79

ug/l

0.32

530

5284

Guttate psoriasis

753

0.86

0.52

2.8

3.0

0.68

0.73

ug/l

0.20

447

Protozoal diseases, including avohilmo

221

2365

0.92

0.52

2.4

3.3

0.64

0.75

ug/l

1.43

148

1560

Contusion of ankle

210

2258

0.92

0.52

2.9

0.71

0.70

ug/l

0.05

133

1303

Myeloproliferative diseases (CML excluded)

543

5669

0.95

0.52

3.1

3.4

0.76

0.79

ug/l

0.20

371

3882

Personal history of allergy to drugs, medicaments and biological substances

464

1.18

0.52

3.2

2.8

0.52

0.75

ug/l

3.16

277

Malignant neoplasm of digestive organs, including Hilmo

4410

32895

0.98

0.52

3.1

2.9

0.79

0.70

ug/l

4.99

3100

21464

Scleritis

605

1.16

0.52

2.9

0.79

0.73

ug/l

0.30

347

Malignant neoplasm of other and ill-defined digestive organs

558

0.83

0.52

3.5

2.9

0.78

0.84

ug/l

0.26

384

Suppurative otitis media, unspecified

113

1247

0.89

0.52

3.3

3.2

0.80

0.75

ug/l

0.22

781

Interstitial lung disease

1550

15881

0.97

0.51

3.2

3.5

0.73

0.82

ug/l

3.52

1122

11334

Interstitial lung disease endpoints

1550

15881

0.97

0.51

3.2

3.5

0.73

0.82

ug/l

3.52

1122

11334

Unspecified threat to breathing

410

0.81

0.51

3.0

2.9

0.47

0.76

ug/l

3.99

235

Benign neoplasm: Pharynx, unspecified

476

1.19

0.51

2.9

3.2

0.68

0.75

ug/l

0.49

300

Congenital malformations of gallbladder, bile ducts and liver

400

1.20

0.51

3.8

3.1

0.84

0.77

ug/l

0.19

253

Other/unspecified enthesopathies, not elsewhere classified

625

6003

1.05

0.51

3.2

3.1

0.70

0.81

ug/l

1.52

387

3876

Drug-induced obesity

312

0.79

0.51

2.8

3.0

0.61

0.75

ug/l

0.67

189

Strabismus

1732

16855

1.03

0.51

3.1

0.79

0.75

ug/l

0.33

1113

10508

Haemorrhagic disorder due to circulating anticoagulants

106

1167

0.89

0.51

3.2

3.4

0.70

0.82

ug/l

0.83

829

Posteruptive colour changes of dental hard tissues

101

1.42

0.51

3.5

2.7

0.55

0.82

ug/l

—

Disorders of optic nerve, not elsewhere classified

162

1497

1.10

0.51

3.4

3.3

0.76

0.79

ug/l

0.18

111

1012

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

569

1.17

0.51

2.8

2.9

0.65

0.68

ug/l

0.12

340

Benign neoplasm: Other and unspecified parts of small intestine

101

911

1.13

0.51

3.1

3.4

0.79

0.80

ug/l

0.03

607

Nezelof syndrome

243

0.75

0.51

2.5

3.2

0.63

0.75

ug/l

0.44

164

Exposure to ignition or melting of other clothing and apparel

261

0.75

0.50

1.7

3.0

0.52

0.81

ug/l

1.92

159

Allergic asthma (mode)

1328

12598

1.03

0.50

2.8

2.9

0.65

0.75

ug/l

2.27

721

7243

Perforation of oesophagus

447

0.81

0.50

3.2

0.67

0.73

ug/l

0.20

301

Hypertensive Heart Disease

2803

21636

0.98

0.50

3.3

3.5

0.81

0.79

ug/l

0.29

2052

15020

Burn and corrosion, body region unspecified

413

1.21

0.50

2.8

2.9

0.77

0.75

ug/l

0.06

244

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

282

0.76

0.50

2.8

0.51

0.72

ug/l

1.20

141

Acute nasopharyngitis (common cold)

1427

13808

1.03

0.50

2.4

2.5

0.67

0.65

ug/l

0.46

675

6953

Rhinophyma

818

1.16

0.50

3.6

3.3

0.95

0.84

ug/l

0.49

563

Pedestrian injured in other and unspecified transport accidents

633

0.85

0.50

3.2

3.1

0.80

0.79

ug/l

0.01

388

Coeliac disease

622

6476

0.96

0.50

3.0

3.2

0.77

ug/l

0.00

420

4190

Other facial nerve disorders

160

1475

1.10

0.50

3.2

3.1

0.76

0.74

ug/l

0.10

101

928

Hyperkinetic disorders (excl. ADHD)

476

1.17

0.50

1.9

0.39

0.61

ug/l

3.92

153

ILD medications: pirfenidone

116

1261

0.88

0.49

3.1

3.6

0.68

0.76

ug/l

0.30

907

Patent foramen ovale

152

1401

1.10

0.49

3.2

2.9

0.78

0.72

ug/l

0.17

789

Pulmonary embolism

2625

26735

0.98

0.49

3.3

3.4

0.80

ug/l

0.05

1857

18224

Scarlet fever, including avohilmo

397

0.81

0.49

1.8

2.4

0.64

ug/l

0.00

179

Injury of muscle and tendon at wrist and hand level

1439

14040

1.03

0.49

3.1

3.0

0.71

0.73

ug/l

0.24

887

8488

Sequelae of intentional self-harm, assault and events of undetermined intent

374

0.81

0.49

2.7

2.5

0.47

0.70

ug/l

2.42

184

Other and unspecified injuries of wrist and hand

212

1977

1.08

0.49

3.3

3.0

0.65

0.74

ug/l

1.18

132

1142

Macular pucker, drug-induced

1.51

0.49

3.4

3.2

0.72

ug/l

—

Granulomatous disorders of skin and subcutaneous tissue

941

0.88

0.49

3.5

3.1

0.75

ug/l

0.02

577

Personal history of certain other diseases

431

0.83

0.49

2.6

2.7

0.60

0.75

ug/l

0.67

235

MS-disease / Multiple Sclerosis

245

2615

0.93

0.49

2.7

2.9

0.59

0.70

ug/l

2.59

158

1440

Spondylolisthesis/Spondylolysis

1302

12674

1.03

0.49

3.1

0.67

0.77

ug/l

1.84

846

8039

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1515

14793

1.03

0.48

3.7

3.0

1.04

0.72

ug/l

7.13

1096

9918

Diseases caused by chlamydiae, including avohilmo

281

1.22

0.48

2.9

2.4

0.60

0.70

ug/l

0.50

131

Pulmonary heart disease

2625

26726

0.98

0.48

3.3

3.4

0.80

ug/l

0.03

1857

18211

Congenital malformations of great arteries

725

0.87

0.48

3.2

2.7

1.12

0.71

ug/l

0.72

404

Artificial joint re-operation

463

4427

1.06

0.48

3.5

0.66

0.78

ug/l

3.46

333

3096

Convergent concomitant strabismus

233

2488

0.93

0.48

2.6

2.7

0.56

0.71

ug/l

2.75

119

1301

Assault by other specified means

577

0.85

0.48

3.1

2.5

0.53

0.71

ug/l

2.22

276

Hypertension, Pulmonary Arterial

406

0.82

0.48

2.5

3.0

0.66

0.82

ug/l

0.74

255

Fracture of foot, except ankle

1749

17091

1.03

0.48

2.9

0.64

0.73

ug/l

5.54

1051

10108

Alzheimer disease, including avohilmo

3590

25236

0.98

0.48

3.3

3.7

0.86

ug/l

0.07

2635

18882

Chronic hepatitis NAS

620

0.85

0.48

2.9

3.1

0.77

0.75

ug/l

0.03

381

Calcific aortic valvular stenosis, including rheumatic fever

3358

32781

0.98

0.48

3.3

3.6

0.80

0.83

ug/l

0.87

2417

23712

Psoriasis vulgaris

1669

17073

0.97

0.48

3.0

3.1

0.68

0.75

ug/l

1.74

1094

10752

Crushing injury of wrist and hand

189

1771

1.10

0.48

3.0

3.1

0.55

0.74

ug/l

6.77

116

1095

Malignant neoplasm of other and unspecified parts of mouth

393

0.81

0.48

2.2

2.9

0.90

0.77

ug/l

0.13

269

Acute hepatitis A, including avohilmo

317

0.79

0.48

2.9

3.0

0.74

0.78

ug/l

0.07

178

Chronic iridocyclitis

263

2793

0.93

0.48

3.5

3.1

0.73

0.77

ug/l

0.33

190

1700

Neuralgic amyotrophy

186

1.34

0.48

3.4

3.0

0.59

0.76

ug/l

0.62

128

Generalized skin eruption due to drugs and medicaments

203

1893

1.08

0.48

3.4

3.3

0.74

0.78

ug/l

0.21

144

1244

Immunodeficiency following hereditary defective response to Epstein-Barr virus

0.00

0.48

0.0

2.4

—

0.67

—

Muscle wasting and atrophy, not elsewhere classified

467

0.83

0.48

2.5

3.1

0.74

0.82

ug/l

0.25

303

Superficial injury of ankle and foot

743

7169

1.04

0.48

2.8

2.9

0.67

0.72

ug/l

1.21

431

4094

Meningococcal infection, including avohilmo

437

0.83

0.48

2.9

2.7

0.68

0.66

ug/l

0.05

227

Esophageal diverticulum (pouch)

204

1.31

0.47

3.2

3.3

0.96

0.76

ug/l

0.36

149

Other rickettsioses

1.79

0.47

3.2

3.1

0.54

0.80

ug/l

—

Multiple myeloma, including Hilmo

350

3678

0.94

0.47

3.0

0.96

0.74

ug/l

1.92

260

2549

Listeriosis

306

0.79

0.47

2.9

3.5

0.72

0.82

ug/l

0.26

211

Leukaemia of unspecified cell type

659

0.86

0.47

3.1

0.57

0.82

ug/l

2.37

420

Superficial injury of forearm

630

6062

1.05

0.47

3.1

3.0

0.69

0.73

ug/l

0.54

412

3690

Other bursitis, not elsewhere classified

691

0.86

0.47

3.2

3.1

0.67

0.80

ug/l

0.86

439

Bus occupant injured in other and unspecified transport accidents

219

1.26

0.47

2.9

0.71

0.72

ug/l

0.03

141

Arteriovenous malformation of cerebral vessels

754

0.87

0.47

3.4

3.0

0.66

0.72

ug/l

0.32

478

Burn and corrosion of ankle and foot

105

1151

0.89

0.47

2.8

3.1

0.66

0.76

ug/l

0.77

716

Benign neoplasm: Scrotum

545

1.20

0.47

2.8

3.1

0.63

0.76

ug/l

0.89

356

Calcific aortic valvular stenosis

3350

32733

0.98

0.47

3.3

3.6

0.80

0.83

ug/l

0.86

2409

23679

Calcific aortic valvular stenosis, operated

3350

32733

0.98

0.47

3.3

3.6

0.80

0.83

ug/l

0.86

2409

23679

Vertigo of central origin

100

906

1.12

0.47

3.9

3.3

0.94

0.77

ug/l

0.44

621

Otosclerosis

470

4498

1.05

0.47

3.4

3.3

0.78

0.76

ug/l

0.19

303

3010

Liposarcoma, including Hilmo

853

1.14

0.47

2.9

0.69

0.74

ug/l

0.26

555

Lichen planus

774

7479

1.04

0.47

3.2

3.3

0.77

ug/l

0.01

487

4926

Pedal cyclist injured in collision with motor vehicle

174

1872

0.92

0.47

3.4

3.0

0.72

0.74

ug/l

0.13

104

1086

Bicuspidal aortic valve syndrome

377

3599

1.06

0.47

3.1

3.0

0.73

0.70

ug/l

0.31

223

2147

Operations 2 for CAVS

3348

32710

0.98

0.47

3.3

3.6

0.80

0.83

ug/l

0.84

2409

23665

Calcific aortic valvular stenosis, diagnosis (helper)

3348

32710

0.98

0.47

3.3

3.6

0.80

0.83

ug/l

0.84

2409

23665

Smallpox

0.00

0.47

0.0

2.9

—

0.78

—

Smallpox, including avohilmo

0.00

0.47

0.0

2.9

—

0.78

—

Parkinson's disease, strict definition

1448

14821

0.97

0.47

3.4

3.6

0.76

0.83

ug/l

2.24

1047

10748

Burns and corrosions

1168

11997

0.97

0.47

3.0

0.68

0.73

ug/l

1.39

722

7106

Perioral dermatitis

328

1.20

0.47

2.6

2.8

0.41

0.75

ug/l

3.97

195

Other local infections of skin and subcutaneous tissue

830

8569

0.96

0.46

3.3

3.2

0.72

0.77

ug/l

1.33

564

5527

Ulcerative colitis (strict definition, all Crohn cases excluded)

1076

11067

0.97

0.46

2.9

0.72

0.73

ug/l

0.17

651

6494

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

113

1.39

0.46

3.0

2.4

0.62

0.64

ug/l

—

Diabetic retinopathy

3004

18947

0.98

0.46

3.3

3.2

0.80

0.77

ug/l

0.72

2149

12866

Contact with other specified venomous animals

397

1.19

0.46

3.0

0.70

0.74

ug/l

0.15

248

Chronic suppurative otitis media, including avohilmo

475

4958

0.95

0.46

3.2

0.91

0.76

ug/l

0.90

315

3179

Aortic aneurysm

3673

35517

1.02

0.46

3.4

3.5

0.80

0.82

ug/l

0.27

2627

25099

Pedestrian injured in collision with pedal cycle

215

2016

1.08

0.46

2.6

3.0

0.75

ug/l

0.01

138

1184

Thyrotoxicosis with toxic single thyroid nodule

247

1.24

0.46

2.4

3.2

0.75

ug/l

0.00

163

Excluding asthma or asthma-COPD overlap

7691

38942

0.99

0.46

3.0

3.1

0.73

0.78

ug/l

1.71

4755

24115

All influenza (not pneumonia)

1376

14095

0.97

0.46

2.9

3.0

0.75

ug/l

0.05

840

8519

Malignant neoplasm of oropharynx, including Hilmo

205

2178

0.92

0.45

3.0

2.9

0.73

0.70

ug/l

0.20

135

1374

Congenital malformations of the respiratory system, including avohilmo

776

0.88

0.45

2.9

3.0

0.62

0.73

ug/l

0.62

465

Foreign body in ear

110

1003

1.11

0.45

3.5

3.1

0.76

0.77

ug/l

0.06

615

Other and unspecified anaemias

4500

41666

1.02

0.45

3.4

3.5

0.85

0.81

ug/l

0.91

3276

29314

Unspecified protein-energy malnutrition

305

0.80

0.45

2.5

3.2

1.89

0.87

ug/l

0.64

196

Superficial injury of abdomen, lower back and pelvis

1147

11164

1.03

0.45

3.1

0.71

0.76

ug/l

0.67

715

6988

Intentional self-harm by unspecified means

511

0.85

0.45

2.4

2.5

0.99

0.74

ug/l

0.30

255

Malaria

343

1.21

0.45

3.0

3.2

0.68

0.76

ug/l

0.44

207

Other salmonella infections

254

2397

1.07

0.45

3.5

3.1

0.73

0.75

ug/l

0.14

173

1500

Meningococcal infection

434

0.83

0.45

2.9

2.7

0.68

0.67

ug/l

0.05

226

Amyloidosis, other/unspecified

169

1577

1.09

0.45

3.4

3.5

0.74

0.79

ug/l

0.36

122

1119

Lumbosacral root disorders, not elsewhere classified

762

0.87

0.45

2.3

3.2

0.65

0.74

ug/l

0.80

514

Acute hepatitis A

303

0.79

0.45

2.9

3.1

0.77

0.79

ug/l

0.04

169

Melanocytic naevi of lip

248

1.23

0.45

3.1

3.0

0.73

0.78

ug/l

0.15

150

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

429

1.19

0.45

3.4

2.9

0.74

0.78

ug/l

0.16

301

Other and unspecified injuries of neck

397

1.18

0.45

3.3

2.7

0.69

0.75

ug/l

0.17

218

Benign neoplasm: Skin of scalp and neck

176

1641

1.09

0.45

3.6

3.3

0.73

0.77

ug/l

0.43

125

1083

Peptic ulcer

698

0.87

0.45

3.1

0.68

0.82

ug/l

1.03

445

Typhus fever

0.00

0.44

0.0

2.9

—

0.81

—

Villonodular synovitis (pigmented)

426

1.18

0.44

2.8

2.7

0.53

0.75

ug/l

2.06

243

Congenital musculoskeletal deformities of head, face, spine and chest

434

1.17

0.44

2.8

2.7

0.67

0.69

ug/l

0.06

227

Sequelae of other and unspecified effects of external causes

371

1.20

0.44

3.0

3.1

0.77

0.78

ug/l

0.02

222

Spinal instabilities

151

1628

0.92

0.44

3.0

2.9

0.60

0.74

ug/l

2.56

106

976

Bulimia nervosa (incl. atypical)

152

0.72

0.44

3.1

2.2

0.38

0.75

ug/l

—

Nonalcoholic steatohepatitis

559

1.15

0.44

2.8

2.9

0.54

0.70

ug/l

1.70

337

Juvenile rheumatoid arthirtis

543

0.86

0.44

2.6

2.3

0.63

0.68

ug/l

0.23

257

Embolic stroke with flimmer

216

2292

0.93

0.44

3.1

3.6

0.85

ug/l

0.00

147

1659

Follicular cysts of skin and subcutaneous tissue

1604

15693

1.03

0.44

3.2

3.1

0.77

0.75

ug/l

0.19

1047

9903

Contracture of joint

835

1.12

0.44

2.6

3.1

0.65

0.82

ug/l

1.30

508

Congenital malformations of oesophagus

297

1.22

0.44

2.9

3.2

0.80

0.77

ug/l

0.06

199

Other anaemias

4532

41855

1.02

0.44

3.4

3.5

0.84

0.81

ug/l

0.93

3299

29439

Acute mastoiditis

588

1.15

0.44

2.4

2.7

0.72

0.73

ug/l

0.04

313

Leiomyosarcoma

333

1.20

0.44

3.9

2.9

0.70

0.79

ug/l

0.48

214

Cauda equina syndrome

730

0.87

0.43

3.2

3.0

0.62

0.73

ug/l

0.86

448

Malignant neoplasm of adrenal gland

288

1.23

0.43

3.3

2.8

1.04

0.74

ug/l

0.54

176

Other disorders of binocular vision

349

0.82

0.43

2.9

2.7

0.58

0.71

ug/l

0.33

200

Mandibular prognathia

647

0.87

0.43

2.9

0.70

0.74

ug/l

0.08

370

Essential (haemorrhagic) thrombocythaemia

243

2293

1.07

0.43

3.0

2.9

0.69

0.73

ug/l

0.45

163

1513

Follicular adenocarcinoma of thyroid gland, including Hilmo

464

1.16

0.43

4.1

2.8

0.71

0.75

ug/l

0.15

289

Anaesthesiology devices associated with adverse incidents

0.00

0.43

0.0

3.1

—

0.92

—

Lesion of radial nerve

268

2827

0.94

0.43

2.9

3.1

0.84

0.74

ug/l

0.23

159

1709

Cicatricial alopecia [scarring hair loss]

268

1.22

0.43

2.2

3.3

1.11

0.76

ug/l

0.37

175

Post-traumatic wound infection, not elsewhere classified

240

2269

1.07

0.43

3.1

0.64

0.75

ug/l

1.83

160

1360

Cluster headache, strict

239

2255

1.07

0.43

2.6

2.8

0.66

0.71

ug/l

0.40

140

1310

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

258

1.21

0.42

3.4

2.8

0.51

0.78

ug/l

2.17

138

Other and unspecified heterotropia

160

1.30

0.42

3.1

3.0

1.14

0.75

ug/l

0.31

102

Contact with other sharp object(s)

508

4887

1.05

0.42

3.2

2.8

0.73

0.69

ug/l

0.74

277

2732

Autoimmune hepatitis

336

0.82

0.42

2.9

3.1

0.53

0.78

ug/l

2.90

206

Viral Sepsis

1949

19866

0.98

0.42

3.1

3.4

0.79

0.80

ug/l

0.04

1405

13523

Tick-borne viral encephalitis, including avohilmo

392

1.19

0.42

3.7

3.1

0.44

0.74

ug/l

4.44

242

Congenital malformations of the musculoskeletal system, not elsewhere classified

240

1.22

0.42

3.5

2.9

0.51

0.79

ug/l

2.10

130

Follicular adenocarcinoma of thyroid gland

316

1.20

0.42

4.0

2.7

0.77

0.78

ug/l

0.02

201

Single delivery by forceps and vacuum extractor

0.00

0.42

0.0

1.0

—

Sarcoidosis

1041

10140

1.03

0.42

3.0

3.1

0.77

0.74

ug/l

0.24

647

6329

Other drug-induced secondary parkinsonism

704

0.87

0.41

3.1

3.2

0.79

0.77

ug/l

0.06

458

Systemic lupus erythematosus, unspecified

729

1.12

0.41

2.6

3.1

0.75

ug/l

0.00

463

Asthma, unspecified (mode), excluding more controls

4863

34347

1.01

0.41

3.3

3.2

0.70

0.78

ug/l

5.30

3292

21742

Central retinal artery occlusion

188

1998

0.92

0.41

3.1

3.6

0.70

0.83

ug/l

1.28

131

1437

Other disorders of electrolyte and fluid balance, not elsewhere classified

505

0.85

0.41

3.1

3.2

0.70

0.76

ug/l

0.23

331

Malnutrition

101

1104

0.90

0.41

2.8

3.2

1.25

0.81

ug/l

0.91

729

Viral pneumonia

1169

11978

0.97

0.41

3.0

3.3

0.73

0.78

ug/l

1.35

807

7781

Fall involving bed

214

2270

0.93

0.41

3.2

3.5

0.81

ug/l

0.03

167

1592

Retinoblastoma

0.00

0.41

0.0

1.7

—

0.74

—

Other bacterial intestinal infections, including avohilmo

1910

18734

1.02

0.41

3.2

3.3

0.80

0.79

ug/l

0.14

1294

12357

Benign lipomatous neoplasm of of intra-abdominal organs

213

0.76

0.41

3.6

3.2

0.97

0.74

ug/l

—

136

Other encephalitis

177

1657

1.08

0.41

2.9

3.1

0.74

0.76

ug/l

0.06

122

1003

311

0.81

0.41

3.1

3.5

0.64

0.80

ug/l

0.80

209

Heart failure and antihypertensive medication

2359

15583

0.98

0.41

2.8

2.9

0.72

0.74

ug/l

0.53

1635

9250

Carcinoid syndrome

744

0.88

0.41

3.4

0.72

0.77

ug/l

0.35

501

Postviral fatigue syndrome

141

1.29

0.41

2.6

2.0

0.57

0.65

ug/l

—

Scoliosis

259

2448

1.06

0.41

3.5

3.1

0.73

0.78

ug/l

0.34

174

1546

Congenital hydrocephalus

159

0.73

0.41

2.7

2.4

0.72

0.75

ug/l

—

LSIL lesion of the cervix uteri

0.00

0.40

0.0

1.1

—

Contact with sharp glass

235

2485

0.94

0.40

2.7

0.78

0.69

ug/l

0.54

125

1316

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

524

0.86

0.40

2.8

3.5

0.79

ug/l

0.00

351

ILD differential diagnosis

7671

38801

0.99

0.40

3.0

3.1

0.74

0.78

ug/l

1.17

4740

24087

Pulmonary eosinophilia, not elsewhere classified

714

0.88

0.40

3.5

3.2

0.68

0.81

ug/l

0.68

463

Immunodeficiency associated with other specified major defects, or unspecified

1.65

0.40

3.2

2.9

0.87

0.74

ug/l

—

Implicit viral Sepsis

1947

19832

0.98

0.40

3.1

3.4

0.79

0.80

ug/l

0.03

1403

13510

Folliculitis decalvans

135

1.34

0.40

2.5

3.3

0.87

0.81

ug/l

—

Disorder of external ear, unspecified

263

2498

1.07

0.40

3.2

0.77

0.75

ug/l

0.08

179

1556

Burn and corrosion of other internal organs

212

0.77

0.40

2.7

0.69

0.77

ug/l

—

110

Accidental poisoning by and exposure to pesticides

153

1.31

0.40

3.9

3.1

0.77

0.85

ug/l

0.21

Corneal scars and opacities

210

1982

1.07

0.40

3.3

3.2

0.70

0.75

ug/l

0.60

145

1246

Rheumatic fever with heart involvement

299

0.81

0.39

3.5

3.1

0.68

0.79

ug/l

0.39

190

Small plaque parapsoriasis

218

1.26

0.39

3.3

0.63

0.73

ug/l

0.40

132

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

211

1.29

0.39

3.2

2.7

1.18

0.84

ug/l

0.22

141

Other disorders of optic [2nd] nerve and visual pathways

411

3944

1.05

0.39

3.3

0.76

0.75

ug/l

0.04

275

2572

Noninfective enteritis and colitis

3824

37682

1.02

0.39

3.0

3.1

0.71

0.76

ug/l

2.22

2430

23448

Erysipelas

6741

57522

1.01

0.39

3.1

3.2

0.74

0.77

ug/l

0.90

4607

36807

Glaucoma secondary to other eye disorders

305

3196

0.94

0.39

3.3

0.87

0.80

ug/l

0.37

218

2153

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

167

1778

0.92

0.39

3.0

2.9

0.71

0.73

ug/l

0.11

111

1161

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5075

50035

1.01

0.39

3.3

0.75

0.79

ug/l

1.35

3461

33804

Burn and corrosion of wrist and hand

253

2665

0.94

0.39

2.7

2.9

0.69

0.71

ug/l

0.12

150

1505

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

596

0.87

0.39

2.4

2.9

0.73

0.74

ug/l

0.02

396

Injury of urinary and pelvic organs

196

1850

1.08

0.39

3.3

3.1

0.69

0.75

ug/l

0.57

125

1133

Other congenital malformations, not elsewhere classified

243

1.21

0.39

3.0

2.8

0.73

0.76

ug/l

0.08

133

Benign neoplasm: Spinal meninges

440

1.16

0.39

3.0

3.3

1.05

0.76

ug/l

0.33

291

Contact with blunt object, undetermined intent

442

1.16

0.39

3.3

3.0

0.77

0.76

ug/l

0.01

248

Optic atrophy, wide definition

102

1109

0.91

0.39

3.0

3.1

0.71

0.74

ug/l

0.15

697

Infection due to other mycobacteria, including avohilmo

1057

0.90

0.39

3.6

3.4

0.79

0.80

ug/l

0.03

703

Osteitis due to dental implant

470

1.16

0.39

3.0

3.1

0.82

0.80

ug/l

0.06

305

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.39

0.0

1.1

—

Benign neoplasm: Hypopharynx

416

1.18

0.39

2.9

3.3

0.98

0.80

ug/l

0.34

271

Other specified and unspecified disorders of eyelid

102

938

1.11

0.39

3.0

3.1

0.63

0.79

ug/l

1.34

590

Pedal cyclist injured in collision with pedestrian or animal

528

1.15

0.39

2.9

3.1

0.60

0.73

ug/l

1.07

320

Other embolism and thrombosis

1036

10105

1.03

0.39

3.3

0.75

0.78

ug/l

0.52

708

6677

Hereditary deficiency of other clotting factors

365

1.17

0.38

3.1

3.0

0.69

0.77

ug/l

0.22

231

Enteropathic arthropathies

113

1224

0.91

0.38

2.9

2.8

0.70

0.76

ug/l

0.42

703

Other keratitis

798

7753

1.03

0.38

3.0

0.73

ug/l

0.03

508

4615

Ankylosing spondylitis, strict definition

334

3195

1.06

0.38

2.7

0.70

0.68

ug/l

0.30

207

1691

Pneumoconiosis due to dust containing silica

411

0.83

0.38

4.3

3.4

0.66

0.81

ug/l

0.72

272

Seronegative juvenile rheumatoid arthritis

247

0.80

0.38

2.1

2.4

0.71

0.74

ug/l

0.10

122

Localized skin eruption due to drugs and medicaments

660

1.13

0.38

3.3

3.1

0.72

0.74

ug/l

0.07

415

Urticaria due to cold and heat

225

1.22

0.38

3.0

2.5

0.59

0.68

ug/l

0.28

128

SLE, strict definition

896

1.10

0.38

2.8

3.0

0.76

0.73

ug/l

0.06

563

SLE, ICD10

896

1.10

0.38

2.8

3.0

0.76

0.73

ug/l

0.06

563

Other rickettsioses, including avohilmo

1.48

0.38

3.0

3.1

0.73

0.74

ug/l

—

Other specified and unspecified disorders of lens

356

1.17

0.38

4.7

3.4

1.08

0.88

ug/l

0.62

254

Mild or no visual impairment, binocular

189

1.25

0.38

3.4

3.0

0.68

0.76

ug/l

0.12

127

Disorders of synovium and tendon in diseases classified elsewhere

188

1773

1.08

0.38

3.2

3.0

0.61

0.75

ug/l

2.53

120

1089

Congenital malformations of spine and bony thorax, including avohilmo

207

1.23

0.38

2.8

2.6

0.50

0.78

ug/l

2.39

110

Other hereditary haemolytic anaemias

348

1.18

0.38

2.9

2.8

0.55

0.76

ug/l

1.16

199

Diseases of arteries, arterioles and capillaries (FINNGEN)

2775

18851

1.02

0.38

2.8

3.0

0.68

0.74

ug/l

2.19

1841

11008

Optic atrophy

1045

0.91

0.38

2.9

3.1

0.70

0.74

ug/l

0.19

664

Congenital malformations of aortic and mitral valves

392

3769

1.05

0.38

3.1

3.0

0.72

0.71

ug/l

0.18

231

2250

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

332

0.83

0.38

2.5

2.7

0.49

0.69

ug/l

2.07

173

Preparatory care for dialysis

454

4382

1.05

0.38

2.8

3.3

1.13

0.74

ug/l

7.27

371

2860

Panniculitis, unspecified

546

1.14

0.38

2.8

3.1

0.63

0.78

ug/l

1.07

347

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

273

0.80

0.38

3.1

2.7

0.67

0.75

ug/l

0.18

171

Struck by thrown, projected or falling objec

487

4701

1.05

0.38

2.8

3.0

0.68

0.72

ug/l

0.51

273

2796

Proteinuria and renal glomerular damage; focal glomerulonephritis

0.66

0.37

4.3

2.8

1.08

0.82

ug/l

—

Atopic conjunctivitis

165

1544

1.07

0.37

2.5

2.8

0.68

0.74

ug/l

0.44

101

848

Chronic nephritic syndrome

320

3341

0.95

0.37

2.8

3.2

1.00

0.75

ug/l

2.48

247

2151

Myositis

199

1880

1.07

0.37

3.1

0.73

0.77

ug/l

0.28

138

1214

Other and unspecified postprocedural disorders of eye and adnexa

177

0.75

0.37

4.1

3.1

0.57

0.81

ug/l

—

113

Transplanted organ and tissue status

897

9198

0.97

0.37

2.6

3.0

0.77

0.73

ug/l

0.82

682

5664

Osteomalacia

426

0.85

0.37

2.9

3.1

0.79

0.73

ug/l

0.14

256

Whooping cough

212

0.79

0.37

2.2

2.6

0.35

0.71

ug/l

—

100

Valgus deformity, not elsewhere classified

282

1.19

0.37

3.1

2.8

0.73

0.78

ug/l

0.10

168

Sixth [abducent] nerve palsy

272

2594

1.06

0.37

3.2

3.4

0.79

0.77

ug/l

0.10

190

1745

Mesothelioma, including Hilmo

113

1215

0.91

0.37

3.3

3.1

0.81

0.78

ug/l

0.17

873

Other haemoglobinopathies

155

1.30

0.37

2.4

2.8

0.48

0.73

ug/l

1.92

Follow-up care involving plastic surgery

114

1234

0.92

0.37

3.9

3.3

0.70

0.76

ug/l

0.70

825

Other disorders of binocular movement

869

0.90

0.37

2.9

3.1

0.58

0.74

ug/l

1.89

528

Listeriosis, including avohilmo

318

0.82

0.37

3.0

3.5

0.73

0.84

ug/l

0.33

217

Juvenile arthritis (FINNGEN)

104

1131

0.92

0.37

2.4

2.6

0.67

0.72

ug/l

0.31

570

Vitreous haemorrhage

861

8836

0.97

0.37

3.2

3.3

0.84

0.78

ug/l

0.58

607

5834

Other and unspecified injuries of thorax

142

1328

1.09

0.37

2.5

3.0

0.60

0.75

ug/l

1.62

798

Benign neoplasm: other/unspecified salivary gland

181

1706

1.07

0.36

3.1

3.4

0.78

0.81

ug/l

0.09

121

1163

Other and unspecified diseases of spleen

285

0.81

0.36

3.9

3.1

0.72

0.87

ug/l

0.42

186

Other secondary coxarthrosis

232

2203

1.06

0.36

3.1

3.2

0.73

0.77

ug/l

0.45

158

1388

Other and unspecified follicular disorders

346

3320

1.05

0.36

3.0

3.1

0.65

0.73

ug/l

1.46

222

2048

Hypocalcemia

137

1466

0.92

0.36

3.6

3.3

1.04

0.76

ug/l

0.50

102

962

Other and unspecified disorders of binocular movement

246

1.21

0.36

3.4

2.7

0.59

0.71

ug/l

0.87

152

Early syphilis, including avohilmo

127

1186

1.09

0.36

2.6

0.59

0.70

ug/l

1.10

617

Retinal haemorrhage

181

1707

1.07

0.36

3.7

3.4

0.76

0.80

ug/l

0.26

123

1143

Lymphoid leukaemia

508

4914

1.04

0.36

3.2

3.4

0.77

0.79

ug/l

0.14

370

3418

Benign neoplasm: Connective and other soft tissue of thorax

294

1.19

0.36

3.4

3.1

0.55

0.74

ug/l

0.79

201

Inflammatory disorders of male genital organs, not elsewhere classified

167

1578

1.08

0.36

3.2

2.6

0.90

0.72

ug/l

0.49

100

895

Raynaud syndrome

441

4246

1.04

0.36

3.2

0.75

0.74

ug/l

0.06

285

2658

Isolated proteinuria

239

2275

1.06

0.36

3.1

3.2

0.94

0.76

ug/l

0.96

172

1458

COPD differential diagnosis

7678

38807

0.99

0.36

3.0

3.1

0.74

0.78

ug/l

1.16

4745

24089

Other disorders of pigmentation

246

2338

1.06

0.36

3.3

3.2

0.82

0.78

ug/l

0.27

158

1521

Other specified/unspecified deforming dorsopathies

719

1.11

0.36

3.4

2.8

0.64

0.80

ug/l

1.43

418

Monoarthritis, not elsewhere classified

286

2731

1.06

0.36

3.0

0.73

0.79

ug/l

0.64

191

1693

Heart failure and hypertrophic cardiomyopathy

159

1686

0.93

0.35

2.9

3.4

0.67

0.79

ug/l

1.31

103

1144

Amblyopia ex anopsia

168

1787

0.93

0.35

3.0

3.1

0.86

0.75

ug/l

0.40

104

1094

Abnormal findings on diagnostic imaging of central nervous system

305

2917

1.05

0.35

3.2

0.72

0.74

ug/l

0.17

191

1842

Vitamin A deficiency

188

0.78

0.35

3.9

3.1

0.81

0.94

ug/l

—

130

Other autoimmune haemolytic anaemias

790

0.89

0.35

3.0

3.3

1.17

0.82

ug/l

0.88

527

Allergic asthma (mode), excluding more controls

1328

12682

1.02

0.35

2.8

2.9

0.65

0.76

ug/l

2.49

721

7315

Use of donepezil

1725

16743

0.98

0.35

3.3

3.7

0.84

0.87

ug/l

0.44

1223

12513

Deficiency of other B group vitamins

118

1268

0.92

0.35

3.1

3.3

0.85

0.81

ug/l

0.11

866

Motorcycle rider injured in other and unspecified transport accidents

530

5133

1.04

0.35

2.9

2.7

0.62

0.67

ug/l

1.12

303

2767

Burn and corrosion of head and neck

171

1810

0.93

0.35

3.5

2.9

0.74

0.73

ug/l

0.05

105

1043

Emotional disorders and disorders of social functioning with onset specific to childhood

521

0.88

0.35

1.7

1.8

0.35

0.55

ug/l

3.07

146

Missing teeth due to accident, extraction or parodontitis

6359

56244

1.01

0.35

3.4

3.3

0.71

0.78

ug/l

6.42

4430

37600

Xanthelasma of eyelid

407

1.15

0.35

2.8

3.1

0.65

0.81

ug/l

0.85

266

Non-Hodgkin lymphoma, all

396

4107

0.95

0.35

3.0

0.78

0.75

ug/l

0.21

272

2835

Ingrowing nail

346

3321

1.05

0.35

3.0

2.8

0.62

0.71

ug/l

1.73

203

1823

Acquired absence of organs, not elsewhere classified

944

0.90

0.34

2.6

3.2

0.96

0.75

ug/l

0.54

624

Other and unspecified syphilis, including avohilmo

325

0.83

0.34

3.1

2.6

0.62

0.71

ug/l

0.38

157

Malignant neoplasm of other and unspecified urinary organs

278

1.21

0.34

3.2

2.8

0.65

0.83

ug/l

0.93

197

Other factor of the environment

810

0.90

0.34

3.3

3.1

0.78

0.76

ug/l

0.08

498

Chloasma

109

1.31

0.34

3.1

0.90

0.74

ug/l

—

Other cranial nerve disorders in other disorders

175

0.77

0.34

2.1

2.8

0.83

0.71

ug/l

—

Drug-induced headache, not elsewhere classified

173

1.24

0.34

3.4

2.8

0.55

0.69

ug/l

0.55

Findings of drugs and other substances, not normally found in blood

315

1.18

0.34

3.9

2.9

0.73

0.72

ug/l

0.02

190

Arthropod-borne viral fevers and viral haemorrhagic fevers

866

8870

0.97

0.34

3.0

3.1

0.79

0.76

ug/l

0.17

529

5581

Gangrene, not elsewhere classified

692

0.89

0.34

2.1

3.3

0.84

0.81

ug/l

0.04

479

Other/unspecified mastoiditis and related conditions

324

1.18

0.34

3.0

3.1

0.66

0.73

ug/l

0.42

200

Perforation of tympanic membrane

653

6721

0.97

0.34

3.2

0.91

0.78

ug/l

0.81

444

4374

Sequelae of inflammatory diseases of the central nervous system

186

0.78

0.34

2.5

2.7

0.39

0.77

ug/l

—

106

Donors of organs and tissues

800

0.90

0.34

2.8

0.79

0.70

ug/l

0.49

452

Shoulder region

1006

0.91

0.34

2.8

3.0

0.64

0.75

ug/l

0.99

619

Congenital malformations of the circulatory system

1019

9668

1.03

0.34

3.1

3.0

0.72

0.73

ug/l

0.06

627

5821

Idiopathic hypercalciuria

381

1.16

0.34

3.1

3.0

0.68

0.75

ug/l

0.45

226

Malignant neoplasm of thymus

240

1.21

0.34

3.6

2.6

0.91

0.75

ug/l

0.43

143

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

336

0.84

0.33

2.6

2.7

0.66

0.77

ug/l

0.33

203

Use of interferon beta-1a

603

0.89

0.33

2.1

2.5

0.60

0.64

ug/l

0.26

278

Viral infections of the central nervous system, including avohilmo

453

4374

1.04

0.33

3.0

0.65

0.73

ug/l

1.30

263

2574

Thyroiditis, ILD-related definition

360

3456

1.04

0.33

3.2

3.1

0.69

0.75

ug/l

0.95

240

2110

Hypersensitivity angiitis

304

0.83

0.33

3.0

3.2

1.03

0.78

ug/l

0.26

209

Other congenital malformations

330

3161

1.05

0.33

2.7

3.0

0.67

0.72

ug/l

0.56

195

1864

Pneumoconiosis due to asbestos and other mineral fibres

242

2528

0.94

0.33

3.4

3.7

0.84

0.86

ug/l

0.11

181

1848

Other specified and unspecified disorders of iris and ciliary body

197

0.79

0.33

4.2

2.8

0.52

0.67

ug/l

—

116

Tic and related disorders

380

0.86

0.33

3.1

2.3

0.64

0.76

ug/l

0.46

164

Immunodeficiencies

224

2355

0.94

0.33

3.1

0.77

0.75

ug/l

0.04

164

1440

Cellulitis

2090

21221

0.98

0.33

3.0

3.1

0.70

0.76

ug/l

1.60

1333

13395

Superficial injury of neck

114

1061

1.09

0.33

3.1

2.7

0.61

0.73

ug/l

1.42

561

Disorders of psychological development

392

3776

0.96

0.33

2.3

2.5

0.61

0.69

ug/l

0.95

230

1792

Aortic stenosis, including avohilmo

120

1.31

0.33

4.1

3.3

0.74

0.81

ug/l

—

Other psoriatic arthropathies

742

7616

0.97

0.33

2.9

3.1

0.61

0.74

ug/l

5.91

462

4654

Ulcerative proctitis

416

4014

1.04

0.33

3.1

0.67

0.72

ug/l

0.63

269

2402

Congenital stenosis of pulmonary valve

230

0.81

0.33

2.3

2.4

0.55

0.68

ug/l

—

112

Other specified/unspecified disorders of bone/cartilage

256

2450

1.06

0.33

3.3

3.0

0.75

0.71

ug/l

0.28

150

1479

Traumatic amputation of wrist and hand

531

5461

0.96

0.33

3.2

0.70

0.76

ug/l

1.20

344

3517

Other aneurysm

560

5762

0.96

0.33

3.1

3.5

0.77

0.83

ug/l

0.55

372

4044

Embedded teeth, including avohilmo

291

3042

0.95

0.33

2.7

2.6

0.69

0.67

ug/l

0.07

163

1543

Blindness, monocular

609

0.89

0.32

3.0

3.2

0.72

0.83

ug/l

0.53

393

Malignant neoplasm of other connective and soft tissue

195

1852

1.07

0.32

3.3

2.9

0.74

0.75

ug/l

0.07

146

1232

Other congenital malformations of respiratory system

1.35

0.32

3.1

2.2

0.66

0.73

ug/l

—

Neuroendocrine tumor and carcinoma of lung

410

0.86

0.32

2.6

2.9

0.56

0.76

ug/l

1.76

259

Malignant neoplasm of pyriform sinus, including Hilmo

150

1.31

0.32

3.4

2.9

0.64

0.79

ug/l

0.57

104

Colour vision deficiencies

212

1.21

0.32

2.6

0.84

0.72

ug/l

0.43

118

Ankyloglossia

208

0.81

0.32

2.5

2.0

0.75

0.69

ug/l

—

Other and unspecified aplastic anaemias

775

1.10

0.32

2.9

3.3

0.89

0.82

ug/l

0.16

513

Other obstructive and reflux uropathy

265

2534

1.05

0.32

3.2

3.3

1.00

0.76

ug/l

1.79

187

1671

Actinomycosis

270

0.82

0.32

3.0

3.1

0.50

0.78

ug/l

2.43

164

Cardiac murmurs and other cardiac sounds

401

3820

1.04

0.32

3.4

3.2

0.80

ug/l

0.01

273

2505

Familial erythrocytosis

374

1.16

0.32

3.1

2.9

0.78

0.76

ug/l

0.05

215

Lesion of plantar nerve

208

1975

1.06

0.32

3.7

3.3

0.71

0.77

ug/l

0.39

131

1271

Use of rotigotine

753

0.90

0.32

3.7

3.2

0.66

0.75

ug/l

0.85

501

Congenital varicose veins

138

1.26

0.32

2.1

2.5

0.60

0.73

ug/l

—

Other specified/unspecified necrotizing vasculopathies

901

1.09

0.31

3.1

3.2

0.69

0.78

ug/l

0.51

592

Asthma mixed form (mode)

302

3146

0.95

0.31

3.1

3.3

0.75

0.85

ug/l

1.12

185

2052

Hypertrophic scar

195

1849

1.06

0.31

3.2

2.9

0.69

0.74

ug/l

0.48

123

1057

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

672

1.12

0.31

3.2

3.0

0.71

0.78

ug/l

0.42

468

Malignant neoplasm of other and unspecified major salivary glands

242

1.20

0.31

2.6

2.9

0.59

0.77

ug/l

1.25

146

Foreign body granuloma of skin and subcutaneous tissue

195

0.80

0.31

3.1

3.0

0.54

0.72

ug/l

—

127

Periodontal disease, other/unspecified

136

1447

0.93

0.31

3.5

3.2

0.66

0.75

ug/l

1.25

900

Benign neoplasm: Pelvic bones, sacrum and coccyx

213

1.20

0.31

3.2

2.8

0.61

0.76

ug/l

0.91

114

Other and unspecified mood [affective] disorders

279

2914

0.95

0.31

2.4

2.7

0.52

0.71

ug/l

6.53

187

1452

Hypertrophy of breast in women and men

477

4612

1.04

0.31

3.5

3.2

0.69

0.75

ug/l

1.05

307

2932

Distal bite

661

1.10

0.31

2.8

2.7

0.73

0.70

ug/l

0.18

368

Malignant neoplasm of ureter, including Hilmo

818

1.11

0.31

2.5

3.1

0.65

0.77

ug/l

0.91

576

Volvulus

182

1917

0.94

0.31

3.0

3.3

0.66

0.84

ug/l

2.08

134

1295

Use of cabergoline

785

1.10

0.31

2.9

3.0

0.72

0.79

ug/l

0.41

473

Inflammatory diseases of the central nervous system

603

5864

1.03

0.31

3.0

3.1

0.68

0.74

ug/l

0.76

396

3626

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

148

0.74

0.31

2.8

0.46

0.75

ug/l

—

Caries in Clefts patients

344

1.15

0.31

2.6

2.4

0.66

0.68

ug/l

0.05

164

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

10141

63619

1.01

0.31

3.3

3.1

0.78

0.77

ug/l

0.05

6910

40551

Varicella [chickenpox]

461

4751

0.96

0.30

2.8

2.7

0.69

0.68

ug/l

0.11

237

2544

Multiple congenital exostoses

112

1.30

0.30

4.5

2.7

1.03

0.85

ug/l

—

Encephalitis

184

1748

1.06

0.30

2.9

3.1

0.75

0.76

ug/l

0.04

128

1062

Fracture of skull and facial bones

2052

20816

0.98

0.30

2.9

3.0

0.68

0.74

ug/l

2.24

1288

12314

Lack of expected normal physiological development

124

0.77

0.30

1.5

2.1

0.37

0.71

ug/l

—

Migraine without aura, drug-induced

228

0.83

0.30

2.3

0.66

0.70

ug/l

—

Disorders of purine and pyrimidine metabolism

499

0.88

0.30

3.5

3.3

0.74

ug/l

0.01

338

Benign neoplasm: Orbit, unspecified

327

1.16

0.30

3.0

3.3

0.90

0.79

ug/l

0.25

212

ILD, hospital admissions

1535

15599

0.98

0.30

3.2

3.5

0.72

0.82

ug/l

3.60

1112

11130

KRA_PSY_EATING, excluding more controls

872

0.92

0.30

2.4

2.6

0.47

0.71

ug/l

3.80

439

Phakomatoses, not elsewhere classified

523

0.89

0.30

2.8

0.73

ug/l

0.00

296

Other disorders starting during childhood or adolescence

708

1.09

0.30

2.2

2.0

0.49

0.66

ug/l

1.55

260

Chronic mastoiditis

202

1927

1.06

0.30

3.5

3.4

0.97

0.79

ug/l

0.84

128

1288

Malignant neoplasm of gallbladder

216

0.82

0.30

2.3

2.9

0.84

0.81

ug/l

0.06

140

Trigeminal neuralgia

284

2725

1.05

0.30

3.5

3.2

0.72

0.77

ug/l

0.44

199

1771

Acute appendicitis, with complications

1776

18032

0.98

0.30

3.1

0.78

0.77

ug/l

0.16

1159

11485

Burn and corrosion of trunk

227

2372

0.95

0.30

3.0

3.1

0.67

0.73

ug/l

0.84

151

1467

Neuralgia and neuritis, unspecified

293

3049

0.96

0.30

3.3

3.0

0.78

0.76

ug/l

0.07

187

1898

Cyclic neutropenia

1.36

0.30

1.9

2.9

0.49

0.80

ug/l

—

Other disorders of peripheral nervous system

452

1.13

0.30

2.9

3.1

0.67

0.77

ug/l

0.37

280

Idiopathic urticaria

708

1.10

0.30

2.6

3.0

0.72

0.74

ug/l

0.05

412

Burns and corrosions confined to eye and internal organs

218

2084

1.06

0.29

2.7

2.8

0.57

0.70

ug/l

3.33

128

1133

L04AD Calcineurin inhibitors

853

8720

0.97

0.29

2.5

3.0

0.78

0.71

ug/l

1.54

644

5224

Superficial injury of thorax

1368

13444

1.02

0.29

3.2

3.1

0.70

0.78

ug/l

1.72

897

8503

Injury of blood vessels at shoulder and upper arm level

160

1.26

0.29

3.4

3.0

1.33

0.75

ug/l

0.62

105

Microscopic polyangiitis

395

1.14

0.29

2.7

3.4

0.72

0.81

ug/l

0.52

263

Other disorders of iris and ciliary body

212

2025

1.06

0.29

3.2

0.69

0.78

ug/l

1.04

131

1288

Unspecified parasitic disease

655

1.11

0.29

2.9

3.3

0.66

0.83

ug/l

1.16

435

Acne keloid

104

1.32

0.29

2.8

2.2

0.49

0.81

ug/l

—

Bronchitis, not specified as acute or chronic

722

7394

0.97

0.29

3.0

3.1

0.76

0.77

ug/l

0.07

429

4519

Post-traumatic stress disorder

210

1999

1.05

0.29

2.8

2.6

0.55

0.69

ug/l

2.98

128

987

Cerebral atherosclerosis

1005

0.92

0.29

3.3

3.4

0.84

0.85

ug/l

0.01

699

Cholesteatoma of middle ear

403

4161

0.96

0.29

3.7

3.4

0.90

0.78

ug/l

0.59

275

2826

Hereditary spherocytosis

131

1.26

0.29

3.3

2.5

0.85

0.70

ug/l

—

Unspecified parasitic disease, including avohilmo

655

1.11

0.29

2.9

3.3

0.66

0.83

ug/l

1.16

435

Cystic disease of liver

318

1.15

0.29

4.0

3.2

0.96

0.78

ug/l

0.52

206

Other specified/unspecified spondylopathies

177

1683

1.06

0.29

3.4

3.3

0.74

0.82

ug/l

0.28

122

1149

Other bursal cyst

105

982

1.08

0.29

4.0

3.2

0.68

0.75

ug/l

0.44

661

Atopic dermatitis, strict definition with reimbursement

1428

13472

1.02

0.29

2.7

0.65

0.71

ug/l

1.88

785

7284

Nephropathy induced by other drugs, medicaments and biological substances

151

1.26

0.29

2.9

2.8

0.78

0.76

ug/l

0.04

Enteropathogenic Escherichia coli infection

244

1.19

0.29

2.2

3.1

0.87

0.72

ug/l

0.31

154

Yaws, including avohilmo

234

1.19

0.29

2.8

3.0

0.95

0.77

ug/l

0.29

138

Frostbite involving multiple body regions and unspecified frostbite

202

0.80

0.29

2.6

3.0

0.51

0.79

ug/l

—

116

Acute poliomyelitis, including avohilmo

615

0.90

0.29

2.7

2.9

0.59

0.80

ug/l

1.49

353

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2588

26204

0.99

0.29

3.0

3.1

0.74

0.76

ug/l

0.46

1631

16371

Haemorrhage, not elsewhere classified

342

3304

1.04

0.29

3.5

0.73

0.81

ug/l

1.37

250

2264

IgA nephropathy (IgA glomerulonephritis)

221

2118

1.06

0.28

2.7

3.1

0.98

0.74

ug/l

2.68

157

1280

Pedal cyclist injured in other and unspecified transport accidents

855

8365

1.03

0.28

2.8

3.0

0.70

0.73

ug/l

0.45

509

5029

Localized adiposity

172

0.80

0.28

2.4

2.7

0.66

0.76

ug/l

—

Injury of nerves at wrist and hand level

336

3246

1.04

0.28

3.0

2.9

0.75

0.72

ug/l

0.11

208

1893

Hypercalcemia

259

2697

0.95

0.28

3.2

3.4

0.96

0.76

ug/l

1.58

194

1836

Crohn disease (strict definition, all UC cases excluded)

291

3024

0.96

0.28

2.7

2.9

0.64

0.70

ug/l

0.83

169

1711

Scarlet fever

363

0.87

0.28

1.8

2.4

0.64

0.63

ug/l

0.02

160

Frontotemporal dementia, wide, incl. Pick's disease

539

0.89

0.28

2.9

3.4

1.04

0.82

ug/l

0.29

368

Alzheimer disease, excluding more controls

1858

12194

0.98

0.28

3.3

3.7

0.85

0.88

ug/l

0.55

1360

9114

Disorders of magnesium metabolism

725

0.90

0.28

2.9

3.4

1.28

0.75

ug/l

0.40

504

Systemic lupus erythematosus

106

990

1.08

0.28

2.8

3.1

0.76

0.73

ug/l

0.08

625

Coagulation defects, purpura and other haemorrhagic conditions

1512

14875

1.02

0.28

3.1

3.3

0.80

0.78

ug/l

0.15

1022

9886

Use of glatiramer acetate

375

0.87

0.28

2.2

2.5

0.70

0.68

ug/l

0.06

175

Neuroendocrine tumor and carcinoma of stomach

320

1.16

0.28

3.2

3.1

0.77

0.76

ug/l

0.02

204

Bursitis of shoulder

157

1489

1.06

0.28

3.6

3.0

0.73

ug/l

0.00

111

913

Caught, crushed, jammed or pinched in or between objects

459

4458

1.04

0.28

2.9

0.67

0.71

ug/l

0.67

264

2617

Sequelae of poliomyelitis

560

0.89

0.28

2.7

3.4

0.93

0.83

ug/l

0.41

408

Other nonthrombocytopenic purpura

578

1.11

0.28

3.3

0.86

0.74

ug/l

0.25

380

Scabies

368

3802

0.96

0.28

2.8

2.9

0.69

0.71

ug/l

0.27

218

2236

Psoriatic arthropathies, ICD10

760

7774

0.97

0.28

2.9

3.1

0.61

0.74

ug/l

6.01

474

4764

Unspecified fall

4653

45238

1.01

0.28

3.2

0.72

0.78

ug/l

3.46

3032

29202

Malignant neoplasm of other connective and soft tissue, including Hilmo

321

3099

1.04

0.28

3.4

2.9

0.74

0.73

ug/l

0.08

229

2057

Glaucoma secondary to eye trauma

561

1.12

0.28

3.4

3.2

0.81

0.82

ug/l

0.06

362

Congenital malformations of posterior segment of eye

301

1.16

0.28

3.8

3.1

0.65

0.77

ug/l

0.50

184

Anuria and oliguria

518

0.89

0.28

4.0

3.3

0.74

0.79

ug/l

0.24

344

Nummular dermatitis

779

7960

0.97

0.28

3.3

3.4

0.81

0.79

ug/l

0.13

539

5343

Other congenital malformations of kidney

150

1.23

0.28

3.3

2.9

0.73

0.71

ug/l

0.04

6-mercaptopurine

172

1808

0.95

0.27

2.9

2.7

0.69

0.71

ug/l

0.13

931

Other localized connective tissue disorders

586

1.10

0.27

3.2

2.9

0.86

0.73

ug/l

0.27

349

Benign neoplasm: Oesophagus

819

0.91

0.27

2.8

3.2

0.54

0.78

ug/l

3.17

542

Injury of intra-abdominal organs

170

1785

0.94

0.27

2.9

0.71

0.73

ug/l

0.12

118

1029

Femoral hernia, unilateral

178

1696

1.06

0.27

3.4

0.87

0.78

ug/l

0.16

119

1169

Inguinal of femoral hernia, unilateral

178

1696

1.06

0.27

3.4

0.87

0.78

ug/l

0.16

119

1169

Inguinal hernia, unilateral

178

1696

1.06

0.27

3.4

0.87

0.78

ug/l

0.16

119

1169

Disorders of optic nerve and visual pathways

523

5086

1.03

0.27

3.2

0.75

ug/l

0.04

341

3213

Reduction defects of lower limb

1.32

0.27

2.3

0.68

0.87

ug/l

—

Chronic myeloid leukaemia

369

1.14

0.27

2.3

2.7

0.63

0.75

ug/l

0.57

228

Other diseases of stomach and duodenum

496

4824

1.03

0.27

3.4

3.3

0.73

0.79

ug/l

1.07

361

3257

Other congenital malformations of ear

196

1.18

0.27

3.0

2.3

0.56

0.69

ug/l

0.73

Malignant neoplasm of penis, including Hilmo

807

1.10

0.27

3.7

2.9

1.00

0.78

ug/l

0.46

524

Failure of sterile precautions during surgical operation

223

0.82

0.27

2.5

3.2

0.59

0.79

ug/l

1.36

140

Car occupant injured in other and unspecified transport accidents

1180

12016

0.98

0.27

3.1

3.0

0.70

0.74

ug/l

1.14

724

7113

Malignant neoplasm of other endocrine glands and related structures

105

1.29

0.27

3.2

2.5

0.83

0.67

ug/l

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

127

1344

0.93

0.27

3.8

3.2

0.71

0.76

ug/l

0.35

845

Malignant neoplasm of tongue

175

1832

0.94

0.27

3.1

2.9

0.78

0.71

ug/l

0.54

123

1173

Burn and corrosion of hip and lower limb, except ankle and foot

167

1753

0.94

0.27

3.0

0.70

0.74

ug/l

0.32

100

1040

Disorders of orbit

204

1949

1.05

0.27

3.1

3.0

0.64

0.74

ug/l

1.66

132

1169

Cervical root disorders

517

0.89

0.27

2.4

2.9

0.67

0.80

ug/l

0.77

326

Hypothyroidism due to medicaments and other exogenous substances

559

1.11

0.27

3.1

3.4

0.62

0.83

ug/l

1.55

366

Procreative management

1906

15917

0.98

0.27

2.5

0.63

0.66

ug/l

0.72

964

7694

10766

54214

1.01

0.27

3.2

0.73

0.80

ug/l

8.57

6920

35443

Malignant neoplasm of small intestine

191

1827

1.06

0.27

3.1

3.0

0.87

0.73

ug/l

0.87

140

1248

Pyoderma gangrenosum

372

0.87

0.27

3.2

3.0

0.52

0.75

ug/l

2.09

226

Coronary atherosclerosis

7527

47123

1.01

0.27

3.0

3.2

0.73

0.78

ug/l

2.01

5033

30213

Chorioretinal scars

217

1.19

0.27

3.5

3.1

0.75

ug/l

0.01

125

Drug-induced acute pancreatitis

1.30

0.27

3.6

2.4

0.71

0.78

ug/l

—

Muscular dystrophy

455

0.89

0.27

3.7

3.0

0.69

0.76

ug/l

0.33

288

Hyperfunction of pituitary gland

177

1685

1.06

0.26

3.0

0.62

0.73

ug/l

1.77

117

977

Amoebiasis

302

1.15

0.26

3.9

3.0

0.65

0.70

ug/l

0.23

188

Early syphilis

119

1126

1.08

0.26

2.7

0.59

0.70

ug/l

0.94

583

Other and unspecified disorders of orbit

318

0.86

0.26

3.5

2.8

0.56

0.75

ug/l

1.06

197

Colon adenocarcinoma, helper endpoint

1193

12131

0.98

0.26

3.3

3.5

0.87

0.82

ug/l

0.67

852

8647

Thyrotropin deficiency

454

1.11

0.26

3.4

2.9

0.57

0.72

ug/l

1.44

275

Acute bronchiolitis

117

1123

0.94

0.26

2.7

2.9

0.66

0.76

ug/l

0.73

635

Benign neoplasm: Nasopharynx

600

1.10

0.26

3.8

3.1

0.74

0.82

ug/l

0.28

375

Pyogenic arthritis

619

6045

1.03

0.26

3.0

3.1

0.71

0.80

ug/l

2.39

419

3935

Hypertensive heart and/or renal disease

3107

22917

0.99

0.26

3.3

3.4

0.82

0.79

ug/l

0.49

2281

15794

Other pulmonary diagnosis

7721

38942

0.99

0.26

3.0

3.1

0.74

0.78

ug/l

1.42

4772

24115

Event of undetermined intent

474

4872

0.97

0.26

3.1

3.0

0.72

0.71

ug/l

0.01

301

2847

1.27

0.26

1.5

1.8

0.46

0.79

ug/l

—

Tularaemia

930

0.92

0.26

2.4

3.1

0.63

0.79

ug/l

1.68

579

Tooth agenesis EXCLUDE clefts and syndromes

721

1.08

0.26

2.6

2.5

0.72

0.71

ug/l

0.05

351

Defect, injury or illness of lumbar spine

142

1.23

0.26

2.8

2.5

0.55

0.71

ug/l

0.62

Increased muscle tone

321

1.14

0.26

3.1

3.0

0.77

0.76

ug/l

0.02

207

Certain disorders involving the immune mechanism

1497

14745

1.02

0.26

3.0

3.1

0.78

0.75

ug/l

0.48

970

9231

Viral haemorrhagic fevers, not elsewhere classified/unspecified

682

6972

0.97

0.26

3.0

3.1

0.83

0.74

ug/l

0.46

415

4360

Deformity of finger(s)

408

1.13

0.26

3.2

3.1

0.60

0.83

ug/l

2.21

270

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

4685

43024

0.99

0.26

3.0

2.9

0.75

0.73

ug/l

0.31

2806

25047

Systemic disorders of connective tissue in diseases classified elsewhere

227

1.18

0.26

2.6

2.9

0.68

0.75

ug/l

0.28

136

Specific development disorders of speech and language

218

2011

1.05

0.26

2.6

2.8

0.72

0.74

ug/l

0.09

131

1123

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

315

0.85

0.26

2.7

2.8

0.55

0.71

ug/l

1.02

160

Use of rasagiline

212

2206

0.95

0.26

3.4

3.5

0.63

0.77

ug/l

3.41

159

1539

Impaction of intestines

398

1.13

0.26

3.0

0.73

0.92

ug/l

0.79

240

Injury of nerves at ankle and foot level

433

0.88

0.26

3.6

2.9

0.72

0.71

ug/l

0.05

263

Hypertrophy of bone

180

1.20

0.26

3.4

2.9

0.62

0.71

ug/l

0.40

105

Habit and impulse disorders

972

0.93

0.26

2.0

2.4

0.45

0.65

ug/l

3.11

466

Benign neoplasm: Larynx

293

3029

0.96

0.26

3.2

3.3

0.71

0.78

ug/l

1.04

192

1985

Benign neoplasm of other and unspecified sites

194

2026

0.95

0.25

3.6

3.1

0.71

0.77

ug/l

0.48

137

1269

Malignant neoplasm of tongue, including Hilmo

232

2409

0.95

0.25

3.0

2.9

0.73

0.72

ug/l

0.12

159

1534

Open wound of ankle and foot

944

9266

1.02

0.25

2.9

3.1

0.67

0.76

ug/l

2.43

582

5759

Mononeuritis multiplex

221

0.83

0.25

3.5

3.0

0.54

0.74

ug/l

1.06

147

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

222

0.84

0.25

2.7

3.0

0.93

0.74

ug/l

0.64

137

Open wounds involving multiple body regions

243

0.84

0.25

3.0

2.7

0.74

0.75

ug/l

0.02

129

Other osteochondrodysplasias, including avohilmo

436

1.11

0.25

4.0

2.9

0.78

0.71

ug/l

0.19

249

Viral encephalitis, not elsewhere classified/unspecified

124

1309

0.94

0.25

3.8

3.1

0.70

0.76

ug/l

0.38

823

Unspecified hairloss

107

1.30

0.25

2.6

2.8

0.52

0.72

ug/l

—

Renal agenesis and other reduction defects of kidney, including avohilmo

348

0.87

0.25

3.0

3.1

0.63

0.75

ug/l

0.47

211

Other diseases of oesophagus

870

8534

1.02

0.25

3.3

0.83

0.81

ug/l

0.09

643

5751

Traumatic amputation of lower leg

240

0.83

0.25

2.4

3.2

2.68

0.77

ug/l

0.54

161

Osteomyelitis of vertebra

294

0.85

0.25

2.6

3.2

0.64

0.84

ug/l

1.06

197

Early lumbar disc prolapse, operated

667

6521

1.03

0.25

2.4

2.2

0.59

0.63

ug/l

0.94

286

2790

Polyarteritis nodosa and related conditions

723

0.92

0.25

2.8

3.1

0.66

0.76

ug/l

0.76

457

Viral conjunctivitis

101

949

1.07

0.25

3.2

2.9

0.71

ug/l

0.01

533

Viral and other specified intestinal infections, including avohilmo

1643

15580

1.02

0.25

2.7

0.70

0.74

ug/l

0.37

860

8240

Disorders of other and unspecified cranial nerves

352

1.13

0.25

3.0

3.2

0.98

0.87

ug/l

0.26

225

Exposure to other and unspecified animate mechanical forces

148

1407

1.06

0.25

2.7

0.70

ug/l

0.01

756

Acute poliomyelitis

609

0.91

0.25

2.7

2.9

0.59

0.80

ug/l

1.51

348

Spinal osteochondrosis

718

1.09

0.25

3.3

2.7

0.50

0.76

ug/l

4.12

398

Allergic bronchopulmonary aspergillosis (ABPA)

439

0.88

0.25

3.7

3.3

0.64

0.75

ug/l

0.64

307

Carcinoma in situ of stomach

1.34

0.24

3.0

3.1

1.23

0.75

ug/l

—

Assault by drugs, medicaments and biological substances

0.74

0.24

3.7

2.1

0.52

0.68

ug/l

—

Tracheo-bronchomalasia

190

0.83

0.24

3.5

2.5

0.40

0.68

ug/l

—

110

Bacterial, viral and other infectious agents, including avohilmo

780

7646

1.02

0.24

2.8

2.7

0.75

0.70

ug/l

0.32

441

4072

Bronchiectasis

587

5735

1.03

0.24

3.7

3.5

0.67

0.83

ug/l

5.66

424

4042

Tongue abnormality

335

3245

1.04

0.24

3.7

3.3

0.76

0.75

ug/l

0.08

241

2121

Asthma mixed form (mode), excluding more controls

302

3122

0.96

0.24

3.1

3.3

0.75

0.85

ug/l

1.07

185

2033

Implicit parasitic Sepsis, including avohilmo

381

1.12

0.24

2.7

3.4

0.57

0.75

ug/l

1.11

251

Follicular lymphoma, hilmo

321

3311

0.96

0.24

3.1

3.4

0.73

0.77

ug/l

0.36

214

2268

Dietary selenium deficiency

0.00

0.24

0.0

3.3

—

0.81

—

Toxic liver disease

907

0.93

0.24

3.0

3.2

0.75

0.74

ug/l

0.05

560

Cholera, including avohilmo

135

0.78

0.24

3.2

2.9

0.98

0.68

ug/l

—

Benign neoplasm: Carotid body

153

1.21

0.24

2.0

3.1

0.79

0.72

ug/l

—

Aplastic and other anaemias

4820

43740

1.01

0.24

3.4

3.5

0.86

0.81

ug/l

1.68

3531

30690

Exposure to other and unspecified man-made environmental factors

111

1174

0.94

0.24

2.9

0.59

0.71

ug/l

0.97

661

Divergent concomitant strabismus

389

4005

0.97

0.24

3.0

0.84

0.71

ug/l

0.51

243

2351

Spondylopathies in diseases classified elsewhere

987

0.93

0.24

4.1

3.3

0.87

0.84

ug/l

0.10

702

Speech and linguistic disorders

298

2758

1.04

0.24

2.4

2.6

0.64

0.71

ug/l

0.66

179

1409

Other congenital malformations of the digestive system

212

2021

1.05

0.24

3.0

3.2

0.72

0.76

ug/l

0.25

145

1264

Open bite that required surgery (Lefort1 or BSSO)

190

0.84

0.24

2.3

2.4

0.51

0.69

ug/l

—

Congenital deformities of feet

1021

0.93

0.24

3.0

2.7

0.73

0.69

ug/l

0.08

539

Wide developmental disorders

710

0.92

0.24

1.9

2.1

0.45

0.57

ug/l

0.84

270

Burns and corrosions of multiple and unspecified body regions

193

1854

1.05

0.24

3.0

0.73

0.75

ug/l

0.17

133

1102

Acne, including avohilmo

663

5241

1.02

0.24

2.7

2.5

0.60

0.67

ug/l

1.49

319

2599

Contact with other and unspecified heat and hot substances

533

0.90

0.23

3.4

2.9

0.74

0.80

ug/l

0.23

296

Congenital malformations of spine and bony thorax

162

1.19

0.23

2.8

2.5

0.50

0.76

ug/l

1.90

Benign neoplasm: Extrahepatic bile ducts

220

1.17

0.23

3.2

2.8

0.63

0.77

ug/l

0.91

138

Viral infections of the central nervous system

419

4076

1.03

0.23

3.0

0.67

0.73

ug/l

0.86

242

2387

Social phobias

358

3689

0.97

0.23

2.8

2.5

0.54

0.67

ug/l

3.77

218

1750

Upper arm

177

0.82

0.23

3.3

2.9

0.68

0.69

ug/l

—

110

Other intracranial haemorrhages

323

3136

1.04

0.23

3.7

3.6

1.20

0.81

ug/l

1.30

230

2271

Abnormality of white blood cells, not elsewhere classified

544

0.91

0.23

3.8

3.0

0.58

0.69

ug/l

1.01

338

Exposure to electric transmission lines

143

0.78

0.23

2.7

0.70

0.76

ug/l

—

Adrenogenital disorders

191

1.17

0.23

2.4

3.3

0.79

0.85

ug/l

0.11

124

Mandibular retrognathia AND surgery (BSSO)

100

942

1.07

0.23

3.1

2.6

0.66

ug/l

0.02

494

Drug-induced polyneuropathy

595

1.09

0.23

3.2

0.90

0.76

ug/l

0.22

380

Other and unspecified syphilis

271

0.86

0.23

3.3

2.7

0.67

0.72

ug/l

0.15

137

Atypical virus infections of central nervous system

564

0.91

0.23

2.8

3.0

0.61

0.76

ug/l

0.97

317

Primary angle-closure glaucoma

269

2601

1.04

0.23

3.6

3.5

0.75

0.80

ug/l

0.45

197

1792

Malignant neoplasm of gum

345

0.88

0.23

2.5

2.8

0.79

0.77

ug/l

0.05

230

Lesion of lateral popliteal nerve

448

4371

1.03

0.23

2.9

3.2

0.68

0.75

ug/l

1.06

288

2785

Other congenital malformations of nervous system

153

1.18

0.22

3.1

2.6

0.52

0.74

ug/l

1.62

Cervicobrachial syndrome

1399

14191

0.98

0.22

3.0

0.67

0.77

ug/l

3.44

906

8828

Benign neoplasm: Mediastinum

219

0.84

0.22

2.5

3.0

1.15

0.78

ug/l

0.32

137

Vascular dementia (undefined)

302

2898

1.04

0.22

3.0

3.7

0.87

0.93

ug/l

0.65

207

2138

Atrial septal defect, secundum type

913

0.93

0.22

2.7

2.9

0.82

0.70

ug/l

0.22

512

Polymorphous light eruption

191

1.16

0.22

2.5

3.0

0.59

0.91

ug/l

—

119

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

280

2710

1.04

0.22

2.9

0.63

0.72

ug/l

1.46

159

1555

Gout due to impairment of renal function

125

1194

1.07

0.22

3.4

3.3

0.99

0.79

ug/l

1.14

101

815

Malignant neoplasm of small intestine, including Hilmo

236

2442

0.96

0.22

3.0

0.84

0.73

ug/l

0.74

170

1649

Cutaneous lupus erythematosus

864

0.93

0.22

3.3

3.1

0.56

0.74

ug/l

2.21

541

Other specified disorders of kidney and ureter

216

2240

0.96

0.22

3.0

3.2

0.78

0.74

ug/l

0.36

153

1450

Exposure to other and unspecified forces of nature

422

1.11

0.22

3.0

0.53

0.75

ug/l

2.10

269

Multiple congenital exostoses, including avohilmo

164

1.19

0.22

4.6

2.6

0.93

0.77

ug/l

0.21

Bullous pemphigoid

176

1691

1.05

0.22

3.1

3.6

1.13

0.83

ug/l

0.69

124

1190

Other deformity of hallux (acquired)

277

1.13

0.22

3.7

2.9

0.71

0.83

ug/l

0.58

191

Ankylosis of teeth

125

1.22

0.22

3.1

2.5

0.99

0.75

ug/l

—

Postpartum care and examination

0.00

0.22

0.0

1.0

—

Haemophagocytic syndrome, infection-associated

0.00

0.22

0.0

2.8

—

0.58

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1159

11063

1.02

0.22

3.2

3.0

0.81

0.73

ug/l

1.20

744

6661

Asthma, including avohilmo

11635

64338

0.99

0.22

3.1

0.70

0.78

ug/l

12.56

7302

40687

Malignant neoplasm of gum, including Hilmo

645

0.92

0.22

2.7

2.8

0.74

0.76

ug/l

0.05

422

Benign neoplasm: Skin of lower limb, including hip

161

1542

1.05

0.22

3.2

0.73

0.75

ug/l

0.10

985

Ankylosing hyperostosis [Forestier]

136

1301

1.06

0.22

3.5

3.2

0.60

0.76

ug/l

3.24

864

Vascular dementia (subcortical)

262

2536

1.04

0.22

3.2

3.7

0.72

0.92

ug/l

3.12

212

1853

Tic and related disorders

367

0.89

0.22

3.1

2.3

0.64

0.69

ug/l

0.18

167

Operations for atrial fibrillation

175

1687

1.06

0.22

3.0

3.3

0.73

0.75

ug/l

0.09

107

1124

Convalescence

260

2688

0.96

0.22

3.4

3.2

0.77

0.74

ug/l

0.15

186

1723

Disorders of peritoneum in infectious diseases classified elsewhere

0.00

0.21

0.0

3.2

—

0.73

—

Otorrhoea

123

0.79

0.21

3.6

3.4

0.55

0.73

ug/l

—

Hyphaema and other vascular disorders of iris and ciliary body

172

1653

1.05

0.21

3.2

0.72

0.79

ug/l

0.53

110

1057

Transient synovitis

272

0.87

0.21

2.8

3.0

0.75

0.77

ug/l

0.04

170

Abscess of tendon sheath

384

1.11

0.21

2.6

3.2

0.48

0.78

ug/l

4.26

236

Artificial opening status

489

4781

1.03

0.21

3.1

3.3

0.81

0.79

ug/l

0.13

341

3250

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

325

3160

1.04

0.21

3.1

3.2

0.83

0.75

ug/l

0.71

215

2044

Hereditary retinal dystrophy

869

1.07

0.21

2.9

3.0

0.63

0.73

ug/l

0.81

514

Iliotibial band syndrome

383

1.11

0.21

3.0

2.7

0.75

0.76

ug/l

0.02

218

Labour and delivery complicated by umbilical cord complications

0.00

0.21

0.0

1.1

—

Failed induction of labour

0.00

0.21

0.0

1.1

—

Multiple delivery

0.00

0.21

0.0

1.0

—

Other puerperal infections

0.00

0.21

0.0

1.1

—

Secondary malignant neoplasm of other and unspecified sites

146

1523

0.95

0.21

4.0

3.1

1.64

0.75

ug/l

4.30

115

1088

Atlantoaxial subluxation

307

1.12

0.21

4.1

3.2

0.69

0.78

ug/l

0.52

207

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

435

4459

0.97

0.21

3.1

3.4

0.81

0.78

ug/l

0.24

302

3030

Delirium, not induced by alcohol and other psychoactive substances

1176

11898

0.98

0.21

3.2

3.5

0.80

0.85

ug/l

0.48

844

8360

Cholinergic urticaria

202

1.16

0.21

3.7

2.7

0.55

0.72

ug/l

1.06

114

Marfan's syndrome

333

0.88

0.21

1.7

2.7

0.57

0.71

ug/l

1.31

184

Carcinoma in situ of oral cavity, oesophagus and stomach

508

0.90

0.21

2.7

3.4

0.66

0.78

ug/l

0.39

339

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.21

0.0

1.1

—

Convergence insufficiency and excess

345

0.89

0.21

2.5

2.9

0.41

0.73

ug/l

4.69

195

Other disorders of thyroid

316

1.12

0.21

3.6

3.3

0.57

0.75

ug/l

1.03

222

Malignant neoplasm of tonsil, including Hilmo

176

1825

0.95

0.21

3.2

2.9

0.72

0.70

ug/l

0.11

120

1142

Atypical facial pain

203

1955

1.04

0.21

3.2

3.1

0.63

0.75

ug/l

1.42

134

1219

Atrial septal defect

156

1617

0.95

0.21

2.9

0.79

0.72

ug/l

0.20

923

Emotional disorders starting during childhood or adolecense, excluding more controls

576

0.92

0.21

1.6

1.8

0.33

0.58

ug/l

5.20

167

Hodgkin lymphoma, hilmo

195

2022

0.96

0.21

3.0

3.2

0.75

0.74

ug/l

0.05

128

1247

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.21

0.0

1.1

—

Specific development disorders of scholastic skills

109

1012

1.06

0.21

2.0

2.1

0.43

0.61

ug/l

2.68

379

Vitiligo

613

0.92

0.20

2.8

2.9

0.71

0.73

ug/l

0.09

364

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

343

0.89

0.20

3.9

3.1

0.69

0.83

ug/l

0.60

220

Benign neoplasm: Bladder

815

0.93

0.20

4.4

3.5

0.75

0.82

ug/l

0.28

582

SLE (Finngen)

106

1005

1.06

0.20

2.8

3.1

0.76

0.75

ug/l

0.03

627

Contact with venomous snakes and lizards

643

0.92

0.20

2.9

3.2

0.78

0.77

ug/l

0.02

405

Disorders of calcium metabolism

436

4464

0.97

0.20

3.3

0.96

0.78

ug/l

1.10

317

2992

Paralytic strabismus

575

5636

1.03

0.20

3.2

3.4

0.73

0.77

ug/l

0.42

402

3805

ILD and respiratory illness in diseases classified elsewhere

332

0.89

0.20

3.0

3.4

0.64

0.79

ug/l

0.74

221

Calcific tendinitis of shoulder

322

3131

1.03

0.20

2.9

3.0

0.59

0.75

ug/l

6.58

213

1972

Crohn disease (strict definition, require KELA)

355

3645

0.97

0.20

2.7

2.9

0.59

0.69

ug/l

2.82

210

2041

Chylothorax

174

0.83

0.20

2.9

3.2

0.62

0.72

ug/l

—

126

Mycoses

2305

23275

0.99

0.20

3.1

3.2

0.72

0.77

ug/l

0.89

1549

15282

Other complications of labour and delivery, not elsewhere classified

0.00

0.20

0.0

1.1

—

Toxic effect of metals

0.70

0.20

2.8

3.0

0.59

0.92

ug/l

—

Striae atrophicae

279

1.12

0.20

3.1

2.9

0.61

0.81

ug/l

0.96

147

Contact with machinery

1542

15585

0.98

0.20

3.2

3.1

0.69

0.74

ug/l

1.44

974

9876

Polyglandular dysfunction

1.26

0.19

2.1

2.4

0.30

0.95

ug/l

—

Papilloedema, unspecified

121

1155

1.05

0.19

3.5

3.1

0.84

0.77

ug/l

0.41

734

Congenital ptosis, including avohilmo

156

1.17

0.19

2.2

2.9

0.83

0.71

ug/l

—

Benign neoplasm: Rectum/anal canal icd-9

446

0.91

0.19

4.1

3.4

0.90

ug/l

0.00

320

Intracranial and intraspinal abscess and granuloma

103

982

1.06

0.19

3.1

0.66

0.74

ug/l

0.51

614

Congenital malformations of cardiac septa

315

3135

0.97

0.19

3.2

3.0

0.77

0.71

ug/l

0.28

198

1831

Von Willebrand disease

228

0.87

0.19

3.5

2.5

0.50

0.75

ug/l

1.81

116

Family history of other conditions

453

1.09

0.19

3.3

2.5

0.67

ug/l

0.00

224

Pyogenic granuloma

115

1098

1.06

0.19

3.3

3.1

0.69

0.74

ug/l

0.40

695

Pemphigus

465

0.91

0.19

3.4

3.3

0.88

0.77

ug/l

0.20

291

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

119

1222

0.95

0.19

2.0

2.1

0.48

0.63

ug/l

2.21

477

Pediculosis and phthiriasis

329

0.88

0.19

2.1

2.6

0.66

0.71

ug/l

0.13

171

Traumatic subarachnoid haemorrhage

359

3676

0.97

0.19

3.1

3.3

0.70

0.82

ug/l

2.39

253

2436

Benign neoplasm: Duodenum

192

1985

0.96

0.19

3.3

3.4

0.63

0.77

ug/l

1.99

144

1351

Congenital myopathies

110

1.22

0.19

2.5

2.9

0.65

0.84

ug/l

—

Other and unspecified hypertrophic disorders of skin

300

1.11

0.19

3.4

3.0

0.75

0.72

ug/l

0.09

180

Sacroiliitis, not elsewhere classified

178

1715

1.04

0.19

2.1

2.5

0.55

0.68

ug/l

2.69

823

Other gastritis (incl. Duodenitis)

2078

20582

1.01

0.18

3.3

0.74

0.80

ug/l

1.70

1527

13862

Other or unspecified paralytic strabismus

444

0.91

0.18

3.5

3.2

0.55

0.72

ug/l

1.55

282

Systemic sclerosis (FG)

609

1.07

0.18

3.2

3.0

0.61

0.80

ug/l

1.31

381

Unspecified transport accident

330

1.11

0.18

2.2

2.6

0.68

0.71

ug/l

0.07

187

Actinomycosis, including avohilmo

278

0.88

0.18

2.8

3.1

0.69

0.78

ug/l

0.17

169

Malignant immunoproliferative diseases

894

0.94

0.18

3.2

3.4

0.72

0.77

ug/l

0.33

621

Cholecystitis

1277

12925

0.99

0.18

3.2

3.4

0.80

0.82

ug/l

0.41

889

8965

Other meningitis

804

0.94

0.18

2.9

0.73

0.74

ug/l

0.04

471

Migraine, unspecified, drug-induced

185

1.15

0.18

2.8

2.6

0.70

0.75

ug/l

0.25

103

Fourth [trochlear] nerve palsy

175

1690

1.04

0.18

3.2

3.4

0.70

0.78

ug/l

0.75

122

1144

Intracranial injury

5769

53421

1.01

0.18

3.2

0.74

0.78

ug/l

2.20

3845

34226

Hypersplenism

319

0.89

0.18

3.1

3.0

0.72

0.74

ug/l

0.06

206

Superficial injury of ankle and foot, unspecified

214

1.14

0.18

2.5

2.8

0.63

0.71

ug/l

0.17

107

Pemphigoid

208

2015

1.04

0.18

3.2

3.6

1.08

0.83

ug/l

0.66

148

1430

Tic disorders

352

0.90

0.18

3.3

2.3

0.65

0.68

ug/l

0.07

162

Other and unspecified water transport accidents

302

1.12

0.18

3.0

0.68

0.77

ug/l

0.36

179

Discitis, unspecified

161

1554

1.05

0.18

3.3

0.69

0.80

ug/l

1.11

116

1060

Malignant neoplasm of nasopharynx

256

0.87

0.18

2.8

2.7

0.61

0.74

ug/l

0.74

158

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

147

1.16

0.18

3.2

2.9

0.72

0.73

ug/l

—

Arthropathy in ulcerative colitis

650

0.93

0.18

3.0

2.8

0.75

0.71

ug/l

0.20

381

Other congenital malformations of digestive system

129

1.19

0.18

3.8

2.7

0.60

0.70

ug/l

—

Calcaneal spur

523

1.08

0.18

3.2

3.0

0.83

0.77

ug/l

0.16

337

Nonsuppurative otitis media, including avohilmo

1701

14540

1.01

0.18

3.1

2.9

0.73

ug/l

0.02

1004

8399

Unspecified visual impairment (binocular)

816

1.06

0.18

3.7

3.2

0.65

0.81

ug/l

1.44

514

Other bursitis of hip

825

1.06

0.18

3.4

3.2

0.74

0.83

ug/l

0.54

551

Pityriasis rosea

291

1.11

0.18

3.1

2.8

0.59

0.76

ug/l

0.82

164

Psoriatic arthropathies

783

7709

1.02

0.18

2.9

3.0

0.61

0.77

ug/l

8.67

487

4757

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

874

0.94

0.18

4.2

3.4

0.94

0.85

ug/l

0.16

616

Short stature, not elsewhere classified

1.22

0.18

1.5

1.3

0.54

0.45

ug/l

—

Crowding of teeth, including avohilmo

186

1485

1.04

0.18

2.6

2.5

0.60

0.66

ug/l

0.61

734

Melanoma in situ, other sites/unspecified

254

1.13

0.18

4.6

3.3

0.94

0.81

ug/l

0.29

162

Background retinopathy and retinal vascular changes

154

1597

0.96

0.18

3.1

3.3

0.82

0.77

ug/l

0.33

101

1047

Mumps, including avohilmo

215

2215

0.96

0.18

2.9

2.8

0.70

0.68

ug/l

0.13

118

1181

Dermatitis

5579

54229

1.01

0.17

3.2

0.73

0.78

ug/l

2.57

3728

35453

Abnormal findings on diagnostic imaging of lung

5331

50759

0.99

0.17

3.3

3.4

0.77

0.80

ug/l

1.05

3689

35071

Ventral hernia

2009

19902

1.01

0.17

3.3

0.75

0.80

ug/l

1.90

1393

13318

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

595

0.92

0.17

3.0

3.5

0.85

0.86

ug/l

0.03

423

Mucinous and mucinous cystic tumor of rectum

429

1.10

0.17

2.7

3.0

0.73

0.75

ug/l

0.06

289

Congenital malformations of heart and great arteries

873

8590

0.98

0.17

3.1

3.0

0.75

0.73

ug/l

0.18

528

5109

Abnormality of red blood cells

370

1.10

0.17

3.3

3.0

0.65

0.81

ug/l

0.71

219

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

178

1.17

0.17

2.7

2.8

0.75

0.76

ug/l

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

256

2626

0.97

0.17

3.1

2.8

0.72

0.70

ug/l

0.20

177

1665

Toxic effect of other noxious substances eaten as food

177

1.15

0.17

3.3

3.0

0.40

0.69

ug/l

2.14

109

Motor disorders, excluding more controls

113

0.83

0.17

1.5

1.3

0.41

0.55

ug/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

264

2712

0.97

0.17

3.2

3.1

0.74

0.75

ug/l

0.03

154

1661

Scleritis and episcleritis in diseases classified elsewhere

0.73

0.17

2.5

3.2

1.09

0.73

ug/l

—

Acromegaly and pituitary gigantism

370

0.91

0.17

2.6

2.8

0.53

0.74

ug/l

2.32

217

Infective bursitis

325

3178

1.03

0.17

3.4

3.0

0.70

0.76

ug/l

1.00

208

1995

Drug-induced thyroiditis

236

1.14

0.17

2.9

3.0

0.74

0.72

ug/l

0.04

152

Varus deformity, not elsewhere classified

311

1.10

0.17

2.4

2.8

0.63

0.89

ug/l

0.83

188

Phantom limb syndrome

203

0.86

0.17

3.0

3.4

0.43

0.76

ug/l

3.38

140

Malignant neoplasm of bone and articular cartilage

682

1.07

0.17

2.6

2.8

0.97

0.74

ug/l

0.76

438

Motor- or nonmotor-vehicle accident in traffic area

442

0.92

0.17

2.6

2.8

0.78

0.76

ug/l

0.05

245

Selective deficiency of immunoglobulin A [IgA]y

206

1.13

0.17

3.2

2.8

0.75

0.76

ug/l

0.01

115

Disorder of thyroid, unspecified

311

1.10

0.17

3.6

3.3

0.56

0.77

ug/l

1.21

219

Precocious central puberty

120

0.83

0.17

1.9

1.7

0.43

0.54

ug/l

—

Chronic drug-induced interstitial lung disorders

102

1.23

0.17

2.1

3.5

0.83

0.78

ug/l

—

Other and unspecified paralytic syndromes

852

0.94

0.17

2.8

2.9

0.90

0.80

ug/l

0.18

506

Malignant neoplasm of ureter

236

1.13

0.17

2.1

2.8

0.63

0.78

ug/l

0.58

164

Malignant neoplasm of other and unspecified parts of tongue

109

1136

0.95

0.16

3.3

2.8

0.77

0.72

ug/l

0.29

730

Atypical virus infections of central nervous system, including avohilmo

575

0.93

0.16

2.8

2.9

0.59

0.76

ug/l

1.16

324

Congenital malformations, deformations and chromosomal abnormalities

4095

39043

0.99

0.16

2.9

0.74

0.73

ug/l

0.25

2447

22532

Benign neoplasm: Lip

143

1482

0.96

0.16

3.5

3.2

0.79

0.78

ug/l

0.03

973

Other congenital malformations of limb(s)

139

1.16

0.16

2.1

2.2

0.60

0.67

ug/l

—

Benign neoplasm: Urethra

1.15

0.16

4.3

3.4

0.79

0.77

ug/l

—

Use of memantine

2599

21073

0.99

0.16

3.3

3.7

0.85

0.88

ug/l

0.38

1873

15815

Use of other anti-dementia drugs

2599

21073

0.99

0.16

3.3

3.7

0.85

0.88

ug/l

0.38

1873

15815

Symptoms and signs concerning food and fluid intake

832

8419

0.98

0.16

3.3

3.4

0.72

0.79

ug/l

1.45

609

5684

Acute lymphocytic leukaemia, including Hilmo

172

0.86

0.16

4.0

2.4

0.63

0.72

ug/l

—

Acute lymphocytic leukaemia, helper endpoint

172

0.86

0.16

4.0

2.4

0.63

0.72

ug/l

—

Acute lymphocytic leukaemia

172

0.86

0.16

4.0

2.4

0.63

0.72

ug/l

—

Adult-onset Still disease

203

0.87

0.16

3.7

2.7

0.53

0.75

ug/l

1.31

116

Mantle cell lymphoma, including Hilmo

145

1402

1.05

0.16

3.3

2.9

0.74

ug/l

0.01

101

954

Parkinson's disease, excluding more controls

1522

14134

0.99

0.16

3.3

3.6

0.75

0.87

ug/l

5.44

1103

10194

Benign neoplasm: Eye, unspecified

226

1.13

0.16

3.5

3.3

0.80

0.75

ug/l

0.09

152

Crohn disease (strict definition, require KELA, min 2 HDR)

351

3589

0.97

0.16

2.7

2.9

0.59

0.69

ug/l

2.74

208

2012

Respiratory disorders in diseases classified elsewhere

820

0.94

0.16

3.2

3.3

0.66

0.78

ug/l

1.04

542

Pityriasis rubra pilaris

202

0.87

0.16

5.1

3.2

0.55

0.70

ug/l

0.76

138

Other papulosquamous disorders

673

1.07

0.16

3.7

3.3

0.66

0.78

ug/l

0.72

443

Idiopathic peripheral autonomic neuropathy

244

0.88

0.16

4.0

3.0

0.82

0.93

ug/l

0.22

146

Enteritis due to Yersinia enterocolitica

284

1.11

0.16

2.9

2.7

0.73

0.74

ug/l

0.01

159

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

326

0.90

0.16

3.3

3.5

0.62

0.86

ug/l

1.28

227

Lifestyle-related condition

748

0.94

0.16

3.3

3.1

0.77

0.76

ug/l

0.05

455

Open wound of abdomen, lower back and pelvis

244

2377

1.03

0.16

2.7

3.0

0.58

0.73

ug/l

3.59

154

1360

Multifocal fibrosclerosis

284

1.11

0.16

3.4

3.5

0.89

0.80

ug/l

0.26

190

Hypertrophic cardiomyopathy

371

3785

0.97

0.16

2.9

3.3

0.65

0.77

ug/l

2.59

251

2491

Algoneurodystrophy

115

1198

0.96

0.16

2.6

2.8

0.54

0.69

ug/l

2.39

669

Blindness or visual impairment, binocular

275

0.89

0.16

3.2

3.0

1.09

0.80

ug/l

1.15

179

Other superficial injuries of ankle and foot

358

0.91

0.16

2.6

2.8

0.76

0.72

ug/l

0.07

205

Other diseases of appendix

576

1.07

0.15

3.9

3.1

0.79

0.72

ug/l

0.35

354

Intestinal malabsorption

314

3070

1.03

0.15

3.0

3.1

0.64

0.73

ug/l

1.51

226

1908

Alzheimer’s disease (Late onset), excluding more controls

1517

9756

1.01

0.15

3.4

3.8

0.85

0.90

ug/l

1.11

1139

7424

Benign neoplasm: Endocrine pancreas

529

1.08

0.15

4.3

3.5

0.84

0.79

ug/l

0.21

355

Myasthenia gravis

134

1294

1.04

0.15

3.0

3.3

0.64

0.76

ug/l

1.75

876

Multiple system atrophy (rare forms of Parkinsonism)

222

0.88

0.15

2.3

3.2

0.53

0.89

ug/l

0.93

158

Congenital lens malformations

171

0.87

0.15

2.6

0.77

0.71

ug/l

—

101

Hereditary motor and sensory neuropathy

538

1.07

0.15

3.1

3.2

0.74

0.75

ug/l

0.04

328

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

140

1350

1.04

0.15

3.5

3.2

0.59

0.77

ug/l

3.10

880

Other acute disseminated demyelination

323

1.09

0.15

2.7

2.8

0.75

0.74

ug/l

0.04

178

Psoriatic and enteropathic arthropathies

878

8893

0.98

0.15

2.9

3.0

0.62

0.76

ug/l

7.04

542

5416

Maxillary retrognathism

664

1.06

0.15

2.9

2.7

0.86

0.73

ug/l

0.32

348

Crohn's disease of small intestine

433

4250

1.02

0.15

2.8

2.9

0.63

0.71

ug/l

1.77

266

2481

Acne conglobata

227

1.11

0.15

2.5

0.82

0.70

ug/l

0.24

110

CR(E)ST syndrome

294

1.09

0.15

2.8

2.9

0.51

0.78

ug/l

2.01

188

Contact with other hot fluids

180

1854

0.97

0.15

3.1

3.0

0.70

0.71

ug/l

0.07

107

1076

Bacterial, viral and other infectious agents

740

7301

1.02

0.15

2.8

2.7

0.76

0.70

ug/l

0.32

417

3903

Dermatopolymyositis, unspecified

346

0.91

0.15

2.8

3.3

1.23

0.78

ug/l

0.35

232

Other and unspecified vaccines and biological substances

202

0.88

0.15

2.6

2.8

0.80

0.82

ug/l

0.04

114

Surgical ablation of atrial fibrillation

681

0.93

0.15

2.8

3.2

0.71

0.73

ug/l

0.11

457

Purpura and other haemorrhagic conditions

1063

10746

0.99

0.14

3.1

3.3

0.83

0.78

ug/l

0.40

722

7187

Onycholysis

266

1.10

0.14

3.0

3.2

0.83

0.78

ug/l

0.13

156

Injury of blood vessels at hip and thigh level

283

0.90

0.14

3.7

3.2

0.59

0.75

ug/l

0.86

198

Other dermatomyositis

191

0.88

0.14

2.4

3.0

1.70

0.82

ug/l

0.37

125

Mesothelioma

100

1038

0.95

0.14

3.3

3.2

0.84

0.79

ug/l

0.26

751

Other and unspecified disorders of pigmentation

305

0.91

0.14

3.4

2.9

0.58

0.79

ug/l

1.16

177

Abnormal weight loss

721

7114

1.02

0.14

3.5

3.4

0.73

0.81

ug/l

1.28

533

4898

Congenital deformities of hip, including avohilmo

265

1.10

0.14

2.8

2.3

0.92

0.71

ug/l

0.45

134

Certolizumab pegol

499

1.07

0.14

2.4

2.6

0.52

0.70

ug/l

1.14

254

Adhesive middle ear disease

823

1.05

0.14

3.5

3.0

0.79

0.78

ug/l

0.02

496

Burns classified according to extent of body surface involved

795

1.06

0.14

2.7

3.0

0.70

0.72

ug/l

0.10

481

Injury of blood vessels at abdomen, lower back and pelvis level

314

0.91

0.14

2.3

3.1

0.53

0.74

ug/l

2.03

202

Sequelae of external causes of morbidity and mortality

2145

21612

0.99

0.14

3.2

3.3

0.72

0.79

ug/l

2.67

1499

14497

Myotonic disorders

432

1.08

0.14

2.8

0.52

0.74

ug/l

2.16

258

Pediculosis and phthiriasis, including avohilmo

407

0.92

0.14

2.2

2.6

0.66

0.69

ug/l

0.09

208

Benign neoplasm: Ill-defined sites within the digestive system

335

1.09

0.14

3.3

0.73

0.76

ug/l

0.04

228

Other disorders of carbohydrate metabolism

314

0.91

0.14

1.9

3.0

0.53

0.70

ug/l

1.24

188

Injury of blood vessels at neck level

324

0.91

0.14

2.9

2.7

0.76

ug/l

0.01

188

Mantle cell lymphoma

101

974

1.05

0.14

3.6

2.9

0.79

0.74

ug/l

0.24

663

Malignant neoplasm of rectum

1006

10164

0.99

0.14

3.2

3.0

0.72

ug/l

0.02

694

6958

Other and unspecified trigeminal disorders

653

0.94

0.14

3.2

3.0

0.70

0.75

ug/l

0.27

420

Benign neoplasm of other and unspecified intrathoracic organs

713

0.94

0.14

3.2

3.3

1.30

0.81

ug/l

0.91

462

Malignant neoplasm of heart, mediastinum and pleura

118

1220

0.96

0.13

3.3

3.1

0.89

0.78

ug/l

0.62

860

Meretoja disease

229

1.11

0.13

3.9

3.0

0.88

0.80

ug/l

0.23

139

Juvenile Open Angle Glaucoma

365

0.92

0.13

3.1

2.8

0.59

0.80

ug/l

1.50

189

Benign neoplasm: Long bones of lower limb

207

2018

1.03

0.13

3.2

3.0

0.68

0.72

ug/l

0.38

131

1163

Thrombocytopenia, unspecified

604

6123

0.98

0.13

3.2

3.4

0.89

0.78

ug/l

0.61

422

4162

Hypersensitivity pneumonitis due to organic dust

113

1091

1.04

0.13

3.3

3.2

0.83

0.78

ug/l

0.15

707

Failure and rejection of transplanted organs and tissues

102

1058

0.96

0.13

2.7

3.0

0.83

0.70

ug/l

0.92

642

Palindromic rheumatism

560

0.94

0.13

4.0

3.0

0.66

0.85

ug/l

1.41

351

Immunodeficiency with predominantly antibody defects

125

1208

1.04

0.13

3.3

3.0

0.64

0.73

ug/l

0.62

724

Tuberculosis of other organs, strict

128

1323

0.96

0.13

3.2

3.4

0.62

0.84

ug/l

2.97

909

Meningitis

325

3186

1.02

0.13

3.0

0.67

0.72

ug/l

0.68

208

1899

Pain in joint

6119

37410

1.01

0.13

3.2

3.1

0.68

0.79

ug/l

11.09

3813

23130

Neuroendocrine tumor and carcinoma of pancreas

528

0.93

0.13

3.3

2.7

0.79

0.74

ug/l

0.19

322

Nonpyogenic thrombosis of intracranial venous system

472

1.07

0.13

3.3

3.0

0.72

0.73

ug/l

0.02

293

Other specified disorders of muscle

210

2152

0.97

0.13

2.5

2.9

0.58

0.75

ug/l

3.75

131

1257

Generalized pustular psoriasis

241

0.90

0.13

2.7

3.2

0.65

0.82

ug/l

0.57

156

Arteriovenous malformation of peripheral vessels

219

1.11

0.13

2.7

2.8

0.72

0.78

ug/l

0.16

127

Other eating disorders

529

1.06

0.13

2.3

2.6

0.49

0.69

ug/l

2.12

283

Contact with hot air and gases

532

1.07

0.13

2.9

3.0

0.87

0.74

ug/l

0.28

326

Bradycardia, unspecified, drug-induced

152

1.14

0.13

2.9

3.1

1.26

0.93

ug/l

—

110

Exclusion endpoint for clefts

712

0.95

0.13

2.5

2.7

0.70

0.67

ug/l

0.09

373

Injury of other and unspecified intrathoracic organs

678

6864

0.98

0.13

3.0

3.2

0.72

0.78

ug/l

0.97

438

4418

Pediculosis, acariasis and other infestations

524

5164

1.02

0.13

2.8

3.0

0.67

0.72

ug/l

0.84

321

3101

Malignant neoplasm of adrenal gland, including Hilmo

414

1.07

0.13

2.9

2.7

0.91

0.75

ug/l

0.30

252

Injury of nerves and spinal cord at neck level

193

1978

0.97

0.13

2.6

3.2

0.60

0.73

ug/l

2.40

131

1242

Other osteochondropathies

557

5492

1.02

0.13

3.0

0.69

0.71

ug/l

0.23

326

3256

Vascular dementia

773

7542

0.99

0.13

3.1

3.7

0.81

0.90

ug/l

2.57

577

5614

Hypoparathyroidism

100

1039

0.96

0.13

3.2

0.77

0.74

ug/l

0.15

651

Acute myringitis

334

0.92

0.13

3.0

0.68

0.77

ug/l

0.17

202

Injury of blood vessels at forearm level

308

1.10

0.13

2.4

2.9

0.73

0.74

ug/l

0.01

189

Malignant neoplasm of base of tongue, including Hilmo

907

1.05

0.13

2.8

0.74

0.70

ug/l

0.27

561

Allergic purpura

168

1634

1.03

0.13

2.9

3.0

0.70

0.74

ug/l

0.22

100

974

Malignant neoplasm of palate, including Hilmo

395

1.08

0.13

2.0

2.9

0.87

0.74

ug/l

0.38

247

Lesion of ulnar nerve

1361

13727

0.99

0.13

3.1

0.68

0.75

ug/l

1.01

919

8596

Schistosomiasis [bilharziasis], including avohilmo

220

1.11

0.13

3.5

3.0

0.79

ug/l

0.01

137

Ventricular septal defect, a heart condition

548

0.94

0.13

2.7

2.9

0.61

0.75

ug/l

1.00

311

Ankle and foot

426

0.93

0.13

3.3

3.2

0.68

0.74

ug/l

0.25

278

Cystic kidney disease

217

2221

0.97

0.13

3.3

3.1

1.13

0.75

ug/l

2.04

164

1373

Benign neoplasm: Other/unspecified site

915

0.96

0.13

3.4

3.2

0.71

0.78

ug/l

0.36

578

Burns and corrosions of multiple body regions

812

0.95

0.13

3.4

3.1

0.73

0.77

ug/l

0.21

506

Fracture of shoulder and upper arm

2749

27279

1.01

0.13

3.1

0.75

0.77

ug/l

0.26

1808

17189

Perichondritis of external ear

118

1142

1.04

0.12

3.4

3.2

0.72

0.81

ug/l

0.67

751

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

156

1602

0.97

0.12

2.6

2.8

0.73

0.69

ug/l

0.31

859

Localized scleroderma [morphea]

365

1.07

0.12

3.5

2.9

0.92

0.72

ug/l

0.27

217

Viral pneumonia (known virus, not influenza)

207

2119

0.97

0.12

3.3

0.70

0.77

ug/l

0.80

152

1414

Myotonic dystrophy (Steinert)

168

0.88

0.12

2.5

2.9

0.68

0.84

ug/l

—

105

Toxic colitis

240

0.90

0.12

2.7

3.1

0.83

0.76

ug/l

0.13

159

Asthma and opportunity respiratory infection

288

2824

1.02

0.12

3.6

3.5

0.58

0.79

ug/l

8.29

197

1980

Benign neoplasm: Small intestine

290

2845

1.02

0.12

3.2

3.4

0.69

0.77

ug/l

0.90

218

1936

Asthma, excluding more controls

7113

36360

1.00

0.12

3.0

3.1

0.67

0.77

ug/l

11.38

4444

22378

Intercostal neuropathy

533

1.06

0.12

3.1

3.3

0.56

0.75

ug/l

1.95

355

Complex cardiac defects

137

0.87

0.12

2.1

2.4

0.35

0.75

ug/l

—

Tuberculosis of other organs, strict, including avohilmo

130

1340

0.97

0.12

3.2

3.4

0.64

0.83

ug/l

2.74

919

Pedestrian injured in collision with two- or three-wheeled motor vehicle

172

1.12

0.12

2.4

2.8

0.58

0.71

ug/l

0.53

104

Protein-energy malnutrition of moderate and mild degree

464

1.06

0.12

3.1

3.4

0.89

0.83

ug/l

0.17

314

Effects of other external causes

185

1896

0.97

0.12

2.8

2.7

0.62

0.69

ug/l

0.65

993

Typhoid and paratyphoid fevers

281

0.91

0.12

3.0

0.65

0.88

ug/l

0.76

162

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

426

1.07

0.12

2.8

2.7

0.98

0.72

ug/l

0.54

266

Other endophthalmitis

318

1.08

0.12

3.3

0.54

0.81

ug/l

1.78

201

Dermatitis due to ingested food

275

1.08

0.12

1.5

2.2

0.66

0.78

ug/l

0.53

107

Benign neoplasm: Ribs, sternum and clavicle

163

1.13

0.12

3.3

2.9

0.50

0.79

ug/l

—

104

Fibrosarcoma

465

1.07

0.12

2.9

2.8

0.65

0.77

ug/l

0.65

299

Malignant neoplasm of meninges, including Hilmo

182

1.12

0.12

4.7

2.8

0.84

0.82

ug/l

0.07

118

Fenamates

872

5870

1.01

0.12

3.3

3.0

0.71

0.87

ug/l

4.97

575

4029

Sequelae of burns, corrosions and frostbite

342

0.92

0.12

2.3

3.0

0.67

0.75

ug/l

0.27

202

Other mosquito-borne viral fevers, including avohilmo

416

1.07

0.11

3.1

2.9

0.71

0.72

ug/l

0.02

238

Mumps

214

2186

0.97

0.11

2.9

2.8

0.70

0.68

ug/l

0.11

118

1163

Systemic sclerosis, icd10

621

1.05

0.11

3.2

3.1

0.61

0.73

ug/l

0.84

383

Intussusception

629

0.95

0.11

3.2

2.9

0.67

0.82

ug/l

0.93

392

Other bullous disorders

164

1682

0.97

0.11

3.2

3.3

0.71

0.76

ug/l

0.24

116

1085

Chronic myeloid leukaemia, including Hilmo

678

0.95

0.11

2.4

2.8

0.69

0.75

ug/l

0.39

433

Benign neoplasm: Scapula and long bones of upper limb

652

1.05

0.11

3.4

3.0

0.79

0.73

ug/l

0.22

385

Other specified congenital malformation syndromes affecting multiple systems

577

0.95

0.11

2.2

2.7

0.67

ug/l

0.01

296

Common variable immunodeficiency

299

1.08

0.11

2.8

2.9

0.60

0.73

ug/l

0.75

164

Hypertrophy of (infrapatellar) fat pad

597

0.95

0.11

3.1

2.9

0.59

0.74

ug/l

1.41

343

Parkinson's disease, strict definition, excluding more controls

1448

13403

1.01

0.11

3.4

3.6

0.76

0.87

ug/l

4.59

1047

9692

Mastocytosis

270

0.92

0.11

3.0

2.9

0.59

0.78

ug/l

1.03

156

Agoraphobia

101

1045

0.96

0.11

2.6

2.3

0.50

0.67

ug/l

2.18

458

Xerosis cutis

125

1286

0.97

0.11

3.2

3.4

0.59

0.79

ug/l

4.15

866

Use of levodopa decarboxylase inhibitor

1414

14244

0.99

0.11

3.4

3.6

0.75

0.83

ug/l

2.79

1034

10404

Malignant neoplasm of anus and anal canal

280

0.92

0.11

1.8

2.8

0.46

0.77

ug/l

2.59

184

Adenocarcinoma of small intestine

222

1.10

0.11

2.6

2.9

0.97

0.80

ug/l

0.36

146

Benign neoplasm: Lower jaw bone

208

0.90

0.11

2.3

2.8

0.82

0.80

ug/l

0.06

128

Operations 1 for CAVS

187

0.89

0.11

4.0

2.9

1.17

0.83

ug/l

—

109

Other bacterial agents as the cause of diseases classified to other chapters

586

0.95

0.11

3.4

1.24

0.76

ug/l

0.33

393

Allergic contact dermatitis

509

5022

1.01

0.11

2.9

3.1

0.83

0.74

ug/l

0.39

310

3084

Migraine with aura, drug-induced

270

0.92

0.11

2.0

2.9

0.64

0.73

ug/l

0.42

159

Radiculopathy

1288

12981

0.99

0.11

3.4

3.3

0.73

0.84

ug/l

2.60

882

8741

Other abnormal findings in urine

117

1204

0.97

0.11

3.6

3.4

0.85

0.81

ug/l

0.23

831

Anorexia

393

0.94

0.11

2.4

3.1

0.55

0.77

ug/l

1.97

241

Asthma

7509

38582

1.00

0.11

3.0

3.1

0.68

0.78

ug/l

12.29

4728

23943

Type of accident

2408

23945

1.01

0.11

3.0

3.1

0.73

0.76

ug/l

0.81

1521

15009

conjunctival degenerations and deposits

117

1136

1.03

0.11

3.0

3.3

0.63

0.78

ug/l

2.25

754

Left ventricular outflow tract obstruction, narrow definition

432

4261

1.02

0.11

3.1

3.0

0.77

0.72

ug/l

0.45

253

2557

Spondyloarthritis

1429

14392

0.99

0.11

3.0

3.1

0.73

0.78

ug/l

1.06

931

8966

Gingival hyperplasia

260

2553

1.02

0.10

3.2

0.77

0.74

ug/l

0.28

196

1632

Guillain-Barre syndrome

131

1276

1.03

0.10

3.6

3.2

0.73

0.76

ug/l

0.22

821

Varicella [chickenpox], including avohilmo

487

4927

0.98

0.10

2.8

2.7

0.69

0.67

ug/l

0.23

254

2632

Disorders of purine and pyrimidine metabolism, other/unspecified

1.16

0.10

5.8

3.7

0.68

0.66

ug/l

—

Injuries involving multiple body regions

236

2315

1.02

0.10

3.3

3.0

0.68

0.74

ug/l

0.77

155

1369

Early complications of trauma

372

3774

0.98

0.10

2.9

3.1

0.65

0.74

ug/l

1.87

249

2316

!Aliquae complicationes praecoces traumatis

372

3774

0.98

0.10

2.9

3.1

0.65

0.74

ug/l

1.87

249

2316

Night blindness

1.13

0.10

3.2

2.8

0.78

0.73

ug/l

—

Disorders of phosphorus metabolism and phosphatases

330

0.93

0.10

3.7

3.1

0.82

0.77

ug/l

0.17

217

Congenital malformation of optic disc

1.18

0.10

2.8

0.54

0.68

ug/l

—

Other disorders of choroid

950

1.04

0.10

3.3

3.2

1.02

0.80

ug/l

0.40

623

Isolated proteinuria with specified morphological lesion

832

1.04

0.10

3.8

3.2

1.18

0.78

ug/l

0.92

535

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1067

10584

1.01

0.10

3.2

3.0

0.76

0.72

ug/l

0.36

736

7245

Disorder of pancreatic internal secretion, other and/or unspecified

381

0.94

0.10

3.0

2.9

0.57

0.74

ug/l

0.97

231

Malignant neoplasm of gallbladder, including Hilmo

330

0.93

0.10

2.7

2.8

0.86

0.79

ug/l

0.22

214

Benign neoplasm: Skin of upper limb, including shoulder

110

1132

0.97

0.10

3.5

3.1

0.79

ug/l

0.01

727

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

376

1.06

0.10

3.2

2.8

0.67

0.74

ug/l

0.32

211

Malignant neoplasm of parotid gland

576

1.05

0.10

3.1

2.8

0.74

0.77

ug/l

0.10

368

Lipomatosis, not elsewhere classified

186

0.90

0.10

2.4

3.1

0.31

0.72

ug/l

6.96

114

Other specified/unspecified disorders of tympanic membrane

268

0.92

0.10

4.0

3.3

0.82

0.78

ug/l

0.14

173

Other disorders of optic disc

743

1.04

0.10

3.5

3.1

0.74

0.75

ug/l

0.07

466

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

878

0.96

0.10

2.8

2.9

0.90

0.74

ug/l

0.50

558

Diseases of spleen

128

1313

0.97

0.10

3.0

3.2

0.77

ug/l

0.04

854

Mucinosis of skin

1.07

0.10

2.0

3.3

0.69

0.73

ug/l

—

Cystic kidney disease, including avohilmo

248

2437

1.02

0.10

3.4

3.2

1.09

0.75

ug/l

2.02

184

1518

Phantom limb syndrome with pain

196

0.90

0.10

3.0

3.2

0.43

0.80

ug/l

3.81

133

Erysipeloid, including avohilmo

227

0.91

0.10

4.8

3.3

0.74

0.76

ug/l

0.06

156

Prurigo nodularis

152

1485

1.03

0.10

3.1

3.3

0.71

0.75

ug/l

0.25

114

966

Diving or jumping into water causing injury other than drowning or submersion

380

1.07

0.10

2.6

2.7

0.52

0.73

ug/l

2.23

209

Viral conjunctivitis, including avohilmo

163

1593

1.03

0.10

3.3

2.9

0.68

0.71

ug/l

0.21

108

907

Glaucoma secondary to eye inflammation

527

1.05

0.10

3.6

3.2

0.70

0.81

ug/l

0.69

325

Other osteochondrodysplasias

340

1.07

0.10

3.7

2.9

0.79

0.72

ug/l

0.13

196

Other specific arthropathies, wide

117

1202

0.97

0.09

3.5

3.0

0.62

0.77

ug/l

1.91

724

Right side

400

0.94

0.09

2.3

3.3

1.01

0.76

ug/l

1.28

277

Eosinophilia

113

1100

1.03

0.09

3.1

3.2

0.83

0.76

ug/l

0.31

728

Disorders of plasma-protein metabolism, not elsewhere classified

512

0.95

0.09

2.1

3.2

0.65

0.72

ug/l

0.34

310

ILD, hospital admissions 1, main diag only

1364

13729

0.99

0.09

3.2

3.5

0.72

0.82

ug/l

3.10

986

9805

Hereditary nephropathy, not elsewhere classified

165

0.89

0.09

3.3

3.1

0.51

0.69

ug/l

—

115

Use of apomorphine

0.83

0.09

3.4

3.2

0.49

0.82

ug/l

—

Toxic effect of other inorganic substances

0.76

0.09

6.0

3.3

0.60

0.81

ug/l

—

Femoral hernia

291

2865

1.02

0.09

3.5

3.4

0.88

0.77

ug/l

0.31

203

1979

Ulcerative rectosigmoiditis

615

6213

0.99

0.09

2.8

3.0

0.77

0.73

ug/l

0.46

379

3687

Bullous disorders

422

4168

1.02

0.09

3.3

3.4

0.88

0.78

ug/l

0.40

290

2883

Traction detachment of retina

603

0.95

0.09

2.9

3.0

0.69

0.74

ug/l

0.24

359

Calcific tendinitis

583

0.95

0.09

2.9

3.1

0.70

0.75

ug/l

0.27

385

Sequelae with surgical and medical care as external cause

1668

16582

1.01

0.09

3.2

3.3

0.73

0.78

ug/l

1.20

1174

11268

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

587

1.05

0.09

3.0

2.7

0.78

0.74

ug/l

0.14

362

Abnormal findings on examination of urine, without diagnosis

360

3553

1.02

0.09

3.3

0.91

0.77

ug/l

1.19

252

2369

Other noninfective disorders of lymphatic vessels and lymph nodes

191

1873

1.02

0.09

3.3

3.1

0.77

0.75

ug/l

0.09

120

1156

Enduring personality changes

267

0.92

0.09

2.8

2.6

0.43

0.71

ug/l

2.25

143

Endocrine disorders, other/unspecified

877

0.97

0.09

4.1

3.0

0.82

0.73

ug/l

0.58

530

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

644

0.96

0.09

2.9

2.8

0.65

0.81

ug/l

1.26

417

Infection of intervertebral disc (pyogenic)

142

1390

1.03

0.09

3.2

0.71

0.80

ug/l

0.58

100

925

Polycythaemia vera

247

2510

0.98

0.09

2.9

0.76

0.73

ug/l

0.12

169

1662

Brachial plexus disorders

439

4337

1.01

0.09

3.0

2.9

0.62

0.68

ug/l

1.33

272

2502

Other congenital malformations of heart

216

0.92

0.09

2.4

2.7

0.47

0.78

ug/l

3.61

123

Renal tubulo-interstitial disorders in diseases classified elsewhere

754

0.96

0.09

2.9

3.2

0.97

0.71

ug/l

1.10

485

Cleft palate

247

0.93

0.09

2.2

2.0

0.73

0.68

ug/l

—

102

Lumbosacral plexus disorders

185

1.10

0.09

3.9

3.2

0.69

0.75

ug/l

0.18

132

Secondary lactase deficiency

0.77

0.09

3.2

3.8

0.45

0.79

ug/l

—

Arthropathic psoriasis

853

8599

0.99

0.09

3.0

3.1

0.62

0.74

ug/l

6.41

536

5318

Qualitative platelet defects

185

0.91

0.09

2.2

3.5

0.92

0.78

ug/l

0.36

123

Other disorders of central nervous system

633

0.96

0.09

3.5

3.0

0.79

ug/l

0.00

410

Granuloma annulare

471

0.95

0.09

3.8

3.2

0.71

0.80

ug/l

0.56

299

Amiodarone users

1131

11383

0.99

0.08

3.1

3.4

0.74

0.79

ug/l

0.62

795

7935

Cushing syndrome

491

0.95

0.08

3.8

3.2

0.81

0.75

ug/l

0.15

318

Disorders of glycoprotein metabolism

1.11

0.08

4.3

3.2

1.68

0.65

ug/l

—

Weight loss

748

7416

1.01

0.08

3.4

0.72

0.80

ug/l

1.44

552

5107

Drug-induced osteoporosis with pathological fracture

704

0.96

0.08

2.9

3.2

0.48

0.77

ug/l

4.49

459

Eating disorder

835

0.97

0.08

2.4

2.5

0.47

0.67

ug/l

3.02

424

Dissection of cerebral arteries, nonruptured

539

1.05

0.08

3.0

0.56

0.72

ug/l

1.04

324

Explosion of other materials

337

0.93

0.08

2.5

2.9

0.52

0.78

ug/l

1.67

193

Congenital malformations of the nervous system

613

0.96

0.08

2.5

2.6

0.52

0.70

ug/l

2.18

311

Infarction of spleen

510

1.05

0.08

2.5

3.4

0.67

0.83

ug/l

0.73

341

Renal agenesis and other reduction defects of kidney

307

0.93

0.08

3.2

3.0

0.63

0.74

ug/l

0.44

186

Golimumab

160

1633

0.98

0.08

2.3

2.5

0.61

0.65

ug/l

0.39

818

Vascular dementia (mixed)

156

1529

1.02

0.08

2.9

3.8

0.80

0.87

ug/l

0.47

115

1136

Hypertensive Renal Disease

376

3716

1.02

0.08

3.1

3.5

0.91

0.83

ug/l

0.84

286

2601

Asthma, unspecified (mode)

5027

36371

1.00

0.08

3.3

3.2

0.71

0.78

ug/l

5.96

3408

23222

Carcinoma in situ of middle ear and respiratory system

408

0.94

0.08

3.8

3.4

0.92

0.82

ug/l

0.48

292

Other and unspecified acute skin changes due to ultraviolet radiation

181

1843

0.98

0.08

3.8

3.3

0.66

0.80

ug/l

2.19

127

1236

Measles

733

0.96

0.08

2.4

2.3

0.61

0.62

ug/l

0.06

325

Measles, including avohilmo

733

0.96

0.08

2.4

2.3

0.61

0.62

ug/l

0.06

325

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

723

0.96

0.08

3.3

3.4

1.12

0.75

ug/l

0.31

473

Glaucoma

5398

45951

1.00

0.08

3.5

3.4

0.79

0.81

ug/l

0.35

3822

32044

Implicit fungal Sepsis, including avohilmo

495

5001

0.99

0.08

3.5

3.4

0.71

0.78

ug/l

0.72

386

3416

Use of dimethyl fumarate

195

1.08

0.08

2.0

2.2

0.64

0.61

ug/l

0.08

Cellulitis of external ear

747

1.04

0.08

2.8

3.0

0.66

0.73

ug/l

0.55

455

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

387

3916

0.99

0.08

2.7

2.9

0.60

0.69

ug/l

2.63

223

2210

Other retinal disorders in diseases classified elsewhere

196

1.10

0.08

3.1

3.2

0.47

0.71

ug/l

1.14

129

Adenocarcinoma and papilloma adenocarcinoma of rectum

1021

10141

1.01

0.08

3.2

3.0

0.76

0.72

ug/l

0.36

707

6933

Bacterial meningitis

242

2384

1.02

0.08

3.1

0.64

0.72

ug/l

1.10

156

1414

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

209

2124

0.98

0.08

3.0

0.91

0.76

ug/l

1.01

155

1484

Multiple myeloma

209

2124

0.98

0.08

3.0

0.91

0.76

ug/l

1.01

155

1484

Asthma, hospital admission 2, infections

4855

47452

1.00

0.08

3.0

3.2

0.67

0.79

ug/l

18.45

3094

30068

Asthma-related infections

4855

47452

1.00

0.08

3.0

3.2

0.67

0.79

ug/l

18.45

3094

30068

Lower back pain or/and sciatica

10427

64894

1.00

0.08

3.1

0.68

0.78

ug/l

17.51

6784

40862

Benign neoplasm: Parathyroid gland

510

1.05

0.08

4.2

3.4

0.83

0.79

ug/l

0.13

343

Right ventricular outflow tract obstruction

164

0.91

0.08

2.1

2.5

0.36

0.85

ug/l

—

Other and unspecified mononeuropathies, also in other diseases

192

1953

0.98

0.08

2.9

3.2

1.04

0.77

ug/l

0.59

115

1280

Other sideroblastic anaemias

235

1.08

0.08

3.0

3.2

0.61

0.77

ug/l

0.66

167

Seronegative rheumatoid arthritis

623

6175

1.01

0.08

3.3

0.72

0.81

ug/l

1.96

453

4132

Other congenital malformations of tongue, mouth and pharynx

243

1.07

0.08

3.3

2.4

0.72

0.73

ug/l

0.02

124

Other secondary gonarthrosis

414

4096

1.01

0.08

3.6

3.2

0.63

0.76

ug/l

3.89

278

2664

Chronic Coagulation defects

747

1.03

0.08

3.2

2.9

0.68

0.77

ug/l

0.41

448

Effects of other deprivation

108

1.13

0.07

3.2

3.0

0.63

0.74

ug/l

—

Absence of one kidney, including avohilmo

204

0.92

0.07

2.3

3.0

0.73

0.80

ug/l

0.17

135

Other acquired deformities of ankle and foot

343

1.06

0.07

3.3

2.7

0.74

0.89

ug/l

0.38

211

Open wound of hip and thigh

271

2674

1.02

0.07

3.2

2.9

0.61

0.71

ug/l

1.97

166

1527

Other specified/unspecified inflammatory spondylopathies

214

2106

1.02

0.07

2.8

0.69

0.73

ug/l

0.25

110

1158

Degenerative myopia

245

0.93

0.07

3.0

3.1

0.60

0.79

ug/l

0.96

152

Malignant neoplasm of palate

226

1.08

0.07

2.3

2.8

1.12

0.79

ug/l

0.70

149

Malignant neoplasm of oropharynx

175

1778

0.98

0.07

3.1

2.9

0.71

ug/l

0.05

120

1115

Lesion of medial popliteal nerve

214

0.92

0.07

2.1

2.9

0.59

0.71

ug/l

0.38

132

Pedestrian injured in transport accident

436

4404

0.99

0.07

2.9

3.1

0.72

0.73

ug/l

0.05

282

2674

Beningn neoplasm: Meninges, unspecified

600

0.96

0.07

4.3

3.3

0.78

0.85

ug/l

0.37

408

Autoimmune thyroiditis

357

0.95

0.07

4.1

3.1

0.65

0.79

ug/l

0.66

220

Kela reimbursement Agammaglobulinemia (D80-84)

383

1.05

0.07

3.0

2.8

0.73

0.69

ug/l

0.08

199

Postprocedural disorders of eye and adnexa, not elsewhere classified

234

0.93

0.07

4.8

3.3

0.49

0.78

ug/l

2.32

152

Foreign body or object entering through skin

551

5464

1.01

0.07

3.2

3.0

0.64

0.72

ug/l

1.88

349

3224

Other corneal oedema

498

0.96

0.07

3.5

3.2

0.75

0.87

ug/l

0.38

326

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

539

0.96

0.07

3.3

3.0

0.64

0.79

ug/l

1.40

322

Allergic contact dermatitis due to drugs in contact with skin

947

1.03

0.07

2.8

3.3

0.76

ug/l

0.00

625

Meckel's diverticulum

453

1.05

0.07

2.8

3.0

0.77

0.75

ug/l

0.06

273

Unequal limb length (acquired)

214

0.93

0.07

3.4

2.6

0.75

0.76

ug/l

0.03

114

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

497

5014

0.99

0.07

3.3

3.0

0.75

0.73

ug/l

0.27

361

3372

Obsessive-compulsive disorder

245

2415

1.02

0.07

2.5

2.6

0.52

0.69

ug/l

4.20

140

1160

conjunctival scars

1.13

0.07

2.9

0.89

0.69

ug/l

—

Pericarditis

346

3424

1.01

0.07

3.0

3.3

0.78

0.80

ug/l

0.11

240

2215

Disorders of mineral metabolism

655

6501

1.01

0.07

3.2

3.3

0.89

0.77

ug/l

0.96

447

4291

Monoplegia

958

1.03

0.07

2.9

3.2

0.65

0.79

ug/l

1.13

606

Acquired clawhand, clubhand, clawfoot and clubfoot

315

0.94

0.07

3.1

2.6

0.73

0.78

ug/l

0.09

178

Corticotropin deficiency

463

1.04

0.06

3.5

3.1

0.63

0.79

ug/l

1.61

287

Sequelae of infectious and parasitic diseases, including avohilmo

568

5635

1.01

0.06

3.0

0.74

0.75

ug/l

0.15

350

3413

Pedal cyclist injured in noncollision transport accidents

845

8504

0.99

0.06

3.0

0.66

0.72

ug/l

2.04

534

4990

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

119

1.12

0.06

1.8

2.7

0.64

0.70

ug/l

—

Mucosal proctocolitis

968

9623

1.01

0.06

2.8

2.9

0.71

0.72

ug/l

0.27

588

5568

Non-seminoma of testis

223

0.93

0.06

3.6

2.3

0.71

0.73

ug/l

0.04

111

Other diseases caused by chlamydiae, including avohilmo

364

1.05

0.06

2.8

2.6

0.58

0.85

ug/l

1.46

194

Other specified/unspecified dorsopathies

188

1852

1.02

0.06

3.1

0.71

0.78

ug/l

0.33

125

1153

Malignant neoplasm of thymus, including Hilmo

286

1.06

0.06

3.5

2.7

0.88

0.73

ug/l

0.39

168

Other disorders of bone density and structure

125

1274

0.98

0.06

3.3

3.1

0.71

0.75

ug/l

0.15

758

Vasculitis limited to skin, not elsewhere classified

168

1654

1.02

0.06

2.8

3.2

0.61

0.78

ug/l

2.10

117

1051

Other misadventures during surgical and medical care

176

1734

1.02

0.06

3.7

3.3

0.81

0.76

ug/l

0.28

127

1144

Disorders of myoneural junction and muscle in diseases classified elsewhere

274

0.94

0.06

3.8

3.1

0.74

0.73

ug/l

0.01

170

Congenital cataract

162

0.92

0.06

2.6

2.7

0.77

0.71

ug/l

—

Injury of nerves and spinal cord at thorax level

395

0.95

0.06

3.5

2.9

0.55

0.77

ug/l

1.62

222

Septal defects

296

2866

1.01

0.06

3.2

3.0

0.77

0.72

ug/l

0.20

182

1668

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

255

2521

1.01

0.06

2.7

3.1

0.93

0.73

ug/l

2.29

177

1525

Other acute skin changes due to ultraviolet radiation

219

2162

1.02

0.06

3.6

3.2

0.63

0.79

ug/l

2.98

144

1423

Cervical disc disorders

3575

35655

1.00

0.06

3.2

3.1

0.70

0.79

ug/l

5.78

2384

23038

Dermatopolymyositis (FG)

771

1.03

0.06

2.8

3.1

0.93

0.76

ug/l

0.36

502

Malignant neoplasm of penis

525

1.05

0.06

3.0

2.8

0.79

0.80

ug/l

0.05

330

Other retinal artery occlusion

203

2004

1.02

0.06

3.5

0.88

0.82

ug/l

0.41

139

1389

Congenital malformations of lung, including avohilmo

129

1.10

0.06

2.3

2.7

0.63

0.80

ug/l

—

Dermatitis herpetiformis

108

1101

0.98

0.06

3.3

3.1

0.63

0.78

ug/l

0.94

712

Gender identity disorders

294

0.95

0.06

1.9

2.2

0.41

0.68

ug/l

1.97

125

Other and unspecified nail disorders

119

1212

0.98

0.06

3.1

0.72

0.78

ug/l

0.33

778

Malignant neoplasm of lip, including Hilmo

889

0.97

0.06

3.4

3.0

0.72

0.82

ug/l

0.89

623

Deep bite

501

4432

0.99

0.06

3.0

0.65

0.71

ug/l

1.58

285

2620

Aspergillosis, including avohilmo

828

0.97

0.06

3.3

3.4

0.61

0.79

ug/l

2.22

549

Pleural plaque

1364

13693

0.99

0.06

3.8

3.7

0.79

0.86

ug/l

1.57

1004

10213

Benign intracranial hypertension

178

1.07

0.06

2.1

2.6

0.57

0.72

ug/l

—

101

Cleft lip and palate

273

0.95

0.05

3.3

2.5

0.59

0.71

ug/l

0.55

138

Other and unspecified vasculitis limited to skin

150

1523

0.98

0.05

2.8

3.2

0.63

0.78

ug/l

1.44

102

968

Exophthalmic conditions

536

0.97

0.05

3.6

2.9

0.56

0.78

ug/l

2.74

336

Other lesions of median nerve

134

1318

1.02

0.05

3.1

3.2

0.66

0.78

ug/l

1.12

872

Nosocomial condition (hospital)

374

0.96

0.05

3.4

3.1

0.77

0.85

ug/l

0.26

243

Other and unspecified pemphigoid

576

0.97

0.05

3.1

3.4

1.59

0.81

ug/l

0.58

407

Other disorders starting during childhood or adolecense, excluding more controls

726

1.03

0.05

2.2

2.1

0.49

0.73

ug/l

1.83

270

Other acute viral hepatitis

842

1.03

0.05

2.6

2.8

0.65

0.72

ug/l

0.45

449

Other and unspecified neuropathies

317

1.05

0.05

3.5

3.3

0.73

0.75

ug/l

0.05

209

Viral infections of central nervous system, not elsewhere classified/unspecified

616

0.97

0.05

3.1

2.8

0.55

0.70

ug/l

1.55

330

Keratoconus

176

1783

0.98

0.05

2.6

2.8

0.74

0.69

ug/l

0.23

970

Lesion of femoral nerve

307

1.05

0.05

3.0

0.71

0.70

ug/l

0.03

200

Malignant neoplasm of base of tongue

655

1.03

0.05

2.9

2.8

0.78

0.71

ug/l

0.35

403

Lymphangioma, anys site

323

0.96

0.05

2.7

0.62

0.77

ug/l

0.83

177

Melanocytic naevi of eyelid, including canthus

444

0.96

0.05

2.3

3.1

1.01

0.74

ug/l

0.34

285

Dermatophytosis

1373

13680

1.00

0.05

3.0

3.2

0.71

0.77

ug/l

0.87

893

9010

Apocrine sweat disorders, other sweat gland disorders

191

0.93

0.05

3.1

3.0

0.67

0.77

ug/l

0.39

125

Erythrasma

221

0.94

0.05

3.6

3.0

0.55

0.73

ug/l

1.18

145

Used for control exclusion in common control thyroid runs

11395

57359

1.00

0.05

3.1

0.73

0.78

ug/l

3.42

7324

35695

Early lumbar disc prolapse operation

690

6862

1.01

0.05

2.3

0.58

0.62

ug/l

0.74

296

3016

Otorrhagia

524

0.97

0.05

3.1

3.0

0.67

0.82

ug/l

0.60

332

Other and unspecified disorders of skin and subcutaneous tissue

385

3821

1.01

0.05

3.9

3.3

0.70

0.77

ug/l

1.35

268

2544

Other hammer toe(s) (acquired)

752

6800

1.01

0.04

3.3

0.71

0.83

ug/l

1.81

503

4668

Juvenile osteochondrosis

166

1639

1.01

0.04

2.5

2.8

0.59

0.73

ug/l

1.82

885

DVT of lower extremities and pulmonary embolism

3994

39678

1.00

0.04

3.3

0.82

0.79

ug/l

0.57

2840

26826

Abnormal findings in peritoneal fluid saliva

219

1.06

0.04

2.7

3.0

0.78

0.76

ug/l

0.06

142

Polycystic kidney disease

183

1809

1.01

0.04

2.9

3.1

1.16

0.76

ug/l

1.68

138

1107

Myocarditis

461

4637

0.99

0.04

2.6

3.0

0.65

0.73

ug/l

1.53

268

2696

Benign neoplasm: Central nervous system, other parts/unspecified

231

0.94

0.04

3.3

2.9

0.88

0.92

ug/l

0.05

134

Disorder of carbohydrate metabolism, other/unspecified

241

0.94

0.04

2.2

2.9

0.49

0.69

ug/l

1.66

139

Cerebral amyloid angiopathy

483

0.96

0.04

3.1

3.7

0.76

0.80

ug/l

0.17

350

Other infestations

160

1.08

0.04

2.8

3.1

0.61

0.76

ug/l

—

102

Systemic sclerosis

635

1.03

0.04

3.2

3.1

0.61

0.73

ug/l

0.88

395

Asymmetry of jaw

407

1.03

0.04

2.5

2.8

0.78

0.69

ug/l

0.26

229

Congenital retinoschisis

180

0.93

0.04

3.4

3.3

0.50

0.84

ug/l

—

111

Eosinophilic disease (BM)

113

1113

1.02

0.04

3.1

3.3

0.83

0.81

ug/l

0.10

724

Drug-induced interstitial lung disorders, unspecified

101

1.11

0.04

2.2

3.1

0.38

0.72

ug/l

—

Polyarthritis, unspecified

230

2278

1.01

0.04

3.4

3.1

0.74

0.81

ug/l

0.96

159

1478

Acute epiglottitis

118

1163

1.02

0.04

2.8

2.9

0.75

0.76

ug/l

0.09

690

Bullous keratopathy

477

1.03

0.04

3.5

3.2

0.55

0.87

ug/l

3.13

316

Other hyperalimentation

170

1.07

0.04

2.7

3.0

0.77

0.72

ug/l

0.14

107

Mixed disorders of conduct and emotions

229

1.05

0.04

1.5

0.32

0.52

ug/l

—

Special screening examination for other diseases and disorders

997

9999

1.00

0.04

3.3

3.2

0.87

0.79

ug/l

0.70

564

6429

Crossbite

244

2266

0.99

0.04

3.1

2.8

0.65

0.71

ug/l

0.66

122

1251

190

0.94

0.04

1.2

2.3

1.02

0.75

ug/l

—

Discharge from other and unspecified firearms

331

0.96

0.04

2.2

2.6

0.74

ug/l

0.01

171

Injury of blood vessels at wrist and hand level

627

1.03

0.04

2.9

3.1

0.79

0.76

ug/l

0.05

384

Disorders of pituitary gland, other and/or unspecified

299

1.04

0.04

3.6

2.8

0.93

0.66

ug/l

0.59

175

Crystalline deposits in vitreous body

806

1.02

0.04

3.1

3.5

0.81

0.80

ug/l

0.05

561

Carcinoma in situ of larynx

151

1.08

0.04

3.6

3.5

0.86

0.75

ug/l

0.47

114

Fracture of neck

609

6062

1.01

0.04

3.1

3.3

0.67

0.79

ug/l

2.70

416

4012

Discontinuity and dislocation of ear ossicles

349

1.04

0.04

3.2

2.9

0.73

0.76

ug/l

0.07

213

Diabetes insipidus

472

0.97

0.03

3.4

2.8

1.01

0.75

ug/l

0.27

281

Other and unspecified pemphigus

250

0.95

0.03

3.6

3.0

0.75

0.72

ug/l

0.03

159

Oesophagitis

486

4885

0.99

0.03

3.3

3.2

0.67

0.79

ug/l

2.21

336

3209

Sequelae of infectious and parasitic diseases

547

5496

0.99

0.03

3.0

0.72

0.75

ug/l

0.38

338

3313

Other infiltrative disorders of skin and subcutaneous tissue

270

0.96

0.03

3.3

3.1

0.57

0.74

ug/l

0.83

160

Cysts of oral region, not elsewhere classified

483

4854

0.99

0.03

3.1

0.85

0.75

ug/l

0.60

308

3055

Chromosomal abnormalities, not elsewhere classified

596

1.02

0.03

2.1

2.5

0.48

0.67

ug/l

1.91

294

Benign neoplasm: Bronchus and lung

108

1066

1.02

0.03

2.9

3.3

0.60

0.78

ug/l

2.75

705

Ischaemic heart disease, wide definition

8473

52067

1.00

0.03

3.0

3.2

0.73

0.77

ug/l

2.24

5581

32974

Congenital malformations of eyelid, lacrimal apparatus and orbit

159

0.94

0.03

2.5

2.7

0.68

0.67

ug/l

—

Other prurigo

602

0.98

0.03

2.9

3.3

0.60

0.86

ug/l

2.33

385

Other and unspecified iron deficiency

2566

25653

1.00

0.03

3.3

3.5

0.91

0.80

ug/l

2.21

1878

17875

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

777

1.02

0.03

3.1

2.8

0.53

0.73

ug/l

2.44

429

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

682

0.98

0.03

3.2

3.3

0.66

0.81

ug/l

1.11

458

Polymyositis

469

1.03

0.03

3.0

3.2

0.70

0.77

ug/l

0.40

304

Other melanin hyperpigmentation

114

1154

0.99

0.03

3.6

3.3

0.80

0.79

ug/l

0.05

781

Abscess of anal and rectal regions

821

8236

1.00

0.03

2.9

0.70

0.75

ug/l

0.48

498

4815

Pedal cyclist injured in transport accident

1752

17556

1.00

0.03

3.0

0.69

0.73

ug/l

1.49

1079

10511

Ehlers-Danlos syndrome, including avohilmo

102

1.08

0.03

3.6

2.9

0.65

0.75

ug/l

—

Malignant neoplasm of mesothelium and soft tissue

319

3172

1.01

0.03

3.2

3.0

0.76

0.75

ug/l

0.17

241

2176

Recurrent and persistent haematuria

619

1.02

0.03

3.7

3.3

1.63

0.84

ug/l

0.53

409

Congenital iodine-deficiency syndrome/hypothyroidism

782

0.98

0.03

3.0

3.2

0.56

0.85

ug/l

3.61

507

Other specified/unspecified systemic involvement of connective tissue

180

1815

0.99

0.03

3.0

3.2

0.71

0.76

ug/l

0.22

120

1153

Injury of nerves at lower leg level

689

1.02

0.02

3.3

3.0

0.72

0.77

ug/l

0.18

411

Other operation for atrial fibrillation

580

1.03

0.02

3.3

3.4

0.74

0.81

ug/l

0.21

394

Onychogryphosis

142

1.07

0.02

2.8

2.9

0.80

0.83

ug/l

—

289

0.96

0.02

2.7

2.6

0.65

0.70

ug/l

0.19

151

Other specified/unspecified disorders of ear

138

0.94

0.02

2.1

2.9

0.41

0.71

ug/l

—

Malignant neoplasm of rectosigmoid junction

143

1417

1.01

0.02

3.0

1.03

0.76

ug/l

0.69

102

956

Chondrosarcoma, including Hilmo

291

1.04

0.02

2.5

2.7

1.02

0.75

ug/l

0.77

183

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

152

1.07

0.02

2.2

2.8

0.36

0.80

ug/l

—

Emotional disorders starting during childhood or adolescence

534

1.02

0.02

1.6

1.8

0.33

0.57

ug/l

4.57

165

Other diseases of liver

1400

14029

1.00

0.02

3.1

0.74

0.75

ug/l

0.13

902

8806

Implicit parasitic Sepsis

321

1.03

0.02

2.4

3.3

0.55

0.75

ug/l

1.15

209

Use of teriflunomide

291

1.03

0.02

2.1

0.55

0.63

ug/l

0.30

124

Fibrosarcoma, including Hilmo

540

0.98

0.02

2.8

0.67

0.74

ug/l

0.38

343

Benign neoplasm: Retina

321

1.03

0.02

3.2

3.3

0.71

0.79

ug/l

0.41

217

Papulosquamous disorders

3353

33571

1.00

0.02

3.1

3.2

0.69

0.76

ug/l

3.18

2180

21535

Other congenital malformations of brain

162

1.05

0.02

2.0

2.4

0.49

0.64

ug/l

0.99

Torticollis

839

1.01

0.02

2.7

2.6

0.60

0.75

ug/l

0.98

453

Carcinoma in situ of penis

272

1.05

0.02

4.2

3.2

0.52

0.85

ug/l

1.53

184

Bilateral sagittal split ramus osteotomy operation

126

1248

1.01

0.02

2.9

2.7

0.81

0.68

ug/l

0.65

646

Other and unspecified primary disorders of muscles

409

0.97

0.02

3.2

3.0

0.69

0.75

ug/l

0.15

249

Colectomy operation

1512

15094

1.00

0.02

3.3

3.4

0.80

0.79

ug/l

0.06

1078

10348

Need for immunization against other single viral diseases

162

1608

1.01

0.02

2.7

3.0

0.77

0.71

ug/l

0.19

116

921

Other acquired deformities of musculoskeletal system and connective tissue

333

3345

0.99

0.02

3.2

3.0

0.82

0.72

ug/l

0.45

209

2011

Other and unspecified disorders of autonomic nervous system

228

0.96

0.02

3.7

3.1

0.65

0.77

ug/l

0.48

150

Speech and linguistic disorders, excluding more controls

298

2808

0.99

0.02

2.4

2.7

0.64

0.75

ug/l

1.26

179

1410

Diseases of the respiratory system

5811

29092

1.00

0.02

3.2

0.77

0.80

ug/l

0.68

3700

18925

Disorders of adrenal gland, other and/or unspecified

278

0.97

0.02

2.8

3.2

2.10

0.72

ug/l

0.50

183

Other and unspecified drugs and medicaments

501

5026

1.00

0.02

3.2

3.3

0.70

0.75

ug/l

0.66

338

3253

Elevated blood glucose level

648

6497

1.00

0.02

3.1

0.68

0.71

ug/l

0.31

449

4114

Other and unspecified bullous disorders

589

0.98

0.02

3.1

3.3

0.96

0.80

ug/l

0.30

374

Typhoid and paratyphoid fevers, including avohilmo

338

0.97

0.02

2.9

3.1

0.86

0.84

ug/l

0.03

202

Cleft lip

117

0.93

0.02

2.1

2.2

0.55

0.71

ug/l

—

Congenital deformities of hip

197

0.96

0.01

3.1

2.3

0.98

0.73

ug/l

0.44

104

Benign neoplasm: Tonsil

759

0.99

0.01

3.0

3.2

0.63

0.74

ug/l

1.26

490

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

137

0.94

0.01

2.8

3.1

0.77

1.00

ug/l

—

Hypertrophy of tongue papillae

769

0.99

0.01

3.5

3.2

0.64

0.75

ug/l

1.06

498

Other and unspecified disorders of white blood cells

286

2872

0.99

0.01

3.2

3.3

0.76

ug/l

0.03

191

1885

Superficial injuries involving multiple body regions

152

1530

0.99

0.01

3.6

3.0

0.66

0.74

ug/l

0.89

108

907

Congenital deformities of feet, including avohilmo

161

1600

1.01

0.01

3.1

2.8

0.72

0.70

ug/l

0.04

873

Benign neoplasm: Heart

203

1.04

0.01

3.3

3.2

1.98

0.74

ug/l

0.77

139

Malignant neoplasm of eye and adnexa, including Hilmo

117

1161

1.01

0.01

3.5

3.0

0.78

ug/l

0.00

772

Other and unspecified myoneural disorders

223

1.04

0.01

2.7

3.2

0.69

0.85

ug/l

0.60

142

Pityriasis lichenoides chronica

243

1.03

0.01

2.7

3.1

0.51

0.82

ug/l

1.92

154

Corneal pigmentations and deposits

263

1.03

0.01

2.9

3.0

0.69

0.80

ug/l

0.45

162

Mixed disorders of conduct and emotions, excluding more controls

233

1.03

0.01

1.5

0.32

0.56

ug/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

111

1115

0.99

0.01

2.5

2.7

0.70

0.68

ug/l

0.08

575

Toxic effect of corrosive substances

303

1.03

0.01

2.8

2.6

0.73

0.68

ug/l

0.18

144

Other juvenile arthritis

838

0.99

0.01

2.1

2.5

0.65

0.73

ug/l

0.50

424

Congenital malformations of anterior segment of eye

323

1.02

0.01

3.0

3.1

0.75

0.81

ug/l

0.19

210

Disorders in reading

363

1.02

0.01

2.2

2.0

0.55

0.61

ug/l

0.22

125

Family history of other specific disorders

387

0.98

0.01

2.8

2.7

0.75

0.72

ug/l

0.06

240

Frontotemporal dementia

467

0.98

0.01

3.0

3.3

1.04

0.84

ug/l

0.26

317

Purulent endophthalmitis

467

0.98

0.01

3.4

3.3

0.99

0.78

ug/l

0.50

307

Benign neoplasm of middle ear and respiratory system

721

7199

1.00

0.01

3.1

3.3

0.76

0.78

ug/l

0.32

479

4767

Diastasis of muscle

483

1.02

0.01

3.4

3.1

0.61

0.77

ug/l

1.06

308

Nonhereditary hypogammaglobulinemia

507

0.98

0.01

3.0

2.9

0.70

0.71

ug/l

0.00

300

Disorders of globe

155

1542

1.01

0.01

3.4

3.3

0.75

0.80

ug/l

0.34

117

1006

Other follicular disorders

501

5000

1.00

0.01

2.8

3.0

0.65

0.73

ug/l

2.00

303

2983

Chorioretinal inflammation

172

1728

0.99

0.01

2.8

3.1

0.74

0.73

ug/l

0.03

113

1072

Dislocation, sprain and strain of joints and ligaments of head

173

1722

1.01

0.01

2.7

2.9

0.61

0.73

ug/l

1.25

957

Benign neoplasm: Other and unspecified parts of mouth

226

2268

1.00

0.01

3.1

3.2

0.59

0.77

ug/l

3.78

154

1448

Abscess of external ear

833

1.01

0.01

2.7

2.9

0.74

0.71

ug/l

0.10

484

Benign neoplasm: Short bones of upper limb

827

0.99

0.01

3.0

0.62

0.73

ug/l

1.17

501

Disorders resulting from impaired renal tubular function

312

3112

1.00

0.01

2.6

3.2

0.89

0.74

ug/l

3.01

253

1979

Other and unspecified disorders of globe

116

0.94

0.01

2.5

2.9

0.60

0.78

ug/l

—

Malignant neoplasm of tonsil

162

1613

1.01

0.00

3.2

2.9

0.73

0.70

ug/l

0.23

112

1008

Acute thyroiditis

144

1.05

0.00

3.7

3.0

0.66

0.76

ug/l

—

Abnormal findings in cerebrospinal fluid

156

0.96

0.00

3.9

2.6

0.89

0.74

ug/l

—

Optic neuritis

145

1443

1.01

0.00

2.9

3.0

0.72

0.75

ug/l

0.15

830

Congenital retinoschisis

224

1.03

0.00

3.7

3.2

0.56

0.80

ug/l

1.32

143

Certain zoonotic bacterial diseases, including avohilmo

194

1933

1.00

0.00

2.9

3.1

0.65

0.78

ug/l

1.77

127

1196

Other specified acquired deformities of limbs

206

0.97

0.00

2.5

2.7

0.44

0.82

ug/l

—

118

Other fibroblastic disorders

246

0.97

0.00

3.4

3.0

0.72

0.80

ug/l

0.20

155

Anaemias

1436

9192

1.00

0.00

2.6

2.3

0.70

0.69

ug/l

0.15

918

4029

Heberden's nodes [with arthropathy]

246

0.97

0.00

4.6

3.3

0.63

0.78

ug/l

0.63

163

Renal cell carcinoma of kidney

262

2613

1.00

0.00

3.4

3.0

0.84

0.76

ug/l

0.56

197

1798

Other, unspecified and serous retinal detachments

269

2683

1.00

0.00

3.7

3.3

0.74

0.77

ug/l

0.25

179

1784

Acute hepatitis B

316

0.98

0.00

2.5

2.9

0.57

0.73

ug/l

0.57

177

Malignant neoplasm of parotid gland, including Hilmo

686

0.99

0.00

3.2

2.8

0.73

0.76

ug/l

0.14

444

Malignant neoplasm of anus and anal canal, including Hilmo

704

1.01

0.00

2.8

2.9

0.86

0.78

ug/l

0.10

479

Aspergillosis

806

0.99

0.00

3.3

0.61

0.80

ug/l

2.07

533

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

101

1016

0.99

0.00

3.0

2.8

0.70

0.74

ug/l

0.20

570

Scar conditions and fibrosis of skin

135

1356

1.00

0.00

3.5

3.0

0.91

0.77

ug/l

0.23

812

Intestinal infectious diseases, including avohilmo, including avohilmo

11336

63092

1.00

0.00

3.1

3.2

0.73

0.78

ug/l

3.80

7074

40431

Additional codes for the location of defect, injury or illness

366

3661

1.00

0.00

3.1

3.2

0.74

0.76

ug/l

0.15

251

2352

Other forms of systemic lupus erythematosus

132

0.98

0.00

2.2

3.0

0.84

0.77

ug/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

102

1025

0.99

0.00

3.8

3.1

0.72

0.74

ug/l

0.13

636

Tularaemia, including avohilmo

133

1325

1.00

0.00

2.6

3.1

0.68

0.78

ug/l

0.78

801

Other specified and unspecified strabismus

507

1.01

0.00

3.2

3.0

0.60

0.72

ug/l

0.59

299

Neurofibromatosis, type 1

248

1.01

0.00

3.2

2.6

0.85

0.66

ug/l

0.68

135

Cleft lip and cleft lip and palate

336

1.01

0.00

3.1

2.5

0.60

0.70

ug/l

0.55

173

Enterobiasis

106

1.04

0.00

2.6

2.7

0.93

0.80

ug/l

—

Tuberculosis of other organs

116

1164

1.00

0.00

3.2

3.4

0.62

0.85

ug/l

2.90

799

Symptoms and signs involving emotional state

135

1354

1.00

0.00

3.3

2.9

0.66

0.76

ug/l

0.80

775

Congenital malformations of ear causing impairment of hearing

146

1.03

0.00

4.2

2.7

0.88

0.71

ug/l

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

186

1.03

0.00

2.9

2.7

0.95

0.71

ug/l

0.64

122

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

522

1.00

0.00

2.4

2.8

0.72

0.76

ug/l

0.19

324

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

534

5344

1.00

0.00

3.2

0.70

0.76

ug/l

0.84

360

3465

Achalasia of cardia

130

1303

1.00

0.00

3.6

3.2

0.68

0.76

ug/l

0.48

850

Third [oculomotor] nerve palsy

132

1317

1.00

0.00

3.0

3.3

0.68

0.77

ug/l

0.93

100

887

Other infective (teno)synovitis

236

1.02

0.00

3.0

2.9

0.74

0.75

ug/l

0.01

150

Malignant neoplasm of lip

652

1.00

0.00

3.1

0.75

0.82

ug/l

0.39

455

Toxoplasmosis, including avohilmo

284

0.98

0.00

2.4

2.9

0.44

0.77

ug/l

1.82

166

Disorders of sphingolipid metabolism and other lipid storage disorders

191

0.99

0.00

2.6

3.5

0.90

0.78

ug/l

0.21

133

Severe visual impairment, binocular

316

1.01

0.00

3.6

3.1

0.76

0.84

ug/l

0.22

204

Dermatopolymyositis

792

1.00

0.00

2.8

3.2

0.93

0.76

ug/l

0.35

508

Osteosarcoma, including Hilmo

219

1.01

0.00

2.0

2.7

0.69

0.76

ug/l

0.18

129

Motor disorders

100

0.99

0.00

1.5

1.3

0.41

0.43

ug/l

—

Other disorders of white blood cells

397

3974

1.00

0.00

3.2

3.3

0.76

ug/l

0.01

268

2624

Other and unspecified haemorrhagic conditions

892

1.00

0.00

3.2

0.65

0.81

ug/l

1.73

575

Neuroendocrine tumor and carcinoma of rectum

249

1.00

0.00

2.6

3.0

0.53

0.78

ug/l

2.20

158

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

249

1.00

0.00

3.6

2.7

0.77

0.76

ug/l

0.01

157

Thromboangiitis obliterans

279

1.00

0.00

2.5

3.3

0.93

0.81

ug/l

0.21

198

Toxoplasmosis

281

1.00

0.00

2.4

2.9

0.44

0.77

ug/l

1.84

165

Benign neoplasm: Brain, unspecified

321

1.00

0.00

3.3

2.9

0.76

0.78

ug/l

0.05

194

Hand

311

1.00

0.00

3.5

2.9

0.68

0.72

ug/l

0.15

183

Anomalies of dental arch relationship, including avohilmo

929

8395

1.00

0.00

3.1

2.9

0.66

0.71

ug/l

1.54

519

4836

Exposure to sunlight

138

1.02

0.00

2.6

3.0

0.57

0.73

ug/l

—

Choroidal detachment

142

0.98

0.00

3.1

3.2

0.54

0.90

ug/l

—

Fractures involving multiple body regions

198

1.01

0.00

2.4

2.7

0.61

0.71

ug/l

0.38

108

Symptoms and signs involving appearance and behaviour

379

1.00

0.00

2.9

0.44

0.79

ug/l

6.14

225

Viral warts

604

6041

1.00

0.00

2.8

3.1

0.66

0.74

ug/l

2.21

378

3687

Non-follicular lymphoma

910

9104

1.00

0.00

3.1

3.5

0.79

0.80

ug/l

0.15

644

6358

Flat foot [pes planus] (acquired)

380

3799

1.00

0.00

3.4

3.1

0.76

0.78

ug/l

0.08

244

2370

Erythema nodosum

911

1.00

0.00

3.0

3.1

0.90

0.71

ug/l

0.79

565

Rare circulating lymphoid malignancy, including Hilmo

230

2294

1.00

0.00

3.5

2.9

0.72

0.74

ug/l

0.14

158

1513

Benign neoplasm: Brain, supratentorial

879

1.00

0.00

3.1

0.83

0.76

ug/l

0.26

537

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

771

1.00

0.00

3.9

3.1

0.70

0.75

ug/l

0.33

504

Traumatic subcutaneous emphysema

129

1.01

0.00

2.7

2.9

0.51

0.80

ug/l

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

128

1281

1.00

0.00

3.0

2.8

0.85

0.74

ug/l

0.49

814

Nephrotic syndrome

244

2443

1.00

0.00

2.7

3.2

0.98

0.75

ug/l

1.52

176

1521

Aggressive periodontitis

162

1621

1.00

0.00

3.2

3.3

0.76

ug/l

0.02

125

1041

Major anomalies of jaw size

149

1493

1.00

0.00

2.9

2.7

0.73

0.68

ug/l

0.28

829

Traumatic amputation of hip and thigh

127

1.03

0.00

2.0

3.3

4.75

0.76

ug/l

—

Erythema in diseases classified elsewhere

127

1.03

0.00

2.6

3.2

0.92

0.70

ug/l

—

Congenital ptosis

127

1.03

0.00

2.5

2.8

0.73

0.71

ug/l

—

Osteosarcoma

127

1.03

0.00

1.9

2.9

0.56

0.79

ug/l

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

269

1.00

0.00

4.4

3.1

0.98

0.77

ug/l

0.74

171

Absence of one kidney

157

1.02

0.00

2.5

3.0

0.72

0.80

ug/l

0.18

106

Benign neoplasm: Bone and articular cartilage, unspecified

457

1.01

0.00

3.3

3.0

1.11

0.76

ug/l

0.27

272

LeFortI or BSSO operation

150

1503

1.00

0.00

2.8

2.6

0.77

0.67

ug/l

0.55

778

Hereditary factor VIII deficiency

167

1.02

0.00

2.9

2.8

0.58

0.70

ug/l

0.38

Osteoporosis with pathological fracture (FG)

687

1.00

0.00

2.9

3.1

0.48

0.83

ug/l

4.92

437

Vitreous prolapse

173

0.98

0.00

3.8

3.4

0.92

0.79

ug/l

—

118

Other disorders involving the immune mechanism, not elsewhere classified

266

2665

1.00

0.00

2.7

3.1

0.93

0.72

ug/l

2.37

183

1616

Calcification and ossification of muscle

187

1.02

0.00

2.9

3.2

0.68

0.80

ug/l

0.33

122

Adrenomedullary hyperfunction

207

1.02

0.00

3.3

3.0

1.02

0.76

ug/l

0.48

135

Other degenerative diseases of the nervous system

2681

19544

1.00

0.00

3.1

3.5

0.81

0.84

ug/l

0.72

1954

13711

Benign neoplasm: Ciliary body

217

1.02

0.00

3.1

0.69

0.77

ug/l

—

143

Clubfoot

457

1.01

0.00

3.0

2.7

0.82

0.70

ug/l

0.14

240

Carcinoma in situ of lip, oral cavity and pharynx

237

1.02

0.00

2.1

3.1

0.50

0.79

ug/l

1.39

159

Other specified and unspecified disorders of choroid

253

0.99

0.00

3.3

2.9

0.60

0.73

ug/l

0.44

153

Impacted maxillary canine

165

1.03

0.00

2.6

3.4

0.95

0.85

ug/l

—

110

Narcolepsy and cataplexy

295

0.98

0.00

3.8

3.2

0.52

0.83

ug/l

2.19

179

Acute inflammation of orbit

375

0.98

0.00

3.2

2.9

0.53

0.77

ug/l

2.00

235

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

705

0.99

0.00

3.0

0.78

0.80

ug/l

0.05

434

Pigmented purpuric dermatosis

685

1.01

0.00

3.1

3.2

1.01

0.80

ug/l

0.65

436

Sequelae of poliomyelitis, including avohilmo

664

0.99

0.00

2.9

3.5

1.05

0.82

ug/l

0.81

480

Congenital malformations of pulmonary and tricuspid valves

136

1.03

0.00

2.1

2.7

0.41

0.82

ug/l

—

Tarsal tunnel syndrome

365

0.98

0.00

2.9

0.69

0.76

ug/l

0.24

232

Folate deficiency anaemia

864

0.99

0.00

3.2

3.3

0.80

0.79

ug/l

0.08

587

Systemic sclerosis,strict definition

204

0.98

0.00

2.0

2.9

0.55

0.81

ug/l

1.24

127

Benign neoplasm: Other parts of oropharynx

574

0.99

0.00

3.2

3.1

0.75

0.76

ug/l

0.03

353

Specific developmental disorder of motor function

0.98

0.00

1.5

1.3

0.41

0.46

ug/l

—

Contusion of toe(s) with damage to nail

714

0.99

0.00

2.9

3.0

0.61

0.75

ug/l

1.44

406

Effects of heat and light

535

0.99

0.00

3.6

3.1

0.62

0.76

ug/l

0.84

331

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

203

0.98

0.00

2.3

2.8

0.78

0.69

ug/l

—

116

Unspecified multiple injuries

198

1.01

0.00

3.3

2.5

0.79

0.66

ug/l

0.47

104

Chronic inflammatory disorders of orbit

185

1.03

0.00

2.3

3.0

0.59

0.70

ug/l

0.38

111

Benign neoplasm: Floor of mouth

242

0.99

0.00

4.2

2.9

0.70

0.74

ug/l

0.12

153

Pityriasis lichenoides et varioliformis acuta

106

1.05

0.00

3.1

2.9

0.43

0.86

ug/l

—

Recurrent cholesteatoma of postmastoidectomy cavity

215

0.97

0.00

3.3

0.59

0.79

ug/l

1.10

136

Maxillary prognathism

155

1.03

0.00

3.0

2.5

0.64

0.74

ug/l

—

Benign neoplasm: Lymph nodes

115

0.95

0.00

2.9

2.6

0.79

0.78

ug/l

—

Hypospadias

255

1.02

0.00

2.8

0.75

0.77

ug/l

0.04

143

Henoch-Schönlein purpura nephritis (HSPN)

235

1.03

0.00

2.3

3.0

0.65

0.78

ug/l

0.37

143

Melanocytic naevi of ear and external auricular canal

272

0.99

0.00

3.4

3.3

0.66

0.79

ug/l

0.39

188

Kaposi sarcoma, including Hilmo

136

1.04

0.00

3.6

2.8

0.69

0.78

ug/l

—

Diseases of thymus

119

1.01

0.00

2.6

3.0

0.41

0.69

ug/l

—

Traumatic spondylopathy

116

1.04

0.00

2.1

3.0

0.54

0.71

ug/l

—

Ophthalmic devices associated with adverse incidents

1.03

0.00

3.0

3.6

0.93

0.66

ug/l

—

Cleft lip, lip and palate or palate

569

1.00

0.00

2.8

2.4

0.68

0.64

ug/l

0.13

263

All dysplastic lesions of the vulva

0.00

0.0

1.0

—

Oligomenorrhoea

0.00

0.0

1.0

—

Hirsutism in women

0.00

0.0

1.0

—

Endometriosis of rectovaginal septum and vagina

0.00

0.0

1.0

—

Cyst of Bartholin Gland

0.00

0.0

1.0

—

Maternal care for cervical incompetence

0.00

0.0

1.0

—

Primary ovarian failure

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.92

-0.00

4.3

2.9

0.60

0.86

ug/l

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

-0.00

0.0

1.0

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

117

1170

1.00

-0.00

3.5

3.4

0.81

ug/l

0.01

809

Polyhydramnios

0.00

-0.00

0.0

1.1

—

Injury of nerves at hip and thigh level

250

1.00

-0.00

2.8

3.4

1.36

0.85

ug/l

0.45

166

Malignant neoplasm of tonsil and base of tongue

227

2270

1.00

-0.00

3.2

2.8

0.73

0.70

ug/l

0.28

160

1415

Shigellosis

210

1.00

-0.00

2.4

3.1

0.83

0.75

ug/l

0.13

131

Female infertility, tubal origin

0.00

-0.00

0.0

1.0

—

Congenital ovarian cysts

0.00

-0.00

0.0

1.0

—

Mucopolysaccharidosis, other/unspecified

0.00

-0.00

0.0

1.6

—

Anthrax, including avohilmo

0.00

-0.00

0.0

3.3

—

0.46

—

Other inflammation of vagina/vulva

0.00

-0.00

0.0

1.0

—

Nutritional and metabolic disorders in diseases classified elsewhere

0.00

-0.00

0.0

2.8

—

1.36

—

Whooping cough, including avohilmo

570

1.00

-0.00

3.1

2.6

0.53

0.69

ug/l

1.44

300

Other disorders of breast and lactation associated with childbirth

0.00

-0.00

0.0

1.0

—

Amenorrhoea

0.00

-0.00

0.0

1.0

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

-0.00

0.0

1.0

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

4.2

—

0.78

—

Acute hepatitis B, including avohilmo

330

1.00

-0.00

2.7

2.9

0.59

0.74

ug/l

0.56

186

Other and unspecified thalassaemias

0.98

-0.00

2.2

2.8

0.59

0.63

ug/l

—

Malignant neoplasm of bone and articular cartilage of limbs

270

1.00

-0.00

2.4

2.8

0.94

0.82

ug/l

0.26

168

Polycystic ovarian syndrome

0.00

-0.00

0.0

1.0

—

Placenta praevia

0.00

-0.00

0.0

1.1

—

Infections of breast associated with childbirth

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS